
<html lang="en"     class="pb-page"  data-request-id="19835378-843a-4ad2-88fe-4ff9b8f3ba45"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2017.60.issue-5;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.6b01840;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Structural Optimization and Pharmacological Evaluation of Inhibitors Targeting Dual-Specificity Tyrosine Phosphorylation-Regulated Kinases (DYRK) and CDC-like kinases (CLK) in Glioblastoma" /></meta><meta name="dc.Creator" content="Qingqing  Zhou" /></meta><meta name="dc.Creator" content="Athena F.  Phoa" /></meta><meta name="dc.Creator" content="Ramzi H.  Abbassi" /></meta><meta name="dc.Creator" content="Monira  Hoque" /></meta><meta name="dc.Creator" content="Tristan A.  Reekie" /></meta><meta name="dc.Creator" content="Josep S.  Font" /></meta><meta name="dc.Creator" content="Renae M.  Ryan" /></meta><meta name="dc.Creator" content="Brett W.  Stringer" /></meta><meta name="dc.Creator" content="Bryan W.  Day" /></meta><meta name="dc.Creator" content="Terrance G.  Johns" /></meta><meta name="dc.Creator" content="Lenka  Munoz" /></meta><meta name="dc.Creator" content="Michael  Kassiou" /></meta><meta name="dc.Description" content="The DYRK family contains kinases that are up-regulated in malignancy and control several cancer hallmarks. To assess the anticancer potential of inhibitors targeting DYRK kinases, we developed a se..." /></meta><meta name="Description" content="The DYRK family contains kinases that are up-regulated in malignancy and control several cancer hallmarks. To assess the anticancer potential of inhibitors targeting DYRK kinases, we developed a se..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 28, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b01840" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01840" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b01840" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01840" /></link>
        
    
    

<title>Structural Optimization and Pharmacological Evaluation of Inhibitors Targeting Dual-Specificity Tyrosine Phosphorylation-Regulated Kinases (DYRK) and CDC-like kinases (CLK) in Glioblastoma | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b01840" /></meta><meta property="og:title" content="Structural Optimization and Pharmacological Evaluation of Inhibitors Targeting Dual-Specificity Tyrosine Phosphorylation-Regulated Kinases (DYRK) and CDC-like kinases (CLK) in Glioblastoma" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01840/20170303/images/large/jm-2016-01840k_0012.jpeg" /></meta><meta property="og:description" content="The DYRK family contains kinases that are up-regulated in malignancy and control several cancer hallmarks. To assess the anticancer potential of inhibitors targeting DYRK kinases, we developed a series of novel DYRK inhibitors based on the 7-azaindole scaffold. All compounds were tested for their ability to inhibit DYRK1A, DYRK1B, DYRK2, and the structurally related CLK1. The library was screened for anticancer efficacy in established and stem cell-like glioblastoma cell lines. The most potent inhibitors (IC50 ≤ 50 nM) significantly decreased viability, clonogenic survival, migration, and invasion of glioblastoma cells. Target engagement was confirmed with genetic knockdown and the cellular thermal shift assay. We demonstrate that DYRK1A’s thermal stability in cells is increased upon compound treatment, confirming binding in cells. In summary, we present synthesis, structure–activity relationship, and efficacy in glioblastoma-relevant models for a library of novel 7-azaindoles." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b01840"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b01840">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b01840&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b01840&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b01840&amp;href=/doi/10.1021/acs.jmedchem.6b01840" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 5</span><span class="cit-fg-pageRange">, 2052-2070</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/5" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b01793" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b01846" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Structural Optimization and Pharmacological Evaluation of Inhibitors Targeting Dual-Specificity Tyrosine Phosphorylation-Regulated Kinases (DYRK) and CDC-like kinases (CLK) in Glioblastoma</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Qingqing++Zhou">Qingqing Zhou</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Athena+F.++Phoa">Athena F. Phoa</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ramzi+H.++Abbassi">Ramzi H. Abbassi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Monira++Hoque">Monira Hoque</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tristan+A.++Reekie">Tristan A. Reekie</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Josep+S.++Font">Josep S. Font</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Renae+M.++Ryan">Renae M. Ryan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-8680-4610" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Brett+W.++Stringer">Brett W. Stringer</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bryan+W.++Day">Bryan W. Day</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Terrance+G.++Johns">Terrance G. Johns</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lenka++Munoz">Lenka Munoz</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-7625-5646" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Kassiou">Michael Kassiou</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-6655-0529" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>School of Chemistry, <sup>‡</sup>School of Medical Sciences, Discipline of Pathology and Charles Perkins Centre, and <sup>§</sup>School of Medical Sciences, Discipline of Pharmacology, The University of Sydney, New South Wales 2006, Australia</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">QIMR Berghofer Medical Research Institute, 300 Herston Road, Herston, Queensland 4006, Australia</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">⊥</span> <span class="aff-text">Oncogenic Signaling Laboratory, Centre for Cancer Research, Hudson Institute of Medical Research, 27 Wright Street, Clayton, Victoria 3168, Australia</span></div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#7f131a11141e51120a1110053f0c061b111a06511a1b0a511e0a"><span class="__cf_email__" data-cfemail="7a161f14111b54170f1415003a09031e141f03541f1e0f541b0f">[email protected]</span></a>; phone: +61 2 9351 2315; fax: +61 2 8627 1606.</div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#1875717b70797d743673796b6b71776d586b617c767d61367d7c6d36796d"><span class="__cf_email__" data-cfemail="b7daded4dfd6d2db99dcd6c4c4ded8c2f7c4ced3d9d2ce99d2d3">[email protected]</span>u.au</a>; phone: +61 2 9351 2745; fax: +61 2 9351 3329.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01840&amp;href=/doi/10.1021%2Facs.jmedchem.6b01840" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 5</span><span class="cit-pageRange">, 2052–2070</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 16, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>16 December 2016</li><li><span class="item_label"><b>Published</b> online</span>28 February 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 9 March 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b01840" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01840</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2052%26pageCount%3D19%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DQingqing%2BZhou%252C%2BAthena%2BF.%2BPhoa%252C%2BRamzi%2BH.%2BAbbassi%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D5%26contentID%3Dacs.jmedchem.6b01840%26title%3DStructural%2BOptimization%2Band%2BPharmacological%2BEvaluation%2Bof%2BInhibitors%2BTargeting%2BDual-Specificity%2BTyrosine%2BPhosphorylation-Regulated%2BKinases%2B%2528DYRK%2529%2Band%2BCDC-like%2Bkinases%2B%2528CLK%2529%2Bin%2BGlioblastoma%26numPages%3D19%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2070%26publicationDate%3DMarch%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b01840"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2895</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">27</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b01840" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Structural Optimization and Pharmacological Evaluation of Inhibitors Targeting Dual-Specificity Tyrosine Phosphorylation-Regulated Kinases (DYRK) and CDC-like kinases (CLK) in Glioblastoma&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Qingqing&quot;,&quot;last_name&quot;:&quot;Zhou&quot;},{&quot;first_name&quot;:&quot;Athena&quot;,&quot;last_name&quot;:&quot;F. Phoa&quot;},{&quot;first_name&quot;:&quot;Ramzi&quot;,&quot;last_name&quot;:&quot;H. Abbassi&quot;},{&quot;first_name&quot;:&quot;Monira&quot;,&quot;last_name&quot;:&quot;Hoque&quot;},{&quot;first_name&quot;:&quot;Tristan&quot;,&quot;last_name&quot;:&quot;A. Reekie&quot;},{&quot;first_name&quot;:&quot;Josep&quot;,&quot;last_name&quot;:&quot;S. Font&quot;},{&quot;first_name&quot;:&quot;Renae&quot;,&quot;last_name&quot;:&quot;M. Ryan&quot;},{&quot;first_name&quot;:&quot;Brett&quot;,&quot;last_name&quot;:&quot;W. Stringer&quot;},{&quot;first_name&quot;:&quot;Bryan&quot;,&quot;last_name&quot;:&quot;W. Day&quot;},{&quot;first_name&quot;:&quot;Terrance&quot;,&quot;last_name&quot;:&quot;G. Johns&quot;},{&quot;first_name&quot;:&quot;Lenka&quot;,&quot;last_name&quot;:&quot;Munoz&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Kassiou&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;28&quot;,&quot;issue&quot;:&quot;5&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;2052-2070&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b01840&quot;},&quot;abstract&quot;:&quot;The DYRK family contains kinases that are up-regulated in malignancy and control several cancer hallmarks. To assess the anticancer potential of inhibitors targeting DYRK kinases, we developed a series of novel DYRK inhibitors based on the 7-azaindole scaffold. All compounds were tested for their ability to inhibit DYRK1A, DYRK1B, DYRK2, and the structurally related CLK1. The library was screened for anticancer efficacy in established and stem cell-like glioblastoma cell lines. The most potent inhibitors (IC50 ≤ 50 nM) significantly decreased viability, clonogenic survival, migration, and invasion of glioblastoma cells. Target engagement was confirmed with genetic knockdown and the cellular thermal shift assay. We demonstrate that DYRK1A’s thermal stability in cells is increased upon compound treatment, confirming binding in cells. In summary, we present synthesis, structure–activity relationship, and efficacy in glioblastoma-relevant models for a library of novel 7-azaindoles.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01840&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01840" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01840&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01840" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01840&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01840" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01840&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01840&amp;href=/doi/10.1021/acs.jmedchem.6b01840" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b01840" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b01840" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01840&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b01840%26sid%3Dliteratum%253Aachs%26pmid%3D28206758%26genre%3Darticle%26aulast%3DZhou%26date%3D2017%26atitle%3DStructural%2BOptimization%2Band%2BPharmacological%2BEvaluation%2Bof%2BInhibitors%2BTargeting%2BDual-Specificity%2BTyrosine%2BPhosphorylation-Regulated%2BKinases%2B%2528DYRK%2529%2Band%2BCDC-like%2Bkinases%2B%2528CLK%2529%2Bin%2BGlioblastoma%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D5%26spage%3D2052%26epage%3D2070%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/5" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/jmcmar.2017.60.issue-5/20170309/jmcmar.2017.60.issue-5.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01840/20170303/images/medium/jm-2016-01840k_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01840/20170303/images/large/jm-2016-01840k_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01840&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The DYRK family contains kinases that are up-regulated in malignancy and control several cancer hallmarks. To assess the anticancer potential of inhibitors targeting DYRK kinases, we developed a series of novel DYRK inhibitors based on the 7-azaindole scaffold. All compounds were tested for their ability to inhibit DYRK1A, DYRK1B, DYRK2, and the structurally related CLK1. The library was screened for anticancer efficacy in established and stem cell-like glioblastoma cell lines. The most potent inhibitors (IC<sub>50</sub> ≤ 50 nM) significantly decreased viability, clonogenic survival, migration, and invasion of glioblastoma cells. Target engagement was confirmed with genetic knockdown and the cellular thermal shift assay. We demonstrate that DYRK1A’s thermal stability in cells is increased upon compound treatment, confirming binding in cells. In summary, we present synthesis, structure–activity relationship, and efficacy in glioblastoma-relevant models for a library of novel 7-azaindoles.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43315" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43315" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Dual-specificity tyrosine phosphorylation-regulated kinases (DYRK) and CDC-like kinases (CLKs) are members of the CMGC group of proline-directed kinases, which also includes cyclin-dependent kinases (CDKs), mitogen-activated protein kinases (MAPKs), and glycogen synthase kinases (GSKs).<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> While the CDK, GSK, and MAPK signaling pathways have been extensively studied with numerous inhibitors developed, less is known about DYRK and CLK signaling, with the development of inhibitors only becoming of interest recently.</div><div class="NLM_p">The DYRK family consist of five kinases (DYRK1A, DYRK1B, DYRK2, DYRK3, and DYRK4), with DYRK1A being the most studied subtype. DYRK1A is produced as a constitutively active kinase, and its activity is controlled by subtle changes in the expression levels, in contrast to the more paradigmatic phosphorylation-regulated activation of MAPKs, CDKs, and CLKs. Increased DYRK1A expression induces phosphorylation of substrates at serine/threonine residues which modulates various pathological processes.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3, 4)</a> Most notably, the <i>DYRK1A</i> gene maps to chromosome 21 and the extra gene copy in Down syndrome individuals results in 1.5-fold increased DYRK1A expression. This alteration in DYRK1A expression levels has been correlated with structural changes and cognitive impairment in the Down syndrome population.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Furthermore, trisomy 21-mediated DYRK1A up-regulation has been linked to increased risk of childhood leukemia and early onset of Alzheimer’s disease.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a></div><div class="NLM_p">Potent ATP-competitive DYRK1A inhibitors have emerged from natural sources, such as meridianines,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> leucettine L41,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> and the alkaloid harmine (<b>1</b>; <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>), which is the most experimentally used DYRK1A inhibitor. This small β-carboline alkaloid (<b>1</b>) inhibits DYRK1A (IC<sub>50</sub> = 33–80 nM)<a onclick="showRef(event, 'ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11">(9-11)</a> and other kinases of the DYRK family; IC<sub>50</sub> values of 0.16 μM (DYRK1B), 2 μM (DYRK2), 0.41 μM (DYRK3), and 80 μM (DYRK4) have been reported.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a> From a series of analogues of the marine sponge leucettine, leucettine L41, with potent inhibition of DYRK1A (IC<sub>50</sub> = 55 nM) and CLK1 (IC<sub>50</sub> = 71 nM), was developed.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01840/20170303/images/medium/jm-2016-01840k_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01840/20170303/images/large/jm-2016-01840k_0001.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Selected DYRK1A inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01840/20170303/images/large/jm-2016-01840k_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01840&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Heterocyclic DYRK1A inhibitors not derived from natural products are represented by the benzothiazole INDY (<b>2a</b>)<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> and the 7-azaindole DANDY (<b>3a</b>)<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). <b>2a</b> is a derivative of the CLK inhibitor TG003 (<b>2b</b>),<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14, 15)</a> which inhibits DYRK1A with IC<sub>50</sub> = 240 nM, although it is equipotent at inhibiting other DYRK and CLK subtypes. The <b>3a</b>-type inhibitors remain one of the most potent DYRK1A inhibitors to date. The lead molecules in this series inhibit DYRK1A and CLK1 at low nanomolar concentrations (IC<sub>50</sub> = 3–20 nM).<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> As all DYRK1A inhibitors inhibit related kinases of the CMGC group (e.g., DYRK1B, DYRK2, CLK1, CLK4, and CDK5), efforts have been directed toward the development of selective DYRK1A inhibitors.<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a> For example, a quinolone-6-carboxylic acid based inhibitor resulted in a DYRK1A selective inhibitor which displayed a 100-fold selectivity for DYRK1A (IC<sub>50</sub> = 6 nM) over DYRK1B (IC<sub>50</sub> = 600 nM) and CLK1 (IC<sub>50</sub> = 500 nM).<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> More recent efforts developed quinazoline-2-carbimidates selective for DYRK1A and DYRK1B.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Selective inhibitors are valuable tools to probe DYRK1A pathways and could serve as leads for the development of new drugs to ameliorate the cognitive deficits in the population affected by Down syndrome.</div><div class="NLM_p">Cancer, however, is a complex disease driven by deregulation of numerous pathways, and molecularly targeted cancer therapy has greatly benefited from kinase inhibitors targeting multiple kinases. Increasing evidence suggests that DYRK and CLK kinases are overexpressed in tumors,<a onclick="showRef(event, 'ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref19 ref20 ref21">(19-21)</a> where they have been linked to the deregulation of cell cycle through various mechanisms.<a onclick="showRef(event, 'ref22 ref23 ref24 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref22 ref23 ref24 ref25 ref26">(22-26)</a> For example, DYRK1A-dependent phosphorylation of Sprouty2 blocks degradation of the epidermal growth factor receptor (EGFR)<a onclick="showRef(event, 'ref27 ref28 ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29 ref30">(27-30)</a> and favors recycling of EGFR to the cell surface to amplify cancer cell proliferation. Furthermore, DYRK1A and CLK1 are prime regulators of alternative splicing. Through this mechanism, DYRK1A and CLK1 not only increase cell proliferation<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> but also increase expression of antiapoptotic proteins Bcl-X<sub>L</sub> and Mcl-1,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> resulting in resistance to apoptotic stimuli. DYRK1B induces reversible cell arrest in a quiescent state, and inhibition of DYRK1B has been suggested to renew the cell cycle and sensitize cancer cells to chemotherapy and molecularly targeted therapy.<a onclick="showRef(event, 'ref25 ref33 ref34 ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref25 ref33 ref34 ref35 ref36">(25, 33-36)</a> Finally, DYRK kinases phosphorylate actin and tubulin, which are cytoskeletal proteins crucial for cell migration.<a onclick="showRef(event, 'ref37 ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref37 ref38 ref39">(37-39)</a> Thus, inhibition of this kinase family might be a beneficial strategy to combat proliferation and migration of cancer cells.</div><div class="NLM_p last">Herein, we describe the synthesis of novel 7-azaindole based inhibitors and pharmacological evaluation against DYRK1A, DYRK1B, DYRK2, and CLK1. We extended the structure–activity relationship (SAR) of this series of compounds by employing primarily a bioisosteric approach where we explored substitution of the phenol group at the C3 or C5 position of compound <b>3a</b> independently. Furthermore, we have chosen to evaluate these novel inhibitors in a glioblastoma-relevant model, as DYRK kinases are overexpressed in glioblastoma tumors and genetic knock-down of DYRK1A reduced tumor growth <i>in vivo</i>, suggesting that DYRK inhibitors could have therapeutic potential.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02466" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02466" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Synthesis</h3><div class="NLM_p">The synthesis of <b>3a</b> followed the published method<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> starting from 5-bromo-7-azaindole (<b>4a</b>) (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Regioselective iodination at the 3-position with <i>N</i>-iodosuccinimide afforded <b>5a</b> followed by <i>p</i>-toluenesulfonyl (tosyl) protection to give <b>6a</b>. Suzuki cross-coupling at both halide positions afforded the diaryl compound <b>7a</b>, which could then be deprotected, first by removing the tosyl group to give <b>8a</b>, followed by demethylation affording the lead compound <b>3a</b>. We then generated a library of <b>3a</b> analogues. Initial investigations focused on the 7-azaindole core and what changes could be tolerated. The indole and indazole based compounds, <b>3b</b> and <b>3c</b>, respectively, were prepared in an analogous manner to <b>3a</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01840/20170303/images/medium/jm-2016-01840k_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01840/20170303/images/large/jm-2016-01840k_0006.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Route of Diphenol–Azaindole Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01840/20170303/images/large/jm-2016-01840k_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01840&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) NIS (1.0 equiv), KOH (0.5 equiv), CH<sub>2</sub>Cl<sub>2</sub>, RT, 10 h; (ii) NaH (60% in mineral oil, 3.0 equiv), TsCl (1.2 equiv), BnEt<sub>3</sub>NCl (0.02 equiv), CH<sub>2</sub>Cl<sub>2</sub>, 0 to RT, 30 min; 80–89% over two steps; (iii) arylboronic acid (2.0 equiv), Pd(PPh<sub>3</sub>)<sub>4</sub> (4 mol %), K<sub>2</sub>CO<sub>3</sub> 2 M (4.0 equiv), toluene/EtOH 3:1, 100 °C, 3.5 h, 84–87%; (iv) KOH (5.0 equiv), MeOH, 80 °C, 2 h, 91–95%; (v) BBr<sub>3</sub> (6.0 equiv), CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to RT, 15 h, 58–65%. NIS = <i>N</i>-iodosuccinimide.</p></p></figure><div class="NLM_p">Next, we focused on the modification of the phenol group at the C3 or C5 position of the azaindole scaffold, utilizing the key intermediate <b>6a</b>. Sequential Suzuki cross-coupling reactions<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40, 41)</a> were employed to first afford <b>7d</b>–<b>g</b>, and then the desired diaryl-substituted compounds <b>8d</b>–<b>i</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). Hydrolysis of the tosyl group under basic conditions resulted in compounds <b>9a</b>–<b>c</b> and <b>9e</b>–<b>g</b>. The desired compounds <b>8j</b>–<b>k</b> were realized by cyclization<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> of the benzonitriles <b>8f</b> or <b>8i</b>, respectively, with TMSN<sub>3</sub> under microwave conditions followed by hydrolysis of the tosyl group. The nitro-substituted compounds <b>9a</b> and <b>9e</b> were reduced in the presence of iron powder under acidic conditions to afford anilines <b>9d</b> and <b>9h</b>, respectively. Further modifications were performed on the newly formed aniline <b>9h</b> by acetylation<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> or sulfonylamide formation<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> with treatment of acetic anhydride in acetic acid or with methanesulfonyl chloride in H<sub>2</sub>O to afford <b>10a</b> and <b>10b</b>, respectively. Compound <b>10c</b> was also obtained in 70% yield from urea and catalyzed by iodine and citric acid in mannitol.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a></div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01840/20170303/images/medium/jm-2016-01840k_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01840/20170303/images/large/jm-2016-01840k_0007.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Route of Aryl-Azaindole Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01840/20170303/images/large/jm-2016-01840k_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01840&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) arylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub> (2 mol %), K<sub>2</sub>CO<sub>3</sub> 2 M (2.0 equiv), toluene/EtOH 3:1, 90 °C, 3–5 h, 78–85%; (ii) arylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub> (2 mol %), K<sub>2</sub>CO<sub>3</sub> 2 M (2.0 equiv), toluene/EtOH 3:1, 110 °C, 3–5 h, 80–93%; (iii) TBAF, TMSN<sub>3</sub>, sodium ascorbate, CuSO<sub>4</sub>·5H<sub>2</sub>O, <i>t</i>BuOH/H<sub>2</sub>O, 1:1 (v/v), MW (100 w, 80 °C), 2 h, 81–83%; (iv) KOH, MeOH, 80 °C, 2 h, 90–95%; (v) Fe powder (10.0 equiv), HCl (3 N solution in water, 0.03 M), 110 °C, 3 h, 70–84%; (vi) Ac<sub>2</sub>O (1.2 equiv), AcOH, 110 °C, 5 h, 77%; (vii) methanesulfonyl chloride (1.5 equiv), H<sub>2</sub>O, RT, 10 h, 64%; (viii) urea (15.0 equiv), I<sub>2</sub> (0.1 equiv), citric acid, mannitol, 80 °C, 6 h, 70%.</p></p></figure><div class="NLM_p">To investigate diverse skeletons with different geometries and increased spatial flexibility, we added a linker between the 7-aza-indole core and the phenol group and varied the phenol substitution, resulting in compounds <b>17a</b>–<b>b</b> and <b>21a</b>–<b>b</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). The 5-carboxamide <b>17a</b>–<b>b</b> could be easily prepared from <b>4a</b>, the same starting material used previously, which was first protected with the tosyl group, followed by the formation of the 5-carboxylic acid <b>12</b> by palladium-catalyzed carboxylation using freshly made acetic-formic anhydride.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> The resulting acid underwent HBTU amide coupling with aniline derivative <b>13a</b> or <b>13b</b> to afford compounds <b>14a</b>–<b>b</b> in comparable yield.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Concomitant deprotection of the tosyl and TBS groups gave compounds <b>15a</b>–<b>b</b>,<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> which, followed by iodination at the C3 position with I<sub>2</sub> and KOH,<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> gave compounds <b>16a</b>–<b>b</b>. The final compounds <b>17a</b>–<b>b</b> could then be easily obtained by a standard Suzuki cross-coupling reaction. Similarly, compounds <b>21a</b>–<b>b</b> could be obtained by again starting with <b>4a</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>), first by acylation with trichloroacetyl chloride<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> followed by hydrolysis to afford carboxylic acid <b>18</b>. Subsequent amide formation with <b>13a</b>–<b>b</b> afforded <b>19a</b>–<b>b</b>, which, followed by Suzuki-coupling, gave <b>20a</b>–<b>b</b>. Final compounds <b>21a</b>–<b>b</b> were obtained in high yield after the TBAF induced deprotection of the TBS group.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a></div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01840/20170303/images/medium/jm-2016-01840k_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01840/20170303/images/large/jm-2016-01840k_0008.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Further Modification for Lead Compound <b>3a</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01840/20170303/images/large/jm-2016-01840k_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01840&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) tosyl chloride (1.2 equiv), NaH (1.5 equiv), THF, 0 °C, 1 h, 90%; (ii) Pd(OAc)<sub>2</sub> (5 mol %), dppf (10 mol %), acetic–formic anhydride (5.0 equiv), DIPEA (5.0 equiv), DMF, 110 °C, 5 h, 83%; (iii) HBTU (1.2 equiv), DIPEA (2.5 equiv), aniline <b>13a</b> or <b>13b</b> (1.1 equiv), DMSO, 0 to RT, 2 h, 61–79%; (iv) KOH (5.0 equiv), MeOH, 80 °C, 1 h, 94–96%; (v) I<sub>2</sub> (1.2 equiv), KOH (3.0 equiv), DMF, RT, 8 h, 80–86%; (vi) arylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub> (2 mol %), K<sub>2</sub>CO<sub>3</sub> 2 M (2.0 equiv), toluene/EtOH 3:1, 100 °C, 3–5 h, 60–65%; (vii) trichloroacetyl chloride (1.2 equiv), AlCl<sub>3</sub> (2.5 equiv), 0 °C, 3 h; (viii) NaOH (3 M), RT, 5 h, 70% over two steps; (ix) TBAF (1.5 equiv), THF, RT, 30 min, 93–95%. DIPEA = <i>N,N</i>-diisopropylethylamine, dppf = 1,1′-ferrocenediyl-bis(diphenylphosphine), HBTU = (2-(1<i>H</i>-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate), TBAF = <i>tetra</i>-<i>n</i>-butylammonium fluoride, OTBS = <i>tert</i>-butyldimethylsilyl ether.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Structure–Actvity Relationship</h3><div class="NLM_p">New derivatives were tested for their potency to inhibit DYRK1A, DYRK1B, DYRK2, and CLK1. Kinase assays were performed with Woodtide as a substrate for DYRK kinases and RS peptide as a substrate for CLK1. ATP concentration (100 μM) was kept constant to allow comparison of potencies across the kinases. In our hands, harmine (<b>1</b>) and the lead analogue <b>3a</b> inhibited DYRK1A with IC<sub>50</sub> of 360 and 14 nM, respectively. Inhibitor <b>3a</b> showed comparable potencies against DYRK1B (15 nM) and CLK1 (48 nM), but it was 10-fold less potent at inhibiting DYRK2 (166 nM, <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Replacement of the azaindole with indole (<b>3b</b>) or benzimidazole (<b>3c</b>) led to the loss of kinase inhibition (>1 μM).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Kinase Inhibition and Cellular Efficacy of <b>3a</b>–<b>c</b> and C3-Modified Analogues <b>9b</b>–<b>d</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01840/20170303/images/medium/jm-2016-01840k_0009.gif" alt="" id="fx1" /></img><div></div></div><div class="NLM_p">Next, we tested how modification of the phenol at the C3 position affects kinase inhibition. Bioisosteric replacement of the phenol moiety with indole (<b>9b</b>) resulted in 10-fold weaker DYRK1A inhibition (169 nM), and comparable loss of activity was observed against DYRK1B (83 nM), DYRK2 (571 nM), and CLK1 (117 nM). Substitution of phenol for a phenyltetrazole moiety at C3 as seen in <b>9c</b> further reduced kinase inhibition activity (85–280 nM), and the aniline analogue (<b>9d</b>) resulted in complete loss of kinase inhibition (>1 μM).</div><div class="NLM_p">Based on this SAR, we retained the 7-azaindole core and C3 phenol, but diversified substitution on C5 (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). 4-Nitrophenyl (<b>9e</b>) and indole (<b>9f</b>) analogues showed weaker DYRK1A inhibition (212 and 204 nM, respectively). Interestingly, indole-analogue <b>9f</b> was more potent at inhibiting DYRK1B (51 nM) and CLK1 (26 nM). Analogues with phenyltetrazole (<b>9g</b>), aniline (<b>9h</b>), sulfonamide (<b>10b</b>), or urea (<b>10c</b>) in the para-position of the C5 phenyl inhibited DYRK1A with IC<sub>50</sub> in double-digit nanomolar potency (31–86 nM). Comparable nanomolar potency was determined for these inhibitors against DYRK1B and CLK1, and approximately 10-fold higher IC<sub>50</sub> values were calculated from the DYRK2 inhibition assay. The introduction of phenylacetamide at C5 (<b>10a</b>) led to the strongest DYRK1A inhibition (6.6 nM), with 5-fold selectivity over DYRK1B (38 nM) and CLK1 (35 nM), and 80-fold selectivity over DYRK2 (536 nM).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Kinase Inhibition and Cellular Efficacy of C5 Analogues</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01840/20170303/images/medium/jm-2016-01840k_0010.gif" alt="" id="fx3" /></img><div></div></div><div class="NLM_p">In the final series (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>), we explored the effect of an amide linker at position C3 or C5 on kinase inhibition. In line with results obtained with C3 modified analogues <b>9b</b>–<b>d</b>, the introduction of an amide linker into the C3 position (<b>21a</b> and <b>21b</b>) resulted in loss of kinase inhibition (all IC<sub>50</sub> > 1 μM). The same modification at the position C5 was better tolerated; however, analogues <b>17a</b> and <b>17b</b> inhibited DYRK1A with higher IC<sub>50</sub> values (344 and 127 nM, respectively). The finding that C3-modified analogues failed to inhibit all kinases underlines the importance of the C3 phenolic group attached to the 7-azaindole core. The C5 position, however, offered scope for improvement of activity and yielded analogues <b>9h</b> and <b>10a</b> with low nanomolar potency.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Kinase Inhibition and Cellular Efficacy of Analogues with an Amide Linker</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01840/20170303/images/medium/jm-2016-01840k_0011.gif" alt="" id="fx5" /></img><div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Cell-Based Screening</h3><div class="NLM_p">Glioblastoma is a heterogeneous cancer with great variability between patients and even within the same patient. Glioblastoma tumors have been subclassified into four molecular subtypes—classical, proneural, neural, and mesenchymal.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> Each subtype is characterized by distinct molecular traits; however, the established glioblastoma cell lines inadequately mirror genotypes and phenotypes seen in glioblastoma patients. Accordingly, we observed that the established U251 and A172 glioblastoma cell lines express higher quantities of DYRK1A than the patient-derived glioblastoma cell lines RN1, JK2, WK1, and SJH1 (<a class="ref internalNav" href="#fig1a" aria-label="Figure 2">Figure 2</a>A). As DYRK1A activity correlates with the protein quantity, higher DYRK1A quantity (thus higher DYRK1A activity) in the established glioblastoma cells could render these cells more sensitive to DYRK1A inhibition; however, this would not be clinically relevant. Furthermore, DYRK1B, DYRK2, and CLK1 expression pattern in patient-derived glioblastoma cells also differs from the profile of U251 and A172 cells (<a class="ref internalNav" href="#fig1a" aria-label="Figure 2">Figure 2</a>A). With the exception of SJH1 cells that express only DYRK1A, the RN1, WK1, and JK2 cells express also DYRK1B, DYRK2, and CLK1—albeit to a lesser degree than DYRK1A expression. We have therefore chosen to screen all inhibitors in patient-derived glioblastoma cells. These cells were grown as stem cells under defined conditions in order to maintain the phenotype and genotype of the primary resected tumors (<a class="ref internalNav" href="#fig1a" aria-label="Figure 2">Figure 2</a>B).<a onclick="showRef(event, 'ref53 ref54 ref55'); return false;" href="javascript:void(0);" class="ref ref53 ref54 ref55">(53-55)</a> Viability of cells treated with test compounds was determined in the Alamar blue assay (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>–<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>).</div><figure id="fig1a" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01840/20170303/images/medium/jm-2016-01840k_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01840/20170303/images/large/jm-2016-01840k_0002.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Expression of DYRK/CLK1 kinases and genotype of patient-derived glioblastoma cell lines. (A) Cell lysates of untreated cells were analyzed with Western blotting using indicated antibodies (representative image of two independent blots). (B) Subtype and genotype of patient-derived glioblastoma cell lines RN1, JK2, WK1, and SJH1 as previously described.<a onclick="showRef(event, 'ref54 ref55'); return false;" href="javascript:void(0);" class="ref ref54 ref55">(54, 55)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01840/20170303/images/large/jm-2016-01840k_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01840&amp;id=fig1a"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The lead compound <b>3a</b> reduced the viability of RN1 cells with EC<sub>50</sub> of 2.0 μM (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). The two most potent kinase inhibitors developed in this study, compounds <b>9h</b> and <b>10a</b>, reduced RN1 viability with 1.1 μM and 2.1 μM potency, respectively (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Compounds <b>10b</b> and <b>10c</b>, inhibiting DYRK1A, DYRK1B, DYRK2, and CLK1 with potencies (9.6–724 nM) comparable to <b>9h</b>, were 13-fold less efficacious in the cell viability assays (EC<sub>50</sub> > 13 μM) compared to <b>9h</b> (EC<sub>50</sub> = 1.1 μM). This reduction in efficacy could arise from the increased polarity and reduced cell membrane permeability; however, off-target effects could also be playing a role. For the remaining compounds, cellular efficacy correlated with the potency in the kinase inhibition assay.</div><div class="NLM_p">For example, compounds <b>10b</b> and <b>17b</b> with nanomolar kinase inhibition activity (IC<sub>50</sub> = 26–644 nM) reduced RN1 viability with midrange micromolar potency (EC<sub>50</sub> > 10 μM), whereas compounds lacking kinase inhibition activity, e.g. <b>3b</b>, <b>9d</b>, and <b>21b</b> (IC<sub>50</sub> > 1 μM) were not cytotoxic to RN1 cancer cells up to 50 μM (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a> and <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>).</div><div class="NLM_p last">This trend in SAR was also observed in WK1, JK2, and SJH1 cells, and DYRK1A inhibition activity correlated with the cellular efficacies (R = 0.71, 0.63, 0.60, and 0.69 for DYRK1A (IC<sub>50</sub>) vs RN1, WK1, JK, and SJH1 (EC<sub>50</sub>), respectively; Spearman correlation). The most efficacious compounds across all cell lines were compounds <b>9h</b> and <b>10a</b>, with the classical RN1 and mesenchymal WK1 cells being most responsive to these inhibitors (EC<sub>50</sub> = 0.9–2.1 μM). Viability of the neural SJH1 and proneural JK2 cell lines was reduced by <b>9h</b> and <b>10a</b>, with the EC<sub>50</sub> values ranging 3.2–8.6 μM.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Cell-Based Functional Evaluation</h3><div class="NLM_p">To evaluate the most potent inhibitors further, we tested analogues <b>9h</b> and <b>10a</b> in several cell-based assays. As a negative control, we employed analogue <b>9d</b>, which lacks the kinase inhibition activity and was not cytotoxic to primary cells (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Accordingly, analogue <b>9d</b> did not reduce the viability of the established A172 and U251 glioblastoma cell lines (EC<sub>50</sub> > 50 μM), whereas <b>9h</b> and <b>10a</b> decreased A172 and U251 viability with efficacies ranging 1.6–4.6 μM.</div><div id="sec2_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13"> Cellular Thermal Shift Assay (CETSA)</h4><div class="NLM_p">To demonstrate target engagement in cells, compound <b>9h</b> was assessed for its ability to penetrate cells and bind to DYRK1A in a manner that was independent of a phenotypic end point (i.e., reduced cell viability). For this, we used a cellular thermal shift assay (CETSA)<a onclick="showRef(event, 'ref56 ref57'); return false;" href="javascript:void(0);" class="ref ref56 ref57">(56, 57)</a> to assess DYRK1A engagement in U251 cells, as this cell line expresses high quantities of DYRK1A. In brief, U251 cells were treated with analogue <b>9h</b> (10 μM) and cell suspensions were heated to different temperatures to induce protein denaturation. Soluble proteins were extracted with an aqueous buffer and analyzed with Western blotting. Inhibitors that bind to their cognate target in cells would yield a stabilized protein, which will be detected at higher temperatures compared to the denaturation profile in cells without drug treatment. Indeed, <b>9h</b> efficiently stabilized DYRK1A, but not p38α MAPK (<a class="ref internalNav" href="#fig2" aria-label="Figure 3">Figure 3</a>A–B), validating that this inhibitor binds to cellular DYRK1A and most likely the related DYRK1B, DYRK2, and CLK1 kinases, whereas the stability of the structurally unrelated p38α MAPK was not affected by <b>9h</b>. To investigate <b>9h</b> concentration effects, we derived the isothermal dose–response fingerprint (ITDRF<sub>CETSA</sub>), which is a characteristic ligand-induced protein stabilization at a constant temperature. In this experiment, the DYRK1A biochemical potency of <b>9h</b> (IC<sub>50</sub> = 43 nM) translated well into its cellular target engagement (ITDFR<sub>CETSA</sub> = 711 nM; <a class="ref internalNav" href="#fig2" aria-label="Figure 3">Figure 3</a>C–D).</div><figure id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01840/20170303/images/medium/jm-2016-01840k_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01840/20170303/images/large/jm-2016-01840k_0003.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Treatment of U251 cells with inhibitor 9h stabilizes DYRK1A and decreases cell viability. CETSA melt curves (40–67 °C) for DYRK1A and p38α (A) and quantification (mean ± SEM) of three independent experiments (B) were determined in intact U251 cells treated with compound <b>9h</b> (1 h, 10 μM). Representative image (C) and quantification (mean ± SEM) of two independent experiments (D) of ITDRF<sub>CETSA</sub> in intact U251 cells treated with compound <b>9h</b> (0–20 μM, 1 h) at 54 °C.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01840/20170303/images/large/jm-2016-01840k_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01840&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> EGFR Degradation</h4><div class="NLM_p">To further confirm DYRK1A inhibition in cells treated with <b>9h</b>, we performed a EGFR degradation assay. EGF binding to EGFR induces dimerization and mutual phosphorylation. The phosphorylated EGFR dimer activates signaling pathways to stimulate cell proliferation. EGFR dimerization also triggers endocytosis and lysosomal degradation of EGFR. DYRK1A overexpression has been shown to block this pathway of EGFR degradation, resulting in a longer half-life of the EGFR protein.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Thus, in cells where DYRK1A is inhibited, EGFR is expected to degrade at a faster rate compared to untreated cells. We therefore tested <b>9h</b> for its ability to increase EGFR degradation in U251 cells. EGFR protein translation was blocked with cyclohexamide, and EGFR degradation was induced with EGF (100 ng/mL). Cell lysates were collected at indicated time points and the amount of nondegraded EGFR quantified by Western blotting (<a class="ref internalNav" href="#fig3" aria-label="Figure 4">Figure 4</a>A). The basal EGFR half-life (<i>t</i><sub>1/2</sub>) in untreated U251 cells was 25.6 ± 7.6 min. Pretreatment of cells with <b>9h</b> (2.5 μM) reduced the EGFR half-life to 11.3 ± 2.5 min (<a class="ref internalNav" href="#fig3" aria-label="Figure 4">Figure 4</a>B). Importantly, a similar effect was observed with genetic knock-down of DYRK1A. Using the <i>si</i>RNA approach, we achieved on average 80% reduction in DYRK1A expression (<a class="ref internalNav" href="#fig3" aria-label="Figure 4">Figure 4</a>C), and this DYRK1A down-regulation reduced the EGFR half-life to 3.3 ± 2.5 min (<a class="ref internalNav" href="#fig3" aria-label="Figure 4">Figure 4</a>D).</div><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01840/20170303/images/medium/jm-2016-01840k_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01840/20170303/images/large/jm-2016-01840k_0004.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. DYRK1A inhibition induces EGFR degradation. (A) U251 cells were treated with DMSO (Ctr) or compound <b>9h</b> (2.5 μM) for 4 h. Cells were incubated with cycloheximide (30 μg/mL; 1 h), and EGF (100 ng/mL) was added for the indicated time points. (B) U251 cells were treated with scramble (Ctr) or DYRK1A-targeting <i>si</i>RNa for 24 h. Cells were incubated with cycloheximide (30 μg/mL; 1 h), and EGF (100 ng/mL) was added for the indicated time points. Cell lysates were analyzed by Western blotting using indicated antibodies. (C and D) EGFR levels were normalized to loading control (β-actin) and are expressed as percentage of untreated cells (0 min). Half-life (<i>t</i><sub>1/2</sub>) values were calculated by nonlinear regression analysis and represent mean ± SEM from three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01840/20170303/images/large/jm-2016-01840k_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01840&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> Clonogenic Survival</h4><div class="NLM_p">Based on kinase inhibition <i>in vitro</i> and in cells, we evaluated compounds <b>9h</b> and <b>10a</b> for their ability to reduce long-term survival of glioblastoma cells. Compounds <b>9h</b> and <b>10a</b> dose-dependently inhibited the clonogenic survival of RN1 with EC<sub>50</sub> values of 0.8 and 2.1 μM (<a class="ref internalNav" href="#fig4" aria-label="Figure 5">Figure 5</a>A–B), respectively, mirroring the EC<sub>50</sub> values obtained in the short term viability assay (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Compound <b>9h</b> was more efficacious at reducing the survival of the established U251 cell line (EC<sub>50</sub> = 0.18 μM, <a class="ref internalNav" href="#fig4" aria-label="Figure 5">Figure 5</a>C).</div><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01840/20170303/images/medium/jm-2016-01840k_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01840/20170303/images/large/jm-2016-01840k_0005.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Clonogenic survival following drug treatment. Patient-derived RN1 glioblastoma cells were treated with <b>9h</b> (A) or <b>10a</b> (B) for 10 days. Established U251 glioblastoma cells were treated with <b>9h</b> (C) for 10 days. Colonies were fixed, stained with Toluidine Blue, and counted using the ImageJ software. Data were normalized to vehicle-treated controls (set as 100% survival) and EC<sub>50</sub> values calculated by nonlinear regression analysis. EC<sub>50</sub> values represent mean ± SEM from three independent experiments performed in duplicate. One-way ANOVA, followed by Dunnett’s multiple comparison test, was used to determine statistical significance. (* <i>P</i> < 0.05, *** <i>P</i> < 0.001, **** <i>P</i> < 0.0001 in relation to vehicle-treated cells).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01840/20170303/images/large/jm-2016-01840k_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01840&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">As numerous kinase inhibitors, including inhibitors targeting DYRK1B,<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> directly bind tubulin and act as tubulin inhibitors, we tested compounds <b>9h</b> and <b>10a</b> together with the inactive analogue <b>9d</b> for their potential effect on tubulin polymerization <i>in vitro</i>. None of the tested compounds altered the rate of tubulin polymerization, whereas the tubulin-targeting agents paclitaxel and vinblastine changed the rate of tubulin polymerization in agreement with their established mechanism of action (data not shown).</div></div><div id="sec2_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> Migration and Invasion</h4><div class="NLM_p">We assessed <b>9h</b> and <b>10a</b>, together with the inactive structural analogue <b>9d</b>, using <i>in vitro</i> assays of cell migration and invasion (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). In the migration assay, the movement across the wound is measured, whereas, in the invasion assay, the motility through the wound coated with Matrigel is measured. We employed U251, A172, and RN1 cell lines, all of which show high basal velocity (υ) of migration (υ > 2,000 μm/h) and invasion (υ > 1,000 μm/h). The inhibitor <b>9h</b> potently reduced migration of A172, U251, and RN1 cells, with more than 75% inhibition of migration reached at 5 μM concentration (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). This inhibitor also blocked invasiveness of A172 and U251 cells in a dose-dependent manner (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). Similar effects were observed across all assays with the analogue <b>10a</b>, whereas the inactive analogue <b>9d</b> that lacks DYRK/CLK kinase inhibition activity (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) was ineffective in the migration and invasion assays (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Inhibition of Migration and Invasion of Glioblastoma Cells by CMGC Inhibitors <b>9h</b> and <b>10a</b>, and Inactive Analogue <b>9d</b><a class="ref internalNav" href="#tbl4-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char=" " /></col><col align="char" char=" " /></col><col align="char" char=" " /></col><col align="char" char=" " /></col><col align="char" char=" " /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."><b>Conc</b> (μM)</th><th class="colsep0 rowsep0" align="center" char=" "><b>U251 migration</b> (ύ, μm/h)</th><th class="colsep0 rowsep0" align="center" char=" "><b>U251 invasion</b> (ύ, μm/h)</th><th class="colsep0 rowsep0" align="center" char=" "><b>A172 migration</b> (ύ, μm/h)</th><th class="colsep0 rowsep0" align="center" char=" "><b>A172 invasion</b> (ύ, μm/h)</th><th class="colsep0 rowsep0" align="center" char=" "><b>RN1 migration</b> (ύ, μm/h)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="4" align="left"><b>9h</b></td><td class="colsep0 rowsep0" align="char" char=".">0.0</td><td class="colsep0 rowsep0" align="char" char=" ">2,163 ± 133</td><td class="colsep0 rowsep0" align="char" char=" ">1,337 ± 93</td><td class="colsep0 rowsep0" align="char" char=" ">3,123 ± 103</td><td class="colsep0 rowsep0" align="char" char=" ">2,659 ± 674</td><td class="colsep0 rowsep0" align="char" char=" ">1,174 ± 158</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="char" char=" ">1,247 ± 176</td><td class="colsep0 rowsep0" align="char" char=" ">1,139 ± 112</td><td class="colsep0 rowsep0" align="char" char=" ">2,828 ± 271</td><td class="colsep0 rowsep0" align="char" char=" ">2,675 ± 475</td><td class="colsep0 rowsep0" align="char" char=" ">355 ± 28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">5.0</td><td class="colsep0 rowsep0" align="char" char=" ">127 ± 56</td><td class="colsep0 rowsep0" align="char" char=" ">234 ± 22</td><td class="colsep0 rowsep0" align="char" char=" ">728 ± 308</td><td class="colsep0 rowsep0" align="char" char=" ">1,538 ± 696</td><td class="colsep0 rowsep0" align="char" char=" ">118 ± 43</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">10.0</td><td class="colsep0 rowsep0" align="char" char=" ">129 ± 52</td><td class="colsep0 rowsep0" align="char" char=" ">–149 ± 12</td><td class="colsep0 rowsep0" align="char" char=" ">131 ± 129</td><td class="colsep0 rowsep0" align="char" char=" ">714 ± 585</td><td class="colsep0 rowsep0" align="char" char=" ">208 ± 77</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="4" align="left"><b>10a</b></td><td class="colsep0 rowsep0" align="char" char=".">0.0</td><td class="colsep0 rowsep0" align="char" char=" ">2,159 ± 48</td><td class="colsep0 rowsep0" align="char" char=" ">1,710 ± 97</td><td class="colsep0 rowsep0" align="char" char=" ">2,739 ± 428</td><td class="colsep0 rowsep0" align="char" char=" ">3,047 ± 506</td><td class="colsep0 rowsep0" align="char" char=" ">1,115 ± 110</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="char" char=" ">1,125 ± 93</td><td class="colsep0 rowsep0" align="char" char=" ">736 ± 117</td><td class="colsep0 rowsep0" align="char" char=" ">2,891 ± 147</td><td class="colsep0 rowsep0" align="char" char=" ">2,731 ± 431</td><td class="colsep0 rowsep0" align="char" char=" ">332 ± 33</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">5.0</td><td class="colsep0 rowsep0" align="char" char=" ">173 ± 38</td><td class="colsep0 rowsep0" align="char" char=" ">34 ± 153</td><td class="colsep0 rowsep0" align="char" char=" ">2,296 ± 564</td><td class="colsep0 rowsep0" align="char" char=" ">2,027 ± 419</td><td class="colsep0 rowsep0" align="char" char=" ">210 ± 64</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">10.0</td><td class="colsep0 rowsep0" align="char" char=" ">111 ± 1</td><td class="colsep0 rowsep0" align="char" char=" ">–118 ± 37</td><td class="colsep0 rowsep0" align="char" char=" ">651 ± 300</td><td class="colsep0 rowsep0" align="char" char=" ">1,718 ± 517</td><td class="colsep0 rowsep0" align="char" char=" ">196 ± 47</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="4" align="left"><b>9d</b></td><td class="colsep0 rowsep0" align="char" char=".">0.0</td><td class="colsep0 rowsep0" align="char" char=" ">2,653 ± 395</td><td class="colsep0 rowsep0" align="char" char=" ">1,151 ± 133</td><td class="colsep0 rowsep0" align="char" char=" ">2,650 ± 675</td><td class="colsep0 rowsep0" align="char" char=" ">2,990 ± 997</td><td class="colsep0 rowsep0" align="char" char=" ">937 ± 17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="char" char=" ">2,331 ± 143</td><td class="colsep0 rowsep0" align="char" char=" ">1,451 ± 69</td><td class="colsep0 rowsep0" align="char" char=" ">3,123 ± 745</td><td class="colsep0 rowsep0" align="char" char=" ">2,411 ± 241</td><td class="colsep0 rowsep0" align="char" char=" ">1,070 ± 246</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">5.0</td><td class="colsep0 rowsep0" align="char" char=" ">2,370 ± 39</td><td class="colsep0 rowsep0" align="char" char=" ">1,481 ± 181</td><td class="colsep0 rowsep0" align="char" char=" ">3,065 ± 718</td><td class="colsep0 rowsep0" align="char" char=" ">2,232 ± 498</td><td class="colsep0 rowsep0" align="char" char=" ">929 ± 253</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">10.0</td><td class="colsep0 rowsep0" align="char" char=" ">2,702 ± 239</td><td class="colsep0 rowsep0" align="char" char=" ">1,380 ± 73</td><td class="colsep0 rowsep0" align="char" char=" ">2,827 ± 709</td><td class="colsep0 rowsep0" align="char" char=" ">2,707 ± 491</td><td class="colsep0 rowsep0" align="char" char=" ">791 ± 236</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl4-fn1"><div class="footnote" id="tbl4-fn1"><sup>a</sup><p class="last">Values represent mean ± SEM from three independent experiments.</p></div></div></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07520" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07520" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">DYRK1B and DYRK2 have been recently implicated in the progression of various cancers;<a onclick="showRef(event, 'ref33 ref37'); return false;" href="javascript:void(0);" class="ref ref33 ref37">(33, 37)</a> however, the therapeutic potential of simultaneously targeting DYRK kinases has not been evaluated. The hypothesis that inhibition of the DYRK protein family would have anticancer efficacy was tested in this study, with glioblastoma being an example of a tumor type where a strong response might be expected. Glioblastoma cells up-regulate DYRK1A, and the link between DYRK1A overexpression and glioblastoma pathogenesis has been established <i>in vivo</i>.<a onclick="showRef(event, 'ref3 ref27'); return false;" href="javascript:void(0);" class="ref ref3 ref27">(3, 27)</a> To address the therapeutic potential of simultaneously targeting DYRK kinases, all of which are variously expressed in glioblastoma subtypes, a series of potent and cell-active DYRK inhibitors have been developed and profiled in biochemical and glioblastoma cell-based models.</div><div class="NLM_p">While others have concentrated on the development of selective DYRK1A inhibitors,<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17, 18)</a> our goal was to understand SAR across the DYRK family. Using compounds within and across series that exhibit a full spectrum of potencies, we demonstrate that the SAR established for inhibition of DYRK1A is nearly identical to that for DYRK1B inhibition. This observation is not surprising, as these two DYRK isoforms share a high degree of homology, with only one amino acid difference in the ATP binding pocket.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> However, while the 7-azaindole-based scaffold explored in this study offers little opportunity for developing selective DYRK1A inhibitors, quinolone-6-carboxylic acid derivatives have been developed into highly selective DYRK1A inhibitors,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> demonstrating that, within the CMGC family of protein kinases, selective inhibition of DYRK1A is possible. Numerous DYRK1A inhibitors potently bind to and inhibit the related CLK family kinases,<a onclick="showRef(event, 'ref13 ref60'); return false;" href="javascript:void(0);" class="ref ref13 ref60">(13, 60)</a> and this has also been demonstrated in our study. The potency of tested analogues to inhibit DYRK1A and DYRK1B activity was comparable to the potency of inhibitors against CLK1, with the exception of compound <b>10c</b>, which inhibited CLK1 with >2-fold higher potency than DYRK1A/B. Nevertheless, CLK1 inhibition offers a therapeutic advantage, as alternative splicing driven by excessive CLK1 activity drives numerous hallmarks of cancer.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Finally, all inhibitors inhibited DYRK2 with >10-fold higher IC<sub>50</sub> values.</div><div class="NLM_p">To address the clinical potential of these novel DYRK inhibitors, their cellular efficacy was assessed in patient-derived glioblastoma cells. Our screening platform considers both the diversity between patients and the heterogeneity of cells within a patient, and it allowed us to identify not only the most efficacious inhibitors from the series, but also the glioblastoma subtype most sensitive to the inhibition of the DYRK and CLK family of kinases. We established a correlation between biochemical and cellular activities across the series, and confirmed that the antiproliferative activity is not a result of a tubulin targeting effect. However, the role of other kinases and nonkinase targets cannot be completely discounted, as the proteome profile of the lead inhibitors is unknown at this stage of the project (?). Nevertheless, the most potent DYRK/CLK inhibitors attenuated viability of glioblastoma cells with low micromolar potency; and RN1 and WK1 cells were most sensitive to inhibitors <b>9h</b> and <b>10a</b>. These two cell lines represent the classical (60%) and mesenchymal (13%) glioblastoma tumors, respectively; thus, our data suggests that DYRK/CLK-targeted therapy could be beneficial for the majority of patients diagnosed with glioblastoma.</div><div class="NLM_p">To further demonstrate the anticancer potential, inhibitor <b>9h</b> was evaluated in the EGFR degradation, clonogenic cell survival, migration, and invasion assays. In all assays, compound <b>9h</b> was efficacious in the low micromolar range. Although the cellular efficacy and biochemical IC<sub>50</sub> values differ, several factors must be taken into consideration when translating the potency values obtained in kinase inhibition assays to the activity of inhibitors in cells. First, kinase inhibition assays are performed with recombinant, preactivated enzymes and a large excess of the phosphoacceptor, which renders kinases more sensitive to the inhibitor.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> Second, for the ATP competitive kinase inhibitors (such as those developed in this study), the IC<sub>50</sub> value depends on the competition from ATP under the assay conditions. We performed all kinase assays at 100 μM ATP, based on the K<sub>M</sub>(ATP) value for DYRK1A (30 μM). However, when the ATP concentration exceeds the K<sub>M</sub>(ATP), the IC<sub>50</sub> value increases as well. As the ATP concentration in cells is in the 1–5 mM range, an inhibitor concentration that is higher than the IC<sub>50</sub> value determined from biochemical kinase inhibition assays will be required to inhibit the targeted kinase in the cell. It is suggested that an ATP-competitive kinase inhibitor should be active in cells at a concentration approximately 10- to 100-fold above its IC<sub>50</sub> value as determined in biochemical assays using the K<sub>M</sub>(ATP) concentration.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> In the cellular assays, the efficacy of <b>9h</b> was significant in the 0.8–2.5 μM range, which is 20- to 70-fold above the biochemical IC<sub>50</sub> values for the inhibition of DYRK1A, DYRK1B, and CLK1 (34–43 nM).</div><div class="NLM_p last">In addition to using an appropriate inhibitor concentration in the functional studies and CETSA assays, we demonstrate that genetic knock-down of DYRK1A induced EGFR degradation comparable to the degradation kinetics determined upon pharmacological DYRK1A inhibition with compound <b>9h</b>. Together, these data imply DYRK1A as a kinase responsible for EGFR stabilization. However, as DYRK1A knock-down had only mild effects on cell viability (data not shown), we conclude that the antiproliferative efficacy of inhibitor <b>9h</b> is due to simultaneously targeting the DYRK-CLK family of kinases, though other off-target effects could also be a factor. In summary, the protein kinases of the DYRK family are emerging as potential targets for small molecule cancer therapy. We present a library of novel potent and cell-active DYRK kinase inhibitors to further explore the role of the DYRK kinases in an <i>in vivo</i> glioblastoma model setting.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26257" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26257" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> General Chemical Synthesis Details</h3><div class="NLM_p last">Unless noted otherwise, commercially obtained reagents were used as purchased without further purification. Solvents for flash chromatography were distilled prior to use, or used as purchased for HPLC grade, with the eluent mixture reported as the volume/volume ratio (v/v). Flash chromatography was performed using Merck Kieselgel 60 (230–400 mesh) silica gel. Analytical thin-layer chromatography was performed using Merck aluminum-backed silica gel 60 F254 (0.2 mm) plates (Merck, Darmstadt, Germany), which were visualized using shortwave (254 nm) ultraviolet fluorescence. Melting points were measured with a rate of 6 °C/min and are uncorrected. Infrared absorption spectra were reported as vibrational frequency (cm<sup>–1</sup>). Nuclear magnetic resonance spectra were recorded at 300 K using a 200 MHz, 300 MHz, 400 MHz, or 500 MHz spectrometer. The data are reported as chemical shift (δ ppm) relative to the residual protonated solvent resonance, relative integral, multiplicity (s = singlet, br.s = broad singlet, d = doublet, dd = doublet of doublets, t = triplet, m = multiplet, etc.), and coupling constants (<i>J</i> Hz). Low resolution mass spectra (LRMS) was obtained from a ThermoQuest Finnigan LCQ Deca ion trap mass spectrometer with electrospray ionization in either positive (+ESI) or negative (-ESI) mode. Data is expressed as observed mass (<i>m</i>/<i>z</i>), assignment (M = molecular ion), and relative intensity (%). High resolution mass spectra were performed on a Bruker Apex Qe 7T Fourier Transform ion cyclotron resonance mass spectrometer equipped with an Apollo Π ESI dual source. Samples were run with syringe infusion at 150 μL/h on a Cole Palmer syringe pump into electrospray ionization (ESI). High performance liquid chromatography (HPLC) analysis of organic purity was conducted on a Waters Alliance 2695 instrument using a SunFire C18 column (5 μm, 2.1 × 150 mm) and detected using a Waters 2996 photodiode array (PDA) detector set at 254 nm. Separation was achieved using water (solvent A) and acetonitrile (solvent B) at a flow rate of 0.2 mL/min and a gradient of 0% B to 100% or 40% over 30 min. HPLC data is reported as percentage purity (≥95%) and retention time (RT) in minutes.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> General Procedure A: Synthesis of 5-Bromo-3-iodo-1-tosyl-Based Derivatives</h3><div class="NLM_p">The compounds ware prepared according to the literature.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> To a solution of indole-based compound <b>4a</b>–<b>c</b> (1.00 equiv) in CH<sub>2</sub>Cl<sub>2</sub> (0.05 M) was added KOH (0.50 equiv) at RT. After 30 min, <i>N</i>-iodosuccinimide (1.00 equiv) was added, and the mixture was stirred for 10 h, quenched with a saturated solution of Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub>, and extracted with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic layers were dried (MgSO<sub>4</sub>) and concentrated <i>in vacuo</i>. The desired product was used in the next step without further purification.</div><div class="NLM_p last">To a solution of <b>5a</b>–<b>c</b> (1.00 equiv) in CH<sub>2</sub>Cl<sub>2</sub> (0.05 M) were added sodium hydride 60% (3.00 equiv) and benzyltriethylammonium chloride (0.02 equiv) under argon at 0 °C. After 30 min, 4-methylbenzenesulfonyl chloride (1.20 equiv) was added at 0 °C, and the mixture was stirred at RT. After 2 h, water was added and extracted with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic layers were dried (MgSO<sub>4</sub>) and concentrated <i>in vacuo</i>.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> General Procedure B for Di-Suzuki Coupling Reaction</h3><div class="NLM_p last">To a solution of <b>6a</b>–<b>c</b> (1.00 equiv) in toluene/ethanol 3:1 (0.02 M) were added (4-methoxyphenyl)boronic acid (2.00 equiv), K<sub>2</sub>CO<sub>3</sub> (2 M solution in water, 4.00 equiv), and Pd(PPh<sub>3</sub>)<sub>4</sub> (4 mol %), and the reaction was heated to 110 °C for 5 h under argon. The reaction mixture was cooled to room temperature, concentrated <i>in vacuo</i>, and then partitioned between water and ethyl acetate. The aqueous layer was extracted with ethyl acetate, and the combined organic layers were dried (MgSO<sub>4</sub>) and concentrated <i>in vacuo</i>. The residue was purified using flash chromatography (hexane/ethyl acetate 5:1 → 3:1) to give the product.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> General Procedure C for Mono-Suzuki Coupling Reaction</h3><div class="NLM_p last">To solution of <b>6a</b> or <b>7d</b>–<b>g</b> or <b>16a</b>–<b>b</b> or <b>19a</b>–<b>b</b> (1.00 equiv) in toluene/ethanol 3:1 (0.02 M) were added arylboronic acid (1.00 equiv), K<sub>2</sub>CO<sub>3</sub> (2 M solution in water, 2.00 equiv), and Pd(PPh<sub>3</sub>)<sub>4</sub> (2 mol %), and the reaction was heated to 90 °C for 3 h under argon. The reaction mixture was cooled to room temperature, solvent was removed under reduce pressure, and then the resulting solid was partitioned between water and ethyl acetate. The aqueous layer was extracted with ethyl acetate, and the combined organic layers were dried (MgSO<sub>4</sub>) and concentrated <i>in vacuo</i>.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> General Procedure D for the Synthesis of Tetrazole</h3><div class="NLM_p last">To a solution of cyanated compound <b>8f</b> or <b>8i</b> (1.00 equiv) in <i>t</i>-BuOH and H<sub>2</sub>O (1:1 v/v, 0.125 M) were added TBAF (1 M in THF, 1.00 equiv), trimethylsilyl azide (10.00 equiv), CuSO<sub>4</sub>·5H<sub>2</sub>O (0.01 equiv) ,and sodium ascorbate (0.03 equiv), and the mixture was stirred at 80 °C under microwave irradiation (100 W) for 2 h. The mixture was quenched with water and extracted with ethyl acetate (3 × 10 mL), and the combined organic layers were dried (MgSO<sub>4</sub>) and concentrated under reduced pressure.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> General Procedure E for Deprotection of the Tosyl-Group</h3><div class="NLM_p last">To a solution of <b>7a</b>–<b>c</b>, <b>8d</b>–<b>k</b>, or <b>14a</b>–<b>b</b> (1.00 equiv) in MeOH (0.02 M) was added KOH (5.00 equiv), and the reaction mixture was heated to 80 °C for 2 h. After completion, the solvent was removed under reduced pressure, and then the resulting solid was partitioned between water and ethyl acetate. The aqueous layer was extracted with ethyl acetate, and the combined organic layers were dried (MgSO<sub>4</sub>) and concentrated <i>in vacuo</i>.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> General Procedure F for Demethylation</h3><div class="NLM_p last">To a solution of <b>8a</b>–<b>c</b> (1.00 equiv) in dry CH<sub>2</sub>Cl<sub>2</sub> (0.05 M) was added BBr<sub>3</sub> (1 M solution in CH<sub>2</sub>Cl<sub>2</sub>, 6.00 equiv) under nitrogen. The reaction mixture was stirred at room temperature for 15 h and then quenched at 0 °C with MeOH and concentrated <i>in vacuo</i>.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> General Procedure G for Reduction of Nitro Compounds</h3><div class="NLM_p last">To a solution of <b>9a</b> or <b>9e</b> (1.00 equiv) in HCl (3 N solution in water, 0.03 M) was added iron powder (10.00 equiv), and the reaction mixture was heated to 110 °C for 3 h. After completion and cooling down, the mixture was neutralized with NaHCO<sub>3</sub> (aq) and extracted with ethyl acetate, and the combined organic layers were dried (MgSO<sub>4</sub>) and concentrated <i>in vacuo</i>.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> General Procedure H for the Protection of 4- or 3-Hydroxyaniline with a <i>tert</i>-Butyldimethyl Group<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a></h3><div class="NLM_p last">To a solution of 4-hydroxyaniline or 3-hydroxyaniline (1.00 equiv, 5 mmol) in dry DMF (0.05 M) was added imidazole (2.50 equiv, 12.5 mmol) at 0 °C, followed by the addition of TBSCl (1.50 equiv, 7.5 mmol). The reaction mixture was stirred at RT for 12 h; after completion monitored by TLC, the mixture was extracted with ethyl acetate (3 × 30 mL) and water (50 mL), and the organic layers were dried (MgSO<sub>4</sub>) and concentrated <i>in vacuo</i>.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> General Procedure I for Amide Coupling Reaction of Aromatic Acid and Substituted Aniline</h3><div class="NLM_p last">To a solution of acid <b>12</b> or <b>18</b> (1.00 equiv) in DMSO (0.05 M) was added HBTU (1.20 equiv) under nitrogen at 0 °C, followed by the addition of DIPEA (2.50 equiv) and aniline <b>13a</b> or aniline <b>13b</b> (1.10 equiv). The reaction mixture was stirred at RT for 2 h; after completion monitored by TLC, the mixture was extracted with ethyl acetate and H<sub>2</sub>O, and the organic layers were dried (MgSO<sub>4</sub>) and concentrated <i>in vacuo</i>. The residue was purified by flash chromatography (hexane/ethyl acetate 5:1 → 3:1) to give the product.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 4,4′-(1<i>H</i>-Pyrrolo[2,3-<i>b</i>]pyridine-3,5-diyl)diphenol (<b>3a</b>)</h3><div class="NLM_p last">This compound was prepared according to general procedure F. The residue was purified by flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 100:1 → 50:1) to give the product as a pale yellow solid (65% yield). <i>R</i><sub><i>f</i></sub> (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 20:1): 0.45; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i>): δ 11.83 (1H, s), 9.69–9.23 (1H, br s), 8.47 (1H, d, <i>J</i> = 2.0 Hz), 8.30 (1H, d, <i>J</i> = 2.0 Hz), 7.71 (1H, d, <i>J</i> = 2.5 Hz), 7.56 (4H, dd, <i>J</i> = 0.9 Hz, <i>J</i> = 8.6 Hz), 6.87 (4H, dq, <i>J</i> = 2.0 Hz, <i>J</i> = 8.6 Hz), one OH signal not observed; <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i>): δ 156.8, 155.7, 147.2, 140.5, 129.5, 128.7, 128.2, 127.7, 125.6, 125.3, 123.2, 117.9, 115.8, 115.7, 115.0; HRMS (ESI+) calcd for C<sub>19</sub>H<sub>14</sub>N<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup> 303.1128, found 303.1130. IR (neat, cm<sup>–1</sup>): ν̃ 3107, 2943, 1611, 1249. HPLC: 98.9%, RT: 16.4 min.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 4,4′-(1<i>H</i>-Indole-3,5-diyl)diphenol (<b>3b</b>)</h3><div class="NLM_p last">This compound was prepared according to general procedure F. The residue was purified by flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 100:1 → 50:1) to give the product as a white solid (60% yield). mp 246–248 °C; <i>R</i><sub><i>f</i></sub> (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 20:1): 0.50; <sup>1</sup>H NMR (500 MHz, MeOD): δ 7.90 (1H, d, <i>J</i> = 1.0 Hz), 7.48 (4H, dd, <i>J</i> = 8.6 Hz, <i>J</i> = 23.2 Hz), 7.42 (1H, d, <i>J</i> = 8.5 Hz), 7.35–7.33 (2H, m), 6.86 (4H, dd, <i>J</i> = 8.5 Hz, <i>J</i> = 14.8 Hz), NH and OH signals not observed; <sup>13</sup>C NMR (125 MHz, MeOD): δ 157.2, 156.5, 137.6, 135.8, 134.2, 129.4, 129.1, 129.0, 127.6, 123.1, 122.0, 118.6, 117.9, 116.5, 116.4, 112.6; HRMS (ESI+) calcd for C<sub>20</sub>H<sub>15</sub>NO<sub>2</sub> [M + Na]<sup>+</sup> 324.0995, found 324.0998. IR (neat, cm<sup>–1</sup>): ν̃ 3402, 3022, 1514, 1219, 1170, 798. HPLC: > 99.9%, RT: 21.7 min.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 4,4′-(1<i>H</i>-Indazole-3,5-diyl)diphenol (<b>3c</b>)</h3><div class="NLM_p last">This compound was prepared according to General procedure F. The residue was purified by flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 100:1 → 50:1) to give the product as a white solid (58% yield). mp 251–252 °C; <i>R</i><sub><i>f</i></sub> (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 20:1): 0.50; <sup>1</sup>H NMR (500 MHz, MeOD): δ 8.11 (1H, s), 7.97 (1H, d, <i>J</i> = 8.7 Hz), 7.82 (2H, d, <i>J</i> = 7.4 Hz), 7.73 (1H, d, <i>J</i> = 8.7 Hz), 7.51 (2H, d, <i>J</i> = 7.4 Hz), 7.06 (2H, d, <i>J</i> = 7.4 Hz), 6.89 (2H, d, <i>J</i> = 7.2 Hz), NH and OH signals not observed; <sup>13</sup>C NMR (125 MHz, MeOD): δ 161.6, 158.7, 144.6, 141.4, 139.2, 133.2, 132.6, 131.1, 129.5, 120.3, 119.6, 119.5, 117.7, 116.9, 112.9; HRMS (ESI+) calcd for C<sub>19</sub>H<sub>14</sub>N<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup> 303.1128, found 303.1131. IR (neat, cm<sup>–1</sup>): ν̃ 3343, 2980, 1609, 1497, 1263, 1182, 809, 507. HPLC: 98.8%, RT: 19.9 min.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 5-Bromo-3-iodo-1-tosyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>6a</b>)</h3><div class="NLM_p last">This compound was prepared according to general procedure A. The residue was purified using flash chromatography (hexane/ethyl acetate 15:1 → 10:1) to give the product as a white solid (81% yield over two steps). mp 186–187 °C; <i>R</i><sub><i>f</i></sub> (hexane/ethyl acetate 10:1): 0.65; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.44 (1H, d, <i>J</i> = 2.1 Hz), 8.06–8.04 (2H, m), 7.86 (1H, s), 7.78 (1H, d, <i>J</i> = 2.1 Hz), 7.29 (2H, d, <i>J</i> = 8.1 Hz), 2.37 (3H, s); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 146.7, 146.0, 144.7, 134.7, 132.5, 131.4, 130.0, 128.4, 126.7, 116.0, 60.4, 21.8; LRMS (+ESI): <i>m</i>/<i>z</i> 499/501 (100/97, [M + Na]<sup>+</sup>). IR (neat, cm<sup>–1</sup>): ν̃ 3138, 1619, 1371, 1167, 1140, 1015, 527. The spectroscopic data matched that reported in the literature.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a></div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 5-Bromo-3-iodo-1-tosyl-1H-indole (<b>6b</b>)</h3><div class="NLM_p last">This compound was prepared according to general procedure A. The residue was purified using flash chromatography (hexane/ethyl acetate 20:1 → 10:1) to give the product as a white solid (89% yield over two steps). <sup>1</sup>H NMR (200 MHz, CDCl<sub>3</sub>): δ 7.83 (1H, d, <i>J</i> = 8.7 Hz), 7.75 (2H, d, <i>J</i> = 8.4 Hz), 7.68 (1H, s), 7.51 (1H, d, <i>J</i> = 1.7 Hz), 7.45 (1H, dd, <i>J</i> = 1.9 Hz, <i>J</i> = 8.7 Hz), 7.25 (2H, d, <i>J</i> = 8.0 Hz), 2.36 (3H, s); <sup>13</sup>C NMR (50 MHz, CDCl<sub>3</sub>): δ 145.8, 134.8, 134.4, 133.3, 131.1, 130.3, 128.8, 127.1, 125.0, 117.7, 115.0, 65.5, 21.8. The spectroscopic data matched that reported in the literature.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a></div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 5-Bromo-3-iodo-1-tosyl-1<i>H</i>-indazole (<b>6c</b>)</h3><div class="NLM_p last">This compound was prepared according to general procedure A. The residue was purified using flash chromatography (hexane/ethyl acetate 20:1 → 10:1) to give the product as an off-white solid (80% yield over two steps). mp 160–161 °C; <i>R</i><sub><i>f</i></sub> (hexane/ethyl acetate 12:1): 0.50; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.05 (1H, dd, <i>J</i> = 0.5 Hz, <i>J</i> = 8.9 Hz), 7.86 (2H, dd, <i>J</i> = 1.7 Hz, <i>J</i> = 6.7 Hz), 7.69 (1H, dd, <i>J</i> = 1.8 Hz, <i>J</i> = 8.9 Hz), 7.60 (1H, d, <i>J</i> = 1.6 Hz), 7.27 (2H, d, <i>J</i> = 8.1 Hz), 2.38 (3H, s); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 146.2, 139.2, 134.1, 133.5, 131.9, 130.2, 127.9, 125.0, 118.2, 114.8, 102.4, 21.8; LRMS (+ESI): <i>m</i>/<i>z</i> 499/501 (100/86, [M + Na]<sup>+</sup>). IR (neat, cm<sup>–1</sup>): ν̃ 3102, 3071, 2923, 1593, 1373, 1238, 663, 531.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 3,5-Bis(4-methoxyphenyl)-1-tosyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>7a</b>)</h3><div class="NLM_p last">This compound was prepared according to general procedure B to give the product as a white solid (87% yield). mp 158–160 °C; <i>R</i><sub><i>f</i></sub> (hexane/ethyl acetate 2:1): 0.45; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.64 (1H, d, <i>J</i> = 2.1 Hz), 8.14 (2H, d, <i>J</i> = 2.0 Hz), 8.12 (1H, d, <i>J</i> = 1.8 Hz), 7.81 (1H, s), 7.54 (2H, dd, <i>J</i> = 2.2 Hz, <i>J</i> = 6.7 Hz), 7.49 (2H, dd, <i>J</i> = 2.2 Hz, <i>J</i> = 6.7 Hz), 7.29 (2H, dd, <i>J</i> = 0.6 Hz, <i>J</i> = 8.6 Hz), 7.01 (4H, dt, <i>J</i> = 2.2 Hz, <i>J</i> = 8.8 Hz), 3.87 (3H, s), 3.85 (3H, s), 2.38 (3H, s); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 159.6, 159.5, 146.8, 145.3, 144.2, 135.7, 132.7, 131.1, 129.8, 128.9, 128.7, 128.2, 126.8, 125.3, 122.7, 122.0, 120.4, 114.8, 114.7, 55.5 (two overlapping signals), 21.8; LRMS (+ESI): <i>m</i>/<i>z</i> 507 (100, [M + Na]<sup>+</sup>). IR (neat, cm<sup>–1</sup>): ν̃ 2920, 2836, 1596, 1381, 1173, 1157, 577.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 3,5-Bis(4-methoxyphenyl)-1-tosyl-1<i>H</i>-indole (<b>7b</b>)</h3><div class="NLM_p last">This compound was prepared according to general procedure B to give the product as a white solid (86% yield). mp 168–170 °C; <i>R</i><sub><i>f</i></sub> (hexane/ethyl acetate 2:1): 0.45; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.08 (1H, d, <i>J</i> = 10.4 Hz), 7.86 (1H, s), 7.83 (2H, d, <i>J</i> = 8.0 Hz), 7.64 (1H, s), 7.56–7.54 (3H, m), 7.51 (2H, d, <i>J</i> = 8.2 Hz), 7.23 (2H, d, <i>J</i> = 8.0 Hz), 7.02 (2H, d, <i>J</i> = 8.2 Hz), 6.97 (2H, d, <i>J</i> = 8.2 Hz), 3.86 (3H, s), 3.84 (3H, s), 2.34 (3H, s); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 159.3, 159.1, 145.1, 136.9, 135.3, 134.6, 134.0, 130.2, 130.0, 129.2, 128.5, 127.0, 125.6, 124.3, 124.1, 123.0, 118.5, 114.5, 114.3, 114.1, 55.5, 55.4, 21.7; LRMS (+ESI): <i>m</i>/<i>z</i> 484 (8, [M + H]<sup>+</sup>), 506 (100, [M + Na]<sup>+</sup>). IR (neat, cm<sup>–1</sup>): ν̃ 2954, 2932, 2834, 1609, 1367, 1170, 835, 576.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 3,5-Bis(4-methoxyphenyl)-1-tosyl-1<i>H</i>-indazole (<b>7c</b>)</h3><div class="NLM_p last">This compound was prepared according to general procedure B to give the product as a white solid (84% yield). mp 115–117 °C; <i>R</i><sub><i>f</i></sub> (hexane/ethyl acetate 2:1): 0.45; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.27 (1H, dd, <i>J</i> = 0.6 Hz, <i>J</i> = 8.8 Hz), 7.98 (1H, dd, <i>J</i> = 0.7 Hz, <i>J</i> = 1.6 Hz), 7.92 (2H, dd, <i>J</i> = 1.7 Hz, <i>J</i> = 6.7 Hz), 7.89 (2H, dd, <i>J</i> = 2.1 Hz, <i>J</i> = 6.8 Hz), 7.75 (1H, dd, <i>J</i> = 1.7 Hz, <i>J</i> = 8.8 Hz), 7.53 (2H, dd, <i>J</i> = 2.1 Hz, <i>J</i> = 6.7 Hz), 7.23 (2H, d, <i>J</i> = 8.0 Hz), 7.01 (4H, ddd, <i>J</i> = 2.1 Hz, <i>J</i> = 6.8 Hz, <i>J</i> = 12.4 Hz), 3.87 (3H, s), 3.85 (3H, s), 2.34 (3H, s); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 160.9, 159.5, 151.9, 145.3, 141.1, 137.9, 134.8, 133.2, 129.9, 129.7, 128.7, 128.6, 127.7, 125.3, 124.1, 119.3, 114.5, 114.4, 113.9, 55.5 (two overlapping signals),, 21.7; LRMS (+ESI): <i>m</i>/<i>z</i> 507 (100, [M + Na]<sup>+</sup>), 523 (8, [M+K]<sup>+</sup>). IR (neat, cm<sup>–1</sup>): ν̃ 2934, 2836, 1609, 1303, 1274, 837, 589, 578.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 5-Bromo-3-(4-nitrophenyl)-1-tosyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>7d</b>)</h3><div class="NLM_p last">This compound was prepared according to general procedure C. The residue was purified by flash chromatography (hexane/ethyl acetate 8:1 → 5:1) to give the product as pale yellow solid (78% yield). mp 253–254 °C; <i>R</i><sub><i>f</i></sub> (hexane/ethyl acetate 4:1): 0.55; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.53 (1H, d, <i>J</i> = 2.1 Hz), 8.34 (2H, dd, <i>J</i> = 2.1 Hz, <i>J</i> = 6.9 Hz), 8.21 (1H, d, <i>J</i> = 2.1 Hz), 8.12 (2H, dd, <i>J</i> = 1.7 Hz, <i>J</i> = 6.7 Hz), 8.03 (1H, s), 7.73 (2H, dd, <i>J</i> = 2.1 Hz, <i>J</i> = 6.9 Hz), 7.32 (2H, d, <i>J</i> = 8.2 Hz), 2.40 (3H, s); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 147.3, 146.5, 146.2, 145.8, 139.0, 134.8, 131.0, 130.1, 128.6, 127.9, 125.7, 124.7, 122.4, 117.4, 116.1, 21.9; LRMS (+ESI): <i>m</i>/<i>z</i> 494/496 (81/100, [M + Na]<sup>+</sup>). IR (neat, cm<sup>–1</sup>): ν̃ 3142, 1597, 1512, 1171, 692.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 5-Bromo-3-(1<i>H</i>-indol-5-yl)-1-tosyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>7e</b>)</h3><div class="NLM_p last">This compound was prepared according to general procedure C. The residue was purified by flash chromatography (hexane/ethyl acetate 8:1 → 5:1) to give the product as colorless semisolid (80% yield). <i>R</i><sub><i>f</i></sub> (hexane/ethyl acetate 5:1): 0.40; <sup>1</sup>H NMR (500 MHz, MeOD): δ 8.40 (1H, d, <i>J</i> = 2.1 Hz), 8.31 (1H, d, <i>J</i> = 2.1 Hz), 8.03 (2H, d, <i>J</i> = 8.5 Hz), 7.93 (1H, s), 7.77 (1H, d, <i>J</i> = 1.1 Hz), 7.49 (1H, d, <i>J</i> = 8.4 Hz), 7.36 (2H, d, <i>J</i> = 8.2 Hz), 7.33 (1H, dd, <i>J</i> = 1.7 Hz, <i>J</i> = 8.4 Hz), 7.29 (1H, d, <i>J</i> = 3.1 Hz), 6.52 (1H, dd, <i>J</i> = 0.8 Hz, <i>J</i> = 3.1 Hz), 2.36 (3H, s), NH signal not observed; <sup>13</sup>C NMR (125 MHz, MeOD): δ 147.3, 147.2, 146.1, 137.5, 136.4, 132.6, 130.9, 130.0, 129.0, 126.7, 125.2, 124.6, 123.7, 123.2, 122.2, 120.4, 116.4, 112.9, 102.8, 21.6; LRMS (+ESI): <i>m</i>/<i>z</i> 464/466 (100/98, [M + H]<sup>+</sup>). IR (neat, cm<sup>–1</sup>): ν̃ 3401, 2922, 1595, 1382, 1173, 582.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 4-(5-Bromo-1-tosyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-3-yl)benzonitrile (<b>7f</b>)</h3><div class="NLM_p last">This compound was prepared according to general procedure C. The residue was purified by flash chromatography (hexane/ethyl acetate 8:1 → 5:1) to give the product as an off-white solid (85% yield). mp 219–220 °C; <i>R</i><sub><i>f</i></sub> (hexane/ethyl acetate 5:1): 0.45; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.52 (1H, d, <i>J</i> = 2.1 Hz), 8.19 (1H, d, <i>J</i> = 2.1 Hz), 8.11 (2H, dd, <i>J</i> = 1.7 Hz, <i>J</i> = 6.7 Hz), 7.98 (1H, s), 7.76 (2H, dd, <i>J</i> = 1.9 Hz, <i>J</i> = 6.6 Hz), 7.67 (2H, dd, <i>J</i> = 1.9 Hz, <i>J</i> = 6.6 Hz), 7.32 (2H, d, <i>J</i> = 8.2 Hz), 2.40 (3H, s); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 146.4, 146.1, 145.8, 137.1, 134.8, 133.2, 130.9, 130.0, 128.5, 127.9, 125.4, 122.4, 118.7, 117.8, 116.0, 111.6, 21.9; LRMS (+ESI): <i>m</i>/<i>z</i> 474/476 (100/68, [M + Na]<sup>+</sup>), 490 (11, [M + K]<sup>+</sup>). IR (neat, cm<sup>–1</sup>): ν̃ 2219, 1607, 1178, 591.</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 4-(5-Bromo-1-tosyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-3-yl)phenol (<b>7g</b>)</h3><div class="NLM_p last">This compound was prepared according to general procedure C. The residue was purified using flash chromatography (hexane/ethyl acetate 6:1 → 4:1) to give the product as a white solid (80% yield). mp 158–168 °C; <i>R</i><sub><i>f</i></sub> (hexane/ethyl acetate 4:1): 0.40; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.47 (1H, d, <i>J</i> = 2.1 Hz), 8.15 (1H, d, <i>J</i> = 2.1 Hz), 8.07 (2H, d, <i>J</i> = 8.4 Hz), 7.79 (1H, s), 7.42 (2H, dd, <i>J</i> = 2.1 Hz, <i>J</i> = 6.6 Hz), 7.29 (2H, d, <i>J</i> = 8.2 Hz), 6.95 (2H, dd, <i>J</i> = 2.1 Hz, <i>J</i> = 6.6 Hz), 2.38 (3H, s), OH signal not observed; <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 155.5, 145.7, 145.6, 145.5, 135.0, 131.0, 129.7, 128.8, 128.1, 125.1, 124.5, 123.3, 119.3, 116.1, 115.4, 21.6; LRMS (+ESI): <i>m</i>/<i>z</i> 443/445 (58/48, [M + H]<sup>+</sup>), 465/467 (100/96, [M + Na]<sup>+</sup>). IR (neat, cm<sup>–1</sup>): ν̃ 3370, 1595, 1386, 1175, 1160, 588.</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 3,5-Bis(4-methoxyphenyl)-1H-pyrrolo[2,3-<i>b</i>]pyridine (<b>8a</b>)</h3><div class="NLM_p last">This compound was prepared according to general procedure E. The residue was purified using flash chromatography (hexane/ethyl acetate 3:1 → 1:1) to give the product as a yellow solid (95% yield). mp 193–194 °C; <i>R</i><sub><i>f</i></sub> (hexane/ethyl acetate 1:1): 0.35; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 11.50 (1H, s), 8.53 (1H, s), 8.37 (1H, d, <i>J</i> = 1.6 Hz), 7.59–7.51 (5H, m), 7.03 (4H, d, <i>J</i> = 8.6 Hz), 3.87 (6H, s); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 159.4, 158.6, 147.3, 140.2, 131.6, 129.9, 128.6, 128.5, 127.6, 127.2, 123.0, 119.8, 116.7, 114.6 (two overlapping signals), 55.5 (two overlapping signals); LRMS (+ESI): <i>m</i>/<i>z</i> 331 (100, [M + H]<sup>+</sup>). IR (neat, cm<sup>–1</sup>): ν̃ 3115, 3031, 2835, 1500, 1241, 1209, 1027, 831.</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 3,5-Bis(4-methoxyphenyl)-1<i>H</i>-indole (<b>8b</b>)</h3><div class="NLM_p last">This compound was prepared according to general procedure E. The residue was purified using flash chromatography (hexane/ethyl acetate 3:1 → 1:1) to give the product as a yellow solid (95% yield). mp 153–154 °C; <i>R</i><sub><i>f</i></sub> (hexane/ethyl acetate 1:1): 0.35; <sup>1</sup>H NMR (400 MHz, acetone-<i>d</i>): δ 10.39 (1H, bs), 8.03 (1H, t, <i>J</i> = 1.0 Hz), 7.67 (2H, dd, <i>J</i> = 2.2 Hz, <i>J</i> = 6.6 Hz), 7.61 (2H, dd, <i>J</i> = 2.2 Hz, <i>J</i> = 6.6 Hz), 7.53–7.51 (2H, m), 7.42 (1H, dd, <i>J</i> = 1.8 Hz, <i>J</i> = 8.4 Hz), 7.04 (1H, d, <i>J</i> = 2.2 Hz), 7.02 (2H, t, <i>J</i> = 2.5 Hz), 7.00 (1H, d, <i>J</i> = 2.2 Hz), 3.84 (3H, s), 3.83 (3H, s); <sup>13</sup>C NMR (100 MHz, acetone-<i>d</i>): δ 159.6, 159.0, 137.4, 136.2, 133.7, 129.5, 129.1, 128.9, 127.3, 123.6, 122.0, 118.1, 117.9, 115.1, 115.0, 112.9, 55.6, 55.5; LRMS (-ESI): <i>m</i>/<i>z</i> 328 (100, [M - H]<sup>−</sup>). IR (neat, cm<sup>–1</sup>): ν̃ 3401, 2953, 2834, 1503, 1273, 837.</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 3,5-Bis(4-methoxyphenyl)-1<i>H</i>-indazole (<b>8c</b>)</h3><div class="NLM_p last">This compound was prepared according to general procedure E. The residue was purified by flash chromatography (hexane/ethyl acetate 3:1 → 1:1) to give the product as a pale yellow solid (91% yield). mp 180–181 °C; <i>R</i><sub><i>f</i></sub> (hexane/ethyl acetate 2:1): 0.50; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i>): δ 13.13 (1H, s), 8.12 (1H, s), 7.98 (2H, d, <i>J</i> = 8.7 Hz), 7.66 (2H, d, <i>J</i> = 8.6 Hz), 7.63 (2H, d, <i>J</i> = 5.9 Hz), 7.10 (2H, d, <i>J</i> = 8.7 Hz), 7.03 (2H, d, <i>J</i> = 8.6 Hz), 3.83 (3H, s), 3.80 (3H, s); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i>): δ 158.9, 158.5, 143.5, 140.7, 133.4, 133.2, 128.2, 128.1, 126.3, 125.6, 120.6, 117.6, 114.3, 114.3, 110.9, 55.1 (two overlapping signals); LRMS (+ESI): <i>m</i>/<i>z</i> 331 (100, [M + H]<sup>+</sup>), 353 (40, [M + Na]<sup>+</sup>). IR (neat, cm<sup>–1</sup>): ν̃ 3128, 3024, 2906, 1611, 1243, 804.</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 4-(3-(4-Nitrophenyl)-1-tosyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-5-yl)phenol (<b>8d</b>)</h3><div class="NLM_p last">This compound was prepared according to general procedure C at 110 °C. The residue was purified by flash chromatography (hexane/ethyl acetate 5:1 → 1:1) to give the product as a yellow solid (87% yield). mp 253–255 °C; <i>R</i><sub><i>f</i></sub> (hexane/ethyl acetate 2:1): 0.40; <sup>1</sup>H NMR (300 MHz, acetone-<i>d</i><sub>6</sub>): δ 8.65 (1H, s), 8.44 (1H, s), 8.35 (3H, d, <i>J</i> = 7.8 Hz), 8.20–8.15 (4H, m), 7.58 (2H, d, <i>J</i> = 7.9 Hz), 7.44 (2H, d, <i>J</i> = 7.9 Hz), 6.97 (2H, d, <i>J</i> = 8.0 Hz), 2.38 (3H, s); <sup>13</sup>C NMR (75 MHz, acetone-<i>d</i><sub>6</sub>): δ 158.5, 147.8, 147.3, 146.9, 144.9, 140.5, 136.1, 134.2, 130.8, 130.0, 129.6, 129.2, 129.1, 127.2, 126.5, 125.0, 121.4, 118.9, 116.8, 21.5; LRMS (+ESI): <i>m</i>/<i>z</i> 508 (100, [M + Na]<sup>+</sup>), 486 (43, [M + H]<sup>+</sup>). IR (neat, cm<sup>–1</sup>): ν̃ 3132, 1594, 1517, 1232, 581.</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 4-(3-(1<i>H</i>-Indol-5-yl)-1-tosyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-5-yl)phenol (<b>8e</b>)</h3><div class="NLM_p last">This compound was prepared according to general procedure C at 110 °C. The residue was purified by flash chromatography (hexane/ethyl acetate 5:1 → 1:1) to give the product as an off-white solid (80% yield). mp 142–145 °C; <i>R</i><sub><i>f</i></sub> (hexane/ethyl acetate 2:1): 0.45; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.62 (1H, d, <i>J</i> = 2.1 Hz), 8.36 (1H, s), 8.22 (1H, d, <i>J</i> = 2.1 Hz), 8.12 (2H, d, <i>J</i> = 8.4 Hz), 7.86–7.85 (2H, m), 7.49 (1H, d, <i>J</i> = 8.4 Hz), 7.42 (3H, dd, <i>J</i> = 2.2 Hz, <i>J</i> = 8.5 Hz), 7.29–7.27 (3H, m), 6.92 (2H, d, <i>J</i> = 8.5 Hz), 6.61 (1H, t, <i>J</i> = 2.2 Hz), 5.46 (1H, br.s), 2.36 (3H, s); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 155.8, 146.9, 145.3, 144.0, 135.7, 135.6, 132.7, 131.2, 129.9, 128.9, 128.6, 128.1, 127.2, 125.3, 124.3, 122.8, 122.5, 122.2, 122.1, 119.9, 116.2, 111.9, 103.1, 21.8; LRMS (+ESI): <i>m</i>/<i>z</i> 502 (100, [M + Na]<sup>+</sup>), 518 (25, [M+K]<sup>+</sup>). IR (neat, cm<sup>–1</sup>): ν̃ 3410, 1703, 1611, 1318, 1230, 584.</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 4-(5-(4-Hydroxyphenyl)-1-tosyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-3-yl)benzonitrile (<b>8f</b>)</h3><div class="NLM_p last">This compound was prepared according to general procedure C at 110 °C. The residue was purified by flash chromatography (hexane/ethyl acetate 3:1 → 1:1) to give the product as an off-white solid (89% yield). mp 167–169 °C; <i>R</i><sub><i>f</i></sub> (hexane/ethyl acetate 3:1): 0.40; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i>): δ 9.64 (1H, s), 8.66 (1H, d, <i>J</i> = 2.1 Hz), 8.45 (1H, s), 8.37 (1H, d, <i>J</i> = 2.1 Hz), 8.08 (4H, dd, <i>J</i> = 7.2 Hz, <i>J</i> = 8.4 Hz), 7.93 (2H, d, <i>J</i> = 8.3 Hz), 7.60 (2H, dd, <i>J</i> = 2.0 Hz, <i>J</i> = 6.6 Hz), 7.44 (2H, d, <i>J</i> = 8.4 Hz), 6.87 (2H, dd, <i>J</i> = 2.0 Hz, <i>J</i> = 6.6 Hz), 2.34 (3H, s); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i>): δ 157.5, 145.8, 145.8, 143.6, 137.0, 134.4, 132.9, 132.7, 130.1, 128.6, 128.1, 127.9, 127.7, 126.3, 125.7, 120.1, 118.9, 117.9, 115.9, 109.8, 21.1; LRMS (+ESI): <i>m</i>/<i>z</i> 488 (100, [M + Na]<sup>+</sup>), 466 (40, [M + H]<sup>+</sup>). IR (neat, cm<sup>–1</sup>): ν̃ 3483, 2226, 1607, 1159, 578.</div></div><div id="sec4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 4-(5-(4-Nitrophenyl)-1-tosyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-3-yl)phenol (<b>8g</b>)</h3><div class="NLM_p last">This compound was prepared according to general procedure C at 110 °C. The residue was purified by flash chromatography (hexane/ethyl acetate 5:1 → 1:1) to give the product as a pale yellow solid (85% yield). mp 136–138 °C; <i>R</i><sub><i>f</i></sub> (hexane/ethyl acetate 1:1): 0.50; <sup>1</sup>H NMR (500 MHz, MeOD): δ 8.68 (1H, d, <i>J</i> = 2.2 Hz), 8.38 (1H, d, <i>J</i> = 2.2 Hz), 8.32 (2H, dd, <i>J</i> = 2.1 Hz, <i>J</i> = 6.9 Hz), 8.06 (2H, d, <i>J</i> = 8.5 Hz), 7.94 (1H, s), 7.90 (2H, dd, <i>J</i> = 2.1 Hz, <i>J</i> = 7.0 Hz), 7.53 (2H, dd, <i>J</i> = 2.1 Hz, <i>J</i> = 6.6 Hz), 7.37 (2H, d, <i>J</i> = 8.3 Hz), 6.92 (2H, dd, <i>J</i> = 2.1 Hz, <i>J</i> = 6.6 Hz), 2.37 (3H, s), OH signal not observed; <sup>13</sup>C NMR (125 MHz, MeOD): δ 158.7, 148.8, 148.7, 147.2, 146.0, 144.8, 136.5, 132.1, 130.9, 130.0, 129.5, 129.0, 128.9, 125.2, 124.5, 124.2, 123.4, 122.5, 117.0, 21.5; LRMS (+ESI): <i>m</i>/<i>z</i> 508 (100, [M + Na]<sup>+</sup>). IR (neat, cm<sup>–1</sup>): ν̃ 2919, 1597, 1515, 1346, 587.</div></div><div id="sec4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 4-(5-(1<i>H</i>-Indol-5-yl)-1-tosyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-3-yl)phenol (<b>8h</b>)</h3><div class="NLM_p last">This compound was prepared according to general procedure C at 110 °C. The residue was purified by flash chromatography (hexane/ethyl acetate 5:1 → 1:1) to give the product as a pale yellow solid (81% yield). mp 136–140 °C; <i>R</i><sub><i>f</i></sub> (hexane/ethyl acetate 2:1): 0.45; <sup>1</sup>H NMR (500 MHz, MeOD): δ 8.60 (1H, d, <i>J</i> = 2.1 Hz), 8.25 (1H, d, <i>J</i> = 2.1 Hz), 8.03 (2H, d, <i>J</i> = 8.4 Hz), 7.85 (1H, s), 7.76 (1H, d, <i>J</i> = 1.2 Hz), 7.50 (2H, dd, <i>J</i> = 2.1 Hz, <i>J</i> = 6.6 Hz), 7.46 (1H, d, <i>J</i> = 8.4 Hz), 7.34–7.32 (3H, m), 7.26 (1H, s), 6.92 (2H, dd, <i>J</i> = 2.1 Hz, <i>J</i> = 6.6 Hz), 6.50–6.49 (1H, m), 2.33 (3H, s), NH and OH signals not observed; <sup>13</sup>C NMR (125 MHz, MeOD): δ 158.6, 147.6, 147.0, 145.0, 137.4, 136.6, 136.3, 130.9, 130.3, 130.2, 129.9, 128.8, 128.4, 126.6, 124.9, 123.5, 123.4, 122.6, 122.1, 120.2, 117.0, 112.8, 102.7, 21.5; LRMS (+ESI): <i>m</i>/<i>z</i> 502 (100, [M + Na]<sup>+</sup>), 480 (64, [M + H]<sup>+</sup>). IR (neat, cm<sup>–1</sup>): ν̃ 3416, 2963, 2926, 1616, 1385, 1172, 589.</div></div><div id="sec4_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 4-(3-(4-Hydroxyphenyl)-1-tosyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-5-yl)benzonitrile (<b>8i</b>)</h3><div class="NLM_p last">This compound was prepared according to general procedure C at 110 °C. The residue was purified by flash chromatography (hexane/ethyl acetate 5:1 → 1:1) to give the product as an off-white solid (93% yield). mp 203–205 °C; <i>R</i><sub><i>f</i></sub> (hexane/ethyl acetate 3:1): 0.40; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.67 (1H, d, <i>J</i> = 2.2 Hz), 8.18 (1H, d, <i>J</i> = 2.2 Hz), 8.13 (2H, d, <i>J</i> = 8.4 Hz), 7.85 (1H, s), 7.75 (2H, dd, <i>J</i> = 2.0 Hz, <i>J</i> = 6.6 Hz), 7.66 (2H, dd, <i>J</i> = 2.0 Hz, <i>J</i> = 6.6 Hz), 7.47 (2H, dd, <i>J</i> = 2.1 Hz, <i>J</i> = 6.6 Hz), 7.30 (2H, d, <i>J</i> = 8.1 Hz), 6.96 (2H, dd, <i>J</i> = 2.1 Hz, <i>J</i> = 6.6 Hz), 2.38 (3H, s), OH signal not observed; <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 155.7, 147.5, 145.6, 144.1, 143.2, 135.4, 133.0, 131.0, 129.9, 129.1, 128.3, 128.2, 127.4, 125.0, 123.3, 122.1, 120.3, 118.8, 116.3, 111.6, 21.8; LRMS (+ESI): <i>m</i>/<i>z</i> 488 (100, [M + Na]<sup>+</sup>). IR (neat, cm<sup>–1</sup>): ν̃ 3510, 3126, 2223, 1609, 1119, 666, 576.</div></div><div id="sec4_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 4-(3-(4-(1<i>H</i>-Tetrazol-5-yl)phenyl)-1-tosyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-5-yl)phenol (<b>8j</b>)</h3><div class="NLM_p last">This compound was prepared according to general procedure D. The residue was purified using flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 100:1 → 50:1) to give the product as a white solid (83% yield). mp 233–235 °C; <i>R</i><sub><i>f</i></sub> (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 20:1): 0.35; <sup>1</sup>H NMR (500 MHz, MeOD): δ 8.41 (1H, d, <i>J</i> = 2.1 Hz), 8.12 (1H, d, <i>J</i> = 2.1 Hz), 8.03–8.01 (3H, m), 7.99 (2H, d, <i>J</i> = 8.7 Hz), 7.71 (2H, d, <i>J</i> = 8.4 Hz), 7.32 (2H, dd, <i>J</i> = 2.0 Hz, <i>J</i> = 6.6 Hz), 7.27 (2H, d, <i>J</i> = 8.2 Hz), 6.81 (2H, dd, <i>J</i> = 2.0 Hz, <i>J</i> = 6.6 Hz), 2.27 (3H, s), NH and OH signals not observed; <sup>13</sup>C NMR (125 MHz, MeOD): δ 158.7, 157.3, 147.5, 147.2, 144.7, 136.9, 136.4, 134.6, 130.9, 130.2, 129.5, 129.1, 129.0, 128.8, 127.6, 125.5, 124.3, 122.3, 120.5, 116.9, 21.6; LRMS (+ESI): <i>m</i>/<i>z</i> 531 (100, [M + Na]<sup>+</sup>). IR (neat, cm<sup>–1</sup>): ν̃ 3137, 2921, 2852, 1378, 1164, 582.</div></div><div id="sec4_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 4-(5-(4-(1<i>H</i>-Tetrazol-5-yl)phenyl)-1-tosyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-3-yl)phenol (<b>8k</b>)</h3><div class="NLM_p last">This compound was prepared according to general procedure D. The residue was purified using flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 100:1 → 50:1) to give the product as a white solid (81% yield). mp 244–245 °C; <i>R</i><sub><i>f</i></sub> (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 20:1): 0.35; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i>): δ 9.66 (1H, br.s), 8.80 (1H, d, <i>J</i> = 1.8 Hz), 8.47 (1H, d, <i>J</i> = 1.8 Hz), 8.16–8.01 (7H, m), 7.67 (2H, d, <i>J</i> = 8.5 Hz), 7.42 (2H, d, <i>J</i> = 8.2 Hz), 6.92 (2H, d, <i>J</i> = 8.5 Hz), 2.33 (3H, s), NH signal not observed; <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i>): δ 157.2, 155.1, 146.7, 145.6, 143.7, 140.1, 134.6, 131.0, 130.0, 128.8, 128.3, 127.6, 127.5, 127.4, 123.5, 122.8, 122.5, 121.0, 120.1, 115.9, 21.1; LRMS (+ESI): <i>m</i>/<i>z</i> 531 (100, [M + Na]<sup>+</sup>). IR (neat, cm<sup>–1</sup>): ν̃ 3400, 3102, 2927, 1508, 1310, 577.</div></div><div id="sec4_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 4-(3-(4-Nitrophenyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-5-yl)phenol (<b>9a</b>)</h3><div class="NLM_p last">This compound was prepared according to general procedure E. The residue was purified by flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 100:1 → 50:1) to give the product as a yellow solid (95% yield). mp 306-316 °C; <i>R</i><sub><i>f</i></sub> (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 20:1): 0.50; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i>): δ 12.33–12.29 (1H, br s), 9.59–9.55 (1H, br s), 8.54 (1H, d, <i>J</i> = 2.1 Hz), 8.47 (1H, d, <i>J</i> = 2.1 Hz), 8.26 (2H, d, <i>J</i> = 1.9 Hz), 8.24 (1H, s), 8.10 (2H, d, <i>J</i> = 1.9 Hz), 7.61 (2H, dd, <i>J</i> = 2.1 Hz, <i>J</i> = 8.6 Hz), 6.90 (2H, dd, <i>J</i> = 2.1 Hz, <i>J</i> = 6.6 Hz; <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i>): δ 156.9, 148.4, 144.5, 142.4, 142.2, 129.8, 129.4, 128.3, 127.5, 126.3, 124.9, 124.3, 117.0, 115.8, 112.5; LRMS (+ESI): <i>m</i>/<i>z</i> 330 (100, [M + H]<sup>+</sup>). IR (neat, cm<sup>–1</sup>): ν̃ 3217, 3173, 3024, 2921, 1591, 1341, 1263, 849.</div></div><div id="sec4_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 4-(3-(1<i>H</i>-Indol-5-yl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-5-yl)phenol (<b>9b</b>)</h3><div class="NLM_p last">This compound was prepared according to general procedure E. The residue was purified by flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 100:1 → 50:1) to give the product as a yellow solid (93% yield). mp 268–271 °C; <i>R</i><sub><i>f</i></sub> (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 20:1): 0.45; <sup>1</sup>H NMR (500 MHz, MeOD): δ 8.40 (2H, dd, <i>J</i> = 1.9 Hz, <i>J</i> = 10.2 Hz), 7.85 (1H, s), 7.56 (1H, s), 7.49 (3H, d, <i>J</i> = 8.6 Hz), 7.44 (1H, dd, <i>J</i> = 1.3 Hz, <i>J</i> = 8.4 Hz), 7.27 (1H, d, <i>J</i> = 3.0 Hz), 6.92 (2H, d, <i>J</i> = 8.5 Hz), 6.52 (1H, d, <i>J</i> = 3.0 Hz), NH and OH signals not observed; <sup>13</sup>C NMR (125 MHz, MeOD): δ 158.0, 148.9, 142.1, 136.7, 132.1, 131.0, 130.1, 129.4, 127.4, 127.1, 126.1, 123.9, 122.5, 120.6, 119.6, 119.1, 116.9, 112.6, 102.5; HRMS (ESI+) calcd for C<sub>21</sub>H<sub>15</sub>N<sub>3</sub>O [M + H]<sup>+</sup> 326.1288, found 326,1288. IR (neat, cm<sup>–1</sup>): ν̃ 3480, 3243, 2916, 1606, 1262, 1248, 690. HPLC: 99.1%, RT: 18.2 min.</div></div><div id="sec4_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> 4-(3-(4-(1<i>H</i>-Tetrazol-5-yl)phenyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-5-yl)phenol (<b>9c</b>)</h3><div class="NLM_p last">This compound was prepared according to general procedure E. The residue was purified by flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 50:1 → 10:1) to give the product as a pale yellow solid (90% yield). mp 282–284 °C; <i>R</i><sub><i>f</i></sub> (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 20:1): 0.20; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i>): δ 12.08 (1H, br s), 9.51 (1H, s), 8.51 (1H, d, <i>J</i> = 2.0 Hz), 8.44 (1H, d, <i>J</i> = 2.0 Hz), 8.11 (2H, d, <i>J</i> = 8.4 Hz), 8.07 (1H, d, <i>J</i> = 2.6 Hz), 8.04 (2H, d, <i>J</i> = 8.4 Hz), 7.60 (2H, d, <i>J</i> = 8.6 Hz), 6.89 (2H, d, <i>J</i> = 8.6 Hz), NH of tetrazole and OH signals not observed; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i>): δ 156.8, 155.3, 148.3, 141.9, 137.9, 129.6, 129.3, 128.3, 127.5, 126.8, 125.6, 124.8, 121.2, 117.1, 115.8, 113.5; HRMS (ESI+) calcd for C<sub>20</sub>H<sub>14</sub>N<sub>6</sub>O [M + H]<sup>+</sup> 355.1302, found 355.1302. IR (neat, cm–1): ν̃ 3477, 3263, 3230, 2919, 1612, 1531, 1326, 1262, 1243, 836. HPLC: 96.4%, RT: 17.1 min.</div></div><div id="sec4_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> 4-(3-(4-Aminophenyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-5-yl)phenol (<b>9d</b>)</h3><div class="NLM_p last">This compound was prepared according to General procedure G. The residue was purified by flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 100:1 → 20:1) to give the product as pale yellow solid (84% yield). mp 113–115 °C; <i>R</i><sub><i>f</i></sub> (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 20:1): 0.40; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i>): δ 9.47 (1H, s), 8.39 (1H, d, <i>J</i> = 1.7 Hz), 7.75 (1H, d, <i>J</i> = 1.7 Hz), 7.47 (2H, d, <i>J</i> = 8.4 Hz), 7.36 (2H, d, <i>J</i> = 8.3 Hz), 6.86 (1H, s), 6.80 (1H, d, <i>J</i> = 8.3 Hz), 6.61 (2H, d, <i>J</i> = 8.4 Hz), 6.09–6.08 (2H, m), OH signal not observed; <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i>): δ 156.2, 148.5, 148.4, 141.8, 129.9, 128.2, 128.1, 127.1, 126.6, 124.4, 123.4, 118.0, 116.3, 115.2, 115.0; HRMS (ESI+) calcd for C<sub>19</sub>H<sub>15</sub>N<sub>3</sub>O [M + H]<sup>+</sup> 302.1288, found 302.1290. IR (neat, cm<sup>–1</sup>): ν̃ 3481, 3444, 3359, 3338, 2918, 1552, 1231, 794. HPLC: 96.0%, RT: 14.4 min.</div></div><div id="sec4_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 4-(5-(4-Nitrophenyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-3-yl)phenol (<b>9e</b>)</h3><div class="NLM_p last">This compound was prepared according to general procedure E. The residue was purified by flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 100:1 → 50:1) to give the product as a yellow solid (93% yield). mp 178–180 °C; <i>R</i><sub><i>f</i></sub> (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 20:1): 0.50; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i>): δ 11.98 (1H, s), 9.39 (1H, s), 8.68 (1H, d, <i>J</i> = 2.1 Hz), 8.52 (1H, d, <i>J</i> = 2.1 Hz), 8.32 (2H, dd, <i>J</i> = 1.9 Hz, <i>J</i> = 6.9 Hz), 8.11 (2H, dd, <i>J</i> = 1.9 Hz, <i>J</i> = 6.9 Hz), 7.78 (1H, d, <i>J</i> = 2.4 Hz), 7.60 (2H, dd, <i>J</i> = 2.0 Hz, <i>J</i> = 6.6 Hz), 6.87 (2H, dd, <i>J</i> = 2.0 Hz, <i>J</i> = 6.6 Hz; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i>): δ 155.8, 149.1, 146.2, 145.9, 142.0, 128.0, 127.8, 126.2, 126.1, 125.4, 124.0, 123.7, 117.5, 115.7, 115.4; HRMS (ESI+) calcd for C<sub>19</sub>H<sub>13</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup> 332.1030, found 332.1032. IR (neat, cm<sup>–1</sup>): ν̃ 3404, 3119, 2858, 1593, 1336,1267. HPLC: 96.8%, RT: 23.0 min.</div></div><div id="sec4_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> 4-(5-(1<i>H</i>-Indol-5-yl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-3-yl)phenol (<b>9f</b>)</h3><div class="NLM_p last">This compound was prepared according to general procedure E. The residue was purified by flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 100:1 → 50:1) to give the product as a yellow solid (94% yield). mp 241–244 °C; <i>R</i><sub><i>f</i></sub> (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 20:1): 0.45; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i>): δ 11.72 (1H, s), 11.13 (1H, s), 9.37 (1H, br s), 8.53 (1H, d, <i>J</i> = 2.1 Hz), 8.32 (1H, d, <i>J</i> = 2.1 Hz), 7.86 (1H, d, <i>J</i> = 1.6 Hz), 7.69 (1H, d, <i>J</i> = 2.4 Hz), 7.57 (2H, dd, <i>J</i> = 2.1 Hz, <i>J</i> = 6.6 Hz), 7.50 (1H, d, <i>J</i> = 3.4 Hz), 7.45 (1H, dd, <i>J</i> = 1.7 Hz, <i>J</i> = 8.4 Hz), 7.38 (1H, t, <i>J</i> = 2.7 Hz), 6.87 (2H, dd, <i>J</i> = 2.1 Hz, <i>J</i> = 6.6 Hz), 6.50 (1H, dt, <i>J</i> = 0.7 Hz, <i>J</i> = 2.7 Hz); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i>): δ 155.6, 148.0, 142.0, 135.2, 130.2, 130.1, 128.3, 127.6, 126.0, 125.9, 125.1, 122.9, 120.9, 118.4, 117.4, 115.7, 114.7, 111.8, 101.4; HRMS (ESI+) calcd for C<sub>21</sub>H<sub>15</sub>N<sub>3</sub>O [M + H]<sup>+</sup> 326.1288, found 326.1288. IR (neat, cm<sup>–1</sup>): ν̃ 3262, 2917, 1459, 1257, 732. HPLC: 96.5%, RT: 18.0 min.</div></div><div id="sec4_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> 4-(5-(4-(1<i>H</i>-Tetrazol-5-yl)phenyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-3-yl)phenol (<b>9g</b>)</h3><div class="NLM_p last">This compound was prepared according to general procedure E. The residue was purified by flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 50:1 → 10:1) to give the product as a pale yellow solid (90% yield). mp 301–303 °C; <i>R</i><sub><i>f</i></sub> (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 20:1): 0.20; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i>): δ 12.06 (1H, s), 8.68 (1H, s), 8.55 (1H, s), 8.19 (2H, d, <i>J</i> = 6.3 Hz), 8.05 (2H, d, <i>J</i> = 6.3 Hz), 7.78 (1H, s), 7.61 (2H, d, <i>J</i> = 6.5 Hz), 6.88 (2H, d, <i>J</i> = 6.5 Hz), NH of tetrazole and OH signals not observed; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i>): δ 155.8, 148.8, 141.7, 141.5, 127.8, 127.7, 127.6, 127.4, 127.4, 127.3, 125.6, 125.5, 123.4, 117.4, 115.7, 115.2; HRMS (ESI+) calcd for C<sub>20</sub>H<sub>14</sub>N<sub>6</sub>O [M + H]<sup>+</sup> 355.1302, found 355.1301. IR (neat, cm<sup>–1</sup>): ν̃ 3330, 2921, 1455, 829, 518. HPLC: 95.8%, RT: 17.1 min.</div></div><div id="sec4_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> 4-(5-(4-Aminophenyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-3-yl)phenol (<b>9h</b>)</h3><div class="NLM_p last">This compound was prepared according to general procedure G. The residue was purified by flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 100:1 → 40:1) to give the product as a pale yellow solid (70% yield). mp 216–220 °C; <i>R</i><sub><i>f</i></sub> (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 20:1): 0.30; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i>): δ 11.66 (1H, s), 9.34 (1H, s), 8.41 (1H, d, <i>J</i> = 2.1 Hz), 8.19 (1H, d, <i>J</i> = 2.1 Hz), 7.65 (1H, d, <i>J</i> = 2.1 Hz), 7.54 (2H, dd, <i>J</i> = 2.1 Hz, <i>J</i> = 6.6 Hz), 7.40 (2H, dd, <i>J</i> = 1.9 Hz, <i>J</i> = 6.6 Hz), 6.85 (2H, dd, <i>J</i> = 2.1 Hz, <i>J</i> = 6.6 Hz), 6.67 (2H, dd, <i>J</i> = 1.9 Hz, <i>J</i> = 6.6 Hz), 5.15 (2H, s); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i>): δ 155.6, 147.9, 147.8, 141.1, 129.2, 127.6, 127.5, 126.4, 125.9, 123.8, 122.8, 117.4, 115.7, 114.6, 114.4; HRMS (ESI+) calcd for C<sub>19</sub>H<sub>15</sub>N<sub>3</sub>O [M + H]<sup>+</sup> 302.1288, found 302.1288. IR (neat, cm<sup>–1</sup>): ν̃ 3351, 3234, 3024, 2870, 1610, 1542, 1478, 1260, 821, 530. HPLC: > 99.9%, RT: 13.7 min.</div></div><div id="sec4_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> <i>N</i>-(4-(3-(4-Hydroxyphenyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-5-yl)phenyl)acetamide (<b>10a</b>)</h3><div class="NLM_p last">To a solution of 4-(5-(4-aminophenyl)-1H-pyrrolo[2,3-<i>b</i>]pyridin-3-yl)phenol (<b>9h</b>) (50 mg, 0.17 mmol) in acetic acid (5 mL) was added acetic anhydride (24 μL, 0.25 mmol), and the reaction was heated to 110 °C for 5 h. After completion and cooling, the mixture was neutralized with Na<sub>2</sub>CO<sub>3</sub> (aq), and extracted with ethyl acetate (3 × 10 mL), and the combined organic layers were dried (MgSO<sub>4</sub>) and concentrated <i>in vacuo</i>. The residue was purified using flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 100:1 → 50:1) to give the product as a plae yellow solid (45 mg, 77% yield). mp 272–275 °C; <i>R</i><sub><i>f</i></sub> (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 20:1): 0.35; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i>): δ 11.78 (1H, s), 10.02 (1H, s), 9.42 (1H, s), 8.51 (1H, s), 8.31 (1H, s), 7.69–7.68 (5H, m), 7.56 (2H, d, <i>J</i> = 8.0 Hz), 6.86 (2H, d, <i>J</i> = 8.0 Hz), 2.07 (3H, s); <sup>13</sup>C NMR (75 MHz, dmso-<i>d</i>): δ 168.3, 155.7, 148.3, 141.5, 138.4, 133.7, 128.2, 127.7, 127.2, 125.7, 124.8, 123.1, 119.5, 117.4, 115.7, 114.9, 24.0; HRMS (ESI+) calcd for C<sub>21</sub>H<sub>17</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup> 344.1394, found 344.1396. IR (neat, cm<sup>–1</sup>): ν̃ 3317, 3088, 2922, 1523, 1244, 886, 516. HPLC: 98.3%, RT: 16.3 min.</div></div><div id="sec4_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> <i>N</i>-(4-(3-(4-Hydroxyphenyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-5-yl)phenyl)methanesulfonamide (<b>10b</b>)</h3><div class="NLM_p last">To a solution of 4-(5-(4-aminophenyl)-1H-pyrrolo[2,3-<i>b</i>]pyridin-3-yl)phenol (<b>9h</b>) (50 mg, 0.17 mmol) in H<sub>2</sub>O (5 mL) was added methanesulfonyl chloride (20 μL, 0.25 mmol), and the mixture was stirred at room temperature for 10 h. After completion, the mixture was extracted with ethyl acetate (3 × 10 mL), and the combined organic layers were dried (MgSO<sub>4</sub>) and concentrated <i>in vacuo</i>. The residue was purified using flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 100:1 → 50:1) to give the product as a pale yellow solid (41 mg, 64% yield). mp 192–195 °C; <i>R</i><sub><i>f</i></sub> (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 20:1): 0.30; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i>): δ 11.83 (1H, d, <i>J</i> = 2.2 Hz), 8.51 (1H, d, <i>J</i> = 2.1 Hz), 8.32 (1H, d, <i>J</i> = 2.1 Hz), 7.74 (1H, s), 7.72 (2H, d, <i>J</i> = 1.6 Hz), 7.56 (2H, d, <i>J</i> = 8.7 Hz), 7.31 (2H, d, <i>J</i> = 8.7 Hz), 6.85 (2H, d, <i>J</i> = 8.7 Hz), 5.76 (1H, s), 3.01 (3H, s), OH signal not observed; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i>): δ 156.1, 148.8, 142.0, 137.9, 135.1, 128.4, 128.1, 126.1, 125.5, 123.6, 120.8, 117.8, 116.2, 115.3, 109.0, 55.4; HRMS (ESI+) calcd for C<sub>20</sub>H<sub>17</sub>N<sub>3</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 380.1063, found 380.1067. IR (neat, cm<sup>–1</sup>): ν̃ 3401, 2920, 2893, 1610, 1520, 1152. HPLC: 95.9%, RT: 17.5 min.</div></div><div id="sec4_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> 1-(4-(3-(4-Hydroxyphenyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-5-yl)phenyl)urea (<b>10c</b>)</h3><div class="NLM_p last">To a mixture of 4-(5-(4-aminophenyl)-1H-pyrrolo[2,3-<i>b</i>]pyridin-3-yl)phenol (<b>9h</b>) (50 mg, 0.17 mmol), citric acid (326 mg, 1.70 mmol), mannitol (310 mg, 1.70 mmol) and urea (153 mg, 2.55 mmol) were added I<sub>2</sub> (4.3 mg, 0.017 mmol), and the reaction was heated to 80 °C for 6 h. After completion and cooling, water (10 mL) was added and extracted with ethyl acetate (3 × 10 mL), and the combined organic layers were dried (MgSO<sub>4</sub>) and concentrated <i>in vacuo</i>. The residue was purified using flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 50:1 → 10:1) to give the product as a pale yellow solid (41 mg, 70% yield). mp 236–239 °C; <i>R</i><sub><i>f</i></sub> (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 20:1): 0.25; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i>): δ 11.75 (1H, s), 9.37 (1H, s), 8.66 (1H, s), 8.49 (1H, d, <i>J</i> = 2.0 Hz), 8.28 (1H, d, <i>J</i> = 2.0 Hz), 7.69 (1H, d, <i>J</i> = 1.4 Hz), 7.61 (2H, d, <i>J</i> = 8.6 Hz), 7.56 (2H, d, <i>J</i> = 8.5 Hz), 7.51 (2H, d, <i>J</i> = 8.6 Hz), 6.86 (2H, d, <i>J</i> = 8.6 Hz), 5.87 (2H, s); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i>): δ 156.1, 155.8, 148.3, 141.5, 139.8, 131.9, 128.5, 127.8, 127.3, 125.9, 124.7, 123.1, 118.3, 117.5, 115.8, 114.9; HRMS (ESI+) calcd for C<sub>20</sub>H<sub>16</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup> 345.1346, found 345.1345. IR (neat, cm<sup>–1</sup>): ν̃ 2954, 2921, 2852, 1535, 1242, 813. HPLC: > 98.3%, RT: 13.3 min.</div></div><div id="sec4_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> 5-Bromo-1-tosyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>11</b>)</h3><div class="NLM_p last">This compound was prepared according to general procedure A. The residue was purified using flash chromatography (hexane/ethyl acetate 20:1 → 10:1) to give the product as a white solid (90% yield). mp 140–141 °C; <i>R</i><sub><i>f</i></sub> (hexane/ethyl acetate 12:1): 0.50; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.41 (1H, d, <i>J</i> = 2.1 Hz), 8.05 (2H, d, <i>J</i> = 8.2 Hz), 7.87 (1H, d, <i>J</i> = 2.1 Hz), 7.73 (1H, d, <i>J</i> = 4.0 Hz), 7.23 (2H, d, <i>J</i> = 8.2 Hz), 6.51 (1H, d, <i>J</i> = 4.0 Hz), 2.29 (3H, s); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 145.3, 145.1, 145.0, 134.8, 131.5, 129.5, 127.8, 127.7, 124.2, 114.9, 104.4, 21.4; LRMS (+ESI): <i>m</i>/<i>z</i> 373/375 (97/100, [M + Na]<sup>+</sup>). IR (neat, cm<sup>–1</sup>): ν̃ 1592, 1438, 1153, 664.</div></div><div id="sec4_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> 1-Tosyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-5-carboxylic Acid (<b>12</b>).<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></h3><div class="NLM_p last">To a solution of <b>11</b> (1.00 equvi, 500 mg), Pd(AcO)<sub>2</sub> (0.05 equiv, 16 mg), 1,1′-Ferrocenediyl-bis(diphenylphosphine) (dppf) (0.10 equiv, 79 mg) and EtN(<i>i</i>-Pr) (5.00 equiv, 1.24 mL) in DMF (0.05 M) was added acetic-formic anhydride (5.00 equiv, 626 mg) which was freshly prepared by treating the Ac<sub>2</sub>O (5.00 equiv, 673 μL) with formic acid (5.00 equiv, 251 μL) at 65 °C for 30 min,<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> The resulting mixture was heated to 110 °C for 5 h. After completion, it was cooled to RT and diluted by ethyl acetate (30 mL) and quenched with 20% KOH (10 mL) to make pH = 9, the aqueous layer was collected and acidified by con. HCl to adjust pH 4–6, and the corresponding acid was precipitated and filtered to get the desired product without further purification. 83% yield. mp 175 °C; <i>R</i><sub><i>f</i></sub> (hexane/ethyl acetate 1:1): 0.25; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i>): δ 13.28 (1H, s), 8.88 (1H, d, <i>J</i> = 2.0 Hz), 8.56 (1H, d, <i>J</i> = 2.0 Hz), 8.03–8.00 (3H, m), 7.42 (2H, d, <i>J</i> = 8.2 Hz), 6.93 (1H, d, <i>J</i> = 4.0 Hz), 2.33 (3H, s); <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i>): δ 166.3, 148.2, 145.9 (two overlapping signals), 134.3, 131.6, 130.1, 128.3, 127.6, 122.4, 122.1, 106.5, 21.1; LRMS (+ESI): <i>m</i>/<i>z</i> 317 (100, [M + H]<sup>+</sup>). IR (neat, cm<sup>–1</sup>): ν̃ 3146, 3102, 2854, 1680, 1528, 1192, 669, 589.</div></div><div id="sec4_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> 4-((<i>tert</i>-Butyldimethylsilyl)oxy)aniline (<b>13a</b>)</h3><div class="NLM_p last">This compound was prepared according to general procedure H. The residue was purified using flash chromatography (hexane/ethyl acetate 10:1 → 5:1) to give the product as a pale yellow oil (87% yield). <i>R</i><sub><i>f</i></sub> (hexane/ethyl acetate 2:1): 0.45; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i>): δ 6.53 (2H, d, <i>J</i> = 8.7 Hz), 8.46 (2H, d, <i>J</i> = 8.7 Hz), 4.59 (2H, s), 0.93 (9H, s), 0.11 (6H, s); <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i>): δ 145.5, 142.8, 119.9, 114.9, 25.6, 17.8, −4.6; The spectroscopic data matched that reported in the literature.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a></div></div><div id="sec4_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> 3-((<i>tert</i>-Butyldimethylsilyl)oxy)aniline (<b>13b</b>)</h3><div class="NLM_p last">This compound was prepared according to general procedure H. The residue was purified using flash chromatography (hexane/ethyl acetate 10:1 → 5:1) to give the product as a pale yellow oil (93% yield). <i>R</i><sub><i>f</i></sub> (hexane/ethyl acetate 2:1): 0.45; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 6.99 (1H, t, <i>J</i> = 8.0 Hz), 6.31–6.26 (2H, m), 6.21–6.20 (1H, m), 3.46 (2H, br.s), 0.99 (9H, s), 0.20 (6H, s); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 156.9, 147.8,130.1, 110.7, 108.7, 107.3, 25.9, 18.3, −4.2; The spectroscopic data matched that reported in the literature.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a></div></div><div id="sec4_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> <i>N</i>-(4-((<i>tert</i>-Butyldimethylsilyl)oxy)phenyl)-1-tosyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-5-carboxamide (<b>14a</b>)</h3><div class="NLM_p last">This compound was prepared according to general procedure I. The residue was purified by flash chromatography (hexane/ethyl acetate 5:1 → 3:1) to give the product as a white solid (61% yield). mp 190–192 °C; <i>R</i><sub><i>f</i></sub> (hexane/ethyl acetate 2:1): 0.35; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.81 (1H, d, <i>J</i> = 2.1 Hz), 8.26 (1H, d, <i>J</i> = 2.1 Hz), 8.06–8.03 (3H, m), 7.72 (1H, d, <i>J</i> = 4.0 Hz), 7.48 (2H, d, <i>J</i> = 8.8 Hz), 7.26 (2H, d, <i>J</i> = 8.1 Hz), 6.82 (2H, dd, <i>J</i> = 2.1 Hz, 6.7 Hz), 6.55 (1H, d, <i>J</i> = 4.0 Hz), 2.36 (3H, s), 0.98 (9H, s), 0.19 (6H, s); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 164.5, 152.9, 148.3, 145.8, 143.7, 135.1, 131.5, 129.9, 129.1, 128.3, 127.9, 126.7, 122.4, 122.1, 120.6, 105.6, 25.8, 21.8, 18.3, −4.3; LRMS (+ESI): <i>m</i>/<i>z</i> 544 (100, [M + Na]<sup>+</sup>). IR (neat, cm<sup>–1</sup>): ν̃ 3363, 2954, 2855, 1672, 1508, 1155, 997.</div></div><div id="sec4_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> <i>N</i>-(3-((<i>tert</i>-Butyldimethylsilyl)oxy)phenyl)-1-tosyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-5-carboxamide (<b>14b</b>)</h3><div class="NLM_p last">This compound was prepared according to general procedure I. The residue was purified by flash chromatography (hexane/ethyl acetate 5:1 → 3:1) to give the product as a white solid (79% yield). mp 105–107 °C; <i>R</i><sub><i>f</i></sub> (hexane/ethyl acetate 2:1): 0.35; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.82 (1H, d, <i>J</i> = 1.7 Hz), 8.62 (1H, s), 8.22 (1H, d, <i>J</i> = 1.7 Hz), 8.06 (2H, d, <i>J</i> = 8.2 Hz), 7.65 (1H, d, <i>J</i> = 4.0 Hz), 7.41–7.39 (1H, m), 7.28–7.25 (3H, m), 7.18 (1H, t, <i>J</i> = 8.0 Hz), 6.67–6.65 (1H, m), 6.46 (1H, d, <i>J</i> = 4.0 Hz), 2.38 (3H, s), 1.00 (9H, s), 0.23 (6H, s); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 164.9, 156.2, 148.0, 145.7, 144.0, 139.1, 134.8, 129.8, 129.6, 128.9, 128.1, 127.5, 126.6, 122.0, 116.4, 113.2, 112.3, 105.5, 25.7, 21.6, 18.2, −4.4; LRMS (+ESI): <i>m</i>/<i>z</i> 544 (100, [M + Na]<sup>+</sup>). IR (neat, cm<sup>–1</sup>): ν̃ 2952, 2929, 2857, 1596, 1374, 1191, 838, 578.</div></div><div id="sec4_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> <i>N</i>-(4-Hydroxyphenyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-5-carboxamide (<b>15a</b>)</h3><div class="NLM_p last">This compound was prepared according to general procedure E, under these conditions the TBS protecting group was removed as well. The residue was purified using flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 50:1 → 30:1) to give the product as a pale yellow solid (96% yield). mp 295–297 °C; <i>R</i><sub><i>f</i></sub> (hexane/ethyl acetate 1:1): 0.20; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i>): δ 11.94 (1H, s), 10.04 (1H, s), 9.24 (1H, s), 8.81 (1H, s), 8.53 (1H, s), 7.57–7.54(3H, m), 6.75 (2H, d, <i>J</i> = 8.4 Hz), 6.59 (1H, d, <i>J</i> = 3.0 Hz); <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i>): δ 164.7, 153.6, 149.5, 142.7, 130.9, 127.8, 127.6, 122.9, 122.2, 118.7, 115.0, 100.9; LRMS (+ESI): <i>m</i>/<i>z</i> 276 (100, [M + Na]<sup>+</sup>). IR (neat, cm<sup>–1</sup>): ν̃ 3334, 3114, 2863, 1636, 1535, 1235, 752.</div></div><div id="sec4_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> <i>N</i>-(3-Hydroxyphenyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-5-carboxamide (<b>15b</b>)</h3><div class="NLM_p last">This compound was prepared according to general procedure E, on which condition, TBS protecting group could also be removed at one-pot. The residue was purified using flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 50:1 → 30:1) to give the product as a pale yellow solid (94% yield). mp 290–295 °C; <i>R</i><sub><i>f</i></sub> (hexane/ethyl acetate 1:1): 0.20; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i>): δ 11.95 (1H, s), 10.13 (1H, s), 9.38 (1H, s), 8.80 (1H, d, <i>J</i> = 2.2 Hz), 8.54 (1H, d, <i>J</i> = 1.8 Hz), 7.59 (1H, dd, <i>J</i> = 2.5 Hz, 3.4 Hz), 7.39 (1H, t, <i>J</i> = 2.1 Hz), 7.20–7.17 (1H, m), 7.11 (1H, t, <i>J</i> = 8.0 Hz), 6.60 (1H, dd, <i>J</i> = 1.8 Hz, 3.4 Hz), 6.50 (1H, ddd, <i>J</i> = 1.0 Hz, 2.4 Hz, 8.0 Hz); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i>): δ 165.7, 158.0, 150.1, 143.3, 140.9, 129.7, 128.5, 128.2, 123.3, 119.1, 111.5, 111.1, 107.9, 101.5; LRMS (-ESI): <i>m</i>/<i>z</i> 252 (100, [M - H]<sup>−</sup>). IR (neat, cm<sup>–1</sup>): ν̃ 3343, 3283, 3135, 2882, 1619, 1597, 1441, 1212, 760.</div></div><div id="sec4_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> <i>N</i>-(4-Hydroxyphenyl)-3-iodo-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-5-carboxamide (<b>16a</b>)</h3><div class="NLM_p last">To a solution of <b>15a</b> (127 mg, 0.50 mmol) in dry DMF (10 mL) was added KOH (345 mg, 2.50 mmol) under nitrogen atmosphere at RT, after 10 min, a solution of I<sub>2</sub> (152 mg, 0.60 mmol) in DMF (1 mL) was added dropwise, and the resulting mixture was stirred at RT for 2 h. After completion monitored by TLC, the reaction was quenched with saturated Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub> aqueous, and extracted with ethyl acetate (3 × 10 mL), the organic layers were dried (MgSO<sub>4</sub>) and concentrated <i>in vacuo</i>. The residue was purified by flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 50:1) to give the product as a white solid (163 mg, 86% yield). mp 209–211 °C; <i>R</i><sub><i>f</i></sub> (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 50:1): 0.20; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i>): δ 12.46–12.32 (1H, br.s), 10.17 (1H, s), 9.30–9.21 (1H, br.s), 8.83 (1H, d, <i>J</i> = 2.1 Hz), 8.29 (1H, d, <i>J</i> = 2.1 Hz), 7.83 (1H, s), 7.55 (2H, dd, <i>J</i> = 2.1 Hz, 6.8 Hz), 6.75 (2H, dd, <i>J</i> = 2.1 Hz, 6.8 Hz); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i>): δ 164.1, 153.7, 149.2, 143.9, 132.1, 130.7, 127.7, 123.7, 122.4, 121.1, 115.0, 55.7; LRMS (-ESI): <i>m</i>/<i>z</i> 378 (100, [M - H]<sup>−</sup>). IR (neat, cm<sup>–1</sup>): ν̃ 3276, 3108, 2921, 1534, 1292, 1167.</div></div><div id="sec4_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> <i>N</i>-(3-Hydroxyphenyl)-3-iodo-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-5-carboxamide (<b>16b</b>)</h3><div class="NLM_p last">To a solution of <b>15b</b> (127 mg, 0.50 mmol) in dry DMF (10 mL) was added KOH (345 mg, 2.50 mmol) under nitrogen atmosphere at RT, after 10 min, a solution of I<sub>2</sub> (152 mg, 0.60 mmol) in DMF (1 mL) was added dropwise, and the resulting mixture was stirred at RT for 2 h. After completion monitored by TLC, the reaction was quenched with saturated Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub> aqueous, and extracted with ethyl acetate (3 × 10 mL), the organic layers were dried (MgSO<sub>4</sub>) and concentrated <i>in vacuo</i>. The residue was purified by flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 50:1) to give the product as a white solid (152 mg, 80% yield). mp 205–208 °C; <i>R</i><sub><i>f</i></sub> (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 50:1): 0.20; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i>): δ 12.40 (1H, br.s), 10.26 (1H, s), 9.41 (1H, br.s), 8.84 (1H, d, <i>J</i> = 1.8 Hz), 8.30 (1H, d, <i>J</i> = 1.8 Hz), 7.85 (1H, s), 7.39–7.38 (1H, m), 7.20–7.10 (2H, m), 6.52 (1H, d, <i>J</i> = 7.6 Hz); <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i>): δ 164.6, 157.5, 149.3, 144.1, 140.2, 132.2, 129.2, 127.9, 123.6, 121.1, 111.2, 110.8, 107.6, 55.8; LRMS (+ESI): <i>m</i>/<i>z</i> 402 (100, [M + Na]<sup>+</sup>). IR (neat, cm<sup>–1</sup>): ν̃ 3103, 3068, 2981, 2851, 1553, 1272, 773, 683.</div></div><div id="sec4_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> <i>N</i>,3-Bis(4-hydroxyphenyl)-1H-pyrrolo[2,3-<i>b</i>]pyridine-5-carboxamide (<b>17a</b>)</h3><div class="NLM_p last">This compound was prepared according to general procedure C at 110 °C. The residue was purified by flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 50:1→ 10:1) to give the product as a pale yellow solid (65% yield). mp 210–212 °C; <i>R</i><sub><i>f</i></sub> (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 20:1): 0.30; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i>): δ 12.04 (1H, s), 10.11 (1H, s), 9.42 (1H, br.s), 9.25 (1H, br.s), 8.82 (1H, d, <i>J</i> = 2.0 Hz), 8.73 (1H, d, <i>J</i> = 2.0 Hz), 7.78 (1H, s), 7.57 (2H, d, <i>J</i> = 8.6 Hz), 7.53 (2H, d, <i>J</i> = 8.9 Hz), 6.88 (2H, d, <i>J</i> = 8.6 Hz), 6.75 (2H, d, <i>J</i> = 8.9 Hz); <sup>13</sup>C NMR (125 MHz,, DMSO-<i>d</i>): δ 164.7, 156.0, 153.6, 150.0, 143.0, 130.7, 127.8, 127.2, 127.0, 125.3, 123.7, 122.9, 122.4, 116.4, 115.7, 115.0; HRMS (ESI+) calcd for C<sub>20</sub>H<sub>15</sub>N<sub>3</sub>O<sub>3</sub> [M + Na]<sup>+</sup> 368.1004, found 368.1006. IR (neat, cm<sup>–1</sup>): ν̃ 3334, 3011, 1636, 1535, 1235. HPLC: 98.8%, RT: 16.8 min.</div></div><div id="sec4_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> <i>N</i>-(3-Hydroxyphenyl)-3-(4-hydroxyphenyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-5-carboxamide (<b>17b</b>)</h3><div class="NLM_p last">This compound was prepared according to general procedure C at 110 °C. The residue was purified by flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 50:1→ 10:1) to give the product as a pale yellow solid (60% yield). mp 197–200 °C; <i>R</i><sub><i>f</i></sub> (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 20:1): 0.30; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i>): δ 12.04 (1H, s), 10.18 (1H, s), 9.39 (2H, br.s), 8.80 (1H, d, <i>J</i> = 2.0 Hz), 8.71 (1H, d, <i>J</i> = 2.0 Hz), 7.76 (1H, s), 7.56 (2H, ddd, <i>J</i> = 2.0 Hz, 2.9 Hz, 6.6 Hz), 7.34 (1H, t, <i>J</i> = 2.1 Hz), 7.17–7.15 (1H, s), 7.10 (1H, t, <i>J</i> = 8.0 Hz), 6.87 (2H, ddd, <i>J</i> = 2.0 Hz, 2.9 Hz, 6.6 Hz), 6.50–6.48 (1H, m); <sup>13</sup>C NMR (125 MHz,, DMSO-<i>d</i>): δ 165.2, 157.5, 156.0, 150.0, 143.1, 140.3, 129.2, 127.9, 127.2, 125.2, 123.7, 122.9, 116.3, 115.8, 115.7, 111.2, 110.7, 107.5; HRMS (ESI+) calcd for C<sub>20</sub>H<sub>15</sub>N<sub>3</sub>O<sub>3</sub> [M + Na]<sup>+</sup> 368.1005, found 368.1006. IR (neat, cm<sup>–1</sup>): ν̃ 3214, 2920, 2851, 1609, 1494, 1312. HPLC: 97.8%, RT: 17.7 min.</div></div><div id="sec4_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> 5-Bromo-1H-pyrrolo[2,3-<i>b</i>]pyridine-3-carboxylic acid (<b>18</b>)<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a></h3><div class="NLM_p last">To a solution of <b>4a</b> (1 g, 5.0 mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (0.1 M) was added AlCl<sub>3</sub> (1.67 g, 12.5 mmol) at 0 °C under nitrogen atmosphere. After 10 min, trichloroacetyl chloride (670 μL, 6 mmol) was added dropwise, and the resulting mixture was stirred at RT for 2 h. After completion monitored by TLC, the reaction was quenched with cold water (20 mL), and extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 10 mL), the organic layers were dried (MgSO<sub>4</sub>) and concentrated <i>in vacuo</i>. The residue was treated with NaOH aqueous (30 mL, 3M) without further purification, and stirred at RT for 3 h, the resulting mixture was added con. HCl dropwise at 0 °C to adjust pH as 4–6, and the resulting precipitate was filtered and washed by water and hexane, dried in <i>vacuo</i> to give the product as a pale yellow solid (856 mg, 70% yield over two steps). mp 289–290 °C, <i>R</i><sub><i>f</i></sub> (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 50:1): 0.25; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i>): δ 12.65 (1H, s), 12.40 (1H, s), 8.41 (1H, d, <i>J</i> = 2.8 Hz), 8.39 (1H, d, <i>J</i> = 2.8 Hz), 8.20 (1H, d, <i>J</i> = 3.7 Hz); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i>): δ 164.9, 147.1, 143.8, 134.2, 130.5, 120.0, 112.8, 106.0; LRMS (-ESI): <i>m</i>/<i>z</i> 239/241 (100/99, [M - H]<sup>−</sup>), IR (neat, cm<sup>–1</sup>): ν̃ 3407, 3119, 2885, 1680, 1528, 1182, 683. The spectroscopic data matched that reported in the literature.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></div></div><div id="sec4_59" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> 5-Bromo-<i>N</i>-(4-((<i>tert</i>-butyldimethylsilyl)oxy)phenyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-3-carboxamide (<b>19a</b>)</h3><div class="NLM_p last">This compound was prepared according to General Procedure I. The residue was purified by flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 100:1 → 50:1) to give the product as a pale yellow solid (70% yield). mp 270–272 °C; <i>R</i><sub><i>f</i></sub> (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 20:1): 0.45; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i>): δ 12.47 (1H, br.s), 9.76 (1H, s), 8.61 (1H, d, <i>J</i> = 2.9 Hz), 8.43 (1H, d, <i>J</i> = 1.7 Hz), 8.38 (1H, d, <i>J</i> = 2.9 Hz), 7.60 (2H, dd, <i>J</i> = 3.2 Hz, 11.3 Hz), 6.83 (2H, ddd, <i>J</i> = 2.6 Hz, 4.2 Hz, 6.8 Hz), 0.96 (9H, s), 0.19 (6H, s); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i>): δ 161.8, 150.7, 146.8, 143.7, 133.0, 131.1, 130.3, 121.5, 120.4, 120.0, 112.4, 109.1, 25.6, 17.9, −4.5; LRMS (+ESI): <i>m</i>/<i>z</i> 468/470 (98/100, [M + Na]<sup>+</sup>). IR (neat, cm<sup>–1</sup>): ν̃ 2924, 2853, 1614, 1508, 1291.</div></div><div id="sec4_60" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> 5-Bromo-<i>N</i>-(3-((<i>tert</i>-butyldimethylsilyl)oxy)phenyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-3-carboxamide (<b>19b</b>)</h3><div class="NLM_p last">This compound was prepared according to General Procedure I. The residue was purified by flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 100:1 → 50:1) to give the product as a pale yellow solid (75% yield). mp 234–235 °C; <i>R</i><sub><i>f</i></sub> (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 20:1): 0.45; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i>): δ 12.52 (1H, s), 9.80 (1H, s), 8.63 (1H, d, <i>J</i> = 2.1 Hz), 8.48 (1H, s), 8.39 (1H, d, <i>J</i> = 2.1 Hz), 7.41–7.40 (1H, m), 7.36 (1H, d, <i>J</i> = 8.2 Hz), 7.19 (1H, t, <i>J</i> = 8.0 Hz), 6.54 (1H, dd, <i>J</i> = 1.4 Hz, 8.0), 0.97 (9H, s), 0.21 (6H, s); <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i>): δ 162.1, 155.2, 146.9, 143.8, 140.5, 131.1, 130.7, 129.4, 120.5, 114.4, 112.9, 112.5, 111.3, 109.0, 25.5, 17.9, −4.5; LRMS (+ESI): <i>m</i>/<i>z</i> 446 (100, [M + H]<sup>+</sup>). IR (neat, cm<sup>–1</sup>): ν̃ 3362, 3091, 2927, 1637, 1536, 837.</div></div><div id="sec4_61" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> <i>N</i>-(4-((<i>tert</i>-Butyldimethylsilyl)oxy)phenyl)-5-(4-hydroxyphenyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-3-carboxamide (<b>20a</b>)</h3><div class="NLM_p last">This compound was prepared according to general procedure C at 110 °C. The residue was purified by flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 50:1→ 20:1) to give the product as a pale yellow solid (63% yield). mp 274–275 °C; <i>R</i><sub><i>f</i></sub> (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 20:1): 0.35; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i>): δ 12.24–12.23 (1H, br.s), 9.73 (1H, s), 9.55 (1H, s), 8.60 (1H, d, <i>J</i> = 2.2 Hz), 8.52 (1H, d, <i>J</i> = 2.2 Hz), 8.38 (1H, d, <i>J</i> = 3.0 Hz), 7.62 (2H, dd, <i>J</i> = 2.2 Hz, 6.8 Hz), 7.52 (2H, dd, <i>J</i> = 2.0 Hz, 6.6 Hz), 6.89 (2H, dd, <i>J</i> = 2.0 Hz, 6.6 Hz), 6.83 (2H, dd, <i>J</i> = 2.2 Hz, 6.8 Hz), 0.96 (9H, s), 0.18 (6H, s); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i>): δ 162.4, 156.9, 150.6, 147.6, 142.3, 133.3, 129.9, 129.4, 129.3, 128.1, 126.4, 121.5, 119.7, 118.7, 115.9, 109.5, 25.6, 17.9, −4.5; LRMS (+ESI): <i>m</i>/<i>z</i> 482 (100, [M + Na]<sup>+</sup>). IR (neat, cm<sup>–1</sup>): ν̃ 3231, 2954, 1508, 1262.</div></div><div id="sec4_62" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> <i>N</i>-(3-((<i>tert</i>-Butyldimethylsilyl)oxy)phenyl)-5-(4-hydroxyphenyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-3-carboxamide (<b>20b</b>)</h3><div class="NLM_p last">This compound was prepared according to general procedure C at 110 °C. The residue was purified by flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 50:1→ 20:1) to give the product as a pale yellow solid (61% yield). mp 242–244 °C; <i>R</i><sub><i>f</i></sub> (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 20:1): 0.35; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i>): δ 12.29 (1H, s), 9.76 (1H, s), 9.55 (1H, s), 8.59 (1H, d, <i>J</i> = 2.2 Hz), 8.53 (1H, d, <i>J</i> = 2.3 Hz), 8.43 (1H, d, <i>J</i> = 2.9 Hz), 7.53 (2H, d, <i>J</i> = 8.6 Hz), 7.42 (1H, t, <i>J</i> = 2.1 Hz), 7.40–7.38 (1H, m), 7.20 (1H, t, <i>J</i> = 8.1 Hz), 6.90 (2H, d, <i>J</i> = 8.6 Hz), 6.56–6.54 (1H, m), 0.98 (9H, s), 0.23 (6H, s); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i>): δ 162.6, 156.9, 155.2, 147.6, 142.4, 140.8, 130.0, 129.7, 129.4, 129.3, 128.1, 126.4, 118.7, 115.9, 114.2, 112.9, 111.2, 109.4, 25.6, 17.9, −4.5; LRMS (+ESI): <i>m</i>/<i>z</i> 482 (100, [M + Na]<sup>+</sup>). IR (neat, cm<sup>–1</sup>): ν̃ 3392, 2953, 2851, 1588, 1203, 830.</div></div><div id="sec4_63" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> <i>N</i>,5-Bis(4-hydroxyphenyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-3-carboxamide (<b>21a</b>).<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a></h3><div class="NLM_p last">To a solution of <b>20a</b> (50 mg, 0.11 mmol) in THF (5 mL) was added TBAF (1 M in THF) (170 μL, 0.17 mmol) dropwise and stirred at RT for 1 h. The solvent was removed <i>in vacuo</i> and the residue was purified by flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 20:1→ 10:1) to give the product as a pale yellow solid (35 mg, 93% yield). mp 225–227 °C; <i>R</i><sub><i>f</i></sub> (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 10:1): 0.30; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i>): δ 12.21–12.20 (1H, br.s), 9.64 (1H, s), 9.54 (1H, s), 9.17 (1H, s),8.60 (1H, d, <i>J</i> = 2.2 Hz), 8.51 (1H, d, <i>J</i> = 2.2 Hz), 8.38 (1H, d, <i>J</i> = 2.8 Hz), 7.52 (4H, d, <i>J</i> = 8.6 Hz), 6.89 (2H, d, <i>J</i> = 8.6 Hz), 6.74 (2H, d, <i>J</i> = 8.8 Hz); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i>): δ 162.3, 156.9, 153.2, 147.6, 142.2, 131.0, 129.9, 129.5, 129.1, 128.1, 126.4, 121.9, 118.8, 115.9, 115.0, 109.6; HRMS (ESI+) calcd for C<sub>20</sub>H<sub>15</sub>N<sub>3</sub>O<sub>3</sub> [M + Na]<sup>+</sup> 368.1006, found 368.1006. IR (neat, cm<sup>–1</sup>): ν̃ 3090, 2960, 2873, 1511, 820. HPLC: 99.7%, RT: 16.3 min.</div></div><div id="sec4_64" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> <i>N</i>-(3-Hydroxyphenyl)-5-(4-hydroxyphenyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-3-carboxamide (<b>21b</b>)</h3><div class="NLM_p last">To a solution of <b>20b</b> (50 mg, 0.11 mmol) in THF (5 mL) was added TBAF (1 M in THF) (170 μL, 0.17 mmol) dropwise and stirred at RT for 1 h. The solvent was removed <i>in vacuo</i> and the residue was purified by flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 20:1→ 10:1) to give the product as a pale yellow solid (36 mg, 95% yield). mp 280–284 °C; <i>R</i><sub><i>f</i></sub> (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 10:1): 0.30; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i>): δ 12.25 (1H, d, <i>J</i> = 2.5 Hz), 9.70 (1H, s), 9.55 (1H, s), 9.34 (1H, s), 8.60 (1H, d, <i>J</i> = 2.3 Hz), 8.52 (1H, d, <i>J</i> = 2.3 Hz), 8.43 (1H, d, <i>J</i> = 2.9 Hz), 7.52 (2H, dd, <i>J</i> = 2.0 Hz, 6.6 Hz), 7.37 (1H, t, <i>J</i> = 2.0 Hz), 7.15 (dt, 1H, <i>J</i> = 1.1 Hz, 8.0 Hz), 7.10 (1H, t, <i>J</i> = 8.0 Hz), 6.90 (2H, dd, <i>J</i> = 2.0 Hz, 6.6 Hz), 6.48–6.45 (1H, m); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i>): δ 162.6, 157.5, 157.0, 147.6, 142.4, 140.6, 130.0, 129.6, 129.5, 129.2, 128.1, 126.4, 118.8, 116.0, 110.6, 110.1, 109.5, 107.0; HRMS (ESI+) calcd for C<sub>20</sub>H<sub>15</sub>N<sub>3</sub>O<sub>3</sub> [M + Na]<sup>+</sup> 368.1006, found 368.1005. IR (neat, cm<sup>–1</sup>): ν̃ 3393, 3091, 2921, 1639, 1365. HPLC: 99.5%, RT: 17.4 min.</div></div><div id="sec4_65" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> Biology Evaluation</h3><div class="NLM_p last">All chemicals were obtained from Sigma-Aldrich (St. Louis, MO, USA). Primary antibodies against DYRK1A (#8765), DYRK1B (#2703), DYRK2 (#8143), and p38α (#9218), and secondary antirabbit (#7074) and antimouse (#7076) HRP-linked antibodies were obtained from Cell Signaling Technology (Danvers, MA, USA). EGFR (#sc03) and β-actin (#A5441) antibodies were obtained from Santa Cruz Biotechnology (Dallas, TX, USA) and Sigma-Aldrich (St. Louis, MO, USA), respectively. CLK1 antibody (#ab209681) was purchased from Abcam (Cambridge, UK). EGF was purchased from Life Technologies (Carlsbad, CA, USA).</div></div><div id="sec4_66" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> Kinase Inhibition Assay</h3><div class="NLM_p last">Active DYRK1A, DYRK1B, DYRK2, and CLK1 (all Life Technologies) were assayed in Tris buffer (50 mM Tris-HCl, pH 7.5) containing 0.1 mM EGTA, 15 mM DTT, MgAc/ATP cocktail (0.5 mM HEPES pH 7.4; 10 mM Mg(CH<sub>3</sub>COO)<sub>2</sub>; 0.1 mM ATP), [γ-<sup>32</sup>P]-ATP 100–300 cpm/pmol, and test compounds diluted in deionized water. As substrate, Woodtide (50 μM, Genscript) was used in DYRK1A, DYRK1B, and DYRK2 activity assays, and RS repeat peptide [KKGRSRSRSRSRSR] (20 μM, Genscript) was used in CLK1 activity assays. The reaction was initiated with 1 ng/μL DYRK1A or 0.5 ng/μL DYRK1B, DYRK2, and CLK1. The reaction mixture was incubated at 30 °C for 10 min (DYRK1A) or 40 min (DYRK1B, DYRK2, and CLK1) Reaction was stopped by pipetting 10 μL of the reaction mixture onto P81 paper (Reaction Biology) and washing with 0.75% w/v H<sub>3</sub>PO<sub>4</sub> and acetone. P81 papers were transferred to sample bags containing Optiphase Supermix scintillation cocktail (PerkinElmer), and radioactivity (cpm) was measured with a MicroBeta Trilux 2 counter (PerkinElmer). Compounds that inhibited DYRK1A activity by more than 50% at 10 μM were tested in an eight-point serial dilution at a Log<sub>3</sub> scale. Data were normalized to controls (set as 100% activity), and IC<sub>50</sub> values were calculated by nonlinear regression analysis using GraphPad Prism 6.0 (GraphPad, La Jolla, CA, USA). IC<sub>50</sub> values represent mean ± SEM from three independent experiments performed in triplicate.</div></div><div id="sec4_67" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> Cell Culture</h3><div class="NLM_p last">U251 and A172 cell lines were obtained from the European Collection of Cell Cultures (EACC, Salisbury, UK) through Cell Bank Australia in 2014. Cells were cultured in DMEM medium supplemented with 10% FBS and Antibiotic-Antimycotic (both Life Technologies) at 37 °C and 5% CO<sub>2</sub>. Primary glioblastoma cell lines (RN1, JK2, WK1, and SJH1) were derived from glioblastoma specimens, characterized as described<a onclick="showRef(event, 'ref54 ref55'); return false;" href="javascript:void(0);" class="ref ref54 ref55">(54, 55)</a> and cultured in KnockOut DMEM/F-12 basal medium supplemented with StemPro NSC SFM supplement, 2 mM GlutaMAX-ICTS, 20 ng/mL EGF, 10 ng/mL FGF-β, and Antibiotic-Antimycotic solution (all Life Technologies) as adherent cells on flasks coated with MatriGel Matrix (BD Falcon). The protocols were approved by the Human Ethics Committee of the University of Sydney (HREC2013/131) and the Human Ethics Committee of the Royal Brisbane & Women’s Hospital (RBWH 2004/161). All cell cultures were routinely tested for mycoplasma infection, and the cumulative length of culturing did not exceed 10 passages.</div></div><div id="sec4_68" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> Cell Viability Assay</h3><div class="NLM_p last">U251, A172, RN1, WK1 (2 × 10<sup>3</sup> cells/well), JK2, and SJH1 (4 × 10<sup>3</sup> cells/well) were seeded in 96-well plate and treated on the following day with vehicle or test compounds (0.001–50 μM) for 3 days (U251, A172, RN1, and JK2) or 5 days (WK1 and SJH1). Ten microliters of Cell-Titer Blue reagent (Promega, WI, USA) was added to each well and incubated at 37 °C for 4 h. Fluorescence was measured with a Tecan M200 PRO+ microplate reader (Tecan, Switzerland) at 585 nm. Data were normalized to controls (set as 100% viability), and EC<sub>50</sub> values were calculated by nonlinear regression analysis using GraphPad Prism 6.0 (GraphPad, La Jolla, CA, USA). EC<sub>50</sub> values represent mean ± SEM from three independent experiments performed in triplicate.</div></div><div id="sec4_69" class="NLM_sec NLM_sec_level_2"><div id="ac_i88" class="anchor-spacer"></div><h3 class="article-section__title" id="_i88"> Clonogenic Survival</h3><div class="NLM_p last">RN1 (2 × 10<sup>3</sup> cells/well) and U251 (0.5 × 10<sup>3</sup> cells/well) were seeded onto 6-well plates and treated on the following day with vehicle or test compounds (0.01–5 μM). Cells were grown for 12 days, fixed with 50% methanol, and stained with Toluidine Blue (Sigma-Aldrich). Colonies were counted using the ImageJ software (Colony Area function). Data were normalized to controls (set as 100% survival) and EC<sub>50</sub> values calculated by nonlinear regression analysis using GraphPad Prism 6.0 (GraphPad, La Jolla, CA, USA). EC<sub>50</sub> values represent mean ± SEM from three independent experiments performed in duplicate. One-way ANOVA, followed by Dunnett’s multiple comparison test (GraphPad Prism 6.0), was used to determine statistical significance. <i>P</i> < 0.05 was considered as significant.</div></div><div id="sec4_70" class="NLM_sec NLM_sec_level_2"><div id="ac_i89" class="anchor-spacer"></div><h3 class="article-section__title" id="_i89"> Migration and Invasion Assays</h3><div class="NLM_p last">U251 (1.7 × 10<sup>3</sup> cells/well), A172 (1.5 × 10<sup>3</sup> cells/well), and RN1 (2.0 × 10<sup>3</sup> cells/well) were seeded onto ImageLock 96-well plates (IncuCyte). For RN1 cells, the plates were precoated with MatriGel Matrix (BD Falcon). After 24 h, each well was scratched using the WoundMaker (IncuCyte) and washed with Dulbecco’s PBS (Sigma-Aldrich). Migration assays were performed in 1% FBS in DMEM (A172, U251) or 0.2% neural supplement in StemPro NSC SFM (RN1) containing test compounds or DMSO (control). For the invasion assays, 45 μL of MatriGel Matrix and 5 μL of 10× inhibitor (or DMSO) were added to each well and allowed to solidify at 37 °C for 30–60 min. Once the Matrigel Matrix was set, cells were treated with test compounds or DMSO in 1% FBS in DMEM (A172, U251). The plates were imaged over 72 h (IncuCyte), and the relative wound density (RWD, defined as the cumulative increase of wound confluence as a percentage over time) was analyzed with IncuCyte Zoom software. Velocity (μm/h) was calculated between 0 and 20 h, where the RWD curves were steep and their slopes constant, following the Wound Healing Data analysis (ibidi GmbH, Version 1.2; <a href="http://tinyurl.com/gv6ehvo" class="extLink">http://tinyurl.com/gv6ehvo</a>).</div></div><div id="sec4_71" class="NLM_sec NLM_sec_level_2"><div id="ac_i90" class="anchor-spacer"></div><h3 class="article-section__title" id="_i90"> Transient DYRK1A Knockdown and EGFR Degradation Asasy</h3><div class="NLM_p last">U251 (7–9 × 10<sup>5</sup> cells/well) were plated on 6-well plates and incubated overnight or until 60–70% confluence. Cells were washed with PBS and treated with transfection medium containing 10 nM <i>si</i>RNA-DYRK1A (5′-CCGUAAACUUCAUAACAUUtt -3′) or 10 nM <i>si</i>RNA-Ctr (both Ambion Silencer Select) diluted in RNAiMAX, Opti-MEM, and serum free DMEM (all Life Technologies), according to manufacturer’s instructions. Cells were incubated in the transfection medium for 12–16 h and then starved overnight in serum free DMEM. For the EGFR degradation assay, starved cells were incubated with cycoheximide (2 μg/mL, 2 h) and treated with EGF (100 ng/mL). Cells were lysed at indicated time points with lysis buffer (1 M Tris, 0.5 M EDTA, 5 M NaCl, 1 M MgCl<sub>2</sub>, Triton X-100, 0.5 M NaF, 10% v/v glycerol, 1 mM PMSF, 1 mM Na<sub>3</sub>VO<sub>4</sub>) supplemented with protease inhibitor cocktail (Roche), the protein concentration in lysates was determined with the BCA Protein Assay Kit (Life Technologies), and samples were analyzed by Western blotting.</div></div><div id="sec4_72" class="NLM_sec NLM_sec_level_2"><div id="ac_i91" class="anchor-spacer"></div><h3 class="article-section__title" id="_i91"> EGFR Degradation Assay upon Drug Treatment</h3><div class="NLM_p last">U251 (3 × 10<sup>5</sup> cells/well) were seeded onto 6-well plates and starved in serum free DMEM overnight. Starved cells were incubated with test compounds (2.5 μM) or DMSO (control), treated with cycloheximide (30 μg/mL; 1 h) and EGF (100 ng/mL) for indicated time points. Cells were lysed with lysis buffer (as above), protein concentration was determined with the BCA Protein Assay Kit (Life Technologies), and samples were analyzed by Western blotting.</div></div><div id="sec4_73" class="NLM_sec NLM_sec_level_2"><div id="ac_i92" class="anchor-spacer"></div><h3 class="article-section__title" id="_i92"> Cellular Thermal Shift Assay</h3><div class="NLM_p">U251 (8 × 10<sup>6</sup> cells/plate) were seeded onto 100 mm Petri dishes and incubated overnight. Cells were treated with test compound (10 μM) or DMSO for 1 h, harvested, washed with PBS, and resuspended in PBS containing protease inhibitor cocktail (Roche). Cell suspensions were divided into 100 μL aliquots in 0.2 mL PCR tubes. Each tube was heated at indicated temperatures (40–70 °C) for 3 min using the Veriti thermal cycler (Life Technologies) followed by 3 min cooling at 25 °C, and then snap-frozen using liquid nitrogen.</div><div class="NLM_p last">For the ITDRF assay, U251 (8 × 10<sup>6</sup> cells/plate) were seeded onto 100 mm Petri dishes and incubated overnight. Cells were treated with test compound (0–20 μM) or DMSO for 1 h, harvested, washed with PBS, and resuspended in PBS containing protease inhibitor cocktail (Roche). Cell suspensions were divided into 100 μL aliquots in 0.2 mL PCR tubes and heated at 54 °C for 3 min using the Veriti Thermal Cycler (Life Technologies) followed by 3 min cooling at 25 °C, and then snap-frozen using liquid nitrogen. The heat-treated cells were lysed by three freeze–thaw cycles using liquid nitrogen and 37 °C water bath. Cell lysates were centrifuged at 15,000 rpm for 20 min at 4 °C. Clear supernatants were removed, subjected to protein quantification using the BCA Protein Assay Kit (Life Technologies, following manufacturer’s instruction), and analyzed by Western blotting.</div></div><div id="sec4_74" class="NLM_sec NLM_sec_level_2"><div id="ac_i93" class="anchor-spacer"></div><h3 class="article-section__title" id="_i93"> Western Blotting</h3><div class="NLM_p last">Cell lysates (20–60 μg) or CETSA samples (30 μg) were resolved on 8% or 4–12% SDS-PAGE gels and transferred onto PVDF membranes (both Life Technologies). Membranes were blocked with 5% (w/v) skim milk or 15% (w/v) BSA in TBST and incubated with primary antibody overnight at 4 °C. After washing with TBST, membranes were incubated with their respective secondary antibody for 1 h in RT. Detection was performed with Immobilon Western HRP Substrate Luminol-Peroxidase reagent (MerckMillipore) and the ChemiDoc MP System (BioRad).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i94"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01840">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07102" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07102" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b01840" class="ext-link">10.1021/acs.jmedchem.6b01840</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline"><sup>1</sup>H and <sup>13</sup>C NMR spectra and HPLC chromatograms (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01840/suppl_file/jm6b01840_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01840/suppl_file/jm6b01840_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01840/suppl_file/jm6b01840_si_001.pdf">jm6b01840_si_001.pdf (10.1 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01840/suppl_file/jm6b01840_si_002.csv">jm6b01840_si_002.csv (3.43 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.6b01840" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26814" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26814" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lenka Munoz</span> - <span class="hlFld-Affiliation affiliation">†School
of Chemistry, ‡School of Medical Sciences, Discipline of Pathology
and Charles Perkins Centre, and §School of Medical Sciences, Discipline of Pharmacology, The University of Sydney, New South Wales 2006, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">QIMR
Berghofer Medical Research Institute, 300 Herston Road, Herston, Queensland 4006, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Oncogenic
Signaling Laboratory, Centre for Cancer Research, Hudson Institute of Medical Research, 27 Wright Street, Clayton, Victoria 3168, Australia</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7625-5646" title="Orcid link">http://orcid.org/0000-0002-7625-5646</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#7c101912171d5211091213063c0f051812190552191809521d09"><span class="__cf_email__" data-cfemail="84e8e1eaefe5aae9f1eaebfec4f7fde0eae1fdaae1e0f1aae5f1">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Kassiou</span> - <span class="hlFld-Affiliation affiliation">†School
of Chemistry, ‡School of Medical Sciences, Discipline of Pathology
and Charles Perkins Centre, and §School of Medical Sciences, Discipline of Pharmacology, The University of Sydney, New South Wales 2006, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">QIMR
Berghofer Medical Research Institute, 300 Herston Road, Herston, Queensland 4006, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Oncogenic
Signaling Laboratory, Centre for Cancer Research, Hudson Institute of Medical Research, 27 Wright Street, Clayton, Victoria 3168, Australia</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6655-0529" title="Orcid link">http://orcid.org/0000-0002-6655-0529</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#5934303a31383c357732382a2a30362c192a203d373c20773c3d2c77382c"><span class="__cf_email__" data-cfemail="8fe2e6ece7eeeae3a1e4eefcfce6e0facffcf6ebe1eaf6a1eaebfaa1eefa">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qingqing Zhou</span> - <span class="hlFld-Affiliation affiliation">†School
of Chemistry, ‡School of Medical Sciences, Discipline of Pathology
and Charles Perkins Centre, and §School of Medical Sciences, Discipline of Pharmacology, The University of Sydney, New South Wales 2006, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">QIMR
Berghofer Medical Research Institute, 300 Herston Road, Herston, Queensland 4006, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Oncogenic
Signaling Laboratory, Centre for Cancer Research, Hudson Institute of Medical Research, 27 Wright Street, Clayton, Victoria 3168, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Athena F. Phoa</span> - <span class="hlFld-Affiliation affiliation">†School
of Chemistry, ‡School of Medical Sciences, Discipline of Pathology
and Charles Perkins Centre, and §School of Medical Sciences, Discipline of Pharmacology, The University of Sydney, New South Wales 2006, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">QIMR
Berghofer Medical Research Institute, 300 Herston Road, Herston, Queensland 4006, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Oncogenic
Signaling Laboratory, Centre for Cancer Research, Hudson Institute of Medical Research, 27 Wright Street, Clayton, Victoria 3168, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ramzi H. Abbassi</span> - <span class="hlFld-Affiliation affiliation">†School
of Chemistry, ‡School of Medical Sciences, Discipline of Pathology
and Charles Perkins Centre, and §School of Medical Sciences, Discipline of Pharmacology, The University of Sydney, New South Wales 2006, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">QIMR
Berghofer Medical Research Institute, 300 Herston Road, Herston, Queensland 4006, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Oncogenic
Signaling Laboratory, Centre for Cancer Research, Hudson Institute of Medical Research, 27 Wright Street, Clayton, Victoria 3168, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Monira Hoque</span> - <span class="hlFld-Affiliation affiliation">†School
of Chemistry, ‡School of Medical Sciences, Discipline of Pathology
and Charles Perkins Centre, and §School of Medical Sciences, Discipline of Pharmacology, The University of Sydney, New South Wales 2006, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">QIMR
Berghofer Medical Research Institute, 300 Herston Road, Herston, Queensland 4006, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Oncogenic
Signaling Laboratory, Centre for Cancer Research, Hudson Institute of Medical Research, 27 Wright Street, Clayton, Victoria 3168, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tristan A. Reekie</span> - <span class="hlFld-Affiliation affiliation">†School
of Chemistry, ‡School of Medical Sciences, Discipline of Pathology
and Charles Perkins Centre, and §School of Medical Sciences, Discipline of Pharmacology, The University of Sydney, New South Wales 2006, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">QIMR
Berghofer Medical Research Institute, 300 Herston Road, Herston, Queensland 4006, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Oncogenic
Signaling Laboratory, Centre for Cancer Research, Hudson Institute of Medical Research, 27 Wright Street, Clayton, Victoria 3168, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Josep S. Font</span> - <span class="hlFld-Affiliation affiliation">†School
of Chemistry, ‡School of Medical Sciences, Discipline of Pathology
and Charles Perkins Centre, and §School of Medical Sciences, Discipline of Pharmacology, The University of Sydney, New South Wales 2006, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">QIMR
Berghofer Medical Research Institute, 300 Herston Road, Herston, Queensland 4006, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Oncogenic
Signaling Laboratory, Centre for Cancer Research, Hudson Institute of Medical Research, 27 Wright Street, Clayton, Victoria 3168, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Renae M. Ryan</span> - <span class="hlFld-Affiliation affiliation">†School
of Chemistry, ‡School of Medical Sciences, Discipline of Pathology
and Charles Perkins Centre, and §School of Medical Sciences, Discipline of Pharmacology, The University of Sydney, New South Wales 2006, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">QIMR
Berghofer Medical Research Institute, 300 Herston Road, Herston, Queensland 4006, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Oncogenic
Signaling Laboratory, Centre for Cancer Research, Hudson Institute of Medical Research, 27 Wright Street, Clayton, Victoria 3168, Australia</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8680-4610" title="Orcid link">http://orcid.org/0000-0002-8680-4610</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brett W. Stringer</span> - <span class="hlFld-Affiliation affiliation">QIMR
Berghofer Medical Research Institute, 300 Herston Road, Herston, Queensland 4006, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bryan W. Day</span> - <span class="hlFld-Affiliation affiliation">QIMR
Berghofer Medical Research Institute, 300 Herston Road, Herston, Queensland 4006, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Terrance G. Johns</span> - <span class="hlFld-Affiliation affiliation">Oncogenic
Signaling Laboratory, Centre for Cancer Research, Hudson Institute of Medical Research, 27 Wright Street, Clayton, Victoria 3168, Australia</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e6673-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i95">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76450" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76450" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by the National Health & Medical Research Council of Australia (APP1106145). LM is a Cancer Institute NSW Career Development Fellow (grant reference 15/CDF/1-07), and the study was supported by Cancer Institute NSW and Brain Foundation Australia. TGJ, BWS, and BWD are members of the Brain Cancer Discovery Collaborative, which is supported by the Cure Brain Cancer Foundation.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i96" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i96"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i97" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i97"> Abbreviations Used</h2><tr><td class="NLM_term">CDK</td><td class="NLM_def"><p class="first last">cyclin-dependent kinase</p></td></tr><tr><td class="NLM_term">CETSA</td><td class="NLM_def"><p class="first last">cellular thermal shift assay</p></td></tr><tr><td class="NLM_term">CLK</td><td class="NLM_def"><p class="first last">CDC-like kinase</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last"><i>N,N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">dppf</td><td class="NLM_def"><p class="first last">1,1′-ferrocenediyl-bis(diphenylphosphine)</p></td></tr><tr><td class="NLM_term">DYRK</td><td class="NLM_def"><p class="first last">dual-specificity tyrosine phosphorylation-regulated kinases</p></td></tr><tr><td class="NLM_term">EGFR</td><td class="NLM_def"><p class="first last">epidermal growth factor receptor</p></td></tr><tr><td class="NLM_term">GSK</td><td class="NLM_def"><p class="first last">glycogen synthase kinase</p></td></tr><tr><td class="NLM_term">HBTU</td><td class="NLM_def"><p class="first last">(2-(1<i>H</i>-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate)</p></td></tr><tr><td class="NLM_term">ITDRF</td><td class="NLM_def"><p class="first last">isothermal dose–response fingerprint</p></td></tr><tr><td class="NLM_term">MAPK</td><td class="NLM_def"><p class="first last">mitogen-activated protein kinase</p></td></tr><tr><td class="NLM_term">NIS</td><td class="NLM_def"><p class="first last"><i>N</i>-iodosuccinimide</p></td></tr><tr><td class="NLM_term">OTBS</td><td class="NLM_def"><p class="first last"><i>tert</i>-butyldimethylsilyl ether</p></td></tr><tr><td class="NLM_term">TBAF</td><td class="NLM_def"><p class="first last"><i>tetra</i>-<i>n</i>-butylammonium fluoride</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i98">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55206" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55206" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 68 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Varjosalo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keskitalo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Drogen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nurkkala, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vichalkovski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aebersold, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gstaiger, M.</span><span> </span><span class="NLM_article-title">The protein interaction landscape of the human CMGC kinase group</span> <span class="citation_source-journal">Cell Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1306</span><span class="NLM_x">–</span> <span class="NLM_lpage">1320</span><span class="refDoi"> DOI: 10.1016/j.celrep.2013.03.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1016%2Fj.celrep.2013.03.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=23602568" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmt1Cmu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=1306-1320&author=M.+Varjosaloauthor=S.+Keskitaloauthor=A.+Van+Drogenauthor=H.+Nurkkalaauthor=A.+Vichalkovskiauthor=R.+Aebersoldauthor=M.+Gstaiger&title=The+protein+interaction+landscape+of+the+human+CMGC+kinase+group&doi=10.1016%2Fj.celrep.2013.03.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The Protein Interaction Landscape of the Human CMGC Kinase Group</span></div><div class="casAuthors">Varjosalo, Markku; Keskitalo, Salla; Van Drogen, Audrey; Nurkkala, Helka; Vichalkovski, Anton; Aebersold, Ruedi; Gstaiger, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1306-1320</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Cellular information processing via reversible protein phosphorylation requires tight control of the localization, activity, and substrate specificity of protein kinases, which to a large extent is accomplished by complex formation with other proteins.  Despite their crit. role in cellular regulation and pathogenesis, protein interaction information is available for only a subset of the 518 human protein kinases.  Here we present a global proteomic anal. of complexes of the human CMGC kinase group.  In addn. to subgroup-specific functional enrichment and modularity, the identified 652 high-confidence kinase-protein interactions provide a specific biochem. context for many poorly studied CMGC kinases.  Furthermore, the anal. revealed a kinase-kinase subnetwork and candidate substrates for CMGC kinases.  Finally, the presented interaction proteome uncovered a large set of interactions with proteins genetically linked to a range of human diseases, including cancer, suggesting addnl. routes for analyzing the role of CMGC kinases in controlling human disease pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyOh3MUOGE47Vg90H21EOLACvtfcHk0lh7vdKHHkz9Kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmt1Cmu7s%253D&md5=09d13e5b27edff77aeb206ab044e8da6</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2013.03.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2013.03.027%26sid%3Dliteratum%253Aachs%26aulast%3DVarjosalo%26aufirst%3DM.%26aulast%3DKeskitalo%26aufirst%3DS.%26aulast%3DVan%2BDrogen%26aufirst%3DA.%26aulast%3DNurkkala%26aufirst%3DH.%26aulast%3DVichalkovski%26aufirst%3DA.%26aulast%3DAebersold%26aufirst%3DR.%26aulast%3DGstaiger%26aufirst%3DM.%26atitle%3DThe%2520protein%2520interaction%2520landscape%2520of%2520the%2520human%2520CMGC%2520kinase%2520group%26jtitle%3DCell%2520Rep.%26date%3D2013%26volume%3D3%26spage%3D1306%26epage%3D1320%26doi%3D10.1016%2Fj.celrep.2013.03.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Loidreau, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubouilh-Benard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nourrisson, M.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duflos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loaëc, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besson, T.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of N-aryl-7-methoxybenzo[b]furo[3,2-d]pyrimidin-4-amines and their N-arylbenzo[b]thieno[3,2-d]pyrimidin-4-amine analogues as dual inhibitors of CLK1 and DYRK1A kinases</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">283</span><span class="NLM_x">–</span> <span class="NLM_lpage">295</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2012.11.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1016%2Fj.ejmech.2012.11.030" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2013&pages=283-295&author=Y.+Loidreauauthor=P.+Marchandauthor=C.+Dubouilh-Benardauthor=M.-R.+Nourrissonauthor=M.+Duflosauthor=N.+Loa%C3%ABcauthor=L.+Meijerauthor=T.+Besson&title=Synthesis+and+biological+evaluation+of+N-aryl-7-methoxybenzo%5Bb%5Dfuro%5B3%2C2-d%5Dpyrimidin-4-amines+and+their+N-arylbenzo%5Bb%5Dthieno%5B3%2C2-d%5Dpyrimidin-4-amine+analogues+as+dual+inhibitors+of+CLK1+and+DYRK1A+kinases&doi=10.1016%2Fj.ejmech.2012.11.030"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2012.11.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2012.11.030%26sid%3Dliteratum%253Aachs%26aulast%3DLoidreau%26aufirst%3DY.%26aulast%3DMarchand%26aufirst%3DP.%26aulast%3DDubouilh-Benard%26aufirst%3DC.%26aulast%3DNourrisson%26aufirst%3DM.-R.%26aulast%3DDuflos%26aufirst%3DM.%26aulast%3DLoa%25C3%25ABc%26aufirst%3DN.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DBesson%26aufirst%3DT.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520N-aryl-7-methoxybenzo%255Bb%255Dfuro%255B3%252C2-d%255Dpyrimidin-4-amines%2520and%2520their%2520N-arylbenzo%255Bb%255Dthieno%255B3%252C2-d%255Dpyrimidin-4-amine%2520analogues%2520as%2520dual%2520inhibitors%2520of%2520CLK1%2520and%2520DYRK1A%2520kinases%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D59%26spage%3D283%26epage%3D295%26doi%3D10.1016%2Fj.ejmech.2012.11.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Abbassi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johns, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassiou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz, L.</span><span> </span><span class="NLM_article-title">DYRK1A in neurodegeneration and cancer: molecular basis and clinical implications</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">151</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">98</span><span class="refDoi"> DOI: 10.1016/j.pharmthera.2015.03.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1016%2Fj.pharmthera.2015.03.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=25795597" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BC2MXltFWgsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=2015&pages=87-98&author=R.+Abbassiauthor=T.+G.+Johnsauthor=M.+Kassiouauthor=L.+Munoz&title=DYRK1A+in+neurodegeneration+and+cancer%3A+molecular+basis+and+clinical+implications&doi=10.1016%2Fj.pharmthera.2015.03.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">DYRK1A in neurodegeneration and cancer: Molecular basis and clinical implications</span></div><div class="casAuthors">Abbassi, Ramzi; Johns, Terrance G.; Kassiou, Michael; Munoz, Lenka</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">151</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">87-98</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Protein kinases are one of the most studied drug targets in current pharmacol. research, as evidenced by the vast no. of kinase-targeting agents enrolled in active clin. trials.  Dual-specificity Tyrosine phosphorylation-Regulated Kinase 1A (DYRK1A) has been much less studied compared to many other kinases.  DYRK1A primary function occurs during early development, where this protein regulates cellular processes related to proliferation and differentiation of neuronal progenitor cells.  Although most extensively characterized for its role in brain development, DYRK1A is over-expressed in a variety of diseases including a no. of human malignancies, such as haematol. and brain cancers.  Here we review the accumulating mol. studies that support our understanding of how DYRK1A signalling could underlie these pathol. functions.  The relevance of DYRK1A in a no. of diseases is also substantiated with intensive drug discovery efforts to develop potent and selective inhibitors of DYRK1A.  Several classes of DYRK1A inhibitors have recently been disclosed and some mols. are promising leads to develop DYRK1A inhibitors as drugs for DYRK1A-dependent diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIdxPFd6Zn0LVg90H21EOLACvtfcHk0lg0ECZIYt95LQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXltFWgsr0%253D&md5=bbe08b211b477f0d4a279c34c6d36b42</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2015.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2015.03.004%26sid%3Dliteratum%253Aachs%26aulast%3DAbbassi%26aufirst%3DR.%26aulast%3DJohns%26aufirst%3DT.%2BG.%26aulast%3DKassiou%26aufirst%3DM.%26aulast%3DMunoz%26aufirst%3DL.%26atitle%3DDYRK1A%2520in%2520neurodegeneration%2520and%2520cancer%253A%2520molecular%2520basis%2520and%2520clinical%2520implications%26jtitle%3DPharmacol.%2520Ther.%26date%3D2015%26volume%3D151%26spage%3D87%26epage%3D98%26doi%3D10.1016%2Fj.pharmthera.2015.03.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Becker, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sippl, W.</span><span> </span><span class="NLM_article-title">Activation, regulation, and inhibition of DYRK1A</span> <span class="citation_source-journal">FEBS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">246</span><span class="NLM_x">–</span> <span class="NLM_lpage">256</span><span class="refDoi"> DOI: 10.1111/j.1742-4658.2010.07956.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1111%2Fj.1742-4658.2010.07956.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=21126318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFGru7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2011&pages=246-256&author=W.+Beckerauthor=W.+Sippl&title=Activation%2C+regulation%2C+and+inhibition+of+DYRK1A&doi=10.1111%2Fj.1742-4658.2010.07956.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Activation, regulation, and inhibition of DYRK1A</span></div><div class="casAuthors">Becker, Walter; Sippl, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">246-256</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) is a protein kinase with diverse functions in neuronal development and adult brain physiol.  Higher than normal levels of DYRK1A are assocd. with the pathol. of neurodegenerative diseases and have been implicated in some neurobiol. alterations of Down syndrome, such as mental retardation.  It is therefore important to understand the mol. mechanisms that control the activity of DYRK1A.  Here, the authors review current knowledge about the initial self-activation of DYRK1A by tyrosine autophosphorylation and propose that this mechanism presents an ancestral feature of the CMGC group of kinases.  However, tyrosine phosphorylation does not appear to regulate the enzymic activity of DYRK1A.  Control of DYRK1A may take place on the level of gene expression, interaction with regulatory proteins, and regulated nuclear translocation.  Finally, the authors compare the properties of small mol. inhibitors that target DYRK1A and evaluate their potential application and limitations.  The β-carboline alkaloid, harmine, is currently the most selective and potent inhibitor of DYRK1A and has proven very useful in cellular assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-_Eqb_-j05bVg90H21EOLACvtfcHk0lg0ECZIYt95LQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFGru7s%253D&md5=958db7f4577f941bd8dfb56afc461335</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-4658.2010.07956.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-4658.2010.07956.x%26sid%3Dliteratum%253Aachs%26aulast%3DBecker%26aufirst%3DW.%26aulast%3DSippl%26aufirst%3DW.%26atitle%3DActivation%252C%2520regulation%252C%2520and%2520inhibition%2520of%2520DYRK1A%26jtitle%3DFEBS%2520J.%26date%3D2011%26volume%3D278%26spage%3D246%26epage%3D256%26doi%3D10.1111%2Fj.1742-4658.2010.07956.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Tejedor, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hämmerle, B.</span><span> </span><span class="NLM_article-title">MNB/DYRK1A as a multiple regulator of neuronal development</span> <span class="citation_source-journal">FEBS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">235</span><span class="refDoi"> DOI: 10.1111/j.1742-4658.2010.07954.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1111%2Fj.1742-4658.2010.07954.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2011&pages=223-235&author=F.+J.+Tejedorauthor=B.+H%C3%A4mmerle&title=MNB%2FDYRK1A+as+a+multiple+regulator+of+neuronal+development&doi=10.1111%2Fj.1742-4658.2010.07954.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-4658.2010.07954.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-4658.2010.07954.x%26sid%3Dliteratum%253Aachs%26aulast%3DTejedor%26aufirst%3DF.%2BJ.%26aulast%3DH%25C3%25A4mmerle%26aufirst%3DB.%26atitle%3DMNB%252FDYRK1A%2520as%2520a%2520multiple%2520regulator%2520of%2520neuronal%2520development%26jtitle%3DFEBS%2520J.%26date%3D2011%26volume%3D278%26spage%3D223%26epage%3D235%26doi%3D10.1111%2Fj.1742-4658.2010.07954.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Smith, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medda, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gokhale, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunckley, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hulme, C.</span><span> </span><span class="NLM_article-title">Recent advances in the design, synthesis, and biological evaluation of selective DYRK1A inhibitors: a new avenue for a disease modifying treatment of Alzheimer’s?</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">857</span><span class="NLM_x">–</span> <span class="NLM_lpage">872</span><span class="refDoi"> DOI: 10.1021/cn300094k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn300094k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1KmsL3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=857-872&author=B.+Smithauthor=F.+Meddaauthor=V.+Gokhaleauthor=T.+Dunckleyauthor=C.+Hulme&title=Recent+advances+in+the+design%2C+synthesis%2C+and+biological+evaluation+of+selective+DYRK1A+inhibitors%3A+a+new+avenue+for+a+disease+modifying+treatment+of+Alzheimer%E2%80%99s%3F&doi=10.1021%2Fcn300094k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Advances in the Design, Synthesis, and Biological Evaluation of Selective DYRK1A Inhibitors: A New Avenue for a Disease Modifying Treatment of Alzheimer's?</span></div><div class="casAuthors">Smith, Breland; Medda, Federico; Gokhale, Vijay; Dunckley, Travis; Hulme, Christopher</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">857-872</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  With 24.3 million people affected in 2005 and an estd. rise to 42.3 million in 2020, dementia is currently a leading unmet medical need and costly burden on public health.  Seventy percent of these cases have been attributed to Alzheimer's disease (AD), a neurodegenerative pathol. whose most evident symptom is a progressive decline in cognitive functions.  Dual specificity tyrosine phosphorylation regulated kinase-1A (DYRK1A) is important in neuronal development and plays a variety of functional roles within the adult central nervous system.  The DYRK1A gene is located within the Down syndrome crit. region (DSCR) on human chromosome 21 and current research suggests that overexpression of DYRK1A may be a significant factor leading to cognitive deficits in people with Alzheimer's disease (AD) and Down syndrome (DS).  Currently, treatment options for cognitive deficiencies assocd. with Down syndrome, as well as Alzheimer's disease, are extremely limited and represent a major unmet therapeutic need.  Small mol. inhibition of DYRK1A activity in the brain may provide an avenue for pharmaceutical intervention of mental impairment assocd. with AD and other neurodegenerative diseases.  We herein review the current state of the art in the development of DYRK1A inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqSAw8CXNiP7Vg90H21EOLACvtfcHk0li1h2h66clXYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1KmsL3K&md5=2009c25bc00389971cd71f64ead2da4a</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fcn300094k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn300094k%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DB.%26aulast%3DMedda%26aufirst%3DF.%26aulast%3DGokhale%26aufirst%3DV.%26aulast%3DDunckley%26aufirst%3DT.%26aulast%3DHulme%26aufirst%3DC.%26atitle%3DRecent%2520advances%2520in%2520the%2520design%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520selective%2520DYRK1A%2520inhibitors%253A%2520a%2520new%2520avenue%2520for%2520a%2520disease%2520modifying%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%253F%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D3%26spage%3D857%26epage%3D872%26doi%3D10.1021%2Fcn300094k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Giraud, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alves, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debiton, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nauton, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Théry, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durieu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferandin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lozach, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anizon, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pereira, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreau, P.</span><span> </span><span class="NLM_article-title">Synthesis, protein kinase inhibitory potencies, and in vitro antiproliferative activities of meridianin derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">4474</span><span class="NLM_x">–</span> <span class="NLM_lpage">4489</span><span class="refDoi"> DOI: 10.1021/jm200464w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200464w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnt12nsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=4474-4489&author=F.+Giraudauthor=G.+Alvesauthor=E.+Debitonauthor=L.+Nautonauthor=V.+Th%C3%A9ryauthor=E.+Durieuauthor=Y.+Ferandinauthor=O.+Lozachauthor=L.+Meijerauthor=F.+Anizonauthor=E.+Pereiraauthor=P.+Moreau&title=Synthesis%2C+protein+kinase+inhibitory+potencies%2C+and+in+vitro+antiproliferative+activities+of+meridianin+derivatives&doi=10.1021%2Fjm200464w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, Protein Kinase Inhibitory Potencies, and in Vitro Antiproliferative Activities of Meridianin Derivatives</span></div><div class="casAuthors">Giraud, Francis; Alves, Georges; Debiton, Eric; Nauton, Lionel; Thery, Vincent; Durieu, Emilie; Ferandin, Yoan; Lozach, Olivier; Meijer, Laurent; Anizon, Fabrice; Pereira, Elisabeth; Moreau, Pascale</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4474-4489</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis of new meridianin derivs., e.g., I (X = H, Y = 7-Br; X = I, Y = 6-Br, 7-Br) (II), is described.  The indolic ring system was substituted at the C-4 to C-7 positions either by a bromine atom or by nitro or amino groups.  Addnl., an iodine atom or various aryl groups were introduced at the C-5 position of the 2-aminopyrimidine ring.  These compds., as well as some of their synthetic intermediates, were tested for their kinase inhibitory potencies and for their in vitro antiproliferative activities.  We found that this series of compds. is particularly interesting in the development of new inhibitors of DYRK1A and CLK1 kinases.  The most effective compds. toward these two kinase families are the 6- and 7-bromo derivs. II that showed more than 45-fold selectivity toward DYRK1A/CLK1 kinases over the other kinases tested.  Meridianin derivs. could thus be developed toward potent and selective inhibitors of key RNA splicing regulators and potential therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBjkvRn0gdELVg90H21EOLACvtfcHk0li1h2h66clXYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnt12nsb4%253D&md5=7689b7e5afd91dd2dc1b1b1c3aec6a5d</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm200464w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200464w%26sid%3Dliteratum%253Aachs%26aulast%3DGiraud%26aufirst%3DF.%26aulast%3DAlves%26aufirst%3DG.%26aulast%3DDebiton%26aufirst%3DE.%26aulast%3DNauton%26aufirst%3DL.%26aulast%3DTh%25C3%25A9ry%26aufirst%3DV.%26aulast%3DDurieu%26aufirst%3DE.%26aulast%3DFerandin%26aufirst%3DY.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DAnizon%26aufirst%3DF.%26aulast%3DPereira%26aufirst%3DE.%26aulast%3DMoreau%26aufirst%3DP.%26atitle%3DSynthesis%252C%2520protein%2520kinase%2520inhibitory%2520potencies%252C%2520and%2520in%2520vitro%2520antiproliferative%2520activities%2520of%2520meridianin%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D4474%26epage%3D4489%26doi%3D10.1021%2Fjm200464w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Debdab, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carreaux, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renault, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soundararajan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lozach, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babault, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahtouh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baratte, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagiwara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenreich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bazureau, J.-P.</span><span> </span><span class="NLM_article-title">Leucettines, a class of potent inhibitors of CDC2-like kinases and dual specificity, tyrosine phosphorylation regulated kinases derived from the marine sponge leucettamine B: modulation of alternative pre-RNA splicing</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">4172</span><span class="NLM_x">–</span> <span class="NLM_lpage">4186</span><span class="refDoi"> DOI: 10.1021/jm200274d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200274d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=4172-4186&author=M.+Debdabauthor=F.+Carreauxauthor=S.+Renaultauthor=M.+Soundararajanauthor=O.+Fedorovauthor=P.+Filippakopoulosauthor=O.+Lozachauthor=L.+Babaultauthor=T.+Tahtouhauthor=B.+Baratteauthor=Y.+Ogawaauthor=M.+Hagiwaraauthor=A.+Eisenreichauthor=U.+Rauchauthor=S.+Knappauthor=L.+Meijerauthor=J.-P.+Bazureau&title=Leucettines%2C+a+class+of+potent+inhibitors+of+CDC2-like+kinases+and+dual+specificity%2C+tyrosine+phosphorylation+regulated+kinases+derived+from+the+marine+sponge+leucettamine+B%3A+modulation+of+alternative+pre-RNA+splicing&doi=10.1021%2Fjm200274d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm200274d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200274d%26sid%3Dliteratum%253Aachs%26aulast%3DDebdab%26aufirst%3DM.%26aulast%3DCarreaux%26aufirst%3DF.%26aulast%3DRenault%26aufirst%3DS.%26aulast%3DSoundararajan%26aufirst%3DM.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DBabault%26aufirst%3DL.%26aulast%3DTahtouh%26aufirst%3DT.%26aulast%3DBaratte%26aufirst%3DB.%26aulast%3DOgawa%26aufirst%3DY.%26aulast%3DHagiwara%26aufirst%3DM.%26aulast%3DEisenreich%26aufirst%3DA.%26aulast%3DRauch%26aufirst%3DU.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DBazureau%26aufirst%3DJ.-P.%26atitle%3DLeucettines%252C%2520a%2520class%2520of%2520potent%2520inhibitors%2520of%2520CDC2-like%2520kinases%2520and%2520dual%2520specificity%252C%2520tyrosine%2520phosphorylation%2520regulated%2520kinases%2520derived%2520from%2520the%2520marine%2520sponge%2520leucettamine%2520B%253A%2520modulation%2520of%2520alternative%2520pre-RNA%2520splicing%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D4172%26epage%3D4186%26doi%3D10.1021%2Fjm200274d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Bain, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plater, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shpiro, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hastie, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLauchlan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klevernic, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arthur, J. S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, P.</span><span> </span><span class="NLM_article-title">The selectivity of protein kinase inhibitors: a further update</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">408</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">315</span><span class="refDoi"> DOI: 10.1042/BJ20070797</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1042%2FBJ20070797" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=17850214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlGmtbjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=408&publication_year=2007&pages=297-315&author=J.+Bainauthor=L.+Platerauthor=M.+Elliottauthor=N.+Shpiroauthor=C.+J.+Hastieauthor=H.+McLauchlanauthor=I.+Klevernicauthor=J.+S.+C.+Arthurauthor=D.+R.+Alessiauthor=P.+Cohen&title=The+selectivity+of+protein+kinase+inhibitors%3A+a+further+update&doi=10.1042%2FBJ20070797"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The selectivity of protein kinase inhibitors: a further update</span></div><div class="casAuthors">Bain, Jenny; Plater, Lorna; Elliott, Matt; Shpiro, Natalia; Hastie, C. James; McLauchlan, Hilary; Klevernic, Iva; Arthur, J. Simon C.; Alessi, Dario R.; Cohen, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">408</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">297-315</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">The specificities of 65 compds. reported to be relatively specific inhibitors of protein kinases have been profiled against a panel of 70-80 protein kinases.  On the basis of this information, the effects of compds. that we have studied in cells and other data in the literature, we recommend the use of the following small-mol. inhibitors: SB 203580/SB202190 and BIRB 0796 to be used in parallel to assess the physiol. roles of p38 MAPK (mitogen-activated protein kinase) isoforms, PI-103 and wortmannin to be used in parallel to inhibit phosphatidylinositol (phosphoinositide) 3-kinases, PP1 or PP2 to be used in parallel with Src-I1 (Src inhibitor-1) to inhibit Src family members; PD 184352 or PD 0325901 to inhibit MKK1 (MAPK kinase-1) or MKK1 plus MKK5, Akt-I-1/2 to inhibit the activation of PKB (protein kinase B/Akt), rapamycin to inhibit TORC1 [mTOR (mammalian target of rapamycin)-raptor (regulatory assocd. protein of mTOR) complex], CT 99021 to inhibit GSK3 (glycogen synthase kinase 3), BI-D1870 and SL0101 or FMK (fluoromethylketone) to be used in parallel to inhibit RSK (ribosomal S6 kinase), D4476 to inhibit CK1 (casein kinase 1), VX680 to inhibit Aurora kinases, and roscovitine as a pan-CDK (cyclin-dependent kinase) inhibitor.  We have also identified harmine as a potent and specific inhibitor of DYRK1A (dual-specificity tyrosine-phosphorylated and -regulated kinase 1A) in vitro.  The results have further emphasized the need for considerable caution in using small-mol. inhibitors of protein kinases to assess the physiol. roles of these enzymes.  Despite being used widely, many of the compds. that we analyzed were too non-specific for useful conclusions to be made, other than to exclude the involvement of particular protein kinases in cellular processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQPaieWftdVrVg90H21EOLACvtfcHk0ljQexQuMcapaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlGmtbjE&md5=e2334e35897dd1b9770bbcca8f82bb9c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1042%2FBJ20070797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20070797%26sid%3Dliteratum%253Aachs%26aulast%3DBain%26aufirst%3DJ.%26aulast%3DPlater%26aufirst%3DL.%26aulast%3DElliott%26aufirst%3DM.%26aulast%3DShpiro%26aufirst%3DN.%26aulast%3DHastie%26aufirst%3DC.%2BJ.%26aulast%3DMcLauchlan%26aufirst%3DH.%26aulast%3DKlevernic%26aufirst%3DI.%26aulast%3DArthur%26aufirst%3DJ.%2BS.%2BC.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DThe%2520selectivity%2520of%2520protein%2520kinase%2520inhibitors%253A%2520a%2520further%2520update%26jtitle%3DBiochem.%2520J.%26date%3D2007%26volume%3D408%26spage%3D297%26epage%3D315%26doi%3D10.1042%2FBJ20070797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Göckler, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jofre, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papadopoulos, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soppa, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tejedor, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, W.</span><span> </span><span class="NLM_article-title">Harmine specifically inhibits protein kinase DYRK1A and interferes with neurite formation</span> <span class="citation_source-journal">FEBS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">6324</span><span class="NLM_x">–</span> <span class="NLM_lpage">6337</span><span class="refDoi"> DOI: 10.1111/j.1742-4658.2009.07346.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1111%2Fj.1742-4658.2009.07346.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=19796173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A280%3ADC%252BD1MnovVSmtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2009&pages=6324-6337&author=N.+G%C3%B6cklerauthor=G.+Jofreauthor=C.+Papadopoulosauthor=U.+Soppaauthor=F.+J.+Tejedorauthor=W.+Becker&title=Harmine+specifically+inhibits+protein+kinase+DYRK1A+and+interferes+with+neurite+formation&doi=10.1111%2Fj.1742-4658.2009.07346.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Harmine specifically inhibits protein kinase DYRK1A and interferes with neurite formation</span></div><div class="casAuthors">Gockler Nora; Jofre Guillermo; Papadopoulos Chrisovalantis; Soppa Ulf; Tejedor Francisco J; Becker Walter</div><div class="citationInfo"><span class="NLM_cas:title">The FEBS journal</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6324-37</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">DYRK1A is a dual-specificity protein kinase that autophosphorylates a conserved tyrosine residue in the activation loop but phosphorylates exogenous substrates only at serine or threonine residues.  Tyrosine autophosphorylation of DYRKs is a one-off event that takes place during translation and induces the activation of the kinase.  Here we characterize the beta-carboline alkaloid harmine as a potent and specific inhibitor of DYRK1A both in vitro and in cultured cells.  Comparative in vitro assays of four kinases of the DYRK family showed that harmine inhibited substrate phosphorylation by DYRK1A more potently than it inhibited substrate phosphorylation by the closely related kinase DYRK1B [half maximal inhibitory concentrations (IC(50)) of 33 nm versus 166 nm, respectively] and by the more distant members of the family, DYRK2 and DYRK4 (1.9 microm and 80 microm, respectively).  Much higher concentrations of harmine were required to suppress tyrosine autophosphorylation of the translational intermediate of DYRK1A in a bacterial in vitro translation system (IC(50) = 1.9 microm).  Importantly, harmine inhibited the phosphorylation of a specific substrate by DYRK1A in cultured cells with a potency similar to that observed in vitro (IC(50) = 48 nm), without negative effects on the viability of the cells.  Overexpression of the DYRK1A gene on chromosome 21 has been implicated in the altered neuronal development observed in Down syndrome.  Here, we show that harmine interferes with neuritogenesis in cultured hippocampal neurons.  In summary, our data show that harmine inhibits DYRK1A substrate phosphorylation more potently than it inhibits tyrosine autophosphorylation, and provide evidence for a role of DYRK1A in the regulation of neurite formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTYQnyD9o3hqhe4jJGKT5N0fW6udTcc2eY64sqZ6n9_Gbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MnovVSmtw%253D%253D&md5=f59bc35eb74546f6351a4705f2d5fda7</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-4658.2009.07346.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-4658.2009.07346.x%26sid%3Dliteratum%253Aachs%26aulast%3DG%25C3%25B6ckler%26aufirst%3DN.%26aulast%3DJofre%26aufirst%3DG.%26aulast%3DPapadopoulos%26aufirst%3DC.%26aulast%3DSoppa%26aufirst%3DU.%26aulast%3DTejedor%26aufirst%3DF.%2BJ.%26aulast%3DBecker%26aufirst%3DW.%26atitle%3DHarmine%2520specifically%2520inhibits%2520protein%2520kinase%2520DYRK1A%2520and%2520interferes%2520with%2520neurite%2520formation%26jtitle%3DFEBS%2520J.%26date%3D2009%26volume%3D276%26spage%3D6324%26epage%3D6337%26doi%3D10.1111%2Fj.1742-4658.2009.07346.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Grabher, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durieu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kouloura, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halabalaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skaltsounis, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span> </span><span class="NLM_article-title">Hamburger, M.; Potterat, O. Library-based discovery of DYRK1A/CLK1 inhibitors from natural product extracts</span> <span class="citation_source-journal">Planta Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">951</span><span class="NLM_x">–</span> <span class="NLM_lpage">956</span><span class="refDoi"> DOI: 10.1055/s-0031-1298625</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1055%2Fs-0031-1298625" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2012&pages=951-956&author=P.+Grabherauthor=E.+Durieuauthor=E.+Koulouraauthor=M.+Halabalakiauthor=L.+A.+Skaltsounisauthor=L.+Meijer&title=Hamburger%2C+M.%3B+Potterat%2C+O.+Library-based+discovery+of+DYRK1A%2FCLK1+inhibitors+from+natural+product+extracts&doi=10.1055%2Fs-0031-1298625"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1055%2Fs-0031-1298625&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0031-1298625%26sid%3Dliteratum%253Aachs%26aulast%3DGrabher%26aufirst%3DP.%26aulast%3DDurieu%26aufirst%3DE.%26aulast%3DKouloura%26aufirst%3DE.%26aulast%3DHalabalaki%26aufirst%3DM.%26aulast%3DSkaltsounis%26aufirst%3DL.%2BA.%26aulast%3DMeijer%26aufirst%3DL.%26atitle%3DHamburger%252C%2520M.%253B%2520Potterat%252C%2520O.%2520Library-based%2520discovery%2520of%2520DYRK1A%252FCLK1%2520inhibitors%2520from%2520natural%2520product%2520extracts%26jtitle%3DPlanta%2520Med.%26date%3D2012%26volume%3D78%26spage%3D951%26epage%3D956%26doi%3D10.1055%2Fs-0031-1298625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Ogawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohnishi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiramatsu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kii, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onogi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibuya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosoya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagiwara, M.</span><span> </span><span class="NLM_article-title">Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">86</span><span class="refDoi"> DOI: 10.1038/ncomms1090</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1038%2Fncomms1090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=20981014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A280%3ADC%252BC3cbislehtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=86&author=Y.+Ogawaauthor=Y.+Nonakaauthor=T.+Gotoauthor=E.+Ohnishiauthor=T.+Hiramatsuauthor=I.+Kiiauthor=M.+Yoshidaauthor=T.+Ikuraauthor=H.+Onogiauthor=H.+Shibuyaauthor=T.+Hosoyaauthor=N.+Itoauthor=M.+Hagiwara&title=Development+of+a+novel+selective+inhibitor+of+the+Down+syndrome-related+kinase+Dyrk1A&doi=10.1038%2Fncomms1090"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A</span></div><div class="casAuthors">Ogawa Yasushi; Nonaka Yosuke; Goto Toshiyasu; Ohnishi Eriko; Hiramatsu Toshiyuki; Kii Isao; Yoshida Miyo; Ikura Teikichi; Onogi Hiroshi; Shibuya Hiroshi; Hosoya Takamitsu; Ito Nobutoshi; Hagiwara Masatoshi</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">86</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Dyrk1A (dual-specificity tyrosine-(Y)-phosphorylation-regulated kinase 1A) is a serine/threonine kinase essential for brain development and function, and its excessive activity is considered a pathogenic factor in Down syndrome.  The development of potent, selective inhibitors of Dyrk1A would help to elucidate the molecular mechanisms of normal and diseased brains, and may provide a new lead compound for molecular-targeted drug discovery.  Here, we report a novel Dyrk1A inhibitor, INDY, a benzothiazole derivative showing a potent ATP-competitive inhibitory effect with IC(50) and K(i) values of 0.24 and 0.18 μM, respectively.  X-ray crystallography of the Dyrk1A/INDY complex revealed the binding of INDY in the ATP pocket of the enzyme.  INDY effectively reversed the aberrant tau-phosphorylation and rescued the repressed NFAT (nuclear factor of activated T cell) signalling induced by Dyrk1A overexpression.  Importantly, proINDY, a prodrug of INDY, effectively recovered Xenopus embryos from head malformation induced by Dyrk1A overexpression, resulting in normally developed embryos and demonstrating the utility of proINDY in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTOCqf6rsXbPtenUz0lpNqnfW6udTcc2eZlalCosOoTE7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cbislehtw%253D%253D&md5=ac1d5972bec4085de101bb86194babd1</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fncomms1090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms1090%26sid%3Dliteratum%253Aachs%26aulast%3DOgawa%26aufirst%3DY.%26aulast%3DNonaka%26aufirst%3DY.%26aulast%3DGoto%26aufirst%3DT.%26aulast%3DOhnishi%26aufirst%3DE.%26aulast%3DHiramatsu%26aufirst%3DT.%26aulast%3DKii%26aufirst%3DI.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DIkura%26aufirst%3DT.%26aulast%3DOnogi%26aufirst%3DH.%26aulast%3DShibuya%26aufirst%3DH.%26aulast%3DHosoya%26aufirst%3DT.%26aulast%3DIto%26aufirst%3DN.%26aulast%3DHagiwara%26aufirst%3DM.%26atitle%3DDevelopment%2520of%2520a%2520novel%2520selective%2520inhibitor%2520of%2520the%2520Down%2520syndrome-related%2520kinase%2520Dyrk1A%26jtitle%3DNat.%2520Commun.%26date%3D2010%26volume%3D1%26spage%3D86%26doi%3D10.1038%2Fncomms1090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Gourdain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dairou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denhez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bui, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigues-Lima, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janel, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delabar, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cariou, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, R. H.</span><span> </span><span class="NLM_article-title">Development of DANDYs, new 3,5-diaryl-7-azaindoles demonstrating potent DYRK1A kinase inhibitory activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">9569</span><span class="NLM_x">–</span> <span class="NLM_lpage">9585</span><span class="refDoi"> DOI: 10.1021/jm401049v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401049v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslWrt77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=9569-9585&author=S.+Gourdainauthor=J.+Dairouauthor=C.+Denhezauthor=L.+C.+Buiauthor=F.+Rodrigues-Limaauthor=N.+Janelauthor=J.+M.+Delabarauthor=K.+Cariouauthor=R.+H.+Dodd&title=Development+of+DANDYs%2C+new+3%2C5-diaryl-7-azaindoles+demonstrating+potent+DYRK1A+kinase+inhibitory+activity&doi=10.1021%2Fjm401049v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Development of DANDYs, New 3,5-Diaryl-7-azaindoles Demonstrating Potent DYRK1A Kinase Inhibitory Activity</span></div><div class="casAuthors">Gourdain, Stephanie; Dairou, Julien; Denhez, Clement; Bui, Linh Chi; Rodrigues-Lima, Fernando; Janel, Nathalie; Delabar, Jean M.; Cariou, Kevin; Dodd, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9569-9585</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of 3,5-diaryl-1H-pyrrolo[2,3-b]pyridines was synthesized and evaluated for inhibition of DYRK1A kinase in vitro.  Derivs. having hydroxy groups on the aryl moieties demonstrated high inhibitory potencies with Kis in the low nanomolar range.  Their methoxy analogs were up to 100 times less active.  Docking studies at the ATP binding site suggested that these compds. bind tightly to this site via a network of multiple H-bonds with the peptide backbone.  None of the active compds. was cytotoxic to KB cells at 10-6 M.  Kinase profiling revealed that compd. I showed 2-fold selectivity for DYRK1A with respect to DYRK2 and DYRK3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1vxODs_tGD7Vg90H21EOLACvtfcHk0lj6yXaJujeA4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslWrt77K&md5=27dcc77a1c0d413cf0ab5c999cf9a195</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm401049v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401049v%26sid%3Dliteratum%253Aachs%26aulast%3DGourdain%26aufirst%3DS.%26aulast%3DDairou%26aufirst%3DJ.%26aulast%3DDenhez%26aufirst%3DC.%26aulast%3DBui%26aufirst%3DL.%2BC.%26aulast%3DRodrigues-Lima%26aufirst%3DF.%26aulast%3DJanel%26aufirst%3DN.%26aulast%3DDelabar%26aufirst%3DJ.%2BM.%26aulast%3DCariou%26aufirst%3DK.%26aulast%3DDodd%26aufirst%3DR.%2BH.%26atitle%3DDevelopment%2520of%2520DANDYs%252C%2520new%25203%252C5-diaryl-7-azaindoles%2520demonstrating%2520potent%2520DYRK1A%2520kinase%2520inhibitory%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D9569%26epage%3D9585%26doi%3D10.1021%2Fjm401049v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Muraki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohkawara, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosoya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onogi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koizumi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koizumi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sumi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yomoda, J.-i.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furuichi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibuya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krainer, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagiwara, M.</span><span> </span><span class="NLM_article-title">Manipulation of Alternative Splicing by a Newly Developed Inhibitor of Clks</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">24246</span><span class="NLM_x">–</span> <span class="NLM_lpage">24254</span><span class="refDoi"> DOI: 10.1074/jbc.M314298200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1074%2Fjbc.M314298200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=24246-24254&author=M.+Murakiauthor=B.+Ohkawaraauthor=T.+Hosoyaauthor=H.+Onogiauthor=J.+Koizumiauthor=T.+Koizumiauthor=K.+Sumiauthor=J.-i.+Yomodaauthor=M.+V.+Murrayauthor=H.+Kimuraauthor=K.+Furuichiauthor=H.+Shibuyaauthor=A.+R.+Krainerauthor=M.+Suzukiauthor=M.+Hagiwara&title=Manipulation+of+Alternative+Splicing+by+a+Newly+Developed+Inhibitor+of+Clks&doi=10.1074%2Fjbc.M314298200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M314298200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M314298200%26sid%3Dliteratum%253Aachs%26aulast%3DMuraki%26aufirst%3DM.%26aulast%3DOhkawara%26aufirst%3DB.%26aulast%3DHosoya%26aufirst%3DT.%26aulast%3DOnogi%26aufirst%3DH.%26aulast%3DKoizumi%26aufirst%3DJ.%26aulast%3DKoizumi%26aufirst%3DT.%26aulast%3DSumi%26aufirst%3DK.%26aulast%3DYomoda%26aufirst%3DJ.-i.%26aulast%3DMurray%26aufirst%3DM.%2BV.%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DFuruichi%26aufirst%3DK.%26aulast%3DShibuya%26aufirst%3DH.%26aulast%3DKrainer%26aufirst%3DA.%2BR.%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DHagiwara%26aufirst%3DM.%26atitle%3DManipulation%2520of%2520Alternative%2520Splicing%2520by%2520a%2520Newly%2520Developed%2520Inhibitor%2520of%2520Clks%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D24246%26epage%3D24254%26doi%3D10.1074%2Fjbc.M314298200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Mott, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanega, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maloney, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinn, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leister, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marugan, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inglese, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misteli, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auld, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, C. J.</span><span> </span><span class="NLM_article-title">Evaluation of substituted 6-arylquinazolin-4-amines as potent and selective inhibitors of cdc2-like kinases (Clk)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">6700</span><span class="NLM_x">–</span> <span class="NLM_lpage">6705</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.09.121</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1016%2Fj.bmcl.2009.09.121" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=6700-6705&author=B.+T.+Mottauthor=C.+Tanegaauthor=M.+Shenauthor=D.+J.+Maloneyauthor=P.+Shinnauthor=W.+Leisterauthor=J.+J.+Maruganauthor=J.+Ingleseauthor=C.+P.+Austinauthor=T.+Misteliauthor=D.+S.+Auldauthor=C.+J.+Thomas&title=Evaluation+of+substituted+6-arylquinazolin-4-amines+as+potent+and+selective+inhibitors+of+cdc2-like+kinases+%28Clk%29&doi=10.1016%2Fj.bmcl.2009.09.121"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.09.121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.09.121%26sid%3Dliteratum%253Aachs%26aulast%3DMott%26aufirst%3DB.%2BT.%26aulast%3DTanega%26aufirst%3DC.%26aulast%3DShen%26aufirst%3DM.%26aulast%3DMaloney%26aufirst%3DD.%2BJ.%26aulast%3DShinn%26aufirst%3DP.%26aulast%3DLeister%26aufirst%3DW.%26aulast%3DMarugan%26aufirst%3DJ.%2BJ.%26aulast%3DInglese%26aufirst%3DJ.%26aulast%3DAustin%26aufirst%3DC.%2BP.%26aulast%3DMisteli%26aufirst%3DT.%26aulast%3DAuld%26aufirst%3DD.%2BS.%26aulast%3DThomas%26aufirst%3DC.%2BJ.%26atitle%3DEvaluation%2520of%2520substituted%25206-arylquinazolin-4-amines%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520cdc2-like%2520kinases%2520%2528Clk%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D6700%26epage%3D6705%26doi%3D10.1016%2Fj.bmcl.2009.09.121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Kii, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sumida, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonamoto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okuno, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato-Sumida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koike, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibuya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosoya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagiwara, M.</span><span> </span><span class="NLM_article-title">Selective inhibition of the kinase DYRK1A by targeting its folding process</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">11391</span><span class="refDoi"> DOI: 10.1038/ncomms11391</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1038%2Fncomms11391" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=27102360" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BC28XmslShtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=11391&author=I.+Kiiauthor=Y.+Sumidaauthor=T.+Gotoauthor=R.+Sonamotoauthor=Y.+Okunoauthor=S.+Yoshidaauthor=T.+Kato-Sumidaauthor=Y.+Koikeauthor=M.+Abeauthor=Y.+Nonakaauthor=T.+Ikuraauthor=N.+Itoauthor=H.+Shibuyaauthor=T.+Hosoyaauthor=M.+Hagiwara&title=Selective+inhibition+of+the+kinase+DYRK1A+by+targeting+its+folding+process&doi=10.1038%2Fncomms11391"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Selective inhibition of the kinase DYRK1A by targeting its folding process</span></div><div class="casAuthors">Kii, Isao; Sumida, Yuto; Goto, Toshiyasu; Sonamoto, Rie; Okuno, Yukiko; Yoshida, Suguru; Kato-Sumida, Tomoe; Koike, Yuka; Abe, Minako; Nonaka, Yosuke; Ikura, Teikichi; Ito, Nobutoshi; Shibuya, Hiroshi; Hosoya, Takamitsu; Hagiwara, Masatoshi</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11391</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Autophosphorylation of amino-acid residues is part of the folding process of various protein kinases.  Conventional chem. screening of mature kinases has missed inhibitors that selectively interfere with the folding process.  Here we report a cell-based assay that evaluates inhibition of a kinase at a transitional state during the folding process and identify a folding intermediate-selective inhibitor of dual-specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A), which we refer to as FINDY.  FINDY suppresses intramol. autophosphorylation of Ser97 in DYRK1A in cultured cells, leading to its degrdn., but does not inhibit substrate phosphorylation catalyzed by the mature kinase.  FINDY also suppresses Ser97 autophosphorylation of recombinant DYRK1A, suggesting direct inhibition, and shows high selectivity for DYRK1A over other DYRK family members.  In addn., FINDY rescues DYRK1A-induced developmental malformations in Xenopus laevis embryos.  Our study demonstrates that transitional folding intermediates of protein kinases can be targeted by small mols., and paves the way for developing novel types of kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE2gsAsp-YjLVg90H21EOLACvtfcHk0liEgSvyUfYhjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmslShtr8%253D&md5=5d64de412dd168a415a3da052d3afedc</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fncomms11391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms11391%26sid%3Dliteratum%253Aachs%26aulast%3DKii%26aufirst%3DI.%26aulast%3DSumida%26aufirst%3DY.%26aulast%3DGoto%26aufirst%3DT.%26aulast%3DSonamoto%26aufirst%3DR.%26aulast%3DOkuno%26aufirst%3DY.%26aulast%3DYoshida%26aufirst%3DS.%26aulast%3DKato-Sumida%26aufirst%3DT.%26aulast%3DKoike%26aufirst%3DY.%26aulast%3DAbe%26aufirst%3DM.%26aulast%3DNonaka%26aufirst%3DY.%26aulast%3DIkura%26aufirst%3DT.%26aulast%3DIto%26aufirst%3DN.%26aulast%3DShibuya%26aufirst%3DH.%26aulast%3DHosoya%26aufirst%3DT.%26aulast%3DHagiwara%26aufirst%3DM.%26atitle%3DSelective%2520inhibition%2520of%2520the%2520kinase%2520DYRK1A%2520by%2520targeting%2520its%2520folding%2520process%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D11391%26doi%3D10.1038%2Fncomms11391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Falke, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaikuad, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loaëc, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lozach, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abu Jhaisha, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunick, C.</span><span> </span><span class="NLM_article-title">10-Iodo-11H-indolo[3,2-c]quinoline-6-carboxylic acids are selective inhibitors of DYRK1A</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">3131</span><span class="NLM_x">–</span> <span class="NLM_lpage">3143</span><span class="refDoi"> DOI: 10.1021/jm501994d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501994d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjs1GhtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3131-3143&author=H.+Falkeauthor=A.+Chaikuadauthor=A.+Beckerauthor=N.+Loa%C3%ABcauthor=O.+Lozachauthor=S.+Abu+Jhaishaauthor=W.+Beckerauthor=P.+G.+Jonesauthor=L.+Preuauthor=K.+Baumannauthor=S.+Knappauthor=L.+Meijerauthor=C.+Kunick&title=10-Iodo-11H-indolo%5B3%2C2-c%5Dquinoline-6-carboxylic+acids+are+selective+inhibitors+of+DYRK1A&doi=10.1021%2Fjm501994d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">10-Iodo-11H-indolo[3,2-c]quinoline-6-carboxylic Acids Are Selective Inhibitors of DYRK1A</span></div><div class="casAuthors">Falke, Hannes; Chaikuad, Apirat; Becker, Anja; Loaec, Nadege; Lozach, Olivier; Abu Jhaisha, Samira; Becker, Walter; Jones, Peter G.; Preu, Lutz; Baumann, Knut; Knapp, Stefan; Meijer, Laurent; Kunick, Conrad</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3131-3143</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The protein kinase DYRK1A has been suggested to act as one of the intracellular regulators contributing to neurol. alterations found in individuals with Down syndrome.  For an assessment of the role of DYRK1A, selective synthetic inhibitors are valuable pharmacol. tools.  However, the DYRK1A inhibitors described in the literature so far either are not sufficiently selective or have not been tested against closely related kinases from the DYRK and the CLK protein kinase families.  The aim of this study was the identification of DYRK1A inhibitors exhibiting selectivity vs. the structurally and functionally closely related DYRK and CLK isoforms.  Structure modification of the screening hit 11H-indolo[3,2-c]quinoline-6-carboxylic acid revealed structure-activity relationships for kinase inhibition and enabled the design of 10-iodo-substituted derivs. as very potent DYRK1A inhibitors with considerable selectivity against CLKs.  X-ray structure detn. of three 11H-indolo[3,2-c]quinoline-6-carboxylic acids cocrystd. with DYRK1A confirmed the predicted binding mode within the ATP binding site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpe4rHbgYJUsbVg90H21EOLACvtfcHk0ljSE52HX8fgAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjs1GhtrY%253D&md5=70efbb6ad590a1240764ccc78af019ec</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm501994d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501994d%26sid%3Dliteratum%253Aachs%26aulast%3DFalke%26aufirst%3DH.%26aulast%3DChaikuad%26aufirst%3DA.%26aulast%3DBecker%26aufirst%3DA.%26aulast%3DLoa%25C3%25ABc%26aufirst%3DN.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DAbu%2BJhaisha%26aufirst%3DS.%26aulast%3DBecker%26aufirst%3DW.%26aulast%3DJones%26aufirst%3DP.%2BG.%26aulast%3DPreu%26aufirst%3DL.%26aulast%3DBaumann%26aufirst%3DK.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DKunick%26aufirst%3DC.%26atitle%3D10-Iodo-11H-indolo%255B3%252C2-c%255Dquinoline-6-carboxylic%2520acids%2520are%2520selective%2520inhibitors%2520of%2520DYRK1A%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3131%26epage%3D3143%26doi%3D10.1021%2Fjm501994d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Chaikuad, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diharce, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schröder, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foucourt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblond, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casagrande, A.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Désiré, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besson, T.</span><span> </span><span class="NLM_article-title">An unusual binding model of the methyl 9-anilinothiazolo[5,4-f] quinazoline-2-carbimidates (EHT 1610 and EHT 5372) confers high selectivity for dual-specificity tyrosine phosphorylation-regulated kinases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">10315</span><span class="NLM_x">–</span> <span class="NLM_lpage">10321</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01083</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01083" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslWjtr%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10315-10321&author=A.+Chaikuadauthor=J.+Diharceauthor=M.+Schr%C3%B6derauthor=A.+Foucourtauthor=B.+Leblondauthor=A.-S.+Casagrandeauthor=L.+D%C3%A9sir%C3%A9author=P.+Bonnetauthor=S.+Knappauthor=T.+Besson&title=An+unusual+binding+model+of+the+methyl+9-anilinothiazolo%5B5%2C4-f%5D+quinazoline-2-carbimidates+%28EHT+1610+and+EHT+5372%29+confers+high+selectivity+for+dual-specificity+tyrosine+phosphorylation-regulated+kinases&doi=10.1021%2Facs.jmedchem.6b01083"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">An Unusual Binding Model of the Methyl 9-Anilinothiazolo[5,4-f] quinazoline-2-carbimidates (EHT 1610 and EHT 5372) Confers High Selectivity for Dual-Specificity Tyrosine Phosphorylation-Regulated Kinases</span></div><div class="casAuthors">Chaikuad, Apirat; Diharce, Julien; Schroder, Martin; Foucourt, Alicia; Leblond, Bertrand; Casagrande, Anne-Sophie; Desire, Laurent; Bonnet, Pascal; Knapp, Stefan; Besson, Thierry</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">10315-10321</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Me 9-anilinothiazolo[5,4-f]quinazoline-2-carbimidates 1 (EHT 5372) and 2 (EHT 1610) are strong inhibitors of DYRK's family kinases.  The crystal structures of the complex revealed a non-canonical binding mode of compd. 1 and 2 in DYRK2 explaining the remarkable selectivity and potency of these inhibitors.  The structural data and comparison presented here provide therefore a template for further improvement of this inhibitor class and for the development of novel inhibitors selectively targeting DYRK kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp91_JqCRXGqLVg90H21EOLACvtfcHk0ljSE52HX8fgAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslWjtr%252FM&md5=856551b47ad21c90c55563b064001358</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01083%26sid%3Dliteratum%253Aachs%26aulast%3DChaikuad%26aufirst%3DA.%26aulast%3DDiharce%26aufirst%3DJ.%26aulast%3DSchr%25C3%25B6der%26aufirst%3DM.%26aulast%3DFoucourt%26aufirst%3DA.%26aulast%3DLeblond%26aufirst%3DB.%26aulast%3DCasagrande%26aufirst%3DA.-S.%26aulast%3DD%25C3%25A9sir%25C3%25A9%26aufirst%3DL.%26aulast%3DBonnet%26aufirst%3DP.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DBesson%26aufirst%3DT.%26atitle%3DAn%2520unusual%2520binding%2520model%2520of%2520the%2520methyl%25209-anilinothiazolo%255B5%252C4-f%255D%2520quinazoline-2-carbimidates%2520%2528EHT%25201610%2520and%2520EHT%25205372%2529%2520confers%2520high%2520selectivity%2520for%2520dual-specificity%2520tyrosine%2520phosphorylation-regulated%2520kinases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D10315%26epage%3D10321%26doi%3D10.1021%2Facs.jmedchem.6b01083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Malinge, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bliss-Moreau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirsammer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diebold, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chlon, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurbuxani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crispino, J. D.</span><span> </span><span class="NLM_article-title">Increased dosage of the chromosome 21 ortholog Dyrk1a promotes megakaryoblastic leukemia in a murine model of Down syndrome</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">948</span><span class="NLM_x">–</span> <span class="NLM_lpage">962</span><span class="refDoi"> DOI: 10.1172/JCI60455</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1172%2FJCI60455" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2012&pages=948-962&author=S.+Malingeauthor=M.+Bliss-Moreauauthor=G.+Kirsammerauthor=L.+Dieboldauthor=T.+Chlonauthor=S.+Gurbuxaniauthor=J.+D.+Crispino&title=Increased+dosage+of+the+chromosome+21+ortholog+Dyrk1a+promotes+megakaryoblastic+leukemia+in+a+murine+model+of+Down+syndrome&doi=10.1172%2FJCI60455"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1172%2FJCI60455&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI60455%26sid%3Dliteratum%253Aachs%26aulast%3DMalinge%26aufirst%3DS.%26aulast%3DBliss-Moreau%26aufirst%3DM.%26aulast%3DKirsammer%26aufirst%3DG.%26aulast%3DDiebold%26aufirst%3DL.%26aulast%3DChlon%26aufirst%3DT.%26aulast%3DGurbuxani%26aufirst%3DS.%26aulast%3DCrispino%26aufirst%3DJ.%2BD.%26atitle%3DIncreased%2520dosage%2520of%2520the%2520chromosome%252021%2520ortholog%2520Dyrk1a%2520promotes%2520megakaryoblastic%2520leukemia%2520in%2520a%2520murine%2520model%2520of%2520Down%2520syndrome%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2012%26volume%3D122%26spage%3D948%26epage%3D962%26doi%3D10.1172%2FJCI60455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Boichuk, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parry, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makielski, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Litovchick, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baron, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zewe, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wozniak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehalek, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korzeniewski, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seneviratne, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schöffski, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debiec-Rychter, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeCaprio, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duensing, A.</span><span> </span><span class="NLM_article-title">The DREAM complex mediates GIST cell quiescence and is a novel therapeutic target to enhance Imatinib-induced apoptosis</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">5120</span><span class="NLM_x">–</span> <span class="NLM_lpage">5129</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-13-0579</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1158%2F0008-5472.CAN-13-0579" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=5120-5129&author=S.+Boichukauthor=J.+A.+Parryauthor=K.+R.+Makielskiauthor=L.+Litovchickauthor=J.+L.+Baronauthor=J.+P.+Zeweauthor=A.+Wozniakauthor=K.+R.+Mehalekauthor=N.+Korzeniewskiauthor=D.+S.+Seneviratneauthor=P.+Sch%C3%B6ffskiauthor=M.+Debiec-Rychterauthor=J.+A.+DeCaprioauthor=A.+Duensing&title=The+DREAM+complex+mediates+GIST+cell+quiescence+and+is+a+novel+therapeutic+target+to+enhance+Imatinib-induced+apoptosis&doi=10.1158%2F0008-5472.CAN-13-0579"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-13-0579&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-13-0579%26sid%3Dliteratum%253Aachs%26aulast%3DBoichuk%26aufirst%3DS.%26aulast%3DParry%26aufirst%3DJ.%2BA.%26aulast%3DMakielski%26aufirst%3DK.%2BR.%26aulast%3DLitovchick%26aufirst%3DL.%26aulast%3DBaron%26aufirst%3DJ.%2BL.%26aulast%3DZewe%26aufirst%3DJ.%2BP.%26aulast%3DWozniak%26aufirst%3DA.%26aulast%3DMehalek%26aufirst%3DK.%2BR.%26aulast%3DKorzeniewski%26aufirst%3DN.%26aulast%3DSeneviratne%26aufirst%3DD.%2BS.%26aulast%3DSch%25C3%25B6ffski%26aufirst%3DP.%26aulast%3DDebiec-Rychter%26aufirst%3DM.%26aulast%3DDeCaprio%26aufirst%3DJ.%2BA.%26aulast%3DDuensing%26aufirst%3DA.%26atitle%3DThe%2520DREAM%2520complex%2520mediates%2520GIST%2520cell%2520quiescence%2520and%2520is%2520a%2520novel%2520therapeutic%2520target%2520to%2520enhance%2520Imatinib-induced%2520apoptosis%26jtitle%3DCancer%2520Res.%26date%3D2013%26volume%3D73%26spage%3D5120%26epage%3D5129%26doi%3D10.1158%2F0008-5472.CAN-13-0579" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Chang, H.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, M.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, C.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Y.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, W. C. Y.</span><span> </span><span class="NLM_article-title">Increased expression of DYRK1a in HPV16 immortalized Keratinocytes enable evasion of apoptosis</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">2377</span><span class="NLM_x">–</span> <span class="NLM_lpage">2385</span><span class="refDoi"> DOI: 10.1002/ijc.22573</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1002%2Fijc.22573" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=17294446" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BD2sXksFSktbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2007&pages=2377-2385&author=H.-S.+Changauthor=C.-H.+Linauthor=C.-H.+Yangauthor=M.-S.+Yenauthor=C.-R.+Laiauthor=Y.-R.+Chenauthor=Y.-J.+Liangauthor=W.+C.+Y.+Yu&title=Increased+expression+of+DYRK1a+in+HPV16+immortalized+Keratinocytes+enable+evasion+of+apoptosis&doi=10.1002%2Fijc.22573"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Increased expression of Dyrk1a in HPV16 immortalized keratinocytes enable evasion of apoptosis</span></div><div class="casAuthors">Chang, Hung-Shu; Lin, Ching-Hui; Yang, Chien-Hui; Yen, Ming-Shyen; Lai, Chiung-Ru; Chen, Yi-Rong; Liang, Yuh-Jin; Yu, Winston C. Y.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2377-2385</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Immortalization is a crit. event in virus-related oncogenesis.  No enough information, however, is currently available to elucidate the changes that occur in cellular mols. during immortalization.  To identify potential cellular markers or regulators involving in immortalization, a paired-cell model of primary foreskin keratinocytes (FK) and HPV16 immortalized foreskin keratinocytes were established.  Using mRNA differential display, RT-PCR and Northern blot methods, we have identified and confirmed that Dyrk1a (dual-specificity tyrosine-phosphorylated and regulated kinase 1A) is present and increased in HPV16 immortalized cells, but is absent in primary keratinocytes.  Moreover, transfection of E7 siRNA oligo into immortalized cells leads to a diminishing E7 expression and the eventual disappearance of Dyrk1a.  Similar results of Dyrk1a expressional differences could also be seen when tissue specimens were compared using LCM/real-time PCR and immunohistochem. anal.; malignant cervical lesions contain significantly more DYRK1A than normal tissue.  It was also demonstrated that raised DYRK1A could rearrange the cellular localization of FKHR (forkhead in rhabdomyosarcoma), an apoptosis activator, and suppress BAD.  Importantly, this phenomenon can be reversed when endogenous Dyrk1a was knocked down in immortalized cells by RNA interference.  These results suggest that the raised Dyrk1a in HPV16 immortalized keratinocytes and cervical lesions may serve as a candidate antiapoptotic factor in the FKHR regulated pathway and initiate immortalization and tumorigenesis gradually.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqe0It7CDgI4rVg90H21EOLACvtfcHk0lhpNteh7PAYcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXksFSktbs%253D&md5=0b1acebae4efef96a83e11bf7ee7b62c</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2Fijc.22573&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.22573%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DH.-S.%26aulast%3DLin%26aufirst%3DC.-H.%26aulast%3DYang%26aufirst%3DC.-H.%26aulast%3DYen%26aufirst%3DM.-S.%26aulast%3DLai%26aufirst%3DC.-R.%26aulast%3DChen%26aufirst%3DY.-R.%26aulast%3DLiang%26aufirst%3DY.-J.%26aulast%3DYu%26aufirst%3DW.%2BC.%2BY.%26atitle%3DIncreased%2520expression%2520of%2520DYRK1a%2520in%2520HPV16%2520immortalized%2520Keratinocytes%2520enable%2520evasion%2520of%2520apoptosis%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2007%26volume%3D120%26spage%3D2377%26epage%3D2385%26doi%3D10.1002%2Fijc.22573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Chen, J.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng-Chiao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, T.</span><span> </span><span class="NLM_article-title">Dosage of Dyrk1A shifts cells within a p21-cyclin D1 signalling map to control the decision to enter the cell cycle</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">100</span><span class="refDoi"> DOI: 10.1016/j.molcel.2013.09.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1016%2Fj.molcel.2013.09.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=87-100&author=J.-Y.+Chenauthor=J.-R.+Linauthor=T.+Feng-Chiaoauthor=T.+Meyer&title=Dosage+of+Dyrk1A+shifts+cells+within+a+p21-cyclin+D1+signalling+map+to+control+the+decision+to+enter+the+cell+cycle&doi=10.1016%2Fj.molcel.2013.09.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2013.09.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2013.09.009%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.-Y.%26aulast%3DLin%26aufirst%3DJ.-R.%26aulast%3DFeng-Chiao%26aufirst%3DT.%26aulast%3DMeyer%26aufirst%3DT.%26atitle%3DDosage%2520of%2520Dyrk1A%2520shifts%2520cells%2520within%2520a%2520p21-cyclin%2520D1%2520signalling%2520map%2520to%2520control%2520the%2520decision%2520to%2520enter%2520the%2520cell%2520cycle%26jtitle%3DMol.%2520Cell%26date%3D2013%26volume%3D52%26spage%3D87%26epage%3D100%26doi%3D10.1016%2Fj.molcel.2013.09.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Litovchick, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Florens, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swanson, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Washburn, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeCaprio, J. A.</span><span> </span><span class="NLM_article-title">DYRK1A protein kinase promotes quiescence and senescence through DREAM complex assembly</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">801</span><span class="NLM_x">–</span> <span class="NLM_lpage">813</span><span class="refDoi"> DOI: 10.1101/gad.2034211</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1101%2Fgad.2034211" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=21498570" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BC3MXltlKntrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=801-813&author=L.+Litovchickauthor=L.+A.+Florensauthor=S.+K.+Swansonauthor=M.+P.+Washburnauthor=J.+A.+DeCaprio&title=DYRK1A+protein+kinase+promotes+quiescence+and+senescence+through+DREAM+complex+assembly&doi=10.1101%2Fgad.2034211"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">DYRK1A protein kinase promotes quiescence and senescence through DREAM complex assembly</span></div><div class="casAuthors">Litovchick, Larisa; Florens, Laurence A.; Swanson, Selene K.; Washburn, Michael P.; DeCaprio, James A.</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">801-813</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">In the absence of growth signals, cells exit the cell cycle and enter into G0 or quiescence.  Alternatively, cells enter senescence in response to inappropriate growth signals such as oncogene expression.  The mol. mechanisms required for cell cycle exit into quiescence or senescence are poorly understood.  The DREAM (DP, RB [retinoblastoma], E2F, and MuvB) complex represses cell cycle-dependent genes during quiescence.  DREAM contains p130, E2F4, DP1, and a stable core complex of five MuvB-like proteins: LIN9, LIN37, LIN52, LIN54, and RBBP4.  In mammalian cells, the MuvB core dissocs. from p130 upon entry into the cell cycle and binds to BMYB during S phase to activate the transcription of genes expressed late in the cell cycle.  We used mass spectroscopic anal. to identify phosphorylation sites that regulate the switch of the MuvB core from BMYB to DREAM.  Here we report that DYRK1A can specifically phosphorylate LIN52 on serine residue 28, and that this phosphorylation is required for DREAM assembly.  Inhibiting DYRK1A activity or point mutation of LIN52 disrupts DREAM assembly and reduces the ability of cells to enter quiescence or undergo Ras-induced senescence.  These data reveal an important role for DYRK1A in the regulation of DREAM activity and entry into quiescence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptXCB-wHS9bLVg90H21EOLACvtfcHk0lhpNteh7PAYcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXltlKntrc%253D&md5=0d3048d4ea6a370a7a230b8f250e3867</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1101%2Fgad.2034211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.2034211%26sid%3Dliteratum%253Aachs%26aulast%3DLitovchick%26aufirst%3DL.%26aulast%3DFlorens%26aufirst%3DL.%2BA.%26aulast%3DSwanson%26aufirst%3DS.%2BK.%26aulast%3DWashburn%26aufirst%3DM.%2BP.%26aulast%3DDeCaprio%26aufirst%3DJ.%2BA.%26atitle%3DDYRK1A%2520protein%2520kinase%2520promotes%2520quiescence%2520and%2520senescence%2520through%2520DREAM%2520complex%2520assembly%26jtitle%3DGenes%2520Dev.%26date%3D2011%26volume%3D25%26spage%3D801%26epage%3D813%26doi%3D10.1101%2Fgad.2034211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Di Vona, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bezdan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Islam</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abul, B. M. M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salichs, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López-Bigas, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ossowski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de la Luna, S.</span><span> </span><span class="NLM_article-title">Chromatin-wide profiling of DYRK1A reveals a role as a gene-specific RNA polymerase II CTD kinase</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">506</span><span class="NLM_x">–</span> <span class="NLM_lpage">520</span><span class="refDoi"> DOI: 10.1016/j.molcel.2014.12.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1016%2Fj.molcel.2014.12.026" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2015&pages=506-520&author=C.+Di+Vonaauthor=D.+Bezdanauthor=+Islamauthor=B.+M.+M.+K.+Abulauthor=E.+Salichsauthor=N.+L%C3%B3pez-Bigasauthor=S.+Ossowskiauthor=S.+de+la+Luna&title=Chromatin-wide+profiling+of+DYRK1A+reveals+a+role+as+a+gene-specific+RNA+polymerase+II+CTD+kinase&doi=10.1016%2Fj.molcel.2014.12.026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2014.12.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2014.12.026%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BVona%26aufirst%3DC.%26aulast%3DBezdan%26aufirst%3DD.%26aulast%3DIslam%26aulast%3DAbul%26aufirst%3DB.%2BM.%2BM.%2BK.%26aulast%3DSalichs%26aufirst%3DE.%26aulast%3DL%25C3%25B3pez-Bigas%26aufirst%3DN.%26aulast%3DOssowski%26aufirst%3DS.%26aulast%3Dde%2Bla%2BLuna%26aufirst%3DS.%26atitle%3DChromatin-wide%2520profiling%2520of%2520DYRK1A%2520reveals%2520a%2520role%2520as%2520a%2520gene-specific%2520RNA%2520polymerase%2520II%2520CTD%2520kinase%26jtitle%3DMol.%2520Cell%26date%3D2015%26volume%3D57%26spage%3D506%26epage%3D520%26doi%3D10.1016%2Fj.molcel.2014.12.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Zhou, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J. J.</span><span> </span><span class="NLM_article-title">Role of dual specificity tyrosine-phosphorylation-regulated kinase 1B (Dyrk1B) in S-phase entry of HPV E7 expressing cells from quiescence</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">30745</span><span class="NLM_x">–</span> <span class="NLM_lpage">30761</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=30745-30761&author=N.+Zhouauthor=S.+Yuanauthor=R.+Wangauthor=W.+Zhangauthor=J.+J.+Chen&title=Role+of+dual+specificity+tyrosine-phosphorylation-regulated+kinase+1B+%28Dyrk1B%29+in+S-phase+entry+of+HPV+E7+expressing+cells+from+quiescence"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DN.%26aulast%3DYuan%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DJ.%2BJ.%26atitle%3DRole%2520of%2520dual%2520specificity%2520tyrosine-phosphorylation-regulated%2520kinase%25201B%2520%2528Dyrk1B%2529%2520in%2520S-phase%2520entry%2520of%2520HPV%2520E7%2520expressing%2520cells%2520from%2520quiescence%26jtitle%3DOncotarget%26date%3D2015%26volume%3D6%26spage%3D30745%26epage%3D30761" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Guo, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banerjee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixon, J. E.</span><span> </span><span class="NLM_article-title">Site-specific proteasome phosphorylation controls cell proliferation and tumorigenesis</span> <span class="citation_source-journal">Nat. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">202</span><span class="NLM_x">–</span> <span class="NLM_lpage">212</span><span class="refDoi"> DOI: 10.1038/ncb3289</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1038%2Fncb3289" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=26655835" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVWqtr3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2016&pages=202-212&author=X.+Guoauthor=X.+Wangauthor=Z.+Wangauthor=S.+Banerjeeauthor=J.+Yangauthor=L.+Huangauthor=J.+E.+Dixon&title=Site-specific+proteasome+phosphorylation+controls+cell+proliferation+and+tumorigenesis&doi=10.1038%2Fncb3289"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Site-specific proteasome phosphorylation controls cell proliferation and tumorigenesis</span></div><div class="casAuthors">Guo, Xing; Wang, Xiaorong; Wang, Zhiping; Banerjee, Sourav; Yang, Jing; Huang, Lan; Dixon, Jack E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">202-212</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Despite the fundamental importance of proteasomal degrdn. in cells, little is known about whether and how the 26S proteasome itself is regulated in coordination with various physiol. processes.  Here we show that the proteasome is dynamically phosphorylated during the cell cycle at Thr 25 of the 19S subunit Rpt3.  CRISPR/Cas9-mediated genome editing, RNA interference and biochem. studies demonstrate that blocking Rpt3-Thr25 phosphorylation markedly impairs proteasome activity and impedes cell proliferation.  Through a kinome-wide screen, we have identified dual-specificity tyrosine-regulated kinase 2 (DYRK2) as the primary kinase that phosphorylates Rpt3-Thr25, leading to enhanced substrate translocation and degrdn.  Importantly, loss of the single phosphorylation of Rpt3-Thr25 or knockout of DYRK2 significantly inhibits tumor formation by proteasome-addicted human breast cancer cells in mice.  These findings define an important mechanism for proteasome regulation and demonstrate the biol. significance of proteasome phosphorylation in regulating cell proliferation and tumorigenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoq1NWkvB5GQ7Vg90H21EOLACvtfcHk0lhLITNtS6CQsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVWqtr3I&md5=f8f3aa4eae939ab0bf558cd49bfd73a4</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fncb3289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb3289%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DDixon%26aufirst%3DJ.%2BE.%26atitle%3DSite-specific%2520proteasome%2520phosphorylation%2520controls%2520cell%2520proliferation%2520and%2520tumorigenesis%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2016%26volume%3D18%26spage%3D202%26epage%3D212%26doi%3D10.1038%2Fncb3289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Pozo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zahonero, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liñares, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayuso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagiwara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ricoy, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernández-Laín, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sepúlveda, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sánchez-Gómez, P.</span><span> </span><span class="NLM_article-title">Inhibition of DYRK1A destabilizes EGFR and reduces EGFR-dependent glioblastoma growth</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x">, </span> <span class="NLM_fpage">2475</span><span class="NLM_x">–</span> <span class="NLM_lpage">2487</span><span class="refDoi"> DOI: 10.1172/JCI63623</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1172%2FJCI63623" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2013&pages=2475-2487&author=N.+Pozoauthor=C.+Zahoneroauthor=P.+Fern%C3%A1ndezauthor=J.+M.+Li%C3%B1aresauthor=A.+Ayusoauthor=M.+Hagiwaraauthor=A.+P%C3%A9rezauthor=J.+R.+Ricoyauthor=A.+Hern%C3%A1ndez-La%C3%ADnauthor=J.+M.+Sep%C3%BAlvedaauthor=P.+S%C3%A1nchez-G%C3%B3mez&title=Inhibition+of+DYRK1A+destabilizes+EGFR+and+reduces+EGFR-dependent+glioblastoma+growth&doi=10.1172%2FJCI63623"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1172%2FJCI63623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI63623%26sid%3Dliteratum%253Aachs%26aulast%3DPozo%26aufirst%3DN.%26aulast%3DZahonero%26aufirst%3DC.%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DP.%26aulast%3DLi%25C3%25B1ares%26aufirst%3DJ.%2BM.%26aulast%3DAyuso%26aufirst%3DA.%26aulast%3DHagiwara%26aufirst%3DM.%26aulast%3DP%25C3%25A9rez%26aufirst%3DA.%26aulast%3DRicoy%26aufirst%3DJ.%2BR.%26aulast%3DHern%25C3%25A1ndez-La%25C3%25ADn%26aufirst%3DA.%26aulast%3DSep%25C3%25BAlveda%26aufirst%3DJ.%2BM.%26aulast%3DS%25C3%25A1nchez-G%25C3%25B3mez%26aufirst%3DP.%26atitle%3DInhibition%2520of%2520DYRK1A%2520destabilizes%2520EGFR%2520and%2520reduces%2520EGFR-dependent%2520glioblastoma%2520growth%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2013%26volume%3D123%26spage%3D2475%26epage%3D2487%26doi%3D10.1172%2FJCI63623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Ferron, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pozo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laguna, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aranda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porlan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fillat, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de la Luna, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sánchez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arbonés, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fariñas, I.</span><span> </span><span class="NLM_article-title">Regulated segregation of kinase Dyrk1A during asymmetric neural stem cell division is critical for EGFR-mediated biased signaling</span> <span class="citation_source-journal">Cell Stem Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">367</span><span class="NLM_x">–</span> <span class="NLM_lpage">379</span><span class="refDoi"> DOI: 10.1016/j.stem.2010.06.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1016%2Fj.stem.2010.06.021" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2010&pages=367-379&author=S.+R.+Ferronauthor=N.+Pozoauthor=A.+Lagunaauthor=S.+Arandaauthor=E.+Porlanauthor=M.+Morenoauthor=C.+Fillatauthor=S.+de+la+Lunaauthor=P.+S%C3%A1nchezauthor=M.+L.+Arbon%C3%A9sauthor=I.+Fari%C3%B1as&title=Regulated+segregation+of+kinase+Dyrk1A+during+asymmetric+neural+stem+cell+division+is+critical+for+EGFR-mediated+biased+signaling&doi=10.1016%2Fj.stem.2010.06.021"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.stem.2010.06.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.stem.2010.06.021%26sid%3Dliteratum%253Aachs%26aulast%3DFerron%26aufirst%3DS.%2BR.%26aulast%3DPozo%26aufirst%3DN.%26aulast%3DLaguna%26aufirst%3DA.%26aulast%3DAranda%26aufirst%3DS.%26aulast%3DPorlan%26aufirst%3DE.%26aulast%3DMoreno%26aufirst%3DM.%26aulast%3DFillat%26aufirst%3DC.%26aulast%3Dde%2Bla%2BLuna%26aufirst%3DS.%26aulast%3DS%25C3%25A1nchez%26aufirst%3DP.%26aulast%3DArbon%25C3%25A9s%26aufirst%3DM.%2BL.%26aulast%3DFari%25C3%25B1as%26aufirst%3DI.%26atitle%3DRegulated%2520segregation%2520of%2520kinase%2520Dyrk1A%2520during%2520asymmetric%2520neural%2520stem%2520cell%2520division%2520is%2520critical%2520for%2520EGFR-mediated%2520biased%2520signaling%26jtitle%3DCell%2520Stem%2520Cell%26date%3D2010%26volume%3D7%26spage%3D367%26epage%3D379%26doi%3D10.1016%2Fj.stem.2010.06.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Takayama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">May, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, R. G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herz, J.</span><span> </span><span class="NLM_article-title">Low density lipoprotein receptor-related Protein 1 (LRP1) controls endocytosis and c-CBL-mediated ubiquitination of the Platelet-Derived Growth Factor Receptor β (PDGFRβ)</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">18504</span><span class="NLM_x">–</span> <span class="NLM_lpage">18510</span><span class="refDoi"> DOI: 10.1074/jbc.M410265200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1074%2Fjbc.M410265200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=15753096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjsl2htbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=18504-18510&author=Y.+Takayamaauthor=P.+Mayauthor=R.+G.+W.+Andersonauthor=J.+Herz&title=Low+density+lipoprotein+receptor-related+Protein+1+%28LRP1%29+controls+endocytosis+and+c-CBL-mediated+ubiquitination+of+the+Platelet-Derived+Growth+Factor+Receptor+%CE%B2+%28PDGFR%CE%B2%29&doi=10.1074%2Fjbc.M410265200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Low density lipoprotein receptor-related protein 1 (LRP1) controls endocytosis and c-CBL-mediated ubiquitination of the platelet-derived growth factor receptor β (PDGFRβ)</span></div><div class="casAuthors">Takayama, Yoshiharu; May, Petra; Anderson, Richard G. W.; Herz, Joachim</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">18504-18510</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The low d. lipoprotein receptor-related protein 1 (LRP1) has been implicated in intracellular signaling functions as well as in lipid metab.  Recent in vivo and in vitro studies suggest that LRP1 is a physiol. modulator of the platelet-derived growth factor (PDGF) signaling pathway.  In mouse fibroblasts LRP1 modulates PDGF-BB signaling by controlling endocytosis and ligand-induced down-regulation of the PDGF receptor β (PDGFRβ).  In LRP1-deficient fibroblasts, basal PDGFRβ tyrosine kinase activity was derepressed, and PDGF-BB-induced endocytosis and degrdn. of PDGFRβ were accelerated as compared with control cells.  This was accompanied by rapid uptake of receptor-bound PDGF-BB into the cells and by attenuated ERK activation in response to PDGF-BB stimulation.  Pulse-chase anal. indicated that the steady-state turnover rate of PDGFRβ was also accelerated in LRP-deficient fibroblasts.  The rapid degrdn. of PDGFRβ in the LRP1-deficient fibroblasts was prevented by MG132 and chloroquine.  Furthermore, the assocn. of PDGFRβ with c-Cbl, a ubiquitin E3-ligase, as well as the ligand-induced ubiquitination of PDGFRβ were increased in LRP1-deficient fibroblasts.  The authors show that LRP1 can directly interact with c-Cbl, suggesting a Sprouty-like role for LRP1 in regulating the access of the PDGFRβ to the ubiquitination machinery.  Thus, LRP1 modulates PDGF signaling by controlling ubiquitination and endocytosis of the PDGFRβ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfC4lhmJd4DbVg90H21EOLACvtfcHk0lg83Gb77fJtww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjsl2htbg%253D&md5=74e4d0e145e97e37c746a77a98cb8512</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M410265200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M410265200%26sid%3Dliteratum%253Aachs%26aulast%3DTakayama%26aufirst%3DY.%26aulast%3DMay%26aufirst%3DP.%26aulast%3DAnderson%26aufirst%3DR.%2BG.%2BW.%26aulast%3DHerz%26aufirst%3DJ.%26atitle%3DLow%2520density%2520lipoprotein%2520receptor-related%2520Protein%25201%2520%2528LRP1%2529%2520controls%2520endocytosis%2520and%2520c-CBL-mediated%2520ubiquitination%2520of%2520the%2520Platelet-Derived%2520Growth%2520Factor%2520Receptor%2520%25CE%25B2%2520%2528PDGFR%25CE%25B2%2529%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D18504%26epage%3D18510%26doi%3D10.1074%2Fjbc.M410265200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Holgren, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dougherty, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerasi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fichera, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bissonnette, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khare, S.</span><span> </span><span class="NLM_article-title">Sprouty-2 controls c-Met expression and metastatic potential of colon cancer cells: sprouty/c-Met upregulation in human colonic adenocarcinomas</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">5241</span><span class="NLM_x">–</span> <span class="NLM_lpage">5253</span><span class="refDoi"> DOI: 10.1038/onc.2010.264</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1038%2Fonc.2010.264" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2010&pages=5241-5253&author=C.+Holgrenauthor=U.+Doughertyauthor=F.+Edwinauthor=D.+Cerasiauthor=I.+Taylorauthor=A.+Ficheraauthor=L.+Josephauthor=M.+Bissonnetteauthor=S.+Khare&title=Sprouty-2+controls+c-Met+expression+and+metastatic+potential+of+colon+cancer+cells%3A+sprouty%2Fc-Met+upregulation+in+human+colonic+adenocarcinomas&doi=10.1038%2Fonc.2010.264"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fonc.2010.264&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2010.264%26sid%3Dliteratum%253Aachs%26aulast%3DHolgren%26aufirst%3DC.%26aulast%3DDougherty%26aufirst%3DU.%26aulast%3DEdwin%26aufirst%3DF.%26aulast%3DCerasi%26aufirst%3DD.%26aulast%3DTaylor%26aufirst%3DI.%26aulast%3DFichera%26aufirst%3DA.%26aulast%3DJoseph%26aufirst%3DL.%26aulast%3DBissonnette%26aufirst%3DM.%26aulast%3DKhare%26aufirst%3DS.%26atitle%3DSprouty-2%2520controls%2520c-Met%2520expression%2520and%2520metastatic%2520potential%2520of%2520colon%2520cancer%2520cells%253A%2520sprouty%252Fc-Met%2520upregulation%2520in%2520human%2520colonic%2520adenocarcinomas%26jtitle%3DOncogene%26date%3D2010%26volume%3D29%26spage%3D5241%26epage%3D5253%26doi%3D10.1038%2Fonc.2010.264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Dominguez, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, Y.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weatheritt, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blencowe, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span> </span><span class="NLM_article-title">An extensive program of periodic alternative splicing linked to cell cycle progression</span> <span class="citation_source-journal">eLife</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">e10288</span><span class="refDoi"> DOI: 10.7554/eLife.10288</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.7554%2FeLife.10288" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2016&pages=e10288&author=D.+Dominguezauthor=Y.-H.+Tsaiauthor=R.+Weatherittauthor=Y.+Wangauthor=B.+J.+Blencoweauthor=Z.+Wang&title=An+extensive+program+of+periodic+alternative+splicing+linked+to+cell+cycle+progression&doi=10.7554%2FeLife.10288"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.7554%2FeLife.10288&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7554%252FeLife.10288%26sid%3Dliteratum%253Aachs%26aulast%3DDominguez%26aufirst%3DD.%26aulast%3DTsai%26aufirst%3DY.-H.%26aulast%3DWeatheritt%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DBlencowe%26aufirst%3DB.%2BJ.%26aulast%3DWang%26aufirst%3DZ.%26atitle%3DAn%2520extensive%2520program%2520of%2520periodic%2520alternative%2520splicing%2520linked%2520to%2520cell%2520cycle%2520progression%26jtitle%3DeLife%26date%3D2016%26volume%3D5%26spage%3De10288%26doi%3D10.7554%2FeLife.10288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Salton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misteli, T.</span><span> </span><span class="NLM_article-title">Small molecule modulators of pre-mRNA splicing in cancer therapy</span> <span class="citation_source-journal">Trends Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">28</span><span class="NLM_x">–</span> <span class="NLM_lpage">37</span><span class="refDoi"> DOI: 10.1016/j.molmed.2015.11.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1016%2Fj.molmed.2015.11.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=26700537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFGitr%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2016&pages=28-37&author=M.+Saltonauthor=T.+Misteli&title=Small+molecule+modulators+of+pre-mRNA+splicing+in+cancer+therapy&doi=10.1016%2Fj.molmed.2015.11.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule Modulators of Pre-mRNA Splicing in Cancer Therapy</span></div><div class="casAuthors">Salton, Maayan; Misteli, Tom</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Molecular Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">28-37</span>CODEN:
                <span class="NLM_cas:coden">TMMRCY</span>;
        ISSN:<span class="NLM_cas:issn">1471-4914</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Pre-mRNA splicing is a fundamental process in mammalian gene expression and alternative RNA splicing plays a considerable role in generating protein diversity.  RNA splicing events are also key to the pathol. of numerous diseases, particularly cancers.  Some tumors are molecularly addicted to specific RNA splicing isoforms making interference with pre-mRNA processing a viable therapeutic strategy.  Several RNA splicing modulators have recently been characterized, some showing promise in preclin. studies.  While the targets of most splicing modulators are constitutive RNA processing components, possibly leading to undesirable side effects, selectivity for individual splicing events has been obsd.  Given the high prevalence of splicing defects in cancer, small mol. modulators of RNA processing represent a potentially promising novel therapeutic strategy in cancer treatment.  Here, we review their reported effects, mechanisms, and limitations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeM5XnpAvEVLVg90H21EOLACvtfcHk0lg83Gb77fJtww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFGitr%252FK&md5=b1c76eb9e583e3e1da2e2c5918a020d7</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.molmed.2015.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmed.2015.11.005%26sid%3Dliteratum%253Aachs%26aulast%3DSalton%26aufirst%3DM.%26aulast%3DMisteli%26aufirst%3DT.%26atitle%3DSmall%2520molecule%2520modulators%2520of%2520pre-mRNA%2520splicing%2520in%2520cancer%2520therapy%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2016%26volume%3D22%26spage%3D28%26epage%3D37%26doi%3D10.1016%2Fj.molmed.2015.11.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Becker, W.</span><span> </span><span class="NLM_article-title">Emerging role of DYRK family protein kinases as regulators of protein stability in cell cycle control</span> <span class="citation_source-journal">Cell Cycle</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">3389</span><span class="NLM_x">–</span> <span class="NLM_lpage">3394</span><span class="refDoi"> DOI: 10.4161/cc.21404</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.4161%2Fcc.21404" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=22918246" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BC3sXovVCqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=3389-3394&author=W.+Becker&title=Emerging+role+of+DYRK+family+protein+kinases+as+regulators+of+protein+stability+in+cell+cycle+control&doi=10.4161%2Fcc.21404"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging role of DYRK family protein kinases as regulators of protein stability in cell cycle control</span></div><div class="casAuthors">Becker, Walter</div><div class="citationInfo"><span class="NLM_cas:title">Cell Cycle</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">3389-3394</span>CODEN:
                <span class="NLM_cas:coden">CCEYAS</span>;
        ISSN:<span class="NLM_cas:issn">1538-4101</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">A review.  Dual-specificity tyrosine phosphorylation-regulated kinases (DYRKs) constitute an evolutionarily conserved family of protein kinases with key roles in the control of cell proliferation and differentiation.  Members of the DYRK family phosphorylate many substrates, including crit. regulators of the cell cycle.  A recent report revealed that human DYRK2 actas as a neg. regulator of G1/S transition by phosphorylating c-Jun and c-Myc, thereby inducing ubiquitination-mediated degrdn.  Other DYRKs also function as cell cycle regulators by modulating the turnover of their target proteins.  DYRK1B can induce reversible cell arrest in a quiescent G0 state by targeting cyclin D1 for proteasomal degrdn. and stabilizing p27Kip1.  The DYRK2 ortholog of C. elegans, MBK-2, triggers the proteasomal destruction of oocyte proteins after meiosis to allow the mitotic divisions in embryo development.  This review summarizes the accumulating results that provide evidence for a general role of DYRKs in the regulation of protein stability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPnd37_01t3rVg90H21EOLACvtfcHk0li2n00MjzKQ0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXovVCqug%253D%253D&md5=df11959806a3cd7029023b270f74800f</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.4161%2Fcc.21404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcc.21404%26sid%3Dliteratum%253Aachs%26aulast%3DBecker%26aufirst%3DW.%26atitle%3DEmerging%2520role%2520of%2520DYRK%2520family%2520protein%2520kinases%2520as%2520regulators%2520of%2520protein%2520stability%2520in%2520cell%2520cycle%2520control%26jtitle%3DCell%2520Cycle%26date%3D2012%26volume%3D11%26spage%3D3389%26epage%3D3394%26doi%3D10.4161%2Fcc.21404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Gruber, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutzinger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmer, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parigger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sternberg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cegielkowski, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaja, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leban, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamm, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitt, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aberger, F.</span><span> </span><span class="NLM_article-title">DYRK1B as therapeutic target in Hedgehog/GLI-dependent cancer cells with Smoothened inhibitor resistance</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">7134</span><span class="NLM_x">–</span> <span class="NLM_lpage">7148</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=7134-7148&author=W.+Gruberauthor=M.+Hutzingerauthor=D.+P.+Elmerauthor=T.+Pariggerauthor=C.+Sternbergauthor=L.+Cegielkowskiauthor=M.+Zajaauthor=J.+Lebanauthor=S.+Michelauthor=S.+Hammauthor=D.+Vittauthor=F.+Aberger&title=DYRK1B+as+therapeutic+target+in+Hedgehog%2FGLI-dependent+cancer+cells+with+Smoothened+inhibitor+resistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGruber%26aufirst%3DW.%26aulast%3DHutzinger%26aufirst%3DM.%26aulast%3DElmer%26aufirst%3DD.%2BP.%26aulast%3DParigger%26aufirst%3DT.%26aulast%3DSternberg%26aufirst%3DC.%26aulast%3DCegielkowski%26aufirst%3DL.%26aulast%3DZaja%26aufirst%3DM.%26aulast%3DLeban%26aufirst%3DJ.%26aulast%3DMichel%26aufirst%3DS.%26aulast%3DHamm%26aufirst%3DS.%26aulast%3DVitt%26aufirst%3DD.%26aulast%3DAberger%26aufirst%3DF.%26atitle%3DDYRK1B%2520as%2520therapeutic%2520target%2520in%2520Hedgehog%252FGLI-dependent%2520cancer%2520cells%2520with%2520Smoothened%2520inhibitor%2520resistance%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D7134%26epage%3D7148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Kettle, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballard, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardelle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cockerill, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colclough, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Critchlow, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debreczeni, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairley, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fillery, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodwin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guichard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittaker, D.</span><span> </span><span class="NLM_article-title">Discovery and optimization of a novel series of Dyrk1B kinase inhibitors to explore a MEK resistance hypothesis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">2834</span><span class="NLM_x">–</span> <span class="NLM_lpage">2844</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00098</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00098" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjslemt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2834-2844&author=J.+G.+Kettleauthor=P.+Ballardauthor=C.+Bardelleauthor=M.+Cockerillauthor=N.+Colcloughauthor=S.+E.+Critchlowauthor=J.+Debreczeniauthor=G.+Fairleyauthor=S.+Filleryauthor=M.+A.+Grahamauthor=L.+Goodwinauthor=S.+Guichardauthor=K.+Hudsonauthor=R.+A.+Wardauthor=D.+Whittaker&title=Discovery+and+optimization+of+a+novel+series+of+Dyrk1B+kinase+inhibitors+to+explore+a+MEK+resistance+hypothesis&doi=10.1021%2Facs.jmedchem.5b00098"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and optimization of a novel series of Dyrk1B kinase inhibitors to explore a MEK resistance hypothesis</span></div><div class="casAuthors">Kettle, Jason G.; Ballard, Peter; Bardelle, Catherine; Cockerill, Mark; Colclough, Nicola; Critchlow, Susan E.; Debreczeni, Judit; Fairley, Gary; Fillery, Shaun; Graham, Mark A.; Goodwin, Louise; Guichard, Sylvie; Hudson, Kevin; Ward, Richard A.; Whittaker, David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2834-2844</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Potent and selective inhibitors of Dyrk1B kinase were developed to explore the hypothesis, based on siRNA studies, that Dyrk1B may be a resistance mechanism in cells undergoing a stress response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrl6v6NWFBOvbVg90H21EOLACvtfcHk0li2n00MjzKQ0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjslemt7c%253D&md5=ab45d835413802a8b75f569eea5b7a2b</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00098%26sid%3Dliteratum%253Aachs%26aulast%3DKettle%26aufirst%3DJ.%2BG.%26aulast%3DBallard%26aufirst%3DP.%26aulast%3DBardelle%26aufirst%3DC.%26aulast%3DCockerill%26aufirst%3DM.%26aulast%3DColclough%26aufirst%3DN.%26aulast%3DCritchlow%26aufirst%3DS.%2BE.%26aulast%3DDebreczeni%26aufirst%3DJ.%26aulast%3DFairley%26aufirst%3DG.%26aulast%3DFillery%26aufirst%3DS.%26aulast%3DGraham%26aufirst%3DM.%2BA.%26aulast%3DGoodwin%26aufirst%3DL.%26aulast%3DGuichard%26aufirst%3DS.%26aulast%3DHudson%26aufirst%3DK.%26aulast%3DWard%26aufirst%3DR.%2BA.%26aulast%3DWhittaker%26aufirst%3DD.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520a%2520novel%2520series%2520of%2520Dyrk1B%2520kinase%2520inhibitors%2520to%2520explore%2520a%2520MEK%2520resistance%2520hypothesis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2834%26epage%3D2844%26doi%3D10.1021%2Facs.jmedchem.5b00098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Ewton, D. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilenchik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luk, K.-c.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polonskaia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zipf, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boylan, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, E. A.</span><span> </span><span class="NLM_article-title">Inactivation of Mirk/Dyrk1b kinase targets quiescent pancreatic cancer cells</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2104</span><span class="NLM_x">–</span> <span class="NLM_lpage">2114</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-11-0498</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1158%2F1535-7163.MCT-11-0498" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=21878655" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVeltLfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=2104-2114&author=D.+Z.+Ewtonauthor=J.+Huauthor=M.+Vilenchikauthor=X.+Dengauthor=K.-c.+Lukauthor=A.+Polonskaiaauthor=A.+F.+Hoffmanauthor=K.+Zipfauthor=J.+F.+Boylanauthor=E.+A.+Friedman&title=Inactivation+of+Mirk%2FDyrk1b+kinase+targets+quiescent+pancreatic+cancer+cells&doi=10.1158%2F1535-7163.MCT-11-0498"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Inactivation of Mirk/Dyrk1b Kinase Targets Quiescent Pancreatic Cancer Cells</span></div><div class="casAuthors">Ewton, Daina Z.; Hu, Jing; Vilenchik, Maria; Deng, Xiaobing; Luk, Kin-chun; Polonskaia, Ann; Hoffman, Ann F.; Zipf, Karen; Boylan, John F.; Friedman, Eileen A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2104-2114</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A major problem in the treatment of cancer arises from quiescent cancer cells that are relatively insensitive to most chemotherapeutic drugs and radiation.  Such residual cancer cells can cause tumor regrowth or recurrence when they reenter the cell cycle.  Earlier studies showed that levels of the serine/theronine kinase Mirk/dyrk1B are elevated up to 10-fold in quiescent G0 tumor cells.  Mirk uses several mechanisms to block cell cycling, and Mirk increases expression of antioxidant genes that decrease reactive oxygen species (ROS) levels and increase quiescent cell viability.  We now show that a novel small mol. Mirk kinase inhibitor blocked tumor cells from undergoing reversible arrest in a quiescent G0 state and enabled some cells to exit quiescence.  The inhibitor increased cycling in Panc1, AsPc1, and SW620 cells that expressed Mirk, but not in HCT116 cells that did not.  Mirk kinase inhibition elevated ROS levels and DNA damage detected by increased phosphorylation of the histone protein H2AX and by S-phase checkpoints.  The Mirk kinase inhibitor increased cleavage of the apoptotic proteins PARP and caspase 3, and increased tumor cell kill several-fold by gemcitabine and cisplatin.  A phenocopy of these effects occurred following Mirk depletion, showing drug specificity.  In previous studies Mirk knockout or depletion had no detectable effect on normal tissue, suggesting that the Mirk kinase inhibitor could have a selective effect on cancer cells expressing elevated levels of Mirk kinase.  Mol Cancer Ther; 10(11); 2104-14.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGricFZy7ipPf7Vg90H21EOLACvtfcHk0li2n00MjzKQ0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVeltLfO&md5=cac5215a69d1b7f72e4a6e564f8acc35</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-11-0498&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-11-0498%26sid%3Dliteratum%253Aachs%26aulast%3DEwton%26aufirst%3DD.%2BZ.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DVilenchik%26aufirst%3DM.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DLuk%26aufirst%3DK.-c.%26aulast%3DPolonskaia%26aufirst%3DA.%26aulast%3DHoffman%26aufirst%3DA.%2BF.%26aulast%3DZipf%26aufirst%3DK.%26aulast%3DBoylan%26aufirst%3DJ.%2BF.%26aulast%3DFriedman%26aufirst%3DE.%2BA.%26atitle%3DInactivation%2520of%2520Mirk%252FDyrk1b%2520kinase%2520targets%2520quiescent%2520pancreatic%2520cancer%2520cells%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2011%26volume%3D10%26spage%3D2104%26epage%3D2114%26doi%3D10.1158%2F1535-7163.MCT-11-0498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Ori-McKenney, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKenney</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hector, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meltzer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jan, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vale, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiita, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jan, Y. N.</span><span> </span><span class="NLM_article-title">Phosphorylation of β-tubulin by the Down syndrome kinase, Minibrain/DYRK1a, regulates microtubule dynamics and dendrite morphogenesis</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">551</span><span class="NLM_x">–</span> <span class="NLM_lpage">563</span><span class="refDoi"> DOI: 10.1016/j.neuron.2016.03.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1016%2Fj.neuron.2016.03.027" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2016&pages=551-563&author=K.+M.+Ori-McKenneyauthor=+McKenneyauthor=J.+Richardauthor=+Huangauthor=H.+Hectorauthor=T.+Liauthor=S.+Meltzerauthor=L.+Y.+Janauthor=R.+D.+Valeauthor=A.+P.+Wiitaauthor=Y.+N.+Jan&title=Phosphorylation+of+%CE%B2-tubulin+by+the+Down+syndrome+kinase%2C+Minibrain%2FDYRK1a%2C+regulates+microtubule+dynamics+and+dendrite+morphogenesis&doi=10.1016%2Fj.neuron.2016.03.027"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2016.03.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2016.03.027%26sid%3Dliteratum%253Aachs%26aulast%3DOri-McKenney%26aufirst%3DK.%2BM.%26aulast%3DMcKenney%26aulast%3DRichard%26aufirst%3DJ.%26aulast%3DHuang%26aulast%3DHector%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DMeltzer%26aufirst%3DS.%26aulast%3DJan%26aufirst%3DL.%2BY.%26aulast%3DVale%26aufirst%3DR.%2BD.%26aulast%3DWiita%26aufirst%3DA.%2BP.%26aulast%3DJan%26aufirst%3DY.%2BN.%26atitle%3DPhosphorylation%2520of%2520%25CE%25B2-tubulin%2520by%2520the%2520Down%2520syndrome%2520kinase%252C%2520Minibrain%252FDYRK1a%252C%2520regulates%2520microtubule%2520dynamics%2520and%2520dendrite%2520morphogenesis%26jtitle%3DNeuron%26date%3D2016%26volume%3D90%26spage%3D551%26epage%3D563%26doi%3D10.1016%2Fj.neuron.2016.03.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Etienne-Manneville, S.</span><span> </span><span class="NLM_article-title">Actin and microtubules in cell motility: which one is in control?</span> <span class="citation_source-journal">Traffic</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">470</span><span class="NLM_x">–</span> <span class="NLM_lpage">477</span><span class="refDoi"> DOI: 10.1111/j.1600-0854.2004.00196.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1111%2Fj.1600-0854.2004.00196.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=470-477&author=S.+Etienne-Manneville&title=Actin+and+microtubules+in+cell+motility%3A+which+one+is+in+control%3F&doi=10.1111%2Fj.1600-0854.2004.00196.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-0854.2004.00196.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-0854.2004.00196.x%26sid%3Dliteratum%253Aachs%26aulast%3DEtienne-Manneville%26aufirst%3DS.%26atitle%3DActin%2520and%2520microtubules%2520in%2520cell%2520motility%253A%2520which%2520one%2520is%2520in%2520control%253F%26jtitle%3DTraffic%26date%3D2004%26volume%3D5%26spage%3D470%26epage%3D477%26doi%3D10.1111%2Fj.1600-0854.2004.00196.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Schneider, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miguel Bayo-Fina, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar Dhanyamraju, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baier, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fendrich, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramaswamy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumeister, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lauth, M.</span><span> </span><span class="NLM_article-title">Identification of a novel actin-dependent signal transducing module allows for the targeted degradation of GLI1</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">8023</span><span class="refDoi"> DOI: 10.1038/ncomms9023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1038%2Fncomms9023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=26310823" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVKhu77P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=8023&author=P.+Schneiderauthor=J.+Miguel+Bayo-Finaauthor=R.+Singhauthor=P.+Kumar+Dhanyamrajuauthor=P.+Holzauthor=A.+Baierauthor=V.+Fendrichauthor=A.+Ramaswamyauthor=S.+Baumeisterauthor=E.+D.+Martinezauthor=M.+Lauth&title=Identification+of+a+novel+actin-dependent+signal+transducing+module+allows+for+the+targeted+degradation+of+GLI1&doi=10.1038%2Fncomms9023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a novel actin-dependent signal transducing module allows for the targeted degradation of GLI1</span></div><div class="casAuthors">Schneider, Philipp; Miguel Bayo-Fina, Juan; Singh, Rajeev; Kumar Dhanyamraju, Pavan; Holz, Philipp; Baier, Aninja; Fendrich, Volker; Ramaswamy, Annette; Baumeister, Stefan; Martinez, Elisabeth D.; Lauth, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">8023</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The Down syndrome-assocd. DYRK1A kinase has been reported as a stimulator of the developmentally important Hedgehog (Hh) pathway, but cells from Down syndrome patients paradoxically display reduced Hh signalling activity.  Here we find that DYRK1A stimulates GLI transcription factor activity through phosphorylation of general nuclear localization clusters.  In contrast, in vivo and in vitro expts. reveal that DYRK1A kinase can also function as an inhibitor of endogenous Hh signalling by neg. regulating ABLIM proteins, the actin cytoskeleton and the transcriptional co-activator MKL1 (MAL).  As a final effector of the DYRK1A-ABLIM-actin-MKL1 sequence, we identify the MKL1 interactor Jumonji domain demethylase 1A (JMJD1A) as a novel Hh pathway component stabilizing the GLI1 protein in a demethylase-independent manner.  Furthermore, a Jumonji-specific small-mol. antagonist represents a novel and powerful inhibitor of Hh signal transduction by inducing GLI1 protein degrdn. in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0fhhTVI3NPrVg90H21EOLACvtfcHk0lgJdr5g6U7yDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVKhu77P&md5=2d1cd606db85133bde46a1818098711f</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1038%2Fncomms9023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms9023%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DP.%26aulast%3DMiguel%2BBayo-Fina%26aufirst%3DJ.%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DKumar%2BDhanyamraju%26aufirst%3DP.%26aulast%3DHolz%26aufirst%3DP.%26aulast%3DBaier%26aufirst%3DA.%26aulast%3DFendrich%26aufirst%3DV.%26aulast%3DRamaswamy%26aufirst%3DA.%26aulast%3DBaumeister%26aufirst%3DS.%26aulast%3DMartinez%26aufirst%3DE.%2BD.%26aulast%3DLauth%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520a%2520novel%2520actin-dependent%2520signal%2520transducing%2520module%2520allows%2520for%2520the%2520targeted%2520degradation%2520of%2520GLI1%26jtitle%3DNat.%2520Commun.%26date%3D2015%26volume%3D6%26spage%3D8023%26doi%3D10.1038%2Fncomms9023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Hong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seo, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, S.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, S.</span><span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of 3,5-disubstituted 7-azaindoles as Trk inhibitors with anticancer and antiangiogenic activities</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">5337</span><span class="NLM_x">–</span> <span class="NLM_lpage">5349</span><span class="refDoi"> DOI: 10.1021/jm3002982</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3002982" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5337-5349&author=S.+Hongauthor=J.+Kimauthor=J.+H.+Seoauthor=K.+H.+Jungauthor=S.-S.+Hongauthor=S.+Hong&title=Design%2C+synthesis%2C+and+evaluation+of+3%2C5-disubstituted+7-azaindoles+as+Trk+inhibitors+with+anticancer+and+antiangiogenic+activities&doi=10.1021%2Fjm3002982"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm3002982&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3002982%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DSeo%26aufirst%3DJ.%2BH.%26aulast%3DJung%26aufirst%3DK.%2BH.%26aulast%3DHong%26aufirst%3DS.-S.%26aulast%3DHong%26aufirst%3DS.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%25203%252C5-disubstituted%25207-azaindoles%2520as%2520Trk%2520inhibitors%2520with%2520anticancer%2520and%2520antiangiogenic%2520activities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D5337%26epage%3D5349%26doi%3D10.1021%2Fjm3002982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Goodfellow, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loweth, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravula, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiemann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Todd, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheppard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollack, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polesskaya, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marker, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewhurst, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelbard, H. A.</span><span> </span><span class="NLM_article-title">Discovery, synthesis, and characterization of an orally bioavailable, brain penetrant inhibitor of mixed lineage kinase 3</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">8032</span><span class="NLM_x">–</span> <span class="NLM_lpage">8048</span><span class="refDoi"> DOI: 10.1021/jm401094t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401094t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVGjtrfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=8032-8048&author=V.+S.+Goodfellowauthor=C.+J.+Lowethauthor=S.+B.+Ravulaauthor=T.+Wiemannauthor=T.+Nguyenauthor=Y.+Xuauthor=D.+E.+Toddauthor=D.+Sheppardauthor=S.+Pollackauthor=O.+Polesskayaauthor=D.+F.+Markerauthor=S.+Dewhurstauthor=H.+A.+Gelbard&title=Discovery%2C+synthesis%2C+and+characterization+of+an+orally+bioavailable%2C+brain+penetrant+inhibitor+of+mixed+lineage+kinase+3&doi=10.1021%2Fjm401094t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery, Synthesis, and Characterization of an Orally Bioavailable, Brain Penetrant Inhibitor of Mixed Lineage Kinase 3</span></div><div class="casAuthors">Goodfellow, Val S.; Loweth, Colin J.; Ravula, Satheesh B.; Wiemann, Torsten; Nguyen, Thong; Xu, Yang; Todd, Daniel E.; Sheppard, David; Pollack, Scott; Polesskaya, Oksana; Marker, Daniel F.; Dewhurst, Stephen; Gelbard, Harris A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8032-8048</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibition of mixed lineage kinase 3 (MLK3) is a potential strategy for treatment of Parkinson's disease and HIV-1 assocd. neurocognitive disorders (HAND), requiring an inhibitor that can achieve significant brain concn. levels.  We report here URMC-099 (1) an orally bioavailable (F = 41%), potent (IC50 = 14 nM) MLK3 inhibitor with excellent brain exposure in mouse PK models and minimal interference with key human CYP450 enzymes or hERG channels.  The compd. inhibits LPS-induced TNFα release in microglial cells, HIV-1 Tat-induced release of cytokines in human monocytes and up-regulation of phospho-JNK in Tat-injected brains of mice.  Compd. 1 likely functions in HAND preclin. models by inhibiting multiple kinase pathways, including MLK3 and LRRK2 (IC50 = 11 nM).  We compare the kinase specificity and BBB penetration of 1 with CEP-1347 (2).  Compd. 1 is well tolerated, with excellent in vivo activity in HAND models, and is under investigation for further development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosmrog4axXu7Vg90H21EOLACvtfcHk0lgJdr5g6U7yDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVGjtrfK&md5=53cb667f098b4de13a3a96b92cd546bf</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm401094t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401094t%26sid%3Dliteratum%253Aachs%26aulast%3DGoodfellow%26aufirst%3DV.%2BS.%26aulast%3DLoweth%26aufirst%3DC.%2BJ.%26aulast%3DRavula%26aufirst%3DS.%2BB.%26aulast%3DWiemann%26aufirst%3DT.%26aulast%3DNguyen%26aufirst%3DT.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DTodd%26aufirst%3DD.%2BE.%26aulast%3DSheppard%26aufirst%3DD.%26aulast%3DPollack%26aufirst%3DS.%26aulast%3DPolesskaya%26aufirst%3DO.%26aulast%3DMarker%26aufirst%3DD.%2BF.%26aulast%3DDewhurst%26aufirst%3DS.%26aulast%3DGelbard%26aufirst%3DH.%2BA.%26atitle%3DDiscovery%252C%2520synthesis%252C%2520and%2520characterization%2520of%2520an%2520orally%2520bioavailable%252C%2520brain%2520penetrant%2520inhibitor%2520of%2520mixed%2520lineage%2520kinase%25203%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D8032%26epage%3D8048%26doi%3D10.1021%2Fjm401094t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Himo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovell, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilgraf, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rostovtsev, V. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noodleman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharpless, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fokin, V. V.</span><span> </span><span class="NLM_article-title">Copper(I)-catalyzed synthesis of azoles. DFT study predicts unprecedented reactivity and intermediates</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">210</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span><span class="refDoi"> DOI: 10.1021/ja0471525</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja0471525" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVKrsrfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2005&pages=210-216&author=F.+Himoauthor=T.+Lovellauthor=R.+Hilgrafauthor=V.+V.+Rostovtsevauthor=L.+Noodlemanauthor=K.+B.+Sharplessauthor=V.+V.+Fokin&title=Copper%28I%29-catalyzed+synthesis+of+azoles.+DFT+study+predicts+unprecedented+reactivity+and+intermediates&doi=10.1021%2Fja0471525"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Copper(I)-Catalyzed Synthesis of Azoles. DFT Study Predicts Unprecedented Reactivity and Intermediates</span></div><div class="casAuthors">Himo, Fahmi; Lovell, Timothy; Hilgraf, Robert; Rostovtsev, Vsevolod V.; Noodleman, Louis; Sharpless, K. Barry; Fokin, Valery V.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">210-216</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Huisgen's 1,3-dipolar cycloaddns. become nonconcerted when copper(I) acetylides react with azides and nitrile oxides, providing ready access to 1,4-disubstituted 1,2,3-triazoles and 3,4-disubstituted isoxazoles, resp.  The process is highly reliable and exhibits an unusually wide scope with respect to both components.  Computational studies revealed a stepwise mechanism involving unprecedented metallacycle intermediates, which appear to be common for a variety of dipoles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAVy1fcwAvN7Vg90H21EOLACvtfcHk0ljSJpg1f8L9Sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVKrsrfO&md5=74d02d60dd00f8f4221bd47da3d6f514</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fja0471525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0471525%26sid%3Dliteratum%253Aachs%26aulast%3DHimo%26aufirst%3DF.%26aulast%3DLovell%26aufirst%3DT.%26aulast%3DHilgraf%26aufirst%3DR.%26aulast%3DRostovtsev%26aufirst%3DV.%2BV.%26aulast%3DNoodleman%26aufirst%3DL.%26aulast%3DSharpless%26aufirst%3DK.%2BB.%26aulast%3DFokin%26aufirst%3DV.%2BV.%26atitle%3DCopper%2528I%2529-catalyzed%2520synthesis%2520of%2520azoles.%2520DFT%2520study%2520predicts%2520unprecedented%2520reactivity%2520and%2520intermediates%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2005%26volume%3D127%26spage%3D210%26epage%3D216%26doi%3D10.1021%2Fja0471525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Halasz, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biljan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novak, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meštrović, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plavec, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mali, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smrečki, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vančik, H.</span><span> </span><span class="NLM_article-title">Cross-dimerization of nitrosobenzenes in solution and in solid state</span> <span class="citation_source-journal">J. Mol. Struct.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">918</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span><span class="refDoi"> DOI: 10.1016/j.molstruc.2008.07.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1016%2Fj.molstruc.2008.07.035" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=918&publication_year=2009&pages=19-25&author=I.+Halaszauthor=I.+Biljanauthor=P.+Novakauthor=E.+Me%C5%A1trovi%C4%87author=J.+Plavecauthor=G.+Maliauthor=V.+Smre%C4%8Dkiauthor=H.+Van%C4%8Dik&title=Cross-dimerization+of+nitrosobenzenes+in+solution+and+in+solid+state&doi=10.1016%2Fj.molstruc.2008.07.035"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.molstruc.2008.07.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molstruc.2008.07.035%26sid%3Dliteratum%253Aachs%26aulast%3DHalasz%26aufirst%3DI.%26aulast%3DBiljan%26aufirst%3DI.%26aulast%3DNovak%26aufirst%3DP.%26aulast%3DMe%25C5%25A1trovi%25C4%2587%26aufirst%3DE.%26aulast%3DPlavec%26aufirst%3DJ.%26aulast%3DMali%26aufirst%3DG.%26aulast%3DSmre%25C4%258Dki%26aufirst%3DV.%26aulast%3DVan%25C4%258Dik%26aufirst%3DH.%26atitle%3DCross-dimerization%2520of%2520nitrosobenzenes%2520in%2520solution%2520and%2520in%2520solid%2520state%26jtitle%3DJ.%2520Mol.%2520Struct.%26date%3D2009%26volume%3D918%26spage%3D19%26epage%3D25%26doi%3D10.1016%2Fj.molstruc.2008.07.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Kamal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bharathi, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dastagiri, D.</span><span> </span><span class="NLM_article-title">Base-free monosulfonylation of amines using tosyl or mesyl chloride in water</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">348</span><span class="NLM_x">–</span> <span class="NLM_lpage">353</span><span class="refDoi"> DOI: 10.1016/j.tetlet.2007.11.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1016%2Fj.tetlet.2007.11.044" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2008&pages=348-353&author=A.+Kamalauthor=J.+S.+Reddyauthor=E.+V.+Bharathiauthor=D.+Dastagiri&title=Base-free+monosulfonylation+of+amines+using+tosyl+or+mesyl+chloride+in+water&doi=10.1016%2Fj.tetlet.2007.11.044"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2007.11.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2007.11.044%26sid%3Dliteratum%253Aachs%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DReddy%26aufirst%3DJ.%2BS.%26aulast%3DBharathi%26aufirst%3DE.%2BV.%26aulast%3DDastagiri%26aufirst%3DD.%26atitle%3DBase-free%2520monosulfonylation%2520of%2520amines%2520using%2520tosyl%2520or%2520mesyl%2520chloride%2520in%2520water%26jtitle%3DTetrahedron%2520Lett.%26date%3D2008%26volume%3D49%26spage%3D348%26epage%3D353%26doi%3D10.1016%2Fj.tetlet.2007.11.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Mahajan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhardwaj, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, S.</span><span> </span><span class="NLM_article-title">Selective synthesis of mono-substituted ureas in low melting citric acid-urea-mannitol mixture</span> <span class="citation_source-journal">Org. Prep. Proced. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">463</span><span class="NLM_x">–</span> <span class="NLM_lpage">468</span><span class="refDoi"> DOI: 10.1080/00304948.2014.944408</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1080%2F00304948.2014.944408" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFKrtL3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2014&pages=463-468&author=H.+Mahajanauthor=M.+Bhardwajauthor=S.+Paul&title=Selective+synthesis+of+mono-substituted+ureas+in+low+melting+citric+acid-urea-mannitol+mixture&doi=10.1080%2F00304948.2014.944408"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Synthesis of Mono-substituted Ureas in Low Melting Citric Acid-Urea-Mannitol Mixture</span></div><div class="casAuthors">Mahajan, Hitesh; Bhardwaj, Madhvi; Paul, Satya</div><div class="citationInfo"><span class="NLM_cas:title">Organic Preparations and Procedures International</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">463-468</span>CODEN:
                <span class="NLM_cas:coden">OPPIAK</span>;
        ISSN:<span class="NLM_cas:issn">0030-4948</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A simple and mild solvent free methodol. for the selective synthesis of monoarylureas using a low melting mixt. of Citric acid, Urea and Mannitol at 80° is presented.  The present protocol has several addnl. benefits including the use of renewable and biodegradable materials, mild reaction conditions, facile work-up, higher product yields with high selectivity and most importantly avoiding toxic org. solvents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTa4UG-cCdFbVg90H21EOLACvtfcHk0ljSJpg1f8L9Sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFKrtL3I&md5=b9870b13643c28492d1f1e1cb9b5c3c2</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1080%2F00304948.2014.944408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00304948.2014.944408%26sid%3Dliteratum%253Aachs%26aulast%3DMahajan%26aufirst%3DH.%26aulast%3DBhardwaj%26aufirst%3DM.%26aulast%3DPaul%26aufirst%3DS.%26atitle%3DSelective%2520synthesis%2520of%2520mono-substituted%2520ureas%2520in%2520low%2520melting%2520citric%2520acid-urea-mannitol%2520mixture%26jtitle%3DOrg.%2520Prep.%2520Proced.%2520Int.%26date%3D2014%26volume%3D46%26spage%3D463%26epage%3D468%26doi%3D10.1080%2F00304948.2014.944408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Gadakh, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chikanna, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rindhe, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karale, B. K.</span><span> </span><span class="NLM_article-title">Heteroaryl hydroxycarbonylation: an efficient, robust, practically scalable approach using formyl acetate as the CO Source</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">658</span><span class="NLM_x">–</span> <span class="NLM_lpage">666</span><span class="refDoi"> DOI: 10.1080/00397911.2010.528851</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1080%2F00397911.2010.528851" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BC38XkslWisro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2012&pages=658-666&author=A.+V.+Gadakhauthor=D.+Chikannaauthor=S.+S.+Rindheauthor=B.+K.+Karale&title=Heteroaryl+hydroxycarbonylation%3A+an+efficient%2C+robust%2C+practically+scalable+approach+using+formyl+acetate+as+the+CO+Source&doi=10.1080%2F00397911.2010.528851"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Heteroaryl Hydroxycarbonylation: An Efficient, Robust, Practically Scalable Approach Using Formyl Acetate as the CO Source</span></div><div class="casAuthors">Gadakh, Amol V.; Chikanna, Dinesh; Rindhe, Sahebrao S.; Karale, Bhausaheb K.</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">658-666</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">A simple, efficient, regioselective, and scalable palladium-catalyzed hydroxycarbonylation of heteroaryl halides to corresponding carboxylic acids using acetic-formic anhydride in presence of Pd(OAc)2, dppf, and diisopropylethyl amine in DMF at 80-90 °C in excellent yields.  E.g., in presence of Pd(OAc)2, dppf, and AcOCHO, hydroxycarbonylation of 5-bromoindazole gave 95% 1H-indazole-5-carboxylic acid.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0cvI5KOiinLVg90H21EOLACvtfcHk0ljMfpscsOpBpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkslWisro%253D&md5=47182e5a6869277a527e185cce38f523</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1080%2F00397911.2010.528851&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397911.2010.528851%26sid%3Dliteratum%253Aachs%26aulast%3DGadakh%26aufirst%3DA.%2BV.%26aulast%3DChikanna%26aufirst%3DD.%26aulast%3DRindhe%26aufirst%3DS.%2BS.%26aulast%3DKarale%26aufirst%3DB.%2BK.%26atitle%3DHeteroaryl%2520hydroxycarbonylation%253A%2520an%2520efficient%252C%2520robust%252C%2520practically%2520scalable%2520approach%2520using%2520formyl%2520acetate%2520as%2520the%2520CO%2520Source%26jtitle%3DSynth.%2520Commun.%26date%3D2012%26volume%3D42%26spage%3D658%26epage%3D666%26doi%3D10.1080%2F00397911.2010.528851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Zhang, L.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hao, X.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, J.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niu, J.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, M.-P.</span><span> </span><span class="NLM_article-title">Cobalt-catalyzed C(sp2)–H alkoxylation of aromatic and olefinic carboxamides</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">272</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span><span class="refDoi"> DOI: 10.1002/anie.201409751</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1002%2Fanie.201409751" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFShu77P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2015&pages=272-275&author=L.-B.+Zhangauthor=X.-Q.+Haoauthor=S.-K.+Zhangauthor=Z.-J.+Liuauthor=X.-X.+Zhengauthor=J.-F.+Gongauthor=J.-L.+Niuauthor=M.-P.+Song&title=Cobalt-catalyzed+C%28sp2%29%E2%80%93H+alkoxylation+of+aromatic+and+olefinic+carboxamides&doi=10.1002%2Fanie.201409751"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Cobalt-Catalyzed C(sp2)-H Alkoxylation of Aromatic and Olefinic Carboxamides</span></div><div class="casAuthors">Zhang, Lin-Bao; Hao, Xin-Qi; Zhang, Shou-Kun; Liu, Zhan-Jiang; Zheng, Xin-Xiang; Gong, Jun-Fang; Niu, Jun-Long; Song, Mao-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">272-275</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The cobalt-catalyzed alkoxylation of C(sp2)-H bonds in arom. and olefinic carboxamides has been developed.  The reaction proceeded under mild conditions in the presence of Co(OAc)2·4H2O as the catalyst and tolerates a wide range of both alcs. and benzamide substrates, including even olefinic carboxamides.  In addn., this reaction is the first example of the direct alkoxylation of alkenes through C-H bond activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqMTC9T_B3o7Vg90H21EOLACvtfcHk0ljMfpscsOpBpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFShu77P&md5=f1e32003a6a1373e2a1fea7de689fcf6</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1002%2Fanie.201409751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201409751%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.-B.%26aulast%3DHao%26aufirst%3DX.-Q.%26aulast%3DZhang%26aufirst%3DS.-K.%26aulast%3DLiu%26aufirst%3DZ.-J.%26aulast%3DZheng%26aufirst%3DX.-X.%26aulast%3DGong%26aufirst%3DJ.-F.%26aulast%3DNiu%26aufirst%3DJ.-L.%26aulast%3DSong%26aufirst%3DM.-P.%26atitle%3DCobalt-catalyzed%2520C%2528sp2%2529%25E2%2580%2593H%2520alkoxylation%2520of%2520aromatic%2520and%2520olefinic%2520carboxamides%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2015%26volume%3D54%26spage%3D272%26epage%3D275%26doi%3D10.1002%2Fanie.201409751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Zhi-Yong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan-Guang, W.</span><span> </span><span class="NLM_article-title">A mild, efficient and selective cleavage of aryl tert-butyldimethysilyl ethers using KOH in ethanol</span> <span class="citation_source-journal">Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">568</span><span class="NLM_x">–</span> <span class="NLM_lpage">569</span><span class="refDoi"> DOI: 10.1246/cl.2003.568</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1246%2Fcl.2003.568" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2003&pages=568-569&author=J.+Zhi-Yongauthor=W.+Yan-Guang&title=A+mild%2C+efficient+and+selective+cleavage+of+aryl+tert-butyldimethysilyl+ethers+using+KOH+in+ethanol&doi=10.1246%2Fcl.2003.568"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1246%2Fcl.2003.568&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1246%252Fcl.2003.568%26sid%3Dliteratum%253Aachs%26aulast%3DZhi-Yong%26aufirst%3DJ.%26aulast%3DYan-Guang%26aufirst%3DW.%26atitle%3DA%2520mild%252C%2520efficient%2520and%2520selective%2520cleavage%2520of%2520aryl%2520tert-butyldimethysilyl%2520ethers%2520using%2520KOH%2520in%2520ethanol%26jtitle%3DChem.%2520Lett.%26date%3D2003%26volume%3D32%26spage%3D568%26epage%3D569%26doi%3D10.1246%2Fcl.2003.568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Oakdale, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boger, D. L.</span><span> </span><span class="NLM_article-title">Total synthesis of Lycogarubin C and Lycogalic acid</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1132</span><span class="NLM_x">–</span> <span class="NLM_lpage">1134</span><span class="refDoi"> DOI: 10.1021/ol100146b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol100146b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhvFGqu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=1132-1134&author=J.+S.+Oakdaleauthor=D.+L.+Boger&title=Total+synthesis+of+Lycogarubin+C+and+Lycogalic+acid&doi=10.1021%2Fol100146b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Total Synthesis of Lycogarubin C and Lycogalic Acid</span></div><div class="casAuthors">Oakdale, James S.; Boger, Dale L.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1132-1134</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Two complementary concise total syntheses of lycogarubin C (I) and lycogalic acid (II, aka chromopyrrolic acid) are detailed utilizing a 1,2,4,5-tetrazine → 1,2-diazine → pyrrole Diels-Alder strategy and enlisting acetylenic dienophiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_HS0RerHxzrVg90H21EOLACvtfcHk0ljMfpscsOpBpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhvFGqu70%253D&md5=f04965ef4eab5fcf9c17432b82aea282</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fol100146b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol100146b%26sid%3Dliteratum%253Aachs%26aulast%3DOakdale%26aufirst%3DJ.%2BS.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26atitle%3DTotal%2520synthesis%2520of%2520Lycogarubin%2520C%2520and%2520Lycogalic%2520acid%26jtitle%3DOrg.%2520Lett.%26date%3D2010%26volume%3D12%26spage%3D1132%26epage%3D1134%26doi%3D10.1021%2Fol100146b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Harrington, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourbeau, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fotsch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frohn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickrell, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichelt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sham, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegmund, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailis, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Escobar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orf, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">San Miguel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zalameda, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, J. G.</span><span> </span><span class="NLM_article-title">The optimization of aminooxadiazoles as orally active inhibitors of Cdc7</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">6396</span><span class="NLM_x">–</span> <span class="NLM_lpage">6400</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.09.055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1016%2Fj.bmcl.2013.09.055" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=6396-6400&author=P.+E.+Harringtonauthor=M.+P.+Bourbeauauthor=C.+Fotschauthor=M.+Frohnauthor=A.+J.+Pickrellauthor=A.+Reicheltauthor=K.+Shamauthor=A.+C.+Siegmundauthor=J.+M.+Bailisauthor=T.+Bushauthor=S.+Escobarauthor=D.+Hickmanauthor=S.+Hellerauthor=F.+Hsiehauthor=J.+N.+Orfauthor=M.+Rongauthor=T.+San+Miguelauthor=H.+Tanauthor=L.+Zalamedaauthor=J.+G.+Allen&title=The+optimization+of+aminooxadiazoles+as+orally+active+inhibitors+of+Cdc7&doi=10.1016%2Fj.bmcl.2013.09.055"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.09.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.09.055%26sid%3Dliteratum%253Aachs%26aulast%3DHarrington%26aufirst%3DP.%2BE.%26aulast%3DBourbeau%26aufirst%3DM.%2BP.%26aulast%3DFotsch%26aufirst%3DC.%26aulast%3DFrohn%26aufirst%3DM.%26aulast%3DPickrell%26aufirst%3DA.%2BJ.%26aulast%3DReichelt%26aufirst%3DA.%26aulast%3DSham%26aufirst%3DK.%26aulast%3DSiegmund%26aufirst%3DA.%2BC.%26aulast%3DBailis%26aufirst%3DJ.%2BM.%26aulast%3DBush%26aufirst%3DT.%26aulast%3DEscobar%26aufirst%3DS.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DHeller%26aufirst%3DS.%26aulast%3DHsieh%26aufirst%3DF.%26aulast%3DOrf%26aufirst%3DJ.%2BN.%26aulast%3DRong%26aufirst%3DM.%26aulast%3DSan%2BMiguel%26aufirst%3DT.%26aulast%3DTan%26aufirst%3DH.%26aulast%3DZalameda%26aufirst%3DL.%26aulast%3DAllen%26aufirst%3DJ.%2BG.%26atitle%3DThe%2520optimization%2520of%2520aminooxadiazoles%2520as%2520orally%2520active%2520inhibitors%2520of%2520Cdc7%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D6396%26epage%3D6400%26doi%3D10.1016%2Fj.bmcl.2013.09.055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Kishore Kumar, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Natarajan, A.</span><span> </span><span class="NLM_article-title">Total synthesis of ovalifoliolatin B, acerogenins A and C</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">2103</span><span class="NLM_x">–</span> <span class="NLM_lpage">2105</span><span class="refDoi"> DOI: 10.1016/j.tetlet.2008.01.135</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1016%2Fj.tetlet.2008.01.135" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2008&pages=2103-2105&author=G.+D.+Kishore+Kumarauthor=A.+Natarajan&title=Total+synthesis+of+ovalifoliolatin+B%2C+acerogenins+A+and+C&doi=10.1016%2Fj.tetlet.2008.01.135"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2008.01.135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2008.01.135%26sid%3Dliteratum%253Aachs%26aulast%3DKishore%2BKumar%26aufirst%3DG.%2BD.%26aulast%3DNatarajan%26aufirst%3DA.%26atitle%3DTotal%2520synthesis%2520of%2520ovalifoliolatin%2520B%252C%2520acerogenins%2520A%2520and%2520C%26jtitle%3DTetrahedron%2520Lett.%26date%3D2008%26volume%3D49%26spage%3D2103%26epage%3D2105%26doi%3D10.1016%2Fj.tetlet.2008.01.135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Brennan, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhaak, R. G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKenna, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campos, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noushmehr, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salama, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakravarty, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanborn, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berman, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beroukhim, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernard, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genovese, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shmulevich, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnholtz-Sloan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vegesna, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shukla, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciriello, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yung, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sougnez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikkelsen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aldape, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigner, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Meir, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prados, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sloan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eschbacher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finocchiaro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guha, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iacocca, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foltz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weisenberger, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penny, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kucherlapati, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perou, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbs, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marra, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lander, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spellman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sander, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstein, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyerson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabriel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laird, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haussler, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Getz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, L.</span><span> </span><span class="NLM_article-title">The somatic genomic landscape of glioblastoma</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">155</span><span class="NLM_x">, </span> <span class="NLM_fpage">462</span><span class="NLM_x">–</span> <span class="NLM_lpage">477</span><span class="refDoi"> DOI: 10.1016/j.cell.2013.09.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1016%2Fj.cell.2013.09.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=24120142" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1Srtb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=2013&pages=462-477&author=C.+W.+Brennanauthor=R.+G.+W.+Verhaakauthor=A.+McKennaauthor=B.+Camposauthor=H.+Noushmehrauthor=S.+R.+Salamaauthor=S.+Zhengauthor=D.+Chakravartyauthor=J.+Z.+Sanbornauthor=S.+H.+Bermanauthor=R.+Beroukhimauthor=B.+Bernardauthor=C.-J.+Wuauthor=G.+Genoveseauthor=I.+Shmulevichauthor=J.+Barnholtz-Sloanauthor=L.+Zouauthor=R.+Vegesnaauthor=S.+A.+Shuklaauthor=G.+Cirielloauthor=W.+K.+Yungauthor=W.+Zhangauthor=C.+Sougnezauthor=T.+Mikkelsenauthor=K.+Aldapeauthor=D.+D.+Bignerauthor=E.+G.+Van+Meirauthor=M.+Pradosauthor=A.+Sloanauthor=K.+L.+Blackauthor=J.+Eschbacherauthor=G.+Finocchiaroauthor=W.+Friedmanauthor=D.+W.+Andrewsauthor=A.+Guhaauthor=M.+Iacoccaauthor=B.+P.+O%E2%80%99Neillauthor=G.+Foltzauthor=J.+Myersauthor=D.+J.+Weisenbergerauthor=R.+Pennyauthor=R.+Kucherlapatiauthor=C.+M.+Perouauthor=D.+N.+Hayesauthor=R.+Gibbsauthor=M.+Marraauthor=G.+B.+Millsauthor=E.+Landerauthor=P.+Spellmanauthor=R.+Wilsonauthor=C.+Sanderauthor=J.+Weinsteinauthor=M.+Meyersonauthor=S.+Gabrielauthor=P.+W.+Lairdauthor=D.+Hausslerauthor=G.+Getzauthor=L.+Chin&title=The+somatic+genomic+landscape+of+glioblastoma&doi=10.1016%2Fj.cell.2013.09.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">The somatic genomic landscape of glioblastoma</span></div><div class="casAuthors">Brennan, Cameron W.; Verhaak, Roel G. W.; McKenna, Aaron; Campos, Benito; Noushmehr, Houtan; Salama, Sofie R.; Zheng, Siyuan; Chakravarty, Debyani; Sanborn, J. Zachary; Berman, Samuel H.; Beroukhim, Rameen; Bernard, Brady; Wu, Chang-Jiun; Genovese, Giannicola; Shmulevich, Ilya; Barnholtz-Sloan, Jill; Zou, Lihua; Vegesna, Rahulsimham; Shukla, Sachet A.; Ciriello, Giovanni; Yung, W. K.; Zhang, Wei; Sougnez, Carrie; Mikkelsen, Tom; Aldape, Kenneth; Bigner, Darell D.; Van Meir, Erwin G.; Prados, Michael; Sloan, Andrew; Black, Keith L.; Eschbacher, Jennifer; Finocchiaro, Gaetano; Friedman, William; Andrews, David W.; Guha, Abhijit; Iacocca, Mary; O'Neill, Brian P.; Foltz, Greg; Myers, Jerome; Weisenberger, Daniel J.; Penny, Robert; Kucherlapati, Raju; Perou, Charles M.; Hayes, D. Neil; Gibbs, Richard; Marra, Marco; Mills, Gordon B.; Lander, Eric; Spellman, Paul; Wilson, Richard; Sander, Chris; Weinstein, John; Meyerson, Matthew; Gabriel, Stacey; Laird, Peter W.; Haussler, David; Getz, Gad; Chin, Lynda</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">155</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">462-477</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">We describe the landscape of somatic genomic alterations based on multidimensional and comprehensive characterization of more than 500 glioblastoma tumors (GBMs).  We identify several novel mutated genes as well as complex rearrangements of signature receptors, including EGFR and PDGFRA.  TERT promoter mutations are shown to correlate with elevated mRNA expression, supporting a role in telomerase reactivation.  Correlative analyses confirm that the survival advantage of the proneural subtype is conferred by the G-CIMP phenotype, and MGMT DNA methylation may be a predictive biomarker for treatment response only in classical subtype GBM.  Integrative anal. of genomic and proteomic profiles challenges the notion of therapeutic inhibition of a pathway as an alternative to inhibition of the target itself.  These data will facilitate the discovery of therapeutic and diagnostic target candidates, the validation of research and clin. observations and the generation of unanticipated hypotheses that can advance our mol. understanding of this lethal cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7Ot1_NzzEC7Vg90H21EOLACvtfcHk0litv3Yy-3ZoGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1Srtb7J&md5=2f514c95e40e18c1e11585dafa845fc3</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2013.09.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2013.09.034%26sid%3Dliteratum%253Aachs%26aulast%3DBrennan%26aufirst%3DC.%2BW.%26aulast%3DVerhaak%26aufirst%3DR.%2BG.%2BW.%26aulast%3DMcKenna%26aufirst%3DA.%26aulast%3DCampos%26aufirst%3DB.%26aulast%3DNoushmehr%26aufirst%3DH.%26aulast%3DSalama%26aufirst%3DS.%2BR.%26aulast%3DZheng%26aufirst%3DS.%26aulast%3DChakravarty%26aufirst%3DD.%26aulast%3DSanborn%26aufirst%3DJ.%2BZ.%26aulast%3DBerman%26aufirst%3DS.%2BH.%26aulast%3DBeroukhim%26aufirst%3DR.%26aulast%3DBernard%26aufirst%3DB.%26aulast%3DWu%26aufirst%3DC.-J.%26aulast%3DGenovese%26aufirst%3DG.%26aulast%3DShmulevich%26aufirst%3DI.%26aulast%3DBarnholtz-Sloan%26aufirst%3DJ.%26aulast%3DZou%26aufirst%3DL.%26aulast%3DVegesna%26aufirst%3DR.%26aulast%3DShukla%26aufirst%3DS.%2BA.%26aulast%3DCiriello%26aufirst%3DG.%26aulast%3DYung%26aufirst%3DW.%2BK.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DSougnez%26aufirst%3DC.%26aulast%3DMikkelsen%26aufirst%3DT.%26aulast%3DAldape%26aufirst%3DK.%26aulast%3DBigner%26aufirst%3DD.%2BD.%26aulast%3DVan%2BMeir%26aufirst%3DE.%2BG.%26aulast%3DPrados%26aufirst%3DM.%26aulast%3DSloan%26aufirst%3DA.%26aulast%3DBlack%26aufirst%3DK.%2BL.%26aulast%3DEschbacher%26aufirst%3DJ.%26aulast%3DFinocchiaro%26aufirst%3DG.%26aulast%3DFriedman%26aufirst%3DW.%26aulast%3DAndrews%26aufirst%3DD.%2BW.%26aulast%3DGuha%26aufirst%3DA.%26aulast%3DIacocca%26aufirst%3DM.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%2BP.%26aulast%3DFoltz%26aufirst%3DG.%26aulast%3DMyers%26aufirst%3DJ.%26aulast%3DWeisenberger%26aufirst%3DD.%2BJ.%26aulast%3DPenny%26aufirst%3DR.%26aulast%3DKucherlapati%26aufirst%3DR.%26aulast%3DPerou%26aufirst%3DC.%2BM.%26aulast%3DHayes%26aufirst%3DD.%2BN.%26aulast%3DGibbs%26aufirst%3DR.%26aulast%3DMarra%26aufirst%3DM.%26aulast%3DMills%26aufirst%3DG.%2BB.%26aulast%3DLander%26aufirst%3DE.%26aulast%3DSpellman%26aufirst%3DP.%26aulast%3DWilson%26aufirst%3DR.%26aulast%3DSander%26aufirst%3DC.%26aulast%3DWeinstein%26aufirst%3DJ.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3DGabriel%26aufirst%3DS.%26aulast%3DLaird%26aufirst%3DP.%2BW.%26aulast%3DHaussler%26aufirst%3DD.%26aulast%3DGetz%26aufirst%3DG.%26aulast%3DChin%26aufirst%3DL.%26atitle%3DThe%2520somatic%2520genomic%2520landscape%2520of%2520glioblastoma%26jtitle%3DCell%26date%3D2013%26volume%3D155%26spage%3D462%26epage%3D477%26doi%3D10.1016%2Fj.cell.2013.09.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Pollard, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshikawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, I. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danovi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stricker, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayani, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Head, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernstein, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Squire, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dirks, P.</span><span> </span><span class="NLM_article-title">Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens</span> <span class="citation_source-journal">Cell Stem Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">568</span><span class="NLM_x">–</span> <span class="NLM_lpage">580</span><span class="refDoi"> DOI: 10.1016/j.stem.2009.03.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1016%2Fj.stem.2009.03.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=19497285" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnt1Ggtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=568-580&author=S.+M.+Pollardauthor=K.+Yoshikawaauthor=I.+D.+Clarkeauthor=D.+Danoviauthor=S.+Strickerauthor=R.+Russellauthor=J.+Bayaniauthor=R.+Headauthor=M.+Leeauthor=M.+Bernsteinauthor=J.+A.+Squireauthor=A.+Smithauthor=P.+Dirks&title=Glioma+stem+cell+lines+expanded+in+adherent+culture+have+tumor-specific+phenotypes+and+are+suitable+for+chemical+and+genetic+screens&doi=10.1016%2Fj.stem.2009.03.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens</span></div><div class="casAuthors">Pollard, Steven M.; Yoshikawa, Koichi; Clarke, Ian D.; Danovi, Davide; Stricker, Stefan; Russell, Roslin; Bayani, Jane; Head, Renee; Lee, Marco; Bernstein, Mark; Squire, Jeremy A.; Smith, Austin; Dirks, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Cell Stem Cell</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">568-580</span>CODEN:
                <span class="NLM_cas:coden">CSCEC4</span>;
        ISSN:<span class="NLM_cas:issn">1934-5909</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Human brain tumors appear to have a hierarchical cellular organization suggestive of a stem cell foundation.  In vitro expansion of the putative cancer stem cells as stable cell lines would provide a powerful model system to study their biol.  Here, we demonstrate routine and efficient derivation of adherent cell lines from malignant glioma that display stem cell properties and initiate high-grade gliomas following xenotransplantation.  Significantly, glioma neural stem (GNS) cell lines from different tumors exhibit divergent gene expression signatures and differentiation behavior that correlate with specific neural progenitor subtypes.  The diversity of gliomas may, therefore, reflect distinct cancer stem cell phenotypes.  The purity and stability of adherent GNS cell lines offer significant advantages compared to "sphere" cultures, enabling refined studies of cancer stem cell behavior.  A proof-of-principle live cell imaging-based chem. screen (450 FDA-approved drugs) identifies both differential sensitivities of GNS cells and a common susceptibility to perturbation of serotonin signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGow_cFBCe3CmrVg90H21EOLACvtfcHk0lj-sL8gwVEAsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnt1Ggtbg%253D&md5=977d5a7f79ab8b7ee60ea571cf85d543</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.stem.2009.03.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.stem.2009.03.014%26sid%3Dliteratum%253Aachs%26aulast%3DPollard%26aufirst%3DS.%2BM.%26aulast%3DYoshikawa%26aufirst%3DK.%26aulast%3DClarke%26aufirst%3DI.%2BD.%26aulast%3DDanovi%26aufirst%3DD.%26aulast%3DStricker%26aufirst%3DS.%26aulast%3DRussell%26aufirst%3DR.%26aulast%3DBayani%26aufirst%3DJ.%26aulast%3DHead%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DBernstein%26aufirst%3DM.%26aulast%3DSquire%26aufirst%3DJ.%2BA.%26aulast%3DSmith%26aufirst%3DA.%26aulast%3DDirks%26aufirst%3DP.%26atitle%3DGlioma%2520stem%2520cell%2520lines%2520expanded%2520in%2520adherent%2520culture%2520have%2520tumor-specific%2520phenotypes%2520and%2520are%2520suitable%2520for%2520chemical%2520and%2520genetic%2520screens%26jtitle%3DCell%2520Stem%2520Cell%26date%3D2009%26volume%3D4%26spage%3D568%26epage%3D580%26doi%3D10.1016%2Fj.stem.2009.03.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Day, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stringer, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Ejeh, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ting</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michael, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ensbey, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jamieson, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruce, Z. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, Yi C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Offenhäuser, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charmsaz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellacott, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harding, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leveque, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inglis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lackmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osborne, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khanna, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lickliter, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, A. W.</span><span> </span><span class="NLM_article-title">EphA3 maintains tumorigenicity and is a therapeutic target in glioblastoma multiforme</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">238</span><span class="NLM_x">–</span> <span class="NLM_lpage">248</span><span class="refDoi"> DOI: 10.1016/j.ccr.2013.01.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1016%2Fj.ccr.2013.01.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=23410976" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BC3sXisVSnt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=238-248&author=B.+W.+Dayauthor=B.+W.+Stringerauthor=F.+Al-Ejehauthor=+Tingauthor=J.+Michaelauthor=J.+Wilsonauthor=K.+S.+Ensbeyauthor=P.+R.+Jamiesonauthor=Z.+C.+Bruceauthor=Yi+C.+Limauthor=C.+Offenh%C3%A4userauthor=S.+Charmsazauthor=L.+T.+Cooperauthor=J.+K.+Ellacottauthor=A.+Hardingauthor=L.+Levequeauthor=P.+Inglisauthor=S.+Allanauthor=D.+G.+Walkerauthor=M.+Lackmannauthor=G.+Osborneauthor=K.+K.+Khannaauthor=B.+A.+Reynoldsauthor=J.+D.+Lickliterauthor=A.+W.+Boyd&title=EphA3+maintains+tumorigenicity+and+is+a+therapeutic+target+in+glioblastoma+multiforme&doi=10.1016%2Fj.ccr.2013.01.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">EphA3 Maintains Tumorigenicity and Is a Therapeutic Target in Glioblastoma Multiforme</span></div><div class="casAuthors">Day, Bryan W.; Stringer, Brett W.; Al-Ejeh, Fares; Ting, Michael J.; Wilson, John; Ensbey, Kathleen S.; Jamieson, Paul R.; Bruce, Zara C.; Lim, Yi Chieh; Offenhauser, Carolin; Charmsaz, Sara; Cooper, Leanne T.; Ellacott, Jennifer K.; Harding, Angus; Leveque, Lucie; Inglis, Po; Allan, Suzanne; Walker, David G.; Lackmann, Martin; Osborne, Geoffrey; Khanna, Kum Kum; Reynolds, Brent A.; Lickliter, Jason D.; Boyd, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">238-248</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Significant endeavor has been applied to identify functional therapeutic targets in glioblastoma (GBM) to halt the growth of this aggressive cancer.  We show that the receptor tyrosine kinase EphA3 is frequently overexpressed in GBM and, in particular, in the most aggressive mesenchymal subtype.  Importantly, EphA3 is highly expressed on the tumor-initiating cell population in glioma and appears critically involved in maintaining tumor cells in a less differentiated state by modulating mitogen-activated protein kinase signaling.  EphA3 knockdown or depletion of EphA3-pos. tumor cells reduced tumorigenic potential to a degree comparable to treatment with a therapeutic radiolabeled EphA3-specific monoclonal antibody.  These results identify EphA3 as a functional, targetable receptor in GBM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4I9LA-du-dLVg90H21EOLACvtfcHk0lj-sL8gwVEAsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXisVSnt7k%253D&md5=011bdb472829931877f9e952c75d497e</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2013.01.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2013.01.007%26sid%3Dliteratum%253Aachs%26aulast%3DDay%26aufirst%3DB.%2BW.%26aulast%3DStringer%26aufirst%3DB.%2BW.%26aulast%3DAl-Ejeh%26aufirst%3DF.%26aulast%3DTing%26aulast%3DMichael%26aufirst%3DJ.%26aulast%3DWilson%26aufirst%3DJ.%26aulast%3DEnsbey%26aufirst%3DK.%2BS.%26aulast%3DJamieson%26aufirst%3DP.%2BR.%26aulast%3DBruce%26aufirst%3DZ.%2BC.%26aulast%3DLim%26aufirst%3DYi%2BC.%26aulast%3DOffenh%25C3%25A4user%26aufirst%3DC.%26aulast%3DCharmsaz%26aufirst%3DS.%26aulast%3DCooper%26aufirst%3DL.%2BT.%26aulast%3DEllacott%26aufirst%3DJ.%2BK.%26aulast%3DHarding%26aufirst%3DA.%26aulast%3DLeveque%26aufirst%3DL.%26aulast%3DInglis%26aufirst%3DP.%26aulast%3DAllan%26aufirst%3DS.%26aulast%3DWalker%26aufirst%3DD.%2BG.%26aulast%3DLackmann%26aufirst%3DM.%26aulast%3DOsborne%26aufirst%3DG.%26aulast%3DKhanna%26aufirst%3DK.%2BK.%26aulast%3DReynolds%26aufirst%3DB.%2BA.%26aulast%3DLickliter%26aufirst%3DJ.%2BD.%26aulast%3DBoyd%26aufirst%3DA.%2BW.%26atitle%3DEphA3%2520maintains%2520tumorigenicity%2520and%2520is%2520a%2520therapeutic%2520target%2520in%2520glioblastoma%2520multiforme%26jtitle%3DCancer%2520Cell%26date%3D2013%26volume%3D23%26spage%3D238%26epage%3D248%26doi%3D10.1016%2Fj.ccr.2013.01.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Day, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stringer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffree, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jamieson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ensbey, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruce, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inglis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tollesson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Findlay, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadrian, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johns, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartlett, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osborne, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, A.</span><span> </span><span class="NLM_article-title">Glioma surgical aspirate: a viable source of tumor tissue for experimental research</span> <span class="citation_source-journal">Cancers</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">357</span><span class="NLM_x">–</span> <span class="NLM_lpage">371</span><span class="refDoi"> DOI: 10.3390/cancers5020357</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.3390%2Fcancers5020357" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=357-371&author=B.+Dayauthor=B.+Stringerauthor=J.+Wilsonauthor=R.+Jeffreeauthor=P.+Jamiesonauthor=K.+Ensbeyauthor=Z.+Bruceauthor=P.+Inglisauthor=S.+Allanauthor=C.+Winterauthor=G.+Tollessonauthor=S.+Campbellauthor=P.+Lucasauthor=W.+Findlayauthor=D.+Kadrianauthor=D.+Johnsonauthor=T.+Robertsonauthor=T.+Johnsauthor=P.+Bartlettauthor=G.+Osborneauthor=A.+Boyd&title=Glioma+surgical+aspirate%3A+a+viable+source+of+tumor+tissue+for+experimental+research&doi=10.3390%2Fcancers5020357"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.3390%2Fcancers5020357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fcancers5020357%26sid%3Dliteratum%253Aachs%26aulast%3DDay%26aufirst%3DB.%26aulast%3DStringer%26aufirst%3DB.%26aulast%3DWilson%26aufirst%3DJ.%26aulast%3DJeffree%26aufirst%3DR.%26aulast%3DJamieson%26aufirst%3DP.%26aulast%3DEnsbey%26aufirst%3DK.%26aulast%3DBruce%26aufirst%3DZ.%26aulast%3DInglis%26aufirst%3DP.%26aulast%3DAllan%26aufirst%3DS.%26aulast%3DWinter%26aufirst%3DC.%26aulast%3DTollesson%26aufirst%3DG.%26aulast%3DCampbell%26aufirst%3DS.%26aulast%3DLucas%26aufirst%3DP.%26aulast%3DFindlay%26aufirst%3DW.%26aulast%3DKadrian%26aufirst%3DD.%26aulast%3DJohnson%26aufirst%3DD.%26aulast%3DRobertson%26aufirst%3DT.%26aulast%3DJohns%26aufirst%3DT.%26aulast%3DBartlett%26aufirst%3DP.%26aulast%3DOsborne%26aufirst%3DG.%26aulast%3DBoyd%26aufirst%3DA.%26atitle%3DGlioma%2520surgical%2520aspirate%253A%2520a%2520viable%2520source%2520of%2520tumor%2520tissue%2520for%2520experimental%2520research%26jtitle%3DCancers%26date%3D2013%26volume%3D5%26spage%3D357%26epage%3D371%26doi%3D10.3390%2Fcancers5020357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Molina, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jafari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ignatushchenko, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsson, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sreekumar, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nordlund, P.</span><span> </span><span class="NLM_article-title">Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">341</span><span class="NLM_x">, </span> <span class="NLM_fpage">84</span><span class="NLM_x">–</span> <span class="NLM_lpage">87</span><span class="refDoi"> DOI: 10.1126/science.1233606</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1126%2Fscience.1233606" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=23828940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVCgs7rP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=2013&pages=84-87&author=D.+M.+Molinaauthor=R.+Jafariauthor=M.+Ignatushchenkoauthor=T.+Sekiauthor=E.+A.+Larssonauthor=C.+Danauthor=L.+Sreekumarauthor=Y.+Caoauthor=P.+Nordlund&title=Monitoring+drug+target+engagement+in+cells+and+tissues+using+the+cellular+thermal+shift+assay&doi=10.1126%2Fscience.1233606"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay</span></div><div class="casAuthors">Molina, Daniel Martinez; Jafari, Rozbeh; Ignatushchenko, Marina; Seki, Takahiro; Larsson, E. Andreas; Dan, Chen; Sreekumar, Lekshmy; Cao, Yihai; Nordlund, Paer</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">341</span>
        (<span class="NLM_cas:issue">6141</span>),
    <span class="NLM_cas:pages">84-87</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The efficacy of therapeutics is dependent on a drug binding to its cognate target.  Optimization of target engagement by drugs in cells is often challenging, because drug binding cannot be monitored inside cells.  We have developed a method for evaluating drug binding to target proteins in cells and tissue samples.  This cellular thermal shift assay (CETSA) is based on the biophys. principle of ligand-induced thermal stabilization of target proteins.  Using this assay, we validated drug binding for a set of important clin. targets and monitored processes of drug transport and activation, off-target effects and drug resistance in cancer cell lines, as well as drug distribution in tissues.  CETSA is likely to become a valuable tool for the validation and optimization of drug target engagement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaaWSoozY7ObVg90H21EOLACvtfcHk0ljpmNgZf-y0Sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVCgs7rP&md5=f8ba686ba38b67dbdf366c49eb7375b4</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1126%2Fscience.1233606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1233606%26sid%3Dliteratum%253Aachs%26aulast%3DMolina%26aufirst%3DD.%2BM.%26aulast%3DJafari%26aufirst%3DR.%26aulast%3DIgnatushchenko%26aufirst%3DM.%26aulast%3DSeki%26aufirst%3DT.%26aulast%3DLarsson%26aufirst%3DE.%2BA.%26aulast%3DDan%26aufirst%3DC.%26aulast%3DSreekumar%26aufirst%3DL.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DNordlund%26aufirst%3DP.%26atitle%3DMonitoring%2520drug%2520target%2520engagement%2520in%2520cells%2520and%2520tissues%2520using%2520the%2520cellular%2520thermal%2520shift%2520assay%26jtitle%3DScience%26date%3D2013%26volume%3D341%26spage%3D84%26epage%3D87%26doi%3D10.1126%2Fscience.1233606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Jafari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almqvist, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Axelsson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ignatushchenko, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundbäck, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nordlund, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molina, D. M.</span><span> </span><span class="NLM_article-title">The cellular thermal shift assay for evaluating drug target interactions in cells</span> <span class="citation_source-journal">Nat. Protoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">2100</span><span class="NLM_x">–</span> <span class="NLM_lpage">2122</span><span class="refDoi"> DOI: 10.1038/nprot.2014.138</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1038%2Fnprot.2014.138" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=25101824" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht12msrfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=2100-2122&author=R.+Jafariauthor=H.+Almqvistauthor=H.+Axelssonauthor=M.+Ignatushchenkoauthor=T.+Lundb%C3%A4ckauthor=P.+Nordlundauthor=D.+M.+Molina&title=The+cellular+thermal+shift+assay+for+evaluating+drug+target+interactions+in+cells&doi=10.1038%2Fnprot.2014.138"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">The cellular thermal shift assay for evaluating drug target interactions in cells</span></div><div class="casAuthors">Jafari, Rozbeh; Almqvist, Helena; Axelsson, Hanna; Ignatushchenko, Marina; Lundbaeck, Thomas; Nordlund, Paer; Molina, Daniel Martinez</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2100-2122</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Thermal shift assays are used to study thermal stabilization of proteins upon ligand binding.  Such assays have been used extensively on purified proteins in the drug discovery industry and in academia to detect interactions.  Recently, we published a proof-of-principle study describing the implementation of thermal shift assays in a cellular format, which we call the cellular thermal shift assay (CETSA).  The method allows studies of target engagement of drug candidates in a cellular context, herein exemplified with exptl. data on the human kinases p38α and ERK1/2.  The assay involves treatment of cells with a compd. of interest, heating to denature and ppt. proteins, cell lysis, and the sepn. of cell debris and aggregates from the sol. protein fraction.  Whereas unbound proteins denature and ppt. at elevated temps., ligand-bound proteins remain in soln.  We describe two procedures for detecting the stabilized protein in the sol. fraction of the samples.  One approach involves sample workup and detection using quant. western blotting, whereas the second is performed directly in soln. and relies on the induced proximity of two target-directed antibodies upon binding to sol. protein.  The latter protocol has been optimized to allow an increased throughput, as potential applications require large nos. of samples.  Both approaches can be completed in a day.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzarqomAK6eLVg90H21EOLACvtfcHk0ljpmNgZf-y0Sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht12msrfJ&md5=e7852e1a306bca1698a8e8463ae566b1</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2014.138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2014.138%26sid%3Dliteratum%253Aachs%26aulast%3DJafari%26aufirst%3DR.%26aulast%3DAlmqvist%26aufirst%3DH.%26aulast%3DAxelsson%26aufirst%3DH.%26aulast%3DIgnatushchenko%26aufirst%3DM.%26aulast%3DLundb%25C3%25A4ck%26aufirst%3DT.%26aulast%3DNordlund%26aufirst%3DP.%26aulast%3DMolina%26aufirst%3DD.%2BM.%26atitle%3DThe%2520cellular%2520thermal%2520shift%2520assay%2520for%2520evaluating%2520drug%2520target%2520interactions%2520in%2520cells%26jtitle%3DNat.%2520Protoc.%26date%3D2014%26volume%3D9%26spage%3D2100%26epage%3D2122%26doi%3D10.1038%2Fnprot.2014.138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, B.</span><span> </span><span class="NLM_article-title">Comparison of cancer cell survival triggered by microtubule damage after turning Dyrk1B kinase on and off</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">731</span><span class="NLM_x">–</span> <span class="NLM_lpage">742</span><span class="refDoi"> DOI: 10.1021/cb4005589</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb4005589" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=731-742&author=L.+Liauthor=Y.+Liuauthor=Q.+Zhangauthor=H.+Zhouauthor=Y.+Zhangauthor=B.+Yan&title=Comparison+of+cancer+cell+survival+triggered+by+microtubule+damage+after+turning+Dyrk1B+kinase+on+and+off&doi=10.1021%2Fcb4005589"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fcb4005589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb4005589%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DYan%26aufirst%3DB.%26atitle%3DComparison%2520of%2520cancer%2520cell%2520survival%2520triggered%2520by%2520microtubule%2520damage%2520after%2520turning%2520Dyrk1B%2520kinase%2520on%2520and%2520off%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2014%26volume%3D9%26spage%3D731%26epage%3D742%26doi%3D10.1021%2Fcb4005589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Becker, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wetzel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eirmbter, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tejedor, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joost, H.</span><span> </span><span class="NLM_article-title">Sequence characteristics, subcellular localization, and substrate specificity of DYRK-related kinases, a novel family of dual specificity protein kinases</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">25893</span><span class="NLM_x">–</span> <span class="NLM_lpage">25902</span><span class="refDoi"> DOI: 10.1074/jbc.273.40.25893</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1074%2Fjbc.273.40.25893" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=9748265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADyaK1cXms1egt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1998&pages=25893-25902&author=W.+Beckerauthor=Y.+Weberauthor=K.+Wetzelauthor=K.+Eirmbterauthor=F.+Tejedorauthor=H.+Joost&title=Sequence+characteristics%2C+subcellular+localization%2C+and+substrate+specificity+of+DYRK-related+kinases%2C+a+novel+family+of+dual+specificity+protein+kinases&doi=10.1074%2Fjbc.273.40.25893"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Sequence characteristics, subcellular localization, and substrate specificity of DYRK-related kinases, a novel family of dual specificity protein kinases</span></div><div class="casAuthors">Becker, Walter; Weber, Yvonne; Wetzel, Kristiane; Eirmbter, Klaus; Tejedor, Francisco J.; Joost, Hans-Georg</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">273</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">25893-25902</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">DYRK1 is a dual specificity protein kinase presumably involved in brain development.  The kinase belongs to a new family of protein kinases comprising at least seven mammalian isoforms (DYRK1A, DYRK1B, DYRK1C, DYRK2, DYRK3, DYRK4A, and DYRK4B), the yeast homolog Yak1p, and the Drosophila kinase minibrain (MNB).  In rat tissues, DYRK1A is expressed ubiquitously, whereas transcripts for DYRK1B, DYRK2, DYRK3, and DYRK4 were detected predominantly in testes of adult but not prepuberal rats.  By fluorescence microscopy and subcellular fractionation, a green fluorescent protein (GFP) fusion protein of DYRK1A was found to accumulate in the nucleus of transfected COS-7 and HEK293 cells, whereas GFP-DYRK2 was predominantly detected in the cytoplasm.  DYRK1A exhibited a punctate pattern of GFP fluorescence inside the nucleus and was co-purified with the nuclear matrix.  Anal. of GFP-DYRK1A deletion constructs showed that the nuclear localization of DYRK1A was mediated by its nuclear targeting signal (amino acids 105-139) but that its characteristics subnuclear distribution depended on addnl. N-terminal elements (amino acids 1-104).  When expressed in Escherichia coli, DYRK1A, DYRK2, DYRK3, MNB, and Yak1p catalyzed their autophosphorylation on tyrosine residues.  The kinases differed in their substrate specificity in that DYRK2 and DYRK3, but not DYRK1A and MNB, catalyzed phosphorylation of histone H2B.  The heterogeneity of their subcellular localization and substrate specificity suggests that the kinases are involved in different cellular functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0Q1vPoFEv4LVg90H21EOLACvtfcHk0ljpmNgZf-y0Sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXms1egt7g%253D&md5=4b8029c26149c1ecb9d65baf50dd978d</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1074%2Fjbc.273.40.25893&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.273.40.25893%26sid%3Dliteratum%253Aachs%26aulast%3DBecker%26aufirst%3DW.%26aulast%3DWeber%26aufirst%3DY.%26aulast%3DWetzel%26aufirst%3DK.%26aulast%3DEirmbter%26aufirst%3DK.%26aulast%3DTejedor%26aufirst%3DF.%26aulast%3DJoost%26aufirst%3DH.%26atitle%3DSequence%2520characteristics%252C%2520subcellular%2520localization%252C%2520and%2520substrate%2520specificity%2520of%2520DYRK-related%2520kinases%252C%2520a%2520novel%2520family%2520of%2520dual%2520specificity%2520protein%2520kinases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1998%26volume%3D273%26spage%3D25893%26epage%3D25902%26doi%3D10.1074%2Fjbc.273.40.25893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Esvan, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeinyeh, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boibessot, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nauton, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Théry, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaikuad, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loaëc, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anizon, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giraud, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreau, P.</span><span> </span><span class="NLM_article-title">Discovery of pyrido[3,4-g]quinazoline derivatives as CMGC family protein kinase inhibitors: Design, synthesis, inhibitory potency and X-ray co–crystal structure</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">170</span><span class="NLM_x">–</span> <span class="NLM_lpage">177</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2016.04.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1016%2Fj.ejmech.2016.04.004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2016&pages=170-177&author=Y.+J.+Esvanauthor=W.+Zeinyehauthor=T.+Boibessotauthor=L.+Nautonauthor=V.+Th%C3%A9ryauthor=S.+Knappauthor=A.+Chaikuadauthor=N.+Loa%C3%ABcauthor=L.+Meijerauthor=F.+Anizonauthor=F.+Giraudauthor=P.+Moreau&title=Discovery+of+pyrido%5B3%2C4-g%5Dquinazoline+derivatives+as+CMGC+family+protein+kinase+inhibitors%3A+Design%2C+synthesis%2C+inhibitory+potency+and+X-ray+co%E2%80%93crystal+structure&doi=10.1016%2Fj.ejmech.2016.04.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.04.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.04.004%26sid%3Dliteratum%253Aachs%26aulast%3DEsvan%26aufirst%3DY.%2BJ.%26aulast%3DZeinyeh%26aufirst%3DW.%26aulast%3DBoibessot%26aufirst%3DT.%26aulast%3DNauton%26aufirst%3DL.%26aulast%3DTh%25C3%25A9ry%26aufirst%3DV.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DChaikuad%26aufirst%3DA.%26aulast%3DLoa%25C3%25ABc%26aufirst%3DN.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DAnizon%26aufirst%3DF.%26aulast%3DGiraud%26aufirst%3DF.%26aulast%3DMoreau%26aufirst%3DP.%26atitle%3DDiscovery%2520of%2520pyrido%255B3%252C4-g%255Dquinazoline%2520derivatives%2520as%2520CMGC%2520family%2520protein%2520kinase%2520inhibitors%253A%2520Design%252C%2520synthesis%252C%2520inhibitory%2520potency%2520and%2520X-ray%2520co%25E2%2580%2593crystal%2520structure%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D118%26spage%3D170%26epage%3D177%26doi%3D10.1016%2Fj.ejmech.2016.04.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Munoz, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selig, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeung, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peifer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufer, S. A.</span><span> </span><span class="NLM_article-title">Fluorescence polarisation binding assay to develop inhibitors of inactive p38a mitogen-activated protein kinase</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">401</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">133</span><span class="refDoi"> DOI: 10.1016/j.ab.2010.02.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1016%2Fj.ab.2010.02.016" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=401&publication_year=2010&pages=125-133&author=L.+Munozauthor=R.+Seligauthor=Y.+Yeungauthor=C.+Peiferauthor=S.+A.+Laufer&title=Fluorescence+polarisation+binding+assay+to+develop+inhibitors+of+inactive+p38a+mitogen-activated+protein+kinase&doi=10.1016%2Fj.ab.2010.02.016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2010.02.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2010.02.016%26sid%3Dliteratum%253Aachs%26aulast%3DMunoz%26aufirst%3DL.%26aulast%3DSelig%26aufirst%3DR.%26aulast%3DYeung%26aufirst%3DY.%26aulast%3DPeifer%26aufirst%3DC.%26aulast%3DLaufer%26aufirst%3DS.%2BA.%26atitle%3DFluorescence%2520polarisation%2520binding%2520assay%2520to%2520develop%2520inhibitors%2520of%2520inactive%2520p38a%2520mitogen-activated%2520protein%2520kinase%26jtitle%3DAnal.%2520Biochem.%26date%3D2010%26volume%3D401%26spage%3D125%26epage%3D133%26doi%3D10.1016%2Fj.ab.2010.02.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Knight, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">Features of selective kinase inhibitors</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">621</span><span class="NLM_x">–</span> <span class="NLM_lpage">637</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2005.04.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1016%2Fj.chembiol.2005.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=15975507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsFGhtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=621-637&author=Z.+A.+Knightauthor=K.+M.+Shokat&title=Features+of+selective+kinase+inhibitors&doi=10.1016%2Fj.chembiol.2005.04.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Features of Selective Kinase Inhibitors</span></div><div class="casAuthors">Knight, Zachary A.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">621-637</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Summary: Small-mol. inhibitors of protein and lipid kinases have emerged as indispensable tools for studying signal transduction.  Despite the widespread use of these reagents, there is little consensus about the biochem. criteria that define their potency and selectivity in cells.  We discuss some of the features that det. the cellular activity of kinase inhibitors and propose a framework for interpreting inhibitor selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAJWhVxtSrCLVg90H21EOLACvtfcHk0lhwKb7Q9FYTtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsFGhtrc%253D&md5=ce5b3505a0326b04479172ec05573152</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2005.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2005.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DKnight%26aufirst%3DZ.%2BA.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DFeatures%2520of%2520selective%2520kinase%2520inhibitors%26jtitle%3DChem.%2520Biol.%26date%3D2005%26volume%3D12%26spage%3D621%26epage%3D637%26doi%3D10.1016%2Fj.chembiol.2005.04.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Montanari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scalvini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belluti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobbi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ligresti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marzo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rampa, A.</span><span> </span><span class="NLM_article-title">Fatty Acid Amide Hydrolase (FAAH), Acetylcholinesterase (AChE), and Butyrylcholinesterase (BuChE): networked targets for the development of carbamates as potential anti-Alzheimer’s disease agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">6387</span><span class="NLM_x">–</span> <span class="NLM_lpage">6406</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00609</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00609" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BC28XpvFylsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=6387-6406&author=S.+Montanariauthor=L.+Scalviniauthor=M.+Bartoliniauthor=F.+Bellutiauthor=S.+Gobbiauthor=V.+Andrisanoauthor=A.+Ligrestiauthor=V.+Di+Marzoauthor=S.+Rivaraauthor=M.+Morauthor=A.+Bisiauthor=A.+Rampa&title=Fatty+Acid+Amide+Hydrolase+%28FAAH%29%2C+Acetylcholinesterase+%28AChE%29%2C+and+Butyrylcholinesterase+%28BuChE%29%3A+networked+targets+for+the+development+of+carbamates+as+potential+anti-Alzheimer%E2%80%99s+disease+agents&doi=10.1021%2Facs.jmedchem.6b00609"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Fatty Acid Amide Hydrolase (FAAH), Acetylcholinesterase (AChE), and Butyrylcholinesterase (BuChE): Networked Targets for the Development of Carbamates as Potential Anti-Alzheimer's Disease Agents</span></div><div class="casAuthors">Montanari, Serena; Scalvini, Laura; Bartolini, Manuela; Belluti, Federica; Gobbi, Silvia; Andrisano, Vincenza; Ligresti, Alessia; Di Marzo, Vincenzo; Rivara, Silvia; Mor, Marco; Bisi, Alessandra; Rampa, Angela</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">6387-6406</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The modulation of the endocannabinoid system is emerging as a viable avenue for the treatment of neurodegeneration, being involved in neuroprotective and anti-inflammatory processes.  In particular, indirectly enhancing endocannabinoid signaling to therapeutic levels through FAAH inhibition might be beneficial for neurodegenerative disorders such as Alzheimer's disease, effectively preventing or slowing the progression of the disease.  Hence, in the search for a more effective treatment for Alzheimer's disease, in this paper, the multitarget-directed ligand paradigm was applied to the design of carbamates able to simultaneously target the recently proposed endocannabinoid system and the classic cholinesterase system, and achieve effective dual FAAH/cholinesterase inhibitors.  Among the two series of synthesized compds., while some derivs. proved to be extremely potent on a single target, compds. 9 and 19 were identified as effective dual FAAH/ChE inhibitors, with well-balanced nanomolar activities.  Thus, 9 and 19 might be considered as new promising candidates for Alzheimer's disease treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKiL1QuQosRrVg90H21EOLACvtfcHk0lhwKb7Q9FYTtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpvFylsL4%253D&md5=b1dcd2958856cf5bfc9d77c451186b5b</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00609%26sid%3Dliteratum%253Aachs%26aulast%3DMontanari%26aufirst%3DS.%26aulast%3DScalvini%26aufirst%3DL.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DBelluti%26aufirst%3DF.%26aulast%3DGobbi%26aufirst%3DS.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DLigresti%26aufirst%3DA.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DRivara%26aufirst%3DS.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DBisi%26aufirst%3DA.%26aulast%3DRampa%26aufirst%3DA.%26atitle%3DFatty%2520Acid%2520Amide%2520Hydrolase%2520%2528FAAH%2529%252C%2520Acetylcholinesterase%2520%2528AChE%2529%252C%2520and%2520Butyrylcholinesterase%2520%2528BuChE%2529%253A%2520networked%2520targets%2520for%2520the%2520development%2520of%2520carbamates%2520as%2520potential%2520anti-Alzheimer%25E2%2580%2599s%2520disease%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D6387%26epage%3D6406%26doi%3D10.1021%2Facs.jmedchem.6b00609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Tasch, B. O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antovic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merkul, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, T. J. J.</span><span> </span><span class="NLM_article-title">One-pot synthesis of camalexins and 3,3′-biindoles by the Masuda Borylation–Suzuki arylation (MBSA) sequence</span> <span class="citation_source-journal">Eur. J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">2013</span><span class="NLM_x">, </span> <span class="NLM_fpage">4564</span><span class="NLM_x">–</span> <span class="NLM_lpage">4569</span><span class="refDoi"> DOI: 10.1002/ejoc.201300133</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1002%2Fejoc.201300133" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2013&publication_year=2013&pages=4564-4569&author=B.+O.+A.+Taschauthor=D.+Antovicauthor=E.+Merkulauthor=T.+J.+J.+M%C3%BCller&title=One-pot+synthesis+of+camalexins+and+3%2C3%E2%80%B2-biindoles+by+the+Masuda+Borylation%E2%80%93Suzuki+arylation+%28MBSA%29+sequence&doi=10.1002%2Fejoc.201300133"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1002%2Fejoc.201300133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejoc.201300133%26sid%3Dliteratum%253Aachs%26aulast%3DTasch%26aufirst%3DB.%2BO.%2BA.%26aulast%3DAntovic%26aufirst%3DD.%26aulast%3DMerkul%26aufirst%3DE.%26aulast%3DM%25C3%25BCller%26aufirst%3DT.%2BJ.%2BJ.%26atitle%3DOne-pot%2520synthesis%2520of%2520camalexins%2520and%25203%252C3%25E2%2580%25B2-biindoles%2520by%2520the%2520Masuda%2520Borylation%25E2%2580%2593Suzuki%2520arylation%2520%2528MBSA%2529%2520sequence%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2013%26volume%3D2013%26spage%3D4564%26epage%3D4569%26doi%3D10.1002%2Fejoc.201300133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Konishi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manabe, K.</span><span> </span><span class="NLM_article-title">Imidazole derivatives as accelerators for ruthenium-catalyzed hydroesterification and hydrocarbamoylation of alkenes: extensive ligand screening and mechanistic study</span> <span class="citation_source-journal">ChemCatChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">836</span><span class="NLM_x">–</span> <span class="NLM_lpage">845</span><span class="refDoi"> DOI: 10.1002/cctc.201402986</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1002%2Fcctc.201402986" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=836-845&author=H.+Konishiauthor=T.+Mutoauthor=T.+Uedaauthor=Y.+Yamadaauthor=M.+Yamaguchiauthor=K.+Manabe&title=Imidazole+derivatives+as+accelerators+for+ruthenium-catalyzed+hydroesterification+and+hydrocarbamoylation+of+alkenes%3A+extensive+ligand+screening+and+mechanistic+study&doi=10.1002%2Fcctc.201402986"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1002%2Fcctc.201402986&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcctc.201402986%26sid%3Dliteratum%253Aachs%26aulast%3DKonishi%26aufirst%3DH.%26aulast%3DMuto%26aufirst%3DT.%26aulast%3DUeda%26aufirst%3DT.%26aulast%3DYamada%26aufirst%3DY.%26aulast%3DYamaguchi%26aufirst%3DM.%26aulast%3DManabe%26aufirst%3DK.%26atitle%3DImidazole%2520derivatives%2520as%2520accelerators%2520for%2520ruthenium-catalyzed%2520hydroesterification%2520and%2520hydrocarbamoylation%2520of%2520alkenes%253A%2520extensive%2520ligand%2520screening%2520and%2520mechanistic%2520study%26jtitle%3DChemCatChem%26date%3D2015%26volume%3D7%26spage%3D836%26epage%3D845%26doi%3D10.1002%2Fcctc.201402986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Chou, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajagopal, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, H.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, C.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyan, Y.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, P.-C.</span><span> </span><span class="NLM_article-title">Thermally induced denitrogenative annulation for the synthesis of dihydroquinolinimines and chroman-4-imines</span> <span class="citation_source-journal">Chem. - Asian J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">757</span><span class="NLM_x">–</span> <span class="NLM_lpage">765</span><span class="refDoi"> DOI: 10.1002/asia.201501239</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1002%2Fasia.201501239" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=26789740" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVOmtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=757-765&author=C.-H.+Chouauthor=Y.-Y.+Chenauthor=B.+Rajagopalauthor=H.-C.+Tuauthor=K.-L.+Chenauthor=S.-F.+Wangauthor=C.-F.+Liangauthor=Y.-C.+Tyanauthor=P.-C.+Lin&title=Thermally+induced+denitrogenative+annulation+for+the+synthesis+of+dihydroquinolinimines+and+chroman-4-imines&doi=10.1002%2Fasia.201501239"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Thermally Induced Denitrogenative Annulation for the Synthesis of Dihydroquinolinimines and Chroman-4-imines</span></div><div class="casAuthors">Chou, Chih-Hung; Chen, Ying-Yu; Rajagopal, Basker; Tu, Hsiu-Chung; Chen, Kuan-Lin; Wang, Sheng-Fu; Liang, Chien-Fu; Tyan, Yu-Chang; Lin, Po-Chiao</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - An Asian Journal</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">757-765</span>CODEN:
                <span class="NLM_cas:coden">CAAJBI</span>;
        ISSN:<span class="NLM_cas:issn">1861-4728</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A rapid growth in synthetic methods for the prepn. of diverse org. mols. using N-sulfonyl-1,2,3-triazoles is of great interest in org. synthesis.  Transition metals are generally used to activate the α-imino diazo intermediates.  Metal-free methods have not been studied in detail, but can be a good complement to transition metal catalysis in the mild reaction conditions.  The authors herein report a novel method for the prepn. of 2,3-dihydroquinolin-4-imine and chroman-4-imine analogs from their corresponding N-sulfonyl-1,2,3-triazoles in the absence of metal catalysts.  To achieve intramol. annulation, the introduction of an electron-donating group is required (substituent effects) at the meta position of N-sulfonyl-1,2,3-triazole Me anilines.  The inclusion of tailored substituents on the aniline moieties and nitrogen atoms enhances the nucleophilicity of the Ph π-electrons, thus allowing them to undergo a Friedel-Crafts-type reaction with the highly electrophilic ketenimines.  This metal-free method was carefully optimized to generate a variety of dihydroquinolin-4-imines and chroman-4-imines in moderate-to-good yields.  Under optimized conditions the synthesis of the target compds. was achieved using N,N-dimethylformamide (i.e., DMF) as a reagent.  Starting materials included N-methyl-1-[(4-methylphenyl)sulfonyl]-N-phenyl-1H-1,2,3-triazole-4-methanamine derivs.  The title compds. thus formed included N-(quinolinylidene)benzenesulfonamide derivs. (quinoline-imines).  Starting materials also included 4-[(3-methoxyphenoxy)methyl]-1-[(4-methylphenyl)sulfonyl]-1H-1,2,3-triazole derivs.  The products thus formed included N-(benzopyranylidene)benzenesulfonamide derivs. (benzopyran-imines).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGry2PvFvQ3mIbVg90H21EOLACvtfcHk0liYpeF15B5Pzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVOmtrw%253D&md5=4b0ad9e2d6c49226e431ce78f7016abe</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1002%2Fasia.201501239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fasia.201501239%26sid%3Dliteratum%253Aachs%26aulast%3DChou%26aufirst%3DC.-H.%26aulast%3DChen%26aufirst%3DY.-Y.%26aulast%3DRajagopal%26aufirst%3DB.%26aulast%3DTu%26aufirst%3DH.-C.%26aulast%3DChen%26aufirst%3DK.-L.%26aulast%3DWang%26aufirst%3DS.-F.%26aulast%3DLiang%26aufirst%3DC.-F.%26aulast%3DTyan%26aufirst%3DY.-C.%26aulast%3DLin%26aufirst%3DP.-C.%26atitle%3DThermally%2520induced%2520denitrogenative%2520annulation%2520for%2520the%2520synthesis%2520of%2520dihydroquinolinimines%2520and%2520chroman-4-imines%26jtitle%3DChem.%2520-%2520Asian%2520J.%26date%3D2016%26volume%3D11%26spage%3D757%26epage%3D765%26doi%3D10.1002%2Fasia.201501239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Aronov, A.; Lauffer, D. J.; Li, P.; Tomlinson, R. C.</span><span> </span><span class="NLM_article-title">Compositions useful as inhibitors of protein kinases</span>. WO 2003078423A1,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=A.+Aronov&author=D.+J.+Lauffer&author=P.+Li&author=R.+C.+Tomlinson&title=Compositions+useful+as+inhibitors+of+protein+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAronov%26aufirst%3DA.%26atitle%3DCompositions%2520useful%2520as%2520inhibitors%2520of%2520protein%2520kinases%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">McKerlie, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudkin, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wynne, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Procter, D. J.</span><span> </span><span class="NLM_article-title">Evaluation of a new linker system cleaved using samarium(ii) iodide. Application in the solid phase synthesis of carbonyl compounds</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">2805</span><span class="NLM_x">–</span> <span class="NLM_lpage">2816</span><span class="refDoi"> DOI: 10.1039/b506294b</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1039%2Fb506294b" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=16032358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmt1Grtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2005&pages=2805-2816&author=F.+McKerlieauthor=I.+M.+Rudkinauthor=G.+Wynneauthor=D.+J.+Procter&title=Evaluation+of+a+new+linker+system+cleaved+using+samarium%28ii%29+iodide.+Application+in+the+solid+phase+synthesis+of+carbonyl+compounds&doi=10.1039%2Fb506294b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of a new linker system cleaved using samarium(II) iodide. Application in the solid phase synthesis of carbonyl compounds</span></div><div class="casAuthors">McKerlie, Fiona; Rudkin, Iain M.; Wynne, Graham; Procter, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2805-2816</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A new linker design for solid phase synthesis has been developed that is cleaved under mild, neutral conditions using samarium(II) iodide.  The feasibility of the linker approach has been illustrated in the solid phase synthesis of ketones and amides using an oxygen linker.  Insights into the mechanism of the samarium(II) iodide cleavage reaction are described and the potential of a sequential cleavage carbon-carbon bond forming process is assessed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrw_jtnjG5hSLVg90H21EOLACvtfcHk0liYpeF15B5Pzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmt1Grtb4%253D&md5=6c7a311c0bd3611d761604ae8e92aaa1</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1039%2Fb506294b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb506294b%26sid%3Dliteratum%253Aachs%26aulast%3DMcKerlie%26aufirst%3DF.%26aulast%3DRudkin%26aufirst%3DI.%2BM.%26aulast%3DWynne%26aufirst%3DG.%26aulast%3DProcter%26aufirst%3DD.%2BJ.%26atitle%3DEvaluation%2520of%2520a%2520new%2520linker%2520system%2520cleaved%2520using%2520samarium%2528ii%2529%2520iodide.%2520Application%2520in%2520the%2520solid%2520phase%2520synthesis%2520of%2520carbonyl%2520compounds%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2005%26volume%3D3%26spage%3D2805%26epage%3D2816%26doi%3D10.1039%2Fb506294b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 27 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Roshan Y Nimje, Devaiah Vytla, Prakasam Kuppusamy, Rajeswari Velayuthaperumal, Lokesh Babu Jarugu, China Anki Reddy, Nanjundaswamy Kanikahalli Chikkananjaiah, Richard A. Rampulla, Cullen L. Cavallaro, Jianqing Li, Arvind Mathur, Anuradha Gupta, <span class="NLM_string-name hlFld-ContribAuthor">Amrita Roy</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Differentially Protected Azatryptophan Analogs via Pd2(dba)3/XPhos Catalyzed Negishi Coupling of N-Ts Azaindole Halides with Zinc Derivative from Fmoc-Protected tert-Butyl (R)-2-Amino-3-iodopropanoate. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (17)
                                     , 11519-11530. <a href="https://doi.org/10.1021/acs.joc.0c00973" title="DOI URL">https://doi.org/10.1021/acs.joc.0c00973</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c00973&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c00973%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252BDifferentially%252BProtected%252BAzatryptophan%252BAnalogs%252Bvia%252BPd2%252528dba%2525293%25252FXPhos%252BCatalyzed%252BNegishi%252BCoupling%252Bof%252BN-Ts%252BAzaindole%252BHalides%252Bwith%252BZinc%252BDerivative%252Bfrom%252BFmoc-Protected%252Btert-Butyl%252B%252528R%252529-2-Amino-3-iodopropanoate%26aulast%3DNimje%26aufirst%3DRoshan%2BY%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D20042020%26date%3D25082020%26date%3D10082020%26volume%3D85%26issue%3D17%26spage%3D11519%26epage%3D11530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Dnyandev
B. Jarhad, Karishma K. Mashelkar, Hong-Rae Kim, Minsoo Noh, <span class="NLM_string-name hlFld-ContribAuthor">Lak Shin Jeong</span>. </span><span class="cited-content_cbyCitation_article-title">Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) Inhibitors as Potential Therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (22)
                                     , 9791-9810. <a href="https://doi.org/10.1021/acs.jmedchem.8b00185" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00185</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00185%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDual-Specificity%252BTyrosine%252BPhosphorylation-Regulated%252BKinase%252B1A%252B%252528DYRK1A%252529%252BInhibitors%252Bas%252BPotential%252BTherapeutics%26aulast%3DJarhad%26aufirst%3DDnyandev%2BB.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D05022018%26date%3D20072018%26date%3D09072018%26volume%3D61%26issue%3D22%26spage%3D9791%26epage%3D9810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sally-Ann  Poulsen</span>  . </span><span class="cited-content_cbyCitation_article-title">Editorial: Excellence in Medicinal Chemistry from Australia. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (20)
                                     , 8253-8256. <a href="https://doi.org/10.1021/acs.jmedchem.7b01439" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01439</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01439&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01439%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DEditorial%25253A%252BExcellence%252Bin%252BMedicinal%252BChemistry%252Bfrom%252BAustralia%26aulast%3DPoulsen%26aufirst%3DSally-Ann%26date%3D2017%26date%3D2017%26date%3D06102017%26date%3D09102017%26date%3D26102017%26volume%3D60%26issue%3D20%26spage%3D8253%26epage%3D8256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Areum  Park</span>, <span class="hlFld-ContribAuthor ">Jieon  Hwang</span>, <span class="hlFld-ContribAuthor ">Joo-Youn  Lee</span>, <span class="hlFld-ContribAuthor ">Eun Ji  Heo</span>, <span class="hlFld-ContribAuthor ">Yoon-Ju  Na</span>, <span class="hlFld-ContribAuthor ">Sein  Kang</span>, <span class="hlFld-ContribAuthor ">Kyu-Sung  Jeong</span>, <span class="hlFld-ContribAuthor ">Ki Young  Kim</span>, <span class="hlFld-ContribAuthor ">Sang Joon  Shin</span>, <span class="hlFld-ContribAuthor ">Hyuk  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of novel 1H-Pyrazolo[3,4-b]pyridine derivatives as DYRK 1A/1B inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>47 </em>, 128226. <a href="https://doi.org/10.1016/j.bmcl.2021.128226" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.128226</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.128226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.128226%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Bof%252Bnovel%252B1H-Pyrazolo%25255B3%25252C4-b%25255Dpyridine%252Bderivatives%252Bas%252BDYRK%252B1A%25252F1B%252Binhibitors%26aulast%3DPark%26aufirst%3DAreum%26date%3D2021%26volume%3D47%26spage%3D128226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael  Tarpley</span>, <span class="hlFld-ContribAuthor ">Helen O.  Oladapo</span>, <span class="hlFld-ContribAuthor ">Dillon  Strepay</span>, <span class="hlFld-ContribAuthor ">Thomas B.  Caligan</span>, <span class="hlFld-ContribAuthor ">Lhoucine  Chdid</span>, <span class="hlFld-ContribAuthor ">Hassan  Shehata</span>, <span class="hlFld-ContribAuthor ">Jose R.  Roques</span>, <span class="hlFld-ContribAuthor ">Rhashad  Thomas</span>, <span class="hlFld-ContribAuthor ">Christopher P.  Laudeman</span>, <span class="hlFld-ContribAuthor ">Rob U.  Onyenwoke</span>, <span class="hlFld-ContribAuthor ">David B.  Darr</span>, <span class="hlFld-ContribAuthor ">Kevin P.  Williams</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of harmine and β-carboline analogs from a high-throughput screen of an approved drug collection; profiling as differential inhibitors of DYRK1A and monoamine oxidase A and for in vitro and in vivo anti-cancer studies. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmaceutical Sciences</span><span> <strong>2021,</strong> <em>162 </em>, 105821. <a href="https://doi.org/10.1016/j.ejps.2021.105821" title="DOI URL">https://doi.org/10.1016/j.ejps.2021.105821</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejps.2021.105821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejps.2021.105821%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DIdentification%252Bof%252Bharmine%252Band%252B%2525CE%2525B2-carboline%252Banalogs%252Bfrom%252Ba%252Bhigh-throughput%252Bscreen%252Bof%252Ban%252Bapproved%252Bdrug%252Bcollection%25253B%252Bprofiling%252Bas%252Bdifferential%252Binhibitors%252Bof%252BDYRK1A%252Band%252Bmonoamine%252Boxidase%252BA%252Band%252Bfor%252Bin%252Bvitro%252Band%252Bin%252Bvivo%252Banti-cancer%252Bstudies%26aulast%3DTarpley%26aufirst%3DMichael%26date%3D2021%26volume%3D162%26spage%3D105821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pin  Wang</span>, <span class="hlFld-ContribAuthor ">Juan  Zhao</span>, <span class="hlFld-ContribAuthor ">Xiulian  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">DYRK1A phosphorylates MEF2D and decreases its transcriptional activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cellular and Molecular Medicine</span><span> <strong>2021,</strong> <em>25 </em>
                                    (13)
                                     , 6082-6093. <a href="https://doi.org/10.1111/jcmm.16505" title="DOI URL">https://doi.org/10.1111/jcmm.16505</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/jcmm.16505&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fjcmm.16505%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cellular%2520and%2520Molecular%2520Medicine%26atitle%3DDYRK1A%252Bphosphorylates%252BMEF2D%252Band%252Bdecreases%252Bits%252Btranscriptional%252Bactivity%26aulast%3DWang%26aufirst%3DPin%26date%3D2021%26date%3D2021%26volume%3D25%26issue%3D13%26spage%3D6082%26epage%3D6093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ariadna  Recasens</span>, <span class="hlFld-ContribAuthor ">Sean J.  Humphrey</span>, <span class="hlFld-ContribAuthor ">Michael  Ellis</span>, <span class="hlFld-ContribAuthor ">Monira  Hoque</span>, <span class="hlFld-ContribAuthor ">Ramzi H.  Abbassi</span>, <span class="hlFld-ContribAuthor ">Brianna  Chen</span>, <span class="hlFld-ContribAuthor ">Mitchell  Longworth</span>, <span class="hlFld-ContribAuthor ">Elise J.  Needham</span>, <span class="hlFld-ContribAuthor ">David E.  James</span>, <span class="hlFld-ContribAuthor ">Terrance G.  Johns</span>, <span class="hlFld-ContribAuthor ">Bryan W.  Day</span>, <span class="hlFld-ContribAuthor ">Michael  Kassiou</span>, <span class="hlFld-ContribAuthor ">Pengyi  Yang</span>, <span class="hlFld-ContribAuthor ">Lenka  Munoz</span>. </span><span class="cited-content_cbyCitation_article-title">Global phosphoproteomics reveals DYRK1A regulates CDK1 activity in glioblastoma cells. </span><span class="cited-content_cbyCitation_journal-name">Cell Death Discovery</span><span> <strong>2021,</strong> <em>7 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41420-021-00456-6" title="DOI URL">https://doi.org/10.1038/s41420-021-00456-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41420-021-00456-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41420-021-00456-6%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Death%2520Discovery%26atitle%3DGlobal%252Bphosphoproteomics%252Breveals%252BDYRK1A%252Bregulates%252BCDK1%252Bactivity%252Bin%252Bglioblastoma%252Bcells%26aulast%3DRecasens%26aufirst%3DAriadna%26date%3D2021%26date%3D2021%26volume%3D7%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mattias F.  Lindberg</span>, <span class="hlFld-ContribAuthor ">Laurent  Meijer</span>. </span><span class="cited-content_cbyCitation_article-title">Dual-Specificity, Tyrosine Phosphorylation-Regulated Kinases (DYRKs) and cdc2-Like Kinases (CLKs) in Human Disease, an Overview. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (11)
                                     , 6047. <a href="https://doi.org/10.3390/ijms22116047" title="DOI URL">https://doi.org/10.3390/ijms22116047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22116047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22116047%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DDual-Specificity%25252C%252BTyrosine%252BPhosphorylation-Regulated%252BKinases%252B%252528DYRKs%252529%252Band%252Bcdc2-Like%252BKinases%252B%252528CLKs%252529%252Bin%252BHuman%252BDisease%25252C%252Ban%252BOverview%26aulast%3DLindberg%26aufirst%3DMattias%2BF.%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D11%26spage%3D6047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ahmed K.  ElHady</span>, <span class="hlFld-ContribAuthor ">Dalia S.  El-Gamil</span>, <span class="hlFld-ContribAuthor ">Po-Jen  Chen</span>, <span class="hlFld-ContribAuthor ">Tsong-Long  Hwang</span>, <span class="hlFld-ContribAuthor ">Ashraf H.  Abadi</span>, <span class="hlFld-ContribAuthor ">Mohammad  Abdel-Halim</span>, <span class="hlFld-ContribAuthor ">Matthias  Engel</span>. </span><span class="cited-content_cbyCitation_article-title">5-Methoxybenzothiophene-2-Carboxamides as Inhibitors of Clk1/4: Optimization of Selectivity and Cellular Potency. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (4)
                                     , 1001. <a href="https://doi.org/10.3390/molecules26041001" title="DOI URL">https://doi.org/10.3390/molecules26041001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26041001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26041001%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3D5-Methoxybenzothiophene-2-Carboxamides%252Bas%252BInhibitors%252Bof%252BClk1%25252F4%25253A%252BOptimization%252Bof%252BSelectivity%252Band%252BCellular%252BPotency%26aulast%3DElHady%26aufirst%3DAhmed%2BK.%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D4%26spage%3D1001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Damoder Reddy  Motati</span>, <span class="hlFld-ContribAuthor ">Radhika  Amaradhi</span>, <span class="hlFld-ContribAuthor ">Thota  Ganesh</span>. </span><span class="cited-content_cbyCitation_article-title">Azaindole therapeutic agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (24)
                                     , 115830. <a href="https://doi.org/10.1016/j.bmc.2020.115830" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115830</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115830&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115830%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DAzaindole%252Btherapeutic%252Bagents%26aulast%3DMotati%26aufirst%3DDamoder%2BReddy%26date%3D2020%26volume%3D28%26issue%3D24%26spage%3D115830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael J.  Zeiler</span>, <span class="hlFld-ContribAuthor ">Roberta J.  Melander</span>, <span class="hlFld-ContribAuthor ">Christian  Melander</span>. </span><span class="cited-content_cbyCitation_article-title">Second‐Generation Meridianin Analogues Inhibit the Formation of
              Mycobacterium smegmatis
              Biofilms and Sensitize Polymyxin‐Resistant Gram‐Negative Bacteria to Colistin. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2020,</strong> <em>15 </em>
                                    (17)
                                     , 1672-1679. <a href="https://doi.org/10.1002/cmdc.202000438" title="DOI URL">https://doi.org/10.1002/cmdc.202000438</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000438&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000438%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DSecond%2525E2%252580%252590Generation%252BMeridianin%252BAnalogues%252BInhibit%252Bthe%252BFormation%252Bof%252BMycobacterium%252Bsmegmatis%252BBiofilms%252Band%252BSensitize%252BPolymyxin%2525E2%252580%252590Resistant%252BGram%2525E2%252580%252590Negative%252BBacteria%252Bto%252BColistin%26aulast%3DZeiler%26aufirst%3DMichael%2BJ.%26date%3D2020%26date%3D2020%26volume%3D15%26issue%3D17%26spage%3D1672%26epage%3D1679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hye Ree  Yoon</span>, <span class="hlFld-ContribAuthor ">Anand  Balupuri</span>, <span class="hlFld-ContribAuthor ">Kwang-Eun  Choi</span>, <span class="hlFld-ContribAuthor ">Nam Sook  Kang</span>. </span><span class="cited-content_cbyCitation_article-title">Small Molecule Inhibitors of DYRK1A Identified by Computational and Experimental Approaches. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (18)
                                     , 6826. <a href="https://doi.org/10.3390/ijms21186826" title="DOI URL">https://doi.org/10.3390/ijms21186826</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21186826&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21186826%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DSmall%252BMolecule%252BInhibitors%252Bof%252BDYRK1A%252BIdentified%252Bby%252BComputational%252Band%252BExperimental%252BApproaches%26aulast%3DYoon%26aufirst%3DHye%2BRee%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D18%26spage%3D6826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Monira  Hoque</span>, <span class="hlFld-ContribAuthor ">Yasmin A.  Elmaghrabi</span>, <span class="hlFld-ContribAuthor ">Meryem  Köse</span>, <span class="hlFld-ContribAuthor ">Syed S.  Beevi</span>, <span class="hlFld-ContribAuthor ">Jaimy  Jose</span>, <span class="hlFld-ContribAuthor ">Elsa  Meneses‐Salas</span>, <span class="hlFld-ContribAuthor ">Patricia  Blanco‐Muñoz</span>, <span class="hlFld-ContribAuthor ">James R. W.  Conway</span>, <span class="hlFld-ContribAuthor ">Alexander  Swarbrick</span>, <span class="hlFld-ContribAuthor ">Paul  Timpson</span>, <span class="hlFld-ContribAuthor ">Francesc  Tebar</span>, <span class="hlFld-ContribAuthor ">Carlos  Enrich</span>, <span class="hlFld-ContribAuthor ">Carles  Rentero</span>, <span class="hlFld-ContribAuthor ">Thomas  Grewal</span>. </span><span class="cited-content_cbyCitation_article-title">Annexin A6 improves anti‐migratory and anti‐invasive properties of tyrosine kinase inhibitors in EGFR overexpressing human squamous epithelial cells. </span><span class="cited-content_cbyCitation_journal-name">The FEBS Journal</span><span> <strong>2020,</strong> <em>287 </em>
                                    (14)
                                     , 2961-2978. <a href="https://doi.org/10.1111/febs.15186" title="DOI URL">https://doi.org/10.1111/febs.15186</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/febs.15186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Ffebs.15186%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520FEBS%2520Journal%26atitle%3DAnnexin%252BA6%252Bimproves%252Banti%2525E2%252580%252590migratory%252Band%252Banti%2525E2%252580%252590invasive%252Bproperties%252Bof%252Btyrosine%252Bkinase%252Binhibitors%252Bin%252BEGFR%252Boverexpressing%252Bhuman%252Bsquamous%252Bepithelial%252Bcells%26aulast%3DHoque%26aufirst%3DMonira%26date%3D2020%26date%3D2020%26volume%3D287%26issue%3D14%26spage%3D2961%26epage%3D2978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chuangchuang  Xu</span>, <span class="hlFld-ContribAuthor ">Wenlai  Xie</span>, <span class="hlFld-ContribAuthor ">Jiaxi  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Metal-free and regiospecific synthesis of 3-arylindoles. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2020,</strong> <em>18 </em>
                                    (14)
                                     , 2661-2671. <a href="https://doi.org/10.1039/D0OB00317D" title="DOI URL">https://doi.org/10.1039/D0OB00317D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0OB00317D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0OB00317D%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DMetal-free%252Band%252Bregiospecific%252Bsynthesis%252Bof%252B3-arylindoles%26aulast%3DXu%26aufirst%3DChuangchuang%26date%3D2020%26date%3D2020%26volume%3D18%26issue%3D14%26spage%3D2661%26epage%3D2671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chao  Zhao</span>, <span class="hlFld-ContribAuthor ">Dun  Wang</span>, <span class="hlFld-ContribAuthor ">Zexuan  Gao</span>, <span class="hlFld-ContribAuthor ">Hongfeng  Kan</span>, <span class="hlFld-ContribAuthor ">Feng  Qiu</span>, <span class="hlFld-ContribAuthor ">Lixia  Chen</span>, <span class="hlFld-ContribAuthor ">Hua  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Licocoumarone induces BxPC-3 pancreatic adenocarcinoma cell death by inhibiting DYRK1A. </span><span class="cited-content_cbyCitation_journal-name">Chemico-Biological Interactions</span><span> <strong>2020,</strong> <em>316 </em>, 108913. <a href="https://doi.org/10.1016/j.cbi.2019.108913" title="DOI URL">https://doi.org/10.1016/j.cbi.2019.108913</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cbi.2019.108913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cbi.2019.108913%26sid%3Dliteratum%253Aachs%26jtitle%3DChemico-Biological%2520Interactions%26atitle%3DLicocoumarone%252Binduces%252BBxPC-3%252Bpancreatic%252Badenocarcinoma%252Bcell%252Bdeath%252Bby%252Binhibiting%252BDYRK1A%26aulast%3DZhao%26aufirst%3DChao%26date%3D2020%26volume%3D316%26spage%3D108913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brett W.  Stringer</span>, <span class="hlFld-ContribAuthor ">Bryan W.  Day</span>, <span class="hlFld-ContribAuthor ">Rochelle C. J.  D’Souza</span>, <span class="hlFld-ContribAuthor ">Paul R.  Jamieson</span>, <span class="hlFld-ContribAuthor ">Kathleen S.  Ensbey</span>, <span class="hlFld-ContribAuthor ">Zara C.  Bruce</span>, <span class="hlFld-ContribAuthor ">Yi Chieh  Lim</span>, <span class="hlFld-ContribAuthor ">Kate  Goasdoué</span>, <span class="hlFld-ContribAuthor ">Carolin  Offenhäuser</span>, <span class="hlFld-ContribAuthor ">Seçkin  Akgül</span>, <span class="hlFld-ContribAuthor ">Suzanne  Allan</span>, <span class="hlFld-ContribAuthor ">Thomas  Robertson</span>, <span class="hlFld-ContribAuthor ">Peter  Lucas</span>, <span class="hlFld-ContribAuthor ">Gert  Tollesson</span>, <span class="hlFld-ContribAuthor ">Scott  Campbell</span>, <span class="hlFld-ContribAuthor ">Craig  Winter</span>, <span class="hlFld-ContribAuthor ">Hongdo  Do</span>, <span class="hlFld-ContribAuthor ">Alexander  Dobrovic</span>, <span class="hlFld-ContribAuthor ">Po-Ling  Inglis</span>, <span class="hlFld-ContribAuthor ">Rosalind L.  Jeffree</span>, <span class="hlFld-ContribAuthor ">Terrance G.  Johns</span>, <span class="hlFld-ContribAuthor ">Andrew W.  Boyd</span>. </span><span class="cited-content_cbyCitation_article-title">A reference collection of patient-derived cell line and xenograft models of proneural, classical and mesenchymal glioblastoma. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2019,</strong> <em>9 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-019-41277-z" title="DOI URL">https://doi.org/10.1038/s41598-019-41277-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-019-41277-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-019-41277-z%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DA%252Breference%252Bcollection%252Bof%252Bpatient-derived%252Bcell%252Bline%252Band%252Bxenograft%252Bmodels%252Bof%252Bproneural%25252C%252Bclassical%252Band%252Bmesenchymal%252Bglioblastoma%26aulast%3DStringer%26aufirst%3DBrett%2BW.%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gianmarco  Pallavicini</span>, <span class="hlFld-ContribAuthor ">Gaia E.  Berto</span>, <span class="hlFld-ContribAuthor ">Ferdinando  Di Cunto</span>. </span><span class="cited-content_cbyCitation_article-title">Precision Revisited: Targeting Microcephaly Kinases in Brain Tumors. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2019,</strong> <em>20 </em>
                                    (9)
                                     , 2098. <a href="https://doi.org/10.3390/ijms20092098" title="DOI URL">https://doi.org/10.3390/ijms20092098</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms20092098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms20092098%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DPrecision%252BRevisited%25253A%252BTargeting%252BMicrocephaly%252BKinases%252Bin%252BBrain%252BTumors%26aulast%3DPallavicini%26aufirst%3DGianmarco%26date%3D2019%26date%3D2019%26volume%3D20%26issue%3D9%26spage%3D2098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guilherme Felipe dos Santos  Fernandes</span>, <span class="hlFld-ContribAuthor ">Barbara Colatto  Fernandes</span>, <span class="hlFld-ContribAuthor ">Valeria  Valente</span>, <span class="hlFld-ContribAuthor ">Jean Leandro  dos Santos</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in the discovery of small molecules targeting glioblastoma. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>164 </em>, 8-26. <a href="https://doi.org/10.1016/j.ejmech.2018.12.033" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.12.033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.12.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.12.033%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Badvances%252Bin%252Bthe%252Bdiscovery%252Bof%252Bsmall%252Bmolecules%252Btargeting%252Bglioblastoma%26aulast%3DFernandes%26aufirst%3DGuilherme%2BFelipe%2Bdos%2BSantos%26date%3D2019%26volume%3D164%26spage%3D8%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Václav  Němec</span>, <span class="hlFld-ContribAuthor ">Michaela  Hylsová</span>, <span class="hlFld-ContribAuthor ">Lukáš  Maier</span>, <span class="hlFld-ContribAuthor ">Jana  Flegel</span>, <span class="hlFld-ContribAuthor ">Sonja  Sievers</span>, <span class="hlFld-ContribAuthor ">Slava  Ziegler</span>, <span class="hlFld-ContribAuthor ">Martin  Schröder</span>, <span class="hlFld-ContribAuthor ">Benedict‐Tilman  Berger</span>, <span class="hlFld-ContribAuthor ">Apirat  Chaikuad</span>, <span class="hlFld-ContribAuthor ">Barbora  Valčíková</span>, <span class="hlFld-ContribAuthor ">Stjepan  Uldrijan</span>, <span class="hlFld-ContribAuthor ">Stanislav  Drápela</span>, <span class="hlFld-ContribAuthor ">Karel  Souček</span>, <span class="hlFld-ContribAuthor ">Herbert  Waldmann</span>, <span class="hlFld-ContribAuthor ">Stefan  Knapp</span>, <span class="hlFld-ContribAuthor ">Kamil  Paruch</span>. </span><span class="cited-content_cbyCitation_article-title">Furo[3,2‐
              b
              ]pyridine: A Privileged Scaffold for Highly Selective Kinase Inhibitors and Effective Modulators of the Hedgehog Pathway. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2019,</strong> <em>131 </em>
                                    (4)
                                     , 1074-1078. <a href="https://doi.org/10.1002/ange.201810312" title="DOI URL">https://doi.org/10.1002/ange.201810312</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201810312&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201810312%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DFuro%25255B3%25252C2%2525E2%252580%252590%252Bb%252B%25255Dpyridine%25253A%252BA%252BPrivileged%252BScaffold%252Bfor%252BHighly%252BSelective%252BKinase%252BInhibitors%252Band%252BEffective%252BModulators%252Bof%252Bthe%252BHedgehog%252BPathway%26aulast%3DN%25C4%259Bmec%26aufirst%3DV%25C3%25A1clav%26date%3D2019%26date%3D2018%26volume%3D131%26issue%3D4%26spage%3D1074%26epage%3D1078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Václav  Němec</span>, <span class="hlFld-ContribAuthor ">Michaela  Hylsová</span>, <span class="hlFld-ContribAuthor ">Lukáš  Maier</span>, <span class="hlFld-ContribAuthor ">Jana  Flegel</span>, <span class="hlFld-ContribAuthor ">Sonja  Sievers</span>, <span class="hlFld-ContribAuthor ">Slava  Ziegler</span>, <span class="hlFld-ContribAuthor ">Martin  Schröder</span>, <span class="hlFld-ContribAuthor ">Benedict‐Tilman  Berger</span>, <span class="hlFld-ContribAuthor ">Apirat  Chaikuad</span>, <span class="hlFld-ContribAuthor ">Barbora  Valčíková</span>, <span class="hlFld-ContribAuthor ">Stjepan  Uldrijan</span>, <span class="hlFld-ContribAuthor ">Stanislav  Drápela</span>, <span class="hlFld-ContribAuthor ">Karel  Souček</span>, <span class="hlFld-ContribAuthor ">Herbert  Waldmann</span>, <span class="hlFld-ContribAuthor ">Stefan  Knapp</span>, <span class="hlFld-ContribAuthor ">Kamil  Paruch</span>. </span><span class="cited-content_cbyCitation_article-title">Furo[3,2‐
              b
              ]pyridine: A Privileged Scaffold for Highly Selective Kinase Inhibitors and Effective Modulators of the Hedgehog Pathway. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2019,</strong> <em>58 </em>
                                    (4)
                                     , 1062-1066. <a href="https://doi.org/10.1002/anie.201810312" title="DOI URL">https://doi.org/10.1002/anie.201810312</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201810312&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201810312%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DFuro%25255B3%25252C2%2525E2%252580%252590%252Bb%252B%25255Dpyridine%25253A%252BA%252BPrivileged%252BScaffold%252Bfor%252BHighly%252BSelective%252BKinase%252BInhibitors%252Band%252BEffective%252BModulators%252Bof%252Bthe%252BHedgehog%252BPathway%26aulast%3DN%25C4%259Bmec%26aufirst%3DV%25C3%25A1clav%26date%3D2019%26volume%3D58%26issue%3D4%26spage%3D1062%26epage%3D1066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qingqing  Zhou</span>, <span class="hlFld-ContribAuthor ">Tristan A.  Reekie</span>, <span class="hlFld-ContribAuthor ">Ramzi H.  Abbassi</span>, <span class="hlFld-ContribAuthor ">Dinesh  Indurthi Venkata</span>, <span class="hlFld-ContribAuthor ">Josep S.  Font</span>, <span class="hlFld-ContribAuthor ">Renae M.  Ryan</span>, <span class="hlFld-ContribAuthor ">Lenka  Munoz</span>, <span class="hlFld-ContribAuthor ">Michael  Kassiou</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and in vitro evaluation of diverse heterocyclic diphenolic compounds as inhibitors of DYRK1A. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (22)
                                     , 5852-5869. <a href="https://doi.org/10.1016/j.bmc.2018.10.034" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.10.034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.10.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.10.034%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bin%252Bvitro%252Bevaluation%252Bof%252Bdiverse%252Bheterocyclic%252Bdiphenolic%252Bcompounds%252Bas%252Binhibitors%252Bof%252BDYRK1A%26aulast%3DZhou%26aufirst%3DQingqing%26date%3D2018%26volume%3D26%26issue%3D22%26spage%3D5852%26epage%3D5869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sarah S.  Darwish</span>, <span class="hlFld-ContribAuthor ">Mohammad  Abdel-Halim</span>, <span class="hlFld-ContribAuthor ">Mohamed  Salah</span>, <span class="hlFld-ContribAuthor ">Ashraf H.  Abadi</span>, <span class="hlFld-ContribAuthor ">Walter  Becker</span>, <span class="hlFld-ContribAuthor ">Matthias  Engel</span>. </span><span class="cited-content_cbyCitation_article-title">Development of novel 2,4-bispyridyl thiophene–based compounds as highly potent and selective Dyrk1A inhibitors. Part I: Benzamide and benzylamide derivatives. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>157 </em>, 1031-1050. <a href="https://doi.org/10.1016/j.ejmech.2018.07.050" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.07.050</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.07.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.07.050%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252Bnovel%252B2%25252C4-bispyridyl%252Bthiophene%2525E2%252580%252593based%252Bcompounds%252Bas%252Bhighly%252Bpotent%252Band%252Bselective%252BDyrk1A%252Binhibitors.%252BPart%252BI%25253A%252BBenzamide%252Band%252Bbenzylamide%252Bderivatives%26aulast%3DDarwish%26aufirst%3DSarah%2BS.%26date%3D2018%26volume%3D157%26spage%3D1031%26epage%3D1050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guo-Tai  Zhang</span>, <span class="hlFld-ContribAuthor ">Jing  Zhang</span>, <span class="hlFld-ContribAuthor ">Yan-Jun  Xu</span>, <span class="hlFld-ContribAuthor ">Lin  Dong</span>. </span><span class="cited-content_cbyCitation_article-title">Metal-Free [3+2] Tandem Cyclization Synthesis of Unique 11
              H
              -Pyrido[3′,2′:4,5]Pyrrolo[3,2-
              b
              ]Indolizine from 7-Azaindoles and Pyridotriazoles. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>2018 </em>
                                    (30)
                                     , 4197-4201. <a href="https://doi.org/10.1002/ejoc.201800764" title="DOI URL">https://doi.org/10.1002/ejoc.201800764</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201800764&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201800764%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DMetal-Free%252B%25255B3%25252B2%25255D%252BTandem%252BCyclization%252BSynthesis%252Bof%252BUnique%252B11%252BH%252B-Pyrido%25255B3%2525E2%252580%2525B2%25252C2%2525E2%252580%2525B2%25253A4%25252C5%25255DPyrrolo%25255B3%25252C2-%252Bb%252B%25255DIndolizine%252Bfrom%252B7-Azaindoles%252Band%252BPyridotriazoles%26aulast%3DZhang%26aufirst%3DGuo-Tai%26date%3D2018%26date%3D2018%26volume%3D2018%26issue%3D30%26spage%3D4197%26epage%3D4201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Esti Wahyu  Widowati</span>, <span class="hlFld-ContribAuthor ">Sabrina  Ernst</span>, <span class="hlFld-ContribAuthor ">Ralf  Hausmann</span>, <span class="hlFld-ContribAuthor ">Gerhard  Müller-Newen</span>, <span class="hlFld-ContribAuthor ">Walter  Becker</span>. </span><span class="cited-content_cbyCitation_article-title">Functional characterization of DYRK1A missense variants associated with a syndromic form of intellectual deficiency and autism. </span><span class="cited-content_cbyCitation_journal-name">Biology Open</span><span> <strong>2018,</strong> <em>7 </em>
                                    (4)
                                     <a href="https://doi.org/10.1242/bio.032862" title="DOI URL">https://doi.org/10.1242/bio.032862</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1242/bio.032862&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1242%2Fbio.032862%26sid%3Dliteratum%253Aachs%26jtitle%3DBiology%2520Open%26atitle%3DFunctional%252Bcharacterization%252Bof%252BDYRK1A%252Bmissense%252Bvariants%252Bassociated%252Bwith%252Ba%252Bsyndromic%252Bform%252Bof%252Bintellectual%252Bdeficiency%252Band%252Bautism%26aulast%3DWidowati%26aufirst%3DEsti%2BWahyu%26date%3D2018%26date%3D2018%26volume%3D7%26issue%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Timo  Lessing</span>, <span class="hlFld-ContribAuthor ">Thomas J. J.  Müller</span>. </span><span class="cited-content_cbyCitation_article-title">Activation-free one-pot alkynylation–cyclization synthesis of 2-substituted 4-azaindoles and indoles. </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Heterocyclic Compounds</span><span> <strong>2018,</strong> <em>54 </em>
                                    (3)
                                     , 334-338. <a href="https://doi.org/10.1007/s10593-018-2269-z" title="DOI URL">https://doi.org/10.1007/s10593-018-2269-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10593-018-2269-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10593-018-2269-z%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Heterocyclic%2520Compounds%26atitle%3DActivation-free%252Bone-pot%252Balkynylation%2525E2%252580%252593cyclization%252Bsynthesis%252Bof%252B2-substituted%252B4-azaindoles%252Band%252Bindoles%26aulast%3DLessing%26aufirst%3DTimo%26date%3D2018%26date%3D2018%26volume%3D54%26issue%3D3%26spage%3D334%26epage%3D338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qingqing  Zhou</span>, <span class="hlFld-ContribAuthor ">Tristan A.  Reekie</span>, <span class="hlFld-ContribAuthor ">Ramzi H.  Abbassi</span>, <span class="hlFld-ContribAuthor ">Dinesh Indurthi  Venkata</span>, <span class="hlFld-ContribAuthor ">Josep S.  Font</span>, <span class="hlFld-ContribAuthor ">Renae M.  Ryan</span>, <span class="hlFld-ContribAuthor ">Louis M.  Rendina</span>, <span class="hlFld-ContribAuthor ">Lenka  Munoz</span>, <span class="hlFld-ContribAuthor ">Michael  Kassiou</span>. </span><span class="cited-content_cbyCitation_article-title">Flexible Analogues of Azaindole DYRK1A Inhibitors Elicit Cytotoxicity in Glioblastoma Cells. </span><span class="cited-content_cbyCitation_journal-name">Australian Journal of Chemistry</span><span> <strong>2018,</strong> <em>71 </em>
                                    (10)
                                     , 789. <a href="https://doi.org/10.1071/CH18251" title="DOI URL">https://doi.org/10.1071/CH18251</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1071/CH18251&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1071%2FCH18251%26sid%3Dliteratum%253Aachs%26jtitle%3DAustralian%2520Journal%2520of%2520Chemistry%26atitle%3DFlexible%252BAnalogues%252Bof%252BAzaindole%252BDYRK1A%252BInhibitors%252BElicit%252BCytotoxicity%252Bin%252BGlioblastoma%252BCells%26aulast%3DZhou%26aufirst%3DQingqing%26date%3D2018%26volume%3D71%26issue%3D10%26spage%3D789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thu Lan  Nguyen</span>, <span class="hlFld-ContribAuthor ">Corinne  Fruit</span>, <span class="hlFld-ContribAuthor ">Yann  Hérault</span>, <span class="hlFld-ContribAuthor ">Laurent  Meijer</span>, <span class="hlFld-ContribAuthor ">Thierry  Besson</span>. </span><span class="cited-content_cbyCitation_article-title">Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors: a survey of recent patent literature. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2017,</strong> <em>27 </em>
                                    (11)
                                     , 1183-1199. <a href="https://doi.org/10.1080/13543776.2017.1360285" title="DOI URL">https://doi.org/10.1080/13543776.2017.1360285</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2017.1360285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2017.1360285%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DDual-specificity%252Btyrosine%252Bphosphorylation-regulated%252Bkinase%252B1A%252B%252528DYRK1A%252529%252Binhibitors%25253A%252Ba%252Bsurvey%252Bof%252Brecent%252Bpatent%252Bliterature%26aulast%3DNguyen%26aufirst%3DThu%2BLan%26date%3D2017%26date%3D2017%26volume%3D27%26issue%3D11%26spage%3D1183%26epage%3D1199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01840/20170303/images/medium/jm-2016-01840k_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01840/20170303/images/large/jm-2016-01840k_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01840&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01840/20170303/images/medium/jm-2016-01840k_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01840/20170303/images/large/jm-2016-01840k_0001.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Selected DYRK1A inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01840/20170303/images/large/jm-2016-01840k_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01840&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01840/20170303/images/medium/jm-2016-01840k_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01840/20170303/images/large/jm-2016-01840k_0006.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Route of Diphenol–Azaindole Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01840/20170303/images/large/jm-2016-01840k_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01840&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) NIS (1.0 equiv), KOH (0.5 equiv), CH<sub>2</sub>Cl<sub>2</sub>, RT, 10 h; (ii) NaH (60% in mineral oil, 3.0 equiv), TsCl (1.2 equiv), BnEt<sub>3</sub>NCl (0.02 equiv), CH<sub>2</sub>Cl<sub>2</sub>, 0 to RT, 30 min; 80–89% over two steps; (iii) arylboronic acid (2.0 equiv), Pd(PPh<sub>3</sub>)<sub>4</sub> (4 mol %), K<sub>2</sub>CO<sub>3</sub> 2 M (4.0 equiv), toluene/EtOH 3:1, 100 °C, 3.5 h, 84–87%; (iv) KOH (5.0 equiv), MeOH, 80 °C, 2 h, 91–95%; (v) BBr<sub>3</sub> (6.0 equiv), CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to RT, 15 h, 58–65%. NIS = <i>N</i>-iodosuccinimide.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01840/20170303/images/medium/jm-2016-01840k_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01840/20170303/images/large/jm-2016-01840k_0007.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Route of Aryl-Azaindole Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01840/20170303/images/large/jm-2016-01840k_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01840&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) arylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub> (2 mol %), K<sub>2</sub>CO<sub>3</sub> 2 M (2.0 equiv), toluene/EtOH 3:1, 90 °C, 3–5 h, 78–85%; (ii) arylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub> (2 mol %), K<sub>2</sub>CO<sub>3</sub> 2 M (2.0 equiv), toluene/EtOH 3:1, 110 °C, 3–5 h, 80–93%; (iii) TBAF, TMSN<sub>3</sub>, sodium ascorbate, CuSO<sub>4</sub>·5H<sub>2</sub>O, <i>t</i>BuOH/H<sub>2</sub>O, 1:1 (v/v), MW (100 w, 80 °C), 2 h, 81–83%; (iv) KOH, MeOH, 80 °C, 2 h, 90–95%; (v) Fe powder (10.0 equiv), HCl (3 N solution in water, 0.03 M), 110 °C, 3 h, 70–84%; (vi) Ac<sub>2</sub>O (1.2 equiv), AcOH, 110 °C, 5 h, 77%; (vii) methanesulfonyl chloride (1.5 equiv), H<sub>2</sub>O, RT, 10 h, 64%; (viii) urea (15.0 equiv), I<sub>2</sub> (0.1 equiv), citric acid, mannitol, 80 °C, 6 h, 70%.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01840/20170303/images/medium/jm-2016-01840k_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01840/20170303/images/large/jm-2016-01840k_0008.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Further Modification for Lead Compound <b>3a</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01840/20170303/images/large/jm-2016-01840k_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01840&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) tosyl chloride (1.2 equiv), NaH (1.5 equiv), THF, 0 °C, 1 h, 90%; (ii) Pd(OAc)<sub>2</sub> (5 mol %), dppf (10 mol %), acetic–formic anhydride (5.0 equiv), DIPEA (5.0 equiv), DMF, 110 °C, 5 h, 83%; (iii) HBTU (1.2 equiv), DIPEA (2.5 equiv), aniline <b>13a</b> or <b>13b</b> (1.1 equiv), DMSO, 0 to RT, 2 h, 61–79%; (iv) KOH (5.0 equiv), MeOH, 80 °C, 1 h, 94–96%; (v) I<sub>2</sub> (1.2 equiv), KOH (3.0 equiv), DMF, RT, 8 h, 80–86%; (vi) arylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub> (2 mol %), K<sub>2</sub>CO<sub>3</sub> 2 M (2.0 equiv), toluene/EtOH 3:1, 100 °C, 3–5 h, 60–65%; (vii) trichloroacetyl chloride (1.2 equiv), AlCl<sub>3</sub> (2.5 equiv), 0 °C, 3 h; (viii) NaOH (3 M), RT, 5 h, 70% over two steps; (ix) TBAF (1.5 equiv), THF, RT, 30 min, 93–95%. DIPEA = <i>N,N</i>-diisopropylethylamine, dppf = 1,1′-ferrocenediyl-bis(diphenylphosphine), HBTU = (2-(1<i>H</i>-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate), TBAF = <i>tetra</i>-<i>n</i>-butylammonium fluoride, OTBS = <i>tert</i>-butyldimethylsilyl ether.</p></p></figure><figure data-id="fig1a" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01840/20170303/images/medium/jm-2016-01840k_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01840/20170303/images/large/jm-2016-01840k_0002.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Expression of DYRK/CLK1 kinases and genotype of patient-derived glioblastoma cell lines. (A) Cell lysates of untreated cells were analyzed with Western blotting using indicated antibodies (representative image of two independent blots). (B) Subtype and genotype of patient-derived glioblastoma cell lines RN1, JK2, WK1, and SJH1 as previously described.<a onclick="showRef(event, 'ref54 ref55'); return false;" href="javascript:void(0);" class="ref ref54 ref55">(54, 55)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01840/20170303/images/large/jm-2016-01840k_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01840&amp;id=fig1a"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01840/20170303/images/medium/jm-2016-01840k_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01840/20170303/images/large/jm-2016-01840k_0003.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Treatment of U251 cells with inhibitor 9h stabilizes DYRK1A and decreases cell viability. CETSA melt curves (40–67 °C) for DYRK1A and p38α (A) and quantification (mean ± SEM) of three independent experiments (B) were determined in intact U251 cells treated with compound <b>9h</b> (1 h, 10 μM). Representative image (C) and quantification (mean ± SEM) of two independent experiments (D) of ITDRF<sub>CETSA</sub> in intact U251 cells treated with compound <b>9h</b> (0–20 μM, 1 h) at 54 °C.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01840/20170303/images/large/jm-2016-01840k_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01840&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01840/20170303/images/medium/jm-2016-01840k_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01840/20170303/images/large/jm-2016-01840k_0004.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. DYRK1A inhibition induces EGFR degradation. (A) U251 cells were treated with DMSO (Ctr) or compound <b>9h</b> (2.5 μM) for 4 h. Cells were incubated with cycloheximide (30 μg/mL; 1 h), and EGF (100 ng/mL) was added for the indicated time points. (B) U251 cells were treated with scramble (Ctr) or DYRK1A-targeting <i>si</i>RNa for 24 h. Cells were incubated with cycloheximide (30 μg/mL; 1 h), and EGF (100 ng/mL) was added for the indicated time points. Cell lysates were analyzed by Western blotting using indicated antibodies. (C and D) EGFR levels were normalized to loading control (β-actin) and are expressed as percentage of untreated cells (0 min). Half-life (<i>t</i><sub>1/2</sub>) values were calculated by nonlinear regression analysis and represent mean ± SEM from three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01840/20170303/images/large/jm-2016-01840k_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01840&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01840/20170303/images/medium/jm-2016-01840k_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01840/20170303/images/large/jm-2016-01840k_0005.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Clonogenic survival following drug treatment. Patient-derived RN1 glioblastoma cells were treated with <b>9h</b> (A) or <b>10a</b> (B) for 10 days. Established U251 glioblastoma cells were treated with <b>9h</b> (C) for 10 days. Colonies were fixed, stained with Toluidine Blue, and counted using the ImageJ software. Data were normalized to vehicle-treated controls (set as 100% survival) and EC<sub>50</sub> values calculated by nonlinear regression analysis. EC<sub>50</sub> values represent mean ± SEM from three independent experiments performed in duplicate. One-way ANOVA, followed by Dunnett’s multiple comparison test, was used to determine statistical significance. (* <i>P</i> < 0.05, *** <i>P</i> < 0.001, **** <i>P</i> < 0.0001 in relation to vehicle-treated cells).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01840/20170303/images/large/jm-2016-01840k_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01840&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i98">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51012" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51012" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 68 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Varjosalo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keskitalo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Drogen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nurkkala, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vichalkovski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aebersold, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gstaiger, M.</span><span> </span><span class="NLM_article-title">The protein interaction landscape of the human CMGC kinase group</span> <span class="citation_source-journal">Cell Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1306</span><span class="NLM_x">–</span> <span class="NLM_lpage">1320</span><span class="refDoi"> DOI: 10.1016/j.celrep.2013.03.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1016%2Fj.celrep.2013.03.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=23602568" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmt1Cmu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=1306-1320&author=M.+Varjosaloauthor=S.+Keskitaloauthor=A.+Van+Drogenauthor=H.+Nurkkalaauthor=A.+Vichalkovskiauthor=R.+Aebersoldauthor=M.+Gstaiger&title=The+protein+interaction+landscape+of+the+human+CMGC+kinase+group&doi=10.1016%2Fj.celrep.2013.03.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The Protein Interaction Landscape of the Human CMGC Kinase Group</span></div><div class="casAuthors">Varjosalo, Markku; Keskitalo, Salla; Van Drogen, Audrey; Nurkkala, Helka; Vichalkovski, Anton; Aebersold, Ruedi; Gstaiger, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1306-1320</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Cellular information processing via reversible protein phosphorylation requires tight control of the localization, activity, and substrate specificity of protein kinases, which to a large extent is accomplished by complex formation with other proteins.  Despite their crit. role in cellular regulation and pathogenesis, protein interaction information is available for only a subset of the 518 human protein kinases.  Here we present a global proteomic anal. of complexes of the human CMGC kinase group.  In addn. to subgroup-specific functional enrichment and modularity, the identified 652 high-confidence kinase-protein interactions provide a specific biochem. context for many poorly studied CMGC kinases.  Furthermore, the anal. revealed a kinase-kinase subnetwork and candidate substrates for CMGC kinases.  Finally, the presented interaction proteome uncovered a large set of interactions with proteins genetically linked to a range of human diseases, including cancer, suggesting addnl. routes for analyzing the role of CMGC kinases in controlling human disease pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyOh3MUOGE47Vg90H21EOLACvtfcHk0lgIvMMgW85t2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmt1Cmu7s%253D&md5=09d13e5b27edff77aeb206ab044e8da6</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2013.03.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2013.03.027%26sid%3Dliteratum%253Aachs%26aulast%3DVarjosalo%26aufirst%3DM.%26aulast%3DKeskitalo%26aufirst%3DS.%26aulast%3DVan%2BDrogen%26aufirst%3DA.%26aulast%3DNurkkala%26aufirst%3DH.%26aulast%3DVichalkovski%26aufirst%3DA.%26aulast%3DAebersold%26aufirst%3DR.%26aulast%3DGstaiger%26aufirst%3DM.%26atitle%3DThe%2520protein%2520interaction%2520landscape%2520of%2520the%2520human%2520CMGC%2520kinase%2520group%26jtitle%3DCell%2520Rep.%26date%3D2013%26volume%3D3%26spage%3D1306%26epage%3D1320%26doi%3D10.1016%2Fj.celrep.2013.03.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Loidreau, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubouilh-Benard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nourrisson, M.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duflos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loaëc, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besson, T.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of N-aryl-7-methoxybenzo[b]furo[3,2-d]pyrimidin-4-amines and their N-arylbenzo[b]thieno[3,2-d]pyrimidin-4-amine analogues as dual inhibitors of CLK1 and DYRK1A kinases</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">283</span><span class="NLM_x">–</span> <span class="NLM_lpage">295</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2012.11.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1016%2Fj.ejmech.2012.11.030" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2013&pages=283-295&author=Y.+Loidreauauthor=P.+Marchandauthor=C.+Dubouilh-Benardauthor=M.-R.+Nourrissonauthor=M.+Duflosauthor=N.+Loa%C3%ABcauthor=L.+Meijerauthor=T.+Besson&title=Synthesis+and+biological+evaluation+of+N-aryl-7-methoxybenzo%5Bb%5Dfuro%5B3%2C2-d%5Dpyrimidin-4-amines+and+their+N-arylbenzo%5Bb%5Dthieno%5B3%2C2-d%5Dpyrimidin-4-amine+analogues+as+dual+inhibitors+of+CLK1+and+DYRK1A+kinases&doi=10.1016%2Fj.ejmech.2012.11.030"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2012.11.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2012.11.030%26sid%3Dliteratum%253Aachs%26aulast%3DLoidreau%26aufirst%3DY.%26aulast%3DMarchand%26aufirst%3DP.%26aulast%3DDubouilh-Benard%26aufirst%3DC.%26aulast%3DNourrisson%26aufirst%3DM.-R.%26aulast%3DDuflos%26aufirst%3DM.%26aulast%3DLoa%25C3%25ABc%26aufirst%3DN.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DBesson%26aufirst%3DT.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520N-aryl-7-methoxybenzo%255Bb%255Dfuro%255B3%252C2-d%255Dpyrimidin-4-amines%2520and%2520their%2520N-arylbenzo%255Bb%255Dthieno%255B3%252C2-d%255Dpyrimidin-4-amine%2520analogues%2520as%2520dual%2520inhibitors%2520of%2520CLK1%2520and%2520DYRK1A%2520kinases%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D59%26spage%3D283%26epage%3D295%26doi%3D10.1016%2Fj.ejmech.2012.11.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Abbassi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johns, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassiou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz, L.</span><span> </span><span class="NLM_article-title">DYRK1A in neurodegeneration and cancer: molecular basis and clinical implications</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">151</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">98</span><span class="refDoi"> DOI: 10.1016/j.pharmthera.2015.03.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1016%2Fj.pharmthera.2015.03.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=25795597" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BC2MXltFWgsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=2015&pages=87-98&author=R.+Abbassiauthor=T.+G.+Johnsauthor=M.+Kassiouauthor=L.+Munoz&title=DYRK1A+in+neurodegeneration+and+cancer%3A+molecular+basis+and+clinical+implications&doi=10.1016%2Fj.pharmthera.2015.03.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">DYRK1A in neurodegeneration and cancer: Molecular basis and clinical implications</span></div><div class="casAuthors">Abbassi, Ramzi; Johns, Terrance G.; Kassiou, Michael; Munoz, Lenka</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">151</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">87-98</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Protein kinases are one of the most studied drug targets in current pharmacol. research, as evidenced by the vast no. of kinase-targeting agents enrolled in active clin. trials.  Dual-specificity Tyrosine phosphorylation-Regulated Kinase 1A (DYRK1A) has been much less studied compared to many other kinases.  DYRK1A primary function occurs during early development, where this protein regulates cellular processes related to proliferation and differentiation of neuronal progenitor cells.  Although most extensively characterized for its role in brain development, DYRK1A is over-expressed in a variety of diseases including a no. of human malignancies, such as haematol. and brain cancers.  Here we review the accumulating mol. studies that support our understanding of how DYRK1A signalling could underlie these pathol. functions.  The relevance of DYRK1A in a no. of diseases is also substantiated with intensive drug discovery efforts to develop potent and selective inhibitors of DYRK1A.  Several classes of DYRK1A inhibitors have recently been disclosed and some mols. are promising leads to develop DYRK1A inhibitors as drugs for DYRK1A-dependent diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIdxPFd6Zn0LVg90H21EOLACvtfcHk0lgYukqwyMBwmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXltFWgsr0%253D&md5=bbe08b211b477f0d4a279c34c6d36b42</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2015.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2015.03.004%26sid%3Dliteratum%253Aachs%26aulast%3DAbbassi%26aufirst%3DR.%26aulast%3DJohns%26aufirst%3DT.%2BG.%26aulast%3DKassiou%26aufirst%3DM.%26aulast%3DMunoz%26aufirst%3DL.%26atitle%3DDYRK1A%2520in%2520neurodegeneration%2520and%2520cancer%253A%2520molecular%2520basis%2520and%2520clinical%2520implications%26jtitle%3DPharmacol.%2520Ther.%26date%3D2015%26volume%3D151%26spage%3D87%26epage%3D98%26doi%3D10.1016%2Fj.pharmthera.2015.03.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Becker, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sippl, W.</span><span> </span><span class="NLM_article-title">Activation, regulation, and inhibition of DYRK1A</span> <span class="citation_source-journal">FEBS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">246</span><span class="NLM_x">–</span> <span class="NLM_lpage">256</span><span class="refDoi"> DOI: 10.1111/j.1742-4658.2010.07956.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1111%2Fj.1742-4658.2010.07956.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=21126318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFGru7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2011&pages=246-256&author=W.+Beckerauthor=W.+Sippl&title=Activation%2C+regulation%2C+and+inhibition+of+DYRK1A&doi=10.1111%2Fj.1742-4658.2010.07956.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Activation, regulation, and inhibition of DYRK1A</span></div><div class="casAuthors">Becker, Walter; Sippl, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">246-256</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) is a protein kinase with diverse functions in neuronal development and adult brain physiol.  Higher than normal levels of DYRK1A are assocd. with the pathol. of neurodegenerative diseases and have been implicated in some neurobiol. alterations of Down syndrome, such as mental retardation.  It is therefore important to understand the mol. mechanisms that control the activity of DYRK1A.  Here, the authors review current knowledge about the initial self-activation of DYRK1A by tyrosine autophosphorylation and propose that this mechanism presents an ancestral feature of the CMGC group of kinases.  However, tyrosine phosphorylation does not appear to regulate the enzymic activity of DYRK1A.  Control of DYRK1A may take place on the level of gene expression, interaction with regulatory proteins, and regulated nuclear translocation.  Finally, the authors compare the properties of small mol. inhibitors that target DYRK1A and evaluate their potential application and limitations.  The β-carboline alkaloid, harmine, is currently the most selective and potent inhibitor of DYRK1A and has proven very useful in cellular assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-_Eqb_-j05bVg90H21EOLACvtfcHk0lgYukqwyMBwmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFGru7s%253D&md5=958db7f4577f941bd8dfb56afc461335</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-4658.2010.07956.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-4658.2010.07956.x%26sid%3Dliteratum%253Aachs%26aulast%3DBecker%26aufirst%3DW.%26aulast%3DSippl%26aufirst%3DW.%26atitle%3DActivation%252C%2520regulation%252C%2520and%2520inhibition%2520of%2520DYRK1A%26jtitle%3DFEBS%2520J.%26date%3D2011%26volume%3D278%26spage%3D246%26epage%3D256%26doi%3D10.1111%2Fj.1742-4658.2010.07956.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Tejedor, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hämmerle, B.</span><span> </span><span class="NLM_article-title">MNB/DYRK1A as a multiple regulator of neuronal development</span> <span class="citation_source-journal">FEBS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">235</span><span class="refDoi"> DOI: 10.1111/j.1742-4658.2010.07954.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1111%2Fj.1742-4658.2010.07954.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2011&pages=223-235&author=F.+J.+Tejedorauthor=B.+H%C3%A4mmerle&title=MNB%2FDYRK1A+as+a+multiple+regulator+of+neuronal+development&doi=10.1111%2Fj.1742-4658.2010.07954.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-4658.2010.07954.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-4658.2010.07954.x%26sid%3Dliteratum%253Aachs%26aulast%3DTejedor%26aufirst%3DF.%2BJ.%26aulast%3DH%25C3%25A4mmerle%26aufirst%3DB.%26atitle%3DMNB%252FDYRK1A%2520as%2520a%2520multiple%2520regulator%2520of%2520neuronal%2520development%26jtitle%3DFEBS%2520J.%26date%3D2011%26volume%3D278%26spage%3D223%26epage%3D235%26doi%3D10.1111%2Fj.1742-4658.2010.07954.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Smith, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medda, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gokhale, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunckley, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hulme, C.</span><span> </span><span class="NLM_article-title">Recent advances in the design, synthesis, and biological evaluation of selective DYRK1A inhibitors: a new avenue for a disease modifying treatment of Alzheimer’s?</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">857</span><span class="NLM_x">–</span> <span class="NLM_lpage">872</span><span class="refDoi"> DOI: 10.1021/cn300094k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn300094k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1KmsL3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=857-872&author=B.+Smithauthor=F.+Meddaauthor=V.+Gokhaleauthor=T.+Dunckleyauthor=C.+Hulme&title=Recent+advances+in+the+design%2C+synthesis%2C+and+biological+evaluation+of+selective+DYRK1A+inhibitors%3A+a+new+avenue+for+a+disease+modifying+treatment+of+Alzheimer%E2%80%99s%3F&doi=10.1021%2Fcn300094k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Advances in the Design, Synthesis, and Biological Evaluation of Selective DYRK1A Inhibitors: A New Avenue for a Disease Modifying Treatment of Alzheimer's?</span></div><div class="casAuthors">Smith, Breland; Medda, Federico; Gokhale, Vijay; Dunckley, Travis; Hulme, Christopher</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">857-872</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  With 24.3 million people affected in 2005 and an estd. rise to 42.3 million in 2020, dementia is currently a leading unmet medical need and costly burden on public health.  Seventy percent of these cases have been attributed to Alzheimer's disease (AD), a neurodegenerative pathol. whose most evident symptom is a progressive decline in cognitive functions.  Dual specificity tyrosine phosphorylation regulated kinase-1A (DYRK1A) is important in neuronal development and plays a variety of functional roles within the adult central nervous system.  The DYRK1A gene is located within the Down syndrome crit. region (DSCR) on human chromosome 21 and current research suggests that overexpression of DYRK1A may be a significant factor leading to cognitive deficits in people with Alzheimer's disease (AD) and Down syndrome (DS).  Currently, treatment options for cognitive deficiencies assocd. with Down syndrome, as well as Alzheimer's disease, are extremely limited and represent a major unmet therapeutic need.  Small mol. inhibition of DYRK1A activity in the brain may provide an avenue for pharmaceutical intervention of mental impairment assocd. with AD and other neurodegenerative diseases.  We herein review the current state of the art in the development of DYRK1A inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqSAw8CXNiP7Vg90H21EOLACvtfcHk0lhMTIj4gA4LCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1KmsL3K&md5=2009c25bc00389971cd71f64ead2da4a</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fcn300094k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn300094k%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DB.%26aulast%3DMedda%26aufirst%3DF.%26aulast%3DGokhale%26aufirst%3DV.%26aulast%3DDunckley%26aufirst%3DT.%26aulast%3DHulme%26aufirst%3DC.%26atitle%3DRecent%2520advances%2520in%2520the%2520design%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520selective%2520DYRK1A%2520inhibitors%253A%2520a%2520new%2520avenue%2520for%2520a%2520disease%2520modifying%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%253F%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D3%26spage%3D857%26epage%3D872%26doi%3D10.1021%2Fcn300094k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Giraud, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alves, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debiton, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nauton, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Théry, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durieu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferandin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lozach, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anizon, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pereira, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreau, P.</span><span> </span><span class="NLM_article-title">Synthesis, protein kinase inhibitory potencies, and in vitro antiproliferative activities of meridianin derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">4474</span><span class="NLM_x">–</span> <span class="NLM_lpage">4489</span><span class="refDoi"> DOI: 10.1021/jm200464w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200464w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnt12nsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=4474-4489&author=F.+Giraudauthor=G.+Alvesauthor=E.+Debitonauthor=L.+Nautonauthor=V.+Th%C3%A9ryauthor=E.+Durieuauthor=Y.+Ferandinauthor=O.+Lozachauthor=L.+Meijerauthor=F.+Anizonauthor=E.+Pereiraauthor=P.+Moreau&title=Synthesis%2C+protein+kinase+inhibitory+potencies%2C+and+in+vitro+antiproliferative+activities+of+meridianin+derivatives&doi=10.1021%2Fjm200464w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, Protein Kinase Inhibitory Potencies, and in Vitro Antiproliferative Activities of Meridianin Derivatives</span></div><div class="casAuthors">Giraud, Francis; Alves, Georges; Debiton, Eric; Nauton, Lionel; Thery, Vincent; Durieu, Emilie; Ferandin, Yoan; Lozach, Olivier; Meijer, Laurent; Anizon, Fabrice; Pereira, Elisabeth; Moreau, Pascale</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4474-4489</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis of new meridianin derivs., e.g., I (X = H, Y = 7-Br; X = I, Y = 6-Br, 7-Br) (II), is described.  The indolic ring system was substituted at the C-4 to C-7 positions either by a bromine atom or by nitro or amino groups.  Addnl., an iodine atom or various aryl groups were introduced at the C-5 position of the 2-aminopyrimidine ring.  These compds., as well as some of their synthetic intermediates, were tested for their kinase inhibitory potencies and for their in vitro antiproliferative activities.  We found that this series of compds. is particularly interesting in the development of new inhibitors of DYRK1A and CLK1 kinases.  The most effective compds. toward these two kinase families are the 6- and 7-bromo derivs. II that showed more than 45-fold selectivity toward DYRK1A/CLK1 kinases over the other kinases tested.  Meridianin derivs. could thus be developed toward potent and selective inhibitors of key RNA splicing regulators and potential therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBjkvRn0gdELVg90H21EOLACvtfcHk0lhMTIj4gA4LCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnt12nsb4%253D&md5=7689b7e5afd91dd2dc1b1b1c3aec6a5d</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm200464w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200464w%26sid%3Dliteratum%253Aachs%26aulast%3DGiraud%26aufirst%3DF.%26aulast%3DAlves%26aufirst%3DG.%26aulast%3DDebiton%26aufirst%3DE.%26aulast%3DNauton%26aufirst%3DL.%26aulast%3DTh%25C3%25A9ry%26aufirst%3DV.%26aulast%3DDurieu%26aufirst%3DE.%26aulast%3DFerandin%26aufirst%3DY.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DAnizon%26aufirst%3DF.%26aulast%3DPereira%26aufirst%3DE.%26aulast%3DMoreau%26aufirst%3DP.%26atitle%3DSynthesis%252C%2520protein%2520kinase%2520inhibitory%2520potencies%252C%2520and%2520in%2520vitro%2520antiproliferative%2520activities%2520of%2520meridianin%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D4474%26epage%3D4489%26doi%3D10.1021%2Fjm200464w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Debdab, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carreaux, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renault, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soundararajan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lozach, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babault, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahtouh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baratte, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagiwara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenreich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bazureau, J.-P.</span><span> </span><span class="NLM_article-title">Leucettines, a class of potent inhibitors of CDC2-like kinases and dual specificity, tyrosine phosphorylation regulated kinases derived from the marine sponge leucettamine B: modulation of alternative pre-RNA splicing</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">4172</span><span class="NLM_x">–</span> <span class="NLM_lpage">4186</span><span class="refDoi"> DOI: 10.1021/jm200274d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200274d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=4172-4186&author=M.+Debdabauthor=F.+Carreauxauthor=S.+Renaultauthor=M.+Soundararajanauthor=O.+Fedorovauthor=P.+Filippakopoulosauthor=O.+Lozachauthor=L.+Babaultauthor=T.+Tahtouhauthor=B.+Baratteauthor=Y.+Ogawaauthor=M.+Hagiwaraauthor=A.+Eisenreichauthor=U.+Rauchauthor=S.+Knappauthor=L.+Meijerauthor=J.-P.+Bazureau&title=Leucettines%2C+a+class+of+potent+inhibitors+of+CDC2-like+kinases+and+dual+specificity%2C+tyrosine+phosphorylation+regulated+kinases+derived+from+the+marine+sponge+leucettamine+B%3A+modulation+of+alternative+pre-RNA+splicing&doi=10.1021%2Fjm200274d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm200274d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200274d%26sid%3Dliteratum%253Aachs%26aulast%3DDebdab%26aufirst%3DM.%26aulast%3DCarreaux%26aufirst%3DF.%26aulast%3DRenault%26aufirst%3DS.%26aulast%3DSoundararajan%26aufirst%3DM.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DBabault%26aufirst%3DL.%26aulast%3DTahtouh%26aufirst%3DT.%26aulast%3DBaratte%26aufirst%3DB.%26aulast%3DOgawa%26aufirst%3DY.%26aulast%3DHagiwara%26aufirst%3DM.%26aulast%3DEisenreich%26aufirst%3DA.%26aulast%3DRauch%26aufirst%3DU.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DBazureau%26aufirst%3DJ.-P.%26atitle%3DLeucettines%252C%2520a%2520class%2520of%2520potent%2520inhibitors%2520of%2520CDC2-like%2520kinases%2520and%2520dual%2520specificity%252C%2520tyrosine%2520phosphorylation%2520regulated%2520kinases%2520derived%2520from%2520the%2520marine%2520sponge%2520leucettamine%2520B%253A%2520modulation%2520of%2520alternative%2520pre-RNA%2520splicing%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D4172%26epage%3D4186%26doi%3D10.1021%2Fjm200274d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Bain, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plater, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shpiro, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hastie, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLauchlan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klevernic, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arthur, J. S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, P.</span><span> </span><span class="NLM_article-title">The selectivity of protein kinase inhibitors: a further update</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">408</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">315</span><span class="refDoi"> DOI: 10.1042/BJ20070797</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1042%2FBJ20070797" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=17850214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlGmtbjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=408&publication_year=2007&pages=297-315&author=J.+Bainauthor=L.+Platerauthor=M.+Elliottauthor=N.+Shpiroauthor=C.+J.+Hastieauthor=H.+McLauchlanauthor=I.+Klevernicauthor=J.+S.+C.+Arthurauthor=D.+R.+Alessiauthor=P.+Cohen&title=The+selectivity+of+protein+kinase+inhibitors%3A+a+further+update&doi=10.1042%2FBJ20070797"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The selectivity of protein kinase inhibitors: a further update</span></div><div class="casAuthors">Bain, Jenny; Plater, Lorna; Elliott, Matt; Shpiro, Natalia; Hastie, C. James; McLauchlan, Hilary; Klevernic, Iva; Arthur, J. Simon C.; Alessi, Dario R.; Cohen, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">408</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">297-315</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">The specificities of 65 compds. reported to be relatively specific inhibitors of protein kinases have been profiled against a panel of 70-80 protein kinases.  On the basis of this information, the effects of compds. that we have studied in cells and other data in the literature, we recommend the use of the following small-mol. inhibitors: SB 203580/SB202190 and BIRB 0796 to be used in parallel to assess the physiol. roles of p38 MAPK (mitogen-activated protein kinase) isoforms, PI-103 and wortmannin to be used in parallel to inhibit phosphatidylinositol (phosphoinositide) 3-kinases, PP1 or PP2 to be used in parallel with Src-I1 (Src inhibitor-1) to inhibit Src family members; PD 184352 or PD 0325901 to inhibit MKK1 (MAPK kinase-1) or MKK1 plus MKK5, Akt-I-1/2 to inhibit the activation of PKB (protein kinase B/Akt), rapamycin to inhibit TORC1 [mTOR (mammalian target of rapamycin)-raptor (regulatory assocd. protein of mTOR) complex], CT 99021 to inhibit GSK3 (glycogen synthase kinase 3), BI-D1870 and SL0101 or FMK (fluoromethylketone) to be used in parallel to inhibit RSK (ribosomal S6 kinase), D4476 to inhibit CK1 (casein kinase 1), VX680 to inhibit Aurora kinases, and roscovitine as a pan-CDK (cyclin-dependent kinase) inhibitor.  We have also identified harmine as a potent and specific inhibitor of DYRK1A (dual-specificity tyrosine-phosphorylated and -regulated kinase 1A) in vitro.  The results have further emphasized the need for considerable caution in using small-mol. inhibitors of protein kinases to assess the physiol. roles of these enzymes.  Despite being used widely, many of the compds. that we analyzed were too non-specific for useful conclusions to be made, other than to exclude the involvement of particular protein kinases in cellular processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQPaieWftdVrVg90H21EOLACvtfcHk0ljDd8_nU5ij2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlGmtbjE&md5=e2334e35897dd1b9770bbcca8f82bb9c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1042%2FBJ20070797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20070797%26sid%3Dliteratum%253Aachs%26aulast%3DBain%26aufirst%3DJ.%26aulast%3DPlater%26aufirst%3DL.%26aulast%3DElliott%26aufirst%3DM.%26aulast%3DShpiro%26aufirst%3DN.%26aulast%3DHastie%26aufirst%3DC.%2BJ.%26aulast%3DMcLauchlan%26aufirst%3DH.%26aulast%3DKlevernic%26aufirst%3DI.%26aulast%3DArthur%26aufirst%3DJ.%2BS.%2BC.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DThe%2520selectivity%2520of%2520protein%2520kinase%2520inhibitors%253A%2520a%2520further%2520update%26jtitle%3DBiochem.%2520J.%26date%3D2007%26volume%3D408%26spage%3D297%26epage%3D315%26doi%3D10.1042%2FBJ20070797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Göckler, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jofre, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papadopoulos, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soppa, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tejedor, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, W.</span><span> </span><span class="NLM_article-title">Harmine specifically inhibits protein kinase DYRK1A and interferes with neurite formation</span> <span class="citation_source-journal">FEBS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">6324</span><span class="NLM_x">–</span> <span class="NLM_lpage">6337</span><span class="refDoi"> DOI: 10.1111/j.1742-4658.2009.07346.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1111%2Fj.1742-4658.2009.07346.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=19796173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A280%3ADC%252BD1MnovVSmtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2009&pages=6324-6337&author=N.+G%C3%B6cklerauthor=G.+Jofreauthor=C.+Papadopoulosauthor=U.+Soppaauthor=F.+J.+Tejedorauthor=W.+Becker&title=Harmine+specifically+inhibits+protein+kinase+DYRK1A+and+interferes+with+neurite+formation&doi=10.1111%2Fj.1742-4658.2009.07346.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Harmine specifically inhibits protein kinase DYRK1A and interferes with neurite formation</span></div><div class="casAuthors">Gockler Nora; Jofre Guillermo; Papadopoulos Chrisovalantis; Soppa Ulf; Tejedor Francisco J; Becker Walter</div><div class="citationInfo"><span class="NLM_cas:title">The FEBS journal</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6324-37</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">DYRK1A is a dual-specificity protein kinase that autophosphorylates a conserved tyrosine residue in the activation loop but phosphorylates exogenous substrates only at serine or threonine residues.  Tyrosine autophosphorylation of DYRKs is a one-off event that takes place during translation and induces the activation of the kinase.  Here we characterize the beta-carboline alkaloid harmine as a potent and specific inhibitor of DYRK1A both in vitro and in cultured cells.  Comparative in vitro assays of four kinases of the DYRK family showed that harmine inhibited substrate phosphorylation by DYRK1A more potently than it inhibited substrate phosphorylation by the closely related kinase DYRK1B [half maximal inhibitory concentrations (IC(50)) of 33 nm versus 166 nm, respectively] and by the more distant members of the family, DYRK2 and DYRK4 (1.9 microm and 80 microm, respectively).  Much higher concentrations of harmine were required to suppress tyrosine autophosphorylation of the translational intermediate of DYRK1A in a bacterial in vitro translation system (IC(50) = 1.9 microm).  Importantly, harmine inhibited the phosphorylation of a specific substrate by DYRK1A in cultured cells with a potency similar to that observed in vitro (IC(50) = 48 nm), without negative effects on the viability of the cells.  Overexpression of the DYRK1A gene on chromosome 21 has been implicated in the altered neuronal development observed in Down syndrome.  Here, we show that harmine interferes with neuritogenesis in cultured hippocampal neurons.  In summary, our data show that harmine inhibits DYRK1A substrate phosphorylation more potently than it inhibits tyrosine autophosphorylation, and provide evidence for a role of DYRK1A in the regulation of neurite formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTYQnyD9o3hqhe4jJGKT5N0fW6udTcc2eak8IDxOzBEIrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MnovVSmtw%253D%253D&md5=f59bc35eb74546f6351a4705f2d5fda7</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-4658.2009.07346.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-4658.2009.07346.x%26sid%3Dliteratum%253Aachs%26aulast%3DG%25C3%25B6ckler%26aufirst%3DN.%26aulast%3DJofre%26aufirst%3DG.%26aulast%3DPapadopoulos%26aufirst%3DC.%26aulast%3DSoppa%26aufirst%3DU.%26aulast%3DTejedor%26aufirst%3DF.%2BJ.%26aulast%3DBecker%26aufirst%3DW.%26atitle%3DHarmine%2520specifically%2520inhibits%2520protein%2520kinase%2520DYRK1A%2520and%2520interferes%2520with%2520neurite%2520formation%26jtitle%3DFEBS%2520J.%26date%3D2009%26volume%3D276%26spage%3D6324%26epage%3D6337%26doi%3D10.1111%2Fj.1742-4658.2009.07346.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Grabher, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durieu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kouloura, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halabalaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skaltsounis, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span> </span><span class="NLM_article-title">Hamburger, M.; Potterat, O. Library-based discovery of DYRK1A/CLK1 inhibitors from natural product extracts</span> <span class="citation_source-journal">Planta Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">951</span><span class="NLM_x">–</span> <span class="NLM_lpage">956</span><span class="refDoi"> DOI: 10.1055/s-0031-1298625</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1055%2Fs-0031-1298625" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2012&pages=951-956&author=P.+Grabherauthor=E.+Durieuauthor=E.+Koulouraauthor=M.+Halabalakiauthor=L.+A.+Skaltsounisauthor=L.+Meijer&title=Hamburger%2C+M.%3B+Potterat%2C+O.+Library-based+discovery+of+DYRK1A%2FCLK1+inhibitors+from+natural+product+extracts&doi=10.1055%2Fs-0031-1298625"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1055%2Fs-0031-1298625&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0031-1298625%26sid%3Dliteratum%253Aachs%26aulast%3DGrabher%26aufirst%3DP.%26aulast%3DDurieu%26aufirst%3DE.%26aulast%3DKouloura%26aufirst%3DE.%26aulast%3DHalabalaki%26aufirst%3DM.%26aulast%3DSkaltsounis%26aufirst%3DL.%2BA.%26aulast%3DMeijer%26aufirst%3DL.%26atitle%3DHamburger%252C%2520M.%253B%2520Potterat%252C%2520O.%2520Library-based%2520discovery%2520of%2520DYRK1A%252FCLK1%2520inhibitors%2520from%2520natural%2520product%2520extracts%26jtitle%3DPlanta%2520Med.%26date%3D2012%26volume%3D78%26spage%3D951%26epage%3D956%26doi%3D10.1055%2Fs-0031-1298625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Ogawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohnishi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiramatsu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kii, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onogi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibuya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosoya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagiwara, M.</span><span> </span><span class="NLM_article-title">Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">86</span><span class="refDoi"> DOI: 10.1038/ncomms1090</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1038%2Fncomms1090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=20981014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A280%3ADC%252BC3cbislehtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=86&author=Y.+Ogawaauthor=Y.+Nonakaauthor=T.+Gotoauthor=E.+Ohnishiauthor=T.+Hiramatsuauthor=I.+Kiiauthor=M.+Yoshidaauthor=T.+Ikuraauthor=H.+Onogiauthor=H.+Shibuyaauthor=T.+Hosoyaauthor=N.+Itoauthor=M.+Hagiwara&title=Development+of+a+novel+selective+inhibitor+of+the+Down+syndrome-related+kinase+Dyrk1A&doi=10.1038%2Fncomms1090"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A</span></div><div class="casAuthors">Ogawa Yasushi; Nonaka Yosuke; Goto Toshiyasu; Ohnishi Eriko; Hiramatsu Toshiyuki; Kii Isao; Yoshida Miyo; Ikura Teikichi; Onogi Hiroshi; Shibuya Hiroshi; Hosoya Takamitsu; Ito Nobutoshi; Hagiwara Masatoshi</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">86</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Dyrk1A (dual-specificity tyrosine-(Y)-phosphorylation-regulated kinase 1A) is a serine/threonine kinase essential for brain development and function, and its excessive activity is considered a pathogenic factor in Down syndrome.  The development of potent, selective inhibitors of Dyrk1A would help to elucidate the molecular mechanisms of normal and diseased brains, and may provide a new lead compound for molecular-targeted drug discovery.  Here, we report a novel Dyrk1A inhibitor, INDY, a benzothiazole derivative showing a potent ATP-competitive inhibitory effect with IC(50) and K(i) values of 0.24 and 0.18 μM, respectively.  X-ray crystallography of the Dyrk1A/INDY complex revealed the binding of INDY in the ATP pocket of the enzyme.  INDY effectively reversed the aberrant tau-phosphorylation and rescued the repressed NFAT (nuclear factor of activated T cell) signalling induced by Dyrk1A overexpression.  Importantly, proINDY, a prodrug of INDY, effectively recovered Xenopus embryos from head malformation induced by Dyrk1A overexpression, resulting in normally developed embryos and demonstrating the utility of proINDY in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTOCqf6rsXbPtenUz0lpNqnfW6udTcc2eZ4YMIuuY-iorntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cbislehtw%253D%253D&md5=ac1d5972bec4085de101bb86194babd1</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fncomms1090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms1090%26sid%3Dliteratum%253Aachs%26aulast%3DOgawa%26aufirst%3DY.%26aulast%3DNonaka%26aufirst%3DY.%26aulast%3DGoto%26aufirst%3DT.%26aulast%3DOhnishi%26aufirst%3DE.%26aulast%3DHiramatsu%26aufirst%3DT.%26aulast%3DKii%26aufirst%3DI.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DIkura%26aufirst%3DT.%26aulast%3DOnogi%26aufirst%3DH.%26aulast%3DShibuya%26aufirst%3DH.%26aulast%3DHosoya%26aufirst%3DT.%26aulast%3DIto%26aufirst%3DN.%26aulast%3DHagiwara%26aufirst%3DM.%26atitle%3DDevelopment%2520of%2520a%2520novel%2520selective%2520inhibitor%2520of%2520the%2520Down%2520syndrome-related%2520kinase%2520Dyrk1A%26jtitle%3DNat.%2520Commun.%26date%3D2010%26volume%3D1%26spage%3D86%26doi%3D10.1038%2Fncomms1090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Gourdain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dairou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denhez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bui, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigues-Lima, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janel, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delabar, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cariou, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, R. H.</span><span> </span><span class="NLM_article-title">Development of DANDYs, new 3,5-diaryl-7-azaindoles demonstrating potent DYRK1A kinase inhibitory activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">9569</span><span class="NLM_x">–</span> <span class="NLM_lpage">9585</span><span class="refDoi"> DOI: 10.1021/jm401049v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401049v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslWrt77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=9569-9585&author=S.+Gourdainauthor=J.+Dairouauthor=C.+Denhezauthor=L.+C.+Buiauthor=F.+Rodrigues-Limaauthor=N.+Janelauthor=J.+M.+Delabarauthor=K.+Cariouauthor=R.+H.+Dodd&title=Development+of+DANDYs%2C+new+3%2C5-diaryl-7-azaindoles+demonstrating+potent+DYRK1A+kinase+inhibitory+activity&doi=10.1021%2Fjm401049v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Development of DANDYs, New 3,5-Diaryl-7-azaindoles Demonstrating Potent DYRK1A Kinase Inhibitory Activity</span></div><div class="casAuthors">Gourdain, Stephanie; Dairou, Julien; Denhez, Clement; Bui, Linh Chi; Rodrigues-Lima, Fernando; Janel, Nathalie; Delabar, Jean M.; Cariou, Kevin; Dodd, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9569-9585</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of 3,5-diaryl-1H-pyrrolo[2,3-b]pyridines was synthesized and evaluated for inhibition of DYRK1A kinase in vitro.  Derivs. having hydroxy groups on the aryl moieties demonstrated high inhibitory potencies with Kis in the low nanomolar range.  Their methoxy analogs were up to 100 times less active.  Docking studies at the ATP binding site suggested that these compds. bind tightly to this site via a network of multiple H-bonds with the peptide backbone.  None of the active compds. was cytotoxic to KB cells at 10-6 M.  Kinase profiling revealed that compd. I showed 2-fold selectivity for DYRK1A with respect to DYRK2 and DYRK3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1vxODs_tGD7Vg90H21EOLACvtfcHk0lhkVle1gwKEFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslWrt77K&md5=27dcc77a1c0d413cf0ab5c999cf9a195</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm401049v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401049v%26sid%3Dliteratum%253Aachs%26aulast%3DGourdain%26aufirst%3DS.%26aulast%3DDairou%26aufirst%3DJ.%26aulast%3DDenhez%26aufirst%3DC.%26aulast%3DBui%26aufirst%3DL.%2BC.%26aulast%3DRodrigues-Lima%26aufirst%3DF.%26aulast%3DJanel%26aufirst%3DN.%26aulast%3DDelabar%26aufirst%3DJ.%2BM.%26aulast%3DCariou%26aufirst%3DK.%26aulast%3DDodd%26aufirst%3DR.%2BH.%26atitle%3DDevelopment%2520of%2520DANDYs%252C%2520new%25203%252C5-diaryl-7-azaindoles%2520demonstrating%2520potent%2520DYRK1A%2520kinase%2520inhibitory%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D9569%26epage%3D9585%26doi%3D10.1021%2Fjm401049v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Muraki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohkawara, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosoya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onogi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koizumi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koizumi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sumi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yomoda, J.-i.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furuichi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibuya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krainer, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagiwara, M.</span><span> </span><span class="NLM_article-title">Manipulation of Alternative Splicing by a Newly Developed Inhibitor of Clks</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">24246</span><span class="NLM_x">–</span> <span class="NLM_lpage">24254</span><span class="refDoi"> DOI: 10.1074/jbc.M314298200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1074%2Fjbc.M314298200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=24246-24254&author=M.+Murakiauthor=B.+Ohkawaraauthor=T.+Hosoyaauthor=H.+Onogiauthor=J.+Koizumiauthor=T.+Koizumiauthor=K.+Sumiauthor=J.-i.+Yomodaauthor=M.+V.+Murrayauthor=H.+Kimuraauthor=K.+Furuichiauthor=H.+Shibuyaauthor=A.+R.+Krainerauthor=M.+Suzukiauthor=M.+Hagiwara&title=Manipulation+of+Alternative+Splicing+by+a+Newly+Developed+Inhibitor+of+Clks&doi=10.1074%2Fjbc.M314298200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M314298200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M314298200%26sid%3Dliteratum%253Aachs%26aulast%3DMuraki%26aufirst%3DM.%26aulast%3DOhkawara%26aufirst%3DB.%26aulast%3DHosoya%26aufirst%3DT.%26aulast%3DOnogi%26aufirst%3DH.%26aulast%3DKoizumi%26aufirst%3DJ.%26aulast%3DKoizumi%26aufirst%3DT.%26aulast%3DSumi%26aufirst%3DK.%26aulast%3DYomoda%26aufirst%3DJ.-i.%26aulast%3DMurray%26aufirst%3DM.%2BV.%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DFuruichi%26aufirst%3DK.%26aulast%3DShibuya%26aufirst%3DH.%26aulast%3DKrainer%26aufirst%3DA.%2BR.%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DHagiwara%26aufirst%3DM.%26atitle%3DManipulation%2520of%2520Alternative%2520Splicing%2520by%2520a%2520Newly%2520Developed%2520Inhibitor%2520of%2520Clks%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D24246%26epage%3D24254%26doi%3D10.1074%2Fjbc.M314298200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Mott, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanega, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maloney, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinn, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leister, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marugan, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inglese, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misteli, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auld, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, C. J.</span><span> </span><span class="NLM_article-title">Evaluation of substituted 6-arylquinazolin-4-amines as potent and selective inhibitors of cdc2-like kinases (Clk)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">6700</span><span class="NLM_x">–</span> <span class="NLM_lpage">6705</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.09.121</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1016%2Fj.bmcl.2009.09.121" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=6700-6705&author=B.+T.+Mottauthor=C.+Tanegaauthor=M.+Shenauthor=D.+J.+Maloneyauthor=P.+Shinnauthor=W.+Leisterauthor=J.+J.+Maruganauthor=J.+Ingleseauthor=C.+P.+Austinauthor=T.+Misteliauthor=D.+S.+Auldauthor=C.+J.+Thomas&title=Evaluation+of+substituted+6-arylquinazolin-4-amines+as+potent+and+selective+inhibitors+of+cdc2-like+kinases+%28Clk%29&doi=10.1016%2Fj.bmcl.2009.09.121"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.09.121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.09.121%26sid%3Dliteratum%253Aachs%26aulast%3DMott%26aufirst%3DB.%2BT.%26aulast%3DTanega%26aufirst%3DC.%26aulast%3DShen%26aufirst%3DM.%26aulast%3DMaloney%26aufirst%3DD.%2BJ.%26aulast%3DShinn%26aufirst%3DP.%26aulast%3DLeister%26aufirst%3DW.%26aulast%3DMarugan%26aufirst%3DJ.%2BJ.%26aulast%3DInglese%26aufirst%3DJ.%26aulast%3DAustin%26aufirst%3DC.%2BP.%26aulast%3DMisteli%26aufirst%3DT.%26aulast%3DAuld%26aufirst%3DD.%2BS.%26aulast%3DThomas%26aufirst%3DC.%2BJ.%26atitle%3DEvaluation%2520of%2520substituted%25206-arylquinazolin-4-amines%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520cdc2-like%2520kinases%2520%2528Clk%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D6700%26epage%3D6705%26doi%3D10.1016%2Fj.bmcl.2009.09.121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Kii, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sumida, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonamoto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okuno, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato-Sumida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koike, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibuya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosoya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagiwara, M.</span><span> </span><span class="NLM_article-title">Selective inhibition of the kinase DYRK1A by targeting its folding process</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">11391</span><span class="refDoi"> DOI: 10.1038/ncomms11391</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1038%2Fncomms11391" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=27102360" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BC28XmslShtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=11391&author=I.+Kiiauthor=Y.+Sumidaauthor=T.+Gotoauthor=R.+Sonamotoauthor=Y.+Okunoauthor=S.+Yoshidaauthor=T.+Kato-Sumidaauthor=Y.+Koikeauthor=M.+Abeauthor=Y.+Nonakaauthor=T.+Ikuraauthor=N.+Itoauthor=H.+Shibuyaauthor=T.+Hosoyaauthor=M.+Hagiwara&title=Selective+inhibition+of+the+kinase+DYRK1A+by+targeting+its+folding+process&doi=10.1038%2Fncomms11391"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Selective inhibition of the kinase DYRK1A by targeting its folding process</span></div><div class="casAuthors">Kii, Isao; Sumida, Yuto; Goto, Toshiyasu; Sonamoto, Rie; Okuno, Yukiko; Yoshida, Suguru; Kato-Sumida, Tomoe; Koike, Yuka; Abe, Minako; Nonaka, Yosuke; Ikura, Teikichi; Ito, Nobutoshi; Shibuya, Hiroshi; Hosoya, Takamitsu; Hagiwara, Masatoshi</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11391</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Autophosphorylation of amino-acid residues is part of the folding process of various protein kinases.  Conventional chem. screening of mature kinases has missed inhibitors that selectively interfere with the folding process.  Here we report a cell-based assay that evaluates inhibition of a kinase at a transitional state during the folding process and identify a folding intermediate-selective inhibitor of dual-specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A), which we refer to as FINDY.  FINDY suppresses intramol. autophosphorylation of Ser97 in DYRK1A in cultured cells, leading to its degrdn., but does not inhibit substrate phosphorylation catalyzed by the mature kinase.  FINDY also suppresses Ser97 autophosphorylation of recombinant DYRK1A, suggesting direct inhibition, and shows high selectivity for DYRK1A over other DYRK family members.  In addn., FINDY rescues DYRK1A-induced developmental malformations in Xenopus laevis embryos.  Our study demonstrates that transitional folding intermediates of protein kinases can be targeted by small mols., and paves the way for developing novel types of kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE2gsAsp-YjLVg90H21EOLACvtfcHk0ljXXlYnMpNYuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmslShtr8%253D&md5=5d64de412dd168a415a3da052d3afedc</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fncomms11391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms11391%26sid%3Dliteratum%253Aachs%26aulast%3DKii%26aufirst%3DI.%26aulast%3DSumida%26aufirst%3DY.%26aulast%3DGoto%26aufirst%3DT.%26aulast%3DSonamoto%26aufirst%3DR.%26aulast%3DOkuno%26aufirst%3DY.%26aulast%3DYoshida%26aufirst%3DS.%26aulast%3DKato-Sumida%26aufirst%3DT.%26aulast%3DKoike%26aufirst%3DY.%26aulast%3DAbe%26aufirst%3DM.%26aulast%3DNonaka%26aufirst%3DY.%26aulast%3DIkura%26aufirst%3DT.%26aulast%3DIto%26aufirst%3DN.%26aulast%3DShibuya%26aufirst%3DH.%26aulast%3DHosoya%26aufirst%3DT.%26aulast%3DHagiwara%26aufirst%3DM.%26atitle%3DSelective%2520inhibition%2520of%2520the%2520kinase%2520DYRK1A%2520by%2520targeting%2520its%2520folding%2520process%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D11391%26doi%3D10.1038%2Fncomms11391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Falke, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaikuad, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loaëc, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lozach, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abu Jhaisha, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunick, C.</span><span> </span><span class="NLM_article-title">10-Iodo-11H-indolo[3,2-c]quinoline-6-carboxylic acids are selective inhibitors of DYRK1A</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">3131</span><span class="NLM_x">–</span> <span class="NLM_lpage">3143</span><span class="refDoi"> DOI: 10.1021/jm501994d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501994d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjs1GhtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3131-3143&author=H.+Falkeauthor=A.+Chaikuadauthor=A.+Beckerauthor=N.+Loa%C3%ABcauthor=O.+Lozachauthor=S.+Abu+Jhaishaauthor=W.+Beckerauthor=P.+G.+Jonesauthor=L.+Preuauthor=K.+Baumannauthor=S.+Knappauthor=L.+Meijerauthor=C.+Kunick&title=10-Iodo-11H-indolo%5B3%2C2-c%5Dquinoline-6-carboxylic+acids+are+selective+inhibitors+of+DYRK1A&doi=10.1021%2Fjm501994d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">10-Iodo-11H-indolo[3,2-c]quinoline-6-carboxylic Acids Are Selective Inhibitors of DYRK1A</span></div><div class="casAuthors">Falke, Hannes; Chaikuad, Apirat; Becker, Anja; Loaec, Nadege; Lozach, Olivier; Abu Jhaisha, Samira; Becker, Walter; Jones, Peter G.; Preu, Lutz; Baumann, Knut; Knapp, Stefan; Meijer, Laurent; Kunick, Conrad</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3131-3143</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The protein kinase DYRK1A has been suggested to act as one of the intracellular regulators contributing to neurol. alterations found in individuals with Down syndrome.  For an assessment of the role of DYRK1A, selective synthetic inhibitors are valuable pharmacol. tools.  However, the DYRK1A inhibitors described in the literature so far either are not sufficiently selective or have not been tested against closely related kinases from the DYRK and the CLK protein kinase families.  The aim of this study was the identification of DYRK1A inhibitors exhibiting selectivity vs. the structurally and functionally closely related DYRK and CLK isoforms.  Structure modification of the screening hit 11H-indolo[3,2-c]quinoline-6-carboxylic acid revealed structure-activity relationships for kinase inhibition and enabled the design of 10-iodo-substituted derivs. as very potent DYRK1A inhibitors with considerable selectivity against CLKs.  X-ray structure detn. of three 11H-indolo[3,2-c]quinoline-6-carboxylic acids cocrystd. with DYRK1A confirmed the predicted binding mode within the ATP binding site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpe4rHbgYJUsbVg90H21EOLACvtfcHk0ljXXlYnMpNYuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjs1GhtrY%253D&md5=70efbb6ad590a1240764ccc78af019ec</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm501994d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501994d%26sid%3Dliteratum%253Aachs%26aulast%3DFalke%26aufirst%3DH.%26aulast%3DChaikuad%26aufirst%3DA.%26aulast%3DBecker%26aufirst%3DA.%26aulast%3DLoa%25C3%25ABc%26aufirst%3DN.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DAbu%2BJhaisha%26aufirst%3DS.%26aulast%3DBecker%26aufirst%3DW.%26aulast%3DJones%26aufirst%3DP.%2BG.%26aulast%3DPreu%26aufirst%3DL.%26aulast%3DBaumann%26aufirst%3DK.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DKunick%26aufirst%3DC.%26atitle%3D10-Iodo-11H-indolo%255B3%252C2-c%255Dquinoline-6-carboxylic%2520acids%2520are%2520selective%2520inhibitors%2520of%2520DYRK1A%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3131%26epage%3D3143%26doi%3D10.1021%2Fjm501994d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Chaikuad, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diharce, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schröder, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foucourt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblond, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casagrande, A.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Désiré, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besson, T.</span><span> </span><span class="NLM_article-title">An unusual binding model of the methyl 9-anilinothiazolo[5,4-f] quinazoline-2-carbimidates (EHT 1610 and EHT 5372) confers high selectivity for dual-specificity tyrosine phosphorylation-regulated kinases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">10315</span><span class="NLM_x">–</span> <span class="NLM_lpage">10321</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01083</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01083" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslWjtr%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10315-10321&author=A.+Chaikuadauthor=J.+Diharceauthor=M.+Schr%C3%B6derauthor=A.+Foucourtauthor=B.+Leblondauthor=A.-S.+Casagrandeauthor=L.+D%C3%A9sir%C3%A9author=P.+Bonnetauthor=S.+Knappauthor=T.+Besson&title=An+unusual+binding+model+of+the+methyl+9-anilinothiazolo%5B5%2C4-f%5D+quinazoline-2-carbimidates+%28EHT+1610+and+EHT+5372%29+confers+high+selectivity+for+dual-specificity+tyrosine+phosphorylation-regulated+kinases&doi=10.1021%2Facs.jmedchem.6b01083"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">An Unusual Binding Model of the Methyl 9-Anilinothiazolo[5,4-f] quinazoline-2-carbimidates (EHT 1610 and EHT 5372) Confers High Selectivity for Dual-Specificity Tyrosine Phosphorylation-Regulated Kinases</span></div><div class="casAuthors">Chaikuad, Apirat; Diharce, Julien; Schroder, Martin; Foucourt, Alicia; Leblond, Bertrand; Casagrande, Anne-Sophie; Desire, Laurent; Bonnet, Pascal; Knapp, Stefan; Besson, Thierry</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">10315-10321</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Me 9-anilinothiazolo[5,4-f]quinazoline-2-carbimidates 1 (EHT 5372) and 2 (EHT 1610) are strong inhibitors of DYRK's family kinases.  The crystal structures of the complex revealed a non-canonical binding mode of compd. 1 and 2 in DYRK2 explaining the remarkable selectivity and potency of these inhibitors.  The structural data and comparison presented here provide therefore a template for further improvement of this inhibitor class and for the development of novel inhibitors selectively targeting DYRK kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp91_JqCRXGqLVg90H21EOLACvtfcHk0ljXXlYnMpNYuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslWjtr%252FM&md5=856551b47ad21c90c55563b064001358</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01083%26sid%3Dliteratum%253Aachs%26aulast%3DChaikuad%26aufirst%3DA.%26aulast%3DDiharce%26aufirst%3DJ.%26aulast%3DSchr%25C3%25B6der%26aufirst%3DM.%26aulast%3DFoucourt%26aufirst%3DA.%26aulast%3DLeblond%26aufirst%3DB.%26aulast%3DCasagrande%26aufirst%3DA.-S.%26aulast%3DD%25C3%25A9sir%25C3%25A9%26aufirst%3DL.%26aulast%3DBonnet%26aufirst%3DP.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DBesson%26aufirst%3DT.%26atitle%3DAn%2520unusual%2520binding%2520model%2520of%2520the%2520methyl%25209-anilinothiazolo%255B5%252C4-f%255D%2520quinazoline-2-carbimidates%2520%2528EHT%25201610%2520and%2520EHT%25205372%2529%2520confers%2520high%2520selectivity%2520for%2520dual-specificity%2520tyrosine%2520phosphorylation-regulated%2520kinases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D10315%26epage%3D10321%26doi%3D10.1021%2Facs.jmedchem.6b01083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Malinge, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bliss-Moreau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirsammer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diebold, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chlon, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurbuxani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crispino, J. D.</span><span> </span><span class="NLM_article-title">Increased dosage of the chromosome 21 ortholog Dyrk1a promotes megakaryoblastic leukemia in a murine model of Down syndrome</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">948</span><span class="NLM_x">–</span> <span class="NLM_lpage">962</span><span class="refDoi"> DOI: 10.1172/JCI60455</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1172%2FJCI60455" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2012&pages=948-962&author=S.+Malingeauthor=M.+Bliss-Moreauauthor=G.+Kirsammerauthor=L.+Dieboldauthor=T.+Chlonauthor=S.+Gurbuxaniauthor=J.+D.+Crispino&title=Increased+dosage+of+the+chromosome+21+ortholog+Dyrk1a+promotes+megakaryoblastic+leukemia+in+a+murine+model+of+Down+syndrome&doi=10.1172%2FJCI60455"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1172%2FJCI60455&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI60455%26sid%3Dliteratum%253Aachs%26aulast%3DMalinge%26aufirst%3DS.%26aulast%3DBliss-Moreau%26aufirst%3DM.%26aulast%3DKirsammer%26aufirst%3DG.%26aulast%3DDiebold%26aufirst%3DL.%26aulast%3DChlon%26aufirst%3DT.%26aulast%3DGurbuxani%26aufirst%3DS.%26aulast%3DCrispino%26aufirst%3DJ.%2BD.%26atitle%3DIncreased%2520dosage%2520of%2520the%2520chromosome%252021%2520ortholog%2520Dyrk1a%2520promotes%2520megakaryoblastic%2520leukemia%2520in%2520a%2520murine%2520model%2520of%2520Down%2520syndrome%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2012%26volume%3D122%26spage%3D948%26epage%3D962%26doi%3D10.1172%2FJCI60455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Boichuk, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parry, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makielski, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Litovchick, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baron, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zewe, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wozniak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehalek, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korzeniewski, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seneviratne, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schöffski, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debiec-Rychter, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeCaprio, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duensing, A.</span><span> </span><span class="NLM_article-title">The DREAM complex mediates GIST cell quiescence and is a novel therapeutic target to enhance Imatinib-induced apoptosis</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">5120</span><span class="NLM_x">–</span> <span class="NLM_lpage">5129</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-13-0579</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1158%2F0008-5472.CAN-13-0579" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=5120-5129&author=S.+Boichukauthor=J.+A.+Parryauthor=K.+R.+Makielskiauthor=L.+Litovchickauthor=J.+L.+Baronauthor=J.+P.+Zeweauthor=A.+Wozniakauthor=K.+R.+Mehalekauthor=N.+Korzeniewskiauthor=D.+S.+Seneviratneauthor=P.+Sch%C3%B6ffskiauthor=M.+Debiec-Rychterauthor=J.+A.+DeCaprioauthor=A.+Duensing&title=The+DREAM+complex+mediates+GIST+cell+quiescence+and+is+a+novel+therapeutic+target+to+enhance+Imatinib-induced+apoptosis&doi=10.1158%2F0008-5472.CAN-13-0579"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-13-0579&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-13-0579%26sid%3Dliteratum%253Aachs%26aulast%3DBoichuk%26aufirst%3DS.%26aulast%3DParry%26aufirst%3DJ.%2BA.%26aulast%3DMakielski%26aufirst%3DK.%2BR.%26aulast%3DLitovchick%26aufirst%3DL.%26aulast%3DBaron%26aufirst%3DJ.%2BL.%26aulast%3DZewe%26aufirst%3DJ.%2BP.%26aulast%3DWozniak%26aufirst%3DA.%26aulast%3DMehalek%26aufirst%3DK.%2BR.%26aulast%3DKorzeniewski%26aufirst%3DN.%26aulast%3DSeneviratne%26aufirst%3DD.%2BS.%26aulast%3DSch%25C3%25B6ffski%26aufirst%3DP.%26aulast%3DDebiec-Rychter%26aufirst%3DM.%26aulast%3DDeCaprio%26aufirst%3DJ.%2BA.%26aulast%3DDuensing%26aufirst%3DA.%26atitle%3DThe%2520DREAM%2520complex%2520mediates%2520GIST%2520cell%2520quiescence%2520and%2520is%2520a%2520novel%2520therapeutic%2520target%2520to%2520enhance%2520Imatinib-induced%2520apoptosis%26jtitle%3DCancer%2520Res.%26date%3D2013%26volume%3D73%26spage%3D5120%26epage%3D5129%26doi%3D10.1158%2F0008-5472.CAN-13-0579" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Chang, H.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, M.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, C.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Y.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, W. C. Y.</span><span> </span><span class="NLM_article-title">Increased expression of DYRK1a in HPV16 immortalized Keratinocytes enable evasion of apoptosis</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">2377</span><span class="NLM_x">–</span> <span class="NLM_lpage">2385</span><span class="refDoi"> DOI: 10.1002/ijc.22573</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1002%2Fijc.22573" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=17294446" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BD2sXksFSktbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2007&pages=2377-2385&author=H.-S.+Changauthor=C.-H.+Linauthor=C.-H.+Yangauthor=M.-S.+Yenauthor=C.-R.+Laiauthor=Y.-R.+Chenauthor=Y.-J.+Liangauthor=W.+C.+Y.+Yu&title=Increased+expression+of+DYRK1a+in+HPV16+immortalized+Keratinocytes+enable+evasion+of+apoptosis&doi=10.1002%2Fijc.22573"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Increased expression of Dyrk1a in HPV16 immortalized keratinocytes enable evasion of apoptosis</span></div><div class="casAuthors">Chang, Hung-Shu; Lin, Ching-Hui; Yang, Chien-Hui; Yen, Ming-Shyen; Lai, Chiung-Ru; Chen, Yi-Rong; Liang, Yuh-Jin; Yu, Winston C. Y.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2377-2385</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Immortalization is a crit. event in virus-related oncogenesis.  No enough information, however, is currently available to elucidate the changes that occur in cellular mols. during immortalization.  To identify potential cellular markers or regulators involving in immortalization, a paired-cell model of primary foreskin keratinocytes (FK) and HPV16 immortalized foreskin keratinocytes were established.  Using mRNA differential display, RT-PCR and Northern blot methods, we have identified and confirmed that Dyrk1a (dual-specificity tyrosine-phosphorylated and regulated kinase 1A) is present and increased in HPV16 immortalized cells, but is absent in primary keratinocytes.  Moreover, transfection of E7 siRNA oligo into immortalized cells leads to a diminishing E7 expression and the eventual disappearance of Dyrk1a.  Similar results of Dyrk1a expressional differences could also be seen when tissue specimens were compared using LCM/real-time PCR and immunohistochem. anal.; malignant cervical lesions contain significantly more DYRK1A than normal tissue.  It was also demonstrated that raised DYRK1A could rearrange the cellular localization of FKHR (forkhead in rhabdomyosarcoma), an apoptosis activator, and suppress BAD.  Importantly, this phenomenon can be reversed when endogenous Dyrk1a was knocked down in immortalized cells by RNA interference.  These results suggest that the raised Dyrk1a in HPV16 immortalized keratinocytes and cervical lesions may serve as a candidate antiapoptotic factor in the FKHR regulated pathway and initiate immortalization and tumorigenesis gradually.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqe0It7CDgI4rVg90H21EOLACvtfcHk0ljcr_h9AjgZyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXksFSktbs%253D&md5=0b1acebae4efef96a83e11bf7ee7b62c</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2Fijc.22573&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.22573%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DH.-S.%26aulast%3DLin%26aufirst%3DC.-H.%26aulast%3DYang%26aufirst%3DC.-H.%26aulast%3DYen%26aufirst%3DM.-S.%26aulast%3DLai%26aufirst%3DC.-R.%26aulast%3DChen%26aufirst%3DY.-R.%26aulast%3DLiang%26aufirst%3DY.-J.%26aulast%3DYu%26aufirst%3DW.%2BC.%2BY.%26atitle%3DIncreased%2520expression%2520of%2520DYRK1a%2520in%2520HPV16%2520immortalized%2520Keratinocytes%2520enable%2520evasion%2520of%2520apoptosis%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2007%26volume%3D120%26spage%3D2377%26epage%3D2385%26doi%3D10.1002%2Fijc.22573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Chen, J.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng-Chiao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, T.</span><span> </span><span class="NLM_article-title">Dosage of Dyrk1A shifts cells within a p21-cyclin D1 signalling map to control the decision to enter the cell cycle</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">100</span><span class="refDoi"> DOI: 10.1016/j.molcel.2013.09.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1016%2Fj.molcel.2013.09.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=87-100&author=J.-Y.+Chenauthor=J.-R.+Linauthor=T.+Feng-Chiaoauthor=T.+Meyer&title=Dosage+of+Dyrk1A+shifts+cells+within+a+p21-cyclin+D1+signalling+map+to+control+the+decision+to+enter+the+cell+cycle&doi=10.1016%2Fj.molcel.2013.09.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2013.09.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2013.09.009%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.-Y.%26aulast%3DLin%26aufirst%3DJ.-R.%26aulast%3DFeng-Chiao%26aufirst%3DT.%26aulast%3DMeyer%26aufirst%3DT.%26atitle%3DDosage%2520of%2520Dyrk1A%2520shifts%2520cells%2520within%2520a%2520p21-cyclin%2520D1%2520signalling%2520map%2520to%2520control%2520the%2520decision%2520to%2520enter%2520the%2520cell%2520cycle%26jtitle%3DMol.%2520Cell%26date%3D2013%26volume%3D52%26spage%3D87%26epage%3D100%26doi%3D10.1016%2Fj.molcel.2013.09.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Litovchick, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Florens, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swanson, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Washburn, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeCaprio, J. A.</span><span> </span><span class="NLM_article-title">DYRK1A protein kinase promotes quiescence and senescence through DREAM complex assembly</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">801</span><span class="NLM_x">–</span> <span class="NLM_lpage">813</span><span class="refDoi"> DOI: 10.1101/gad.2034211</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1101%2Fgad.2034211" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=21498570" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BC3MXltlKntrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=801-813&author=L.+Litovchickauthor=L.+A.+Florensauthor=S.+K.+Swansonauthor=M.+P.+Washburnauthor=J.+A.+DeCaprio&title=DYRK1A+protein+kinase+promotes+quiescence+and+senescence+through+DREAM+complex+assembly&doi=10.1101%2Fgad.2034211"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">DYRK1A protein kinase promotes quiescence and senescence through DREAM complex assembly</span></div><div class="casAuthors">Litovchick, Larisa; Florens, Laurence A.; Swanson, Selene K.; Washburn, Michael P.; DeCaprio, James A.</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">801-813</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">In the absence of growth signals, cells exit the cell cycle and enter into G0 or quiescence.  Alternatively, cells enter senescence in response to inappropriate growth signals such as oncogene expression.  The mol. mechanisms required for cell cycle exit into quiescence or senescence are poorly understood.  The DREAM (DP, RB [retinoblastoma], E2F, and MuvB) complex represses cell cycle-dependent genes during quiescence.  DREAM contains p130, E2F4, DP1, and a stable core complex of five MuvB-like proteins: LIN9, LIN37, LIN52, LIN54, and RBBP4.  In mammalian cells, the MuvB core dissocs. from p130 upon entry into the cell cycle and binds to BMYB during S phase to activate the transcription of genes expressed late in the cell cycle.  We used mass spectroscopic anal. to identify phosphorylation sites that regulate the switch of the MuvB core from BMYB to DREAM.  Here we report that DYRK1A can specifically phosphorylate LIN52 on serine residue 28, and that this phosphorylation is required for DREAM assembly.  Inhibiting DYRK1A activity or point mutation of LIN52 disrupts DREAM assembly and reduces the ability of cells to enter quiescence or undergo Ras-induced senescence.  These data reveal an important role for DYRK1A in the regulation of DREAM activity and entry into quiescence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptXCB-wHS9bLVg90H21EOLACvtfcHk0lgHiFqJBNc8YA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXltlKntrc%253D&md5=0d3048d4ea6a370a7a230b8f250e3867</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1101%2Fgad.2034211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.2034211%26sid%3Dliteratum%253Aachs%26aulast%3DLitovchick%26aufirst%3DL.%26aulast%3DFlorens%26aufirst%3DL.%2BA.%26aulast%3DSwanson%26aufirst%3DS.%2BK.%26aulast%3DWashburn%26aufirst%3DM.%2BP.%26aulast%3DDeCaprio%26aufirst%3DJ.%2BA.%26atitle%3DDYRK1A%2520protein%2520kinase%2520promotes%2520quiescence%2520and%2520senescence%2520through%2520DREAM%2520complex%2520assembly%26jtitle%3DGenes%2520Dev.%26date%3D2011%26volume%3D25%26spage%3D801%26epage%3D813%26doi%3D10.1101%2Fgad.2034211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Di Vona, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bezdan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Islam</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abul, B. M. M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salichs, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López-Bigas, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ossowski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de la Luna, S.</span><span> </span><span class="NLM_article-title">Chromatin-wide profiling of DYRK1A reveals a role as a gene-specific RNA polymerase II CTD kinase</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">506</span><span class="NLM_x">–</span> <span class="NLM_lpage">520</span><span class="refDoi"> DOI: 10.1016/j.molcel.2014.12.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1016%2Fj.molcel.2014.12.026" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2015&pages=506-520&author=C.+Di+Vonaauthor=D.+Bezdanauthor=+Islamauthor=B.+M.+M.+K.+Abulauthor=E.+Salichsauthor=N.+L%C3%B3pez-Bigasauthor=S.+Ossowskiauthor=S.+de+la+Luna&title=Chromatin-wide+profiling+of+DYRK1A+reveals+a+role+as+a+gene-specific+RNA+polymerase+II+CTD+kinase&doi=10.1016%2Fj.molcel.2014.12.026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2014.12.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2014.12.026%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BVona%26aufirst%3DC.%26aulast%3DBezdan%26aufirst%3DD.%26aulast%3DIslam%26aulast%3DAbul%26aufirst%3DB.%2BM.%2BM.%2BK.%26aulast%3DSalichs%26aufirst%3DE.%26aulast%3DL%25C3%25B3pez-Bigas%26aufirst%3DN.%26aulast%3DOssowski%26aufirst%3DS.%26aulast%3Dde%2Bla%2BLuna%26aufirst%3DS.%26atitle%3DChromatin-wide%2520profiling%2520of%2520DYRK1A%2520reveals%2520a%2520role%2520as%2520a%2520gene-specific%2520RNA%2520polymerase%2520II%2520CTD%2520kinase%26jtitle%3DMol.%2520Cell%26date%3D2015%26volume%3D57%26spage%3D506%26epage%3D520%26doi%3D10.1016%2Fj.molcel.2014.12.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Zhou, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J. J.</span><span> </span><span class="NLM_article-title">Role of dual specificity tyrosine-phosphorylation-regulated kinase 1B (Dyrk1B) in S-phase entry of HPV E7 expressing cells from quiescence</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">30745</span><span class="NLM_x">–</span> <span class="NLM_lpage">30761</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=30745-30761&author=N.+Zhouauthor=S.+Yuanauthor=R.+Wangauthor=W.+Zhangauthor=J.+J.+Chen&title=Role+of+dual+specificity+tyrosine-phosphorylation-regulated+kinase+1B+%28Dyrk1B%29+in+S-phase+entry+of+HPV+E7+expressing+cells+from+quiescence"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DN.%26aulast%3DYuan%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DJ.%2BJ.%26atitle%3DRole%2520of%2520dual%2520specificity%2520tyrosine-phosphorylation-regulated%2520kinase%25201B%2520%2528Dyrk1B%2529%2520in%2520S-phase%2520entry%2520of%2520HPV%2520E7%2520expressing%2520cells%2520from%2520quiescence%26jtitle%3DOncotarget%26date%3D2015%26volume%3D6%26spage%3D30745%26epage%3D30761" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Guo, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banerjee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixon, J. E.</span><span> </span><span class="NLM_article-title">Site-specific proteasome phosphorylation controls cell proliferation and tumorigenesis</span> <span class="citation_source-journal">Nat. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">202</span><span class="NLM_x">–</span> <span class="NLM_lpage">212</span><span class="refDoi"> DOI: 10.1038/ncb3289</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1038%2Fncb3289" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=26655835" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVWqtr3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2016&pages=202-212&author=X.+Guoauthor=X.+Wangauthor=Z.+Wangauthor=S.+Banerjeeauthor=J.+Yangauthor=L.+Huangauthor=J.+E.+Dixon&title=Site-specific+proteasome+phosphorylation+controls+cell+proliferation+and+tumorigenesis&doi=10.1038%2Fncb3289"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Site-specific proteasome phosphorylation controls cell proliferation and tumorigenesis</span></div><div class="casAuthors">Guo, Xing; Wang, Xiaorong; Wang, Zhiping; Banerjee, Sourav; Yang, Jing; Huang, Lan; Dixon, Jack E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">202-212</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Despite the fundamental importance of proteasomal degrdn. in cells, little is known about whether and how the 26S proteasome itself is regulated in coordination with various physiol. processes.  Here we show that the proteasome is dynamically phosphorylated during the cell cycle at Thr 25 of the 19S subunit Rpt3.  CRISPR/Cas9-mediated genome editing, RNA interference and biochem. studies demonstrate that blocking Rpt3-Thr25 phosphorylation markedly impairs proteasome activity and impedes cell proliferation.  Through a kinome-wide screen, we have identified dual-specificity tyrosine-regulated kinase 2 (DYRK2) as the primary kinase that phosphorylates Rpt3-Thr25, leading to enhanced substrate translocation and degrdn.  Importantly, loss of the single phosphorylation of Rpt3-Thr25 or knockout of DYRK2 significantly inhibits tumor formation by proteasome-addicted human breast cancer cells in mice.  These findings define an important mechanism for proteasome regulation and demonstrate the biol. significance of proteasome phosphorylation in regulating cell proliferation and tumorigenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoq1NWkvB5GQ7Vg90H21EOLACvtfcHk0lgHiFqJBNc8YA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVWqtr3I&md5=f8f3aa4eae939ab0bf558cd49bfd73a4</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fncb3289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb3289%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DDixon%26aufirst%3DJ.%2BE.%26atitle%3DSite-specific%2520proteasome%2520phosphorylation%2520controls%2520cell%2520proliferation%2520and%2520tumorigenesis%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2016%26volume%3D18%26spage%3D202%26epage%3D212%26doi%3D10.1038%2Fncb3289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Pozo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zahonero, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liñares, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayuso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagiwara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ricoy, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernández-Laín, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sepúlveda, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sánchez-Gómez, P.</span><span> </span><span class="NLM_article-title">Inhibition of DYRK1A destabilizes EGFR and reduces EGFR-dependent glioblastoma growth</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x">, </span> <span class="NLM_fpage">2475</span><span class="NLM_x">–</span> <span class="NLM_lpage">2487</span><span class="refDoi"> DOI: 10.1172/JCI63623</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1172%2FJCI63623" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2013&pages=2475-2487&author=N.+Pozoauthor=C.+Zahoneroauthor=P.+Fern%C3%A1ndezauthor=J.+M.+Li%C3%B1aresauthor=A.+Ayusoauthor=M.+Hagiwaraauthor=A.+P%C3%A9rezauthor=J.+R.+Ricoyauthor=A.+Hern%C3%A1ndez-La%C3%ADnauthor=J.+M.+Sep%C3%BAlvedaauthor=P.+S%C3%A1nchez-G%C3%B3mez&title=Inhibition+of+DYRK1A+destabilizes+EGFR+and+reduces+EGFR-dependent+glioblastoma+growth&doi=10.1172%2FJCI63623"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1172%2FJCI63623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI63623%26sid%3Dliteratum%253Aachs%26aulast%3DPozo%26aufirst%3DN.%26aulast%3DZahonero%26aufirst%3DC.%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DP.%26aulast%3DLi%25C3%25B1ares%26aufirst%3DJ.%2BM.%26aulast%3DAyuso%26aufirst%3DA.%26aulast%3DHagiwara%26aufirst%3DM.%26aulast%3DP%25C3%25A9rez%26aufirst%3DA.%26aulast%3DRicoy%26aufirst%3DJ.%2BR.%26aulast%3DHern%25C3%25A1ndez-La%25C3%25ADn%26aufirst%3DA.%26aulast%3DSep%25C3%25BAlveda%26aufirst%3DJ.%2BM.%26aulast%3DS%25C3%25A1nchez-G%25C3%25B3mez%26aufirst%3DP.%26atitle%3DInhibition%2520of%2520DYRK1A%2520destabilizes%2520EGFR%2520and%2520reduces%2520EGFR-dependent%2520glioblastoma%2520growth%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2013%26volume%3D123%26spage%3D2475%26epage%3D2487%26doi%3D10.1172%2FJCI63623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Ferron, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pozo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laguna, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aranda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porlan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fillat, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de la Luna, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sánchez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arbonés, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fariñas, I.</span><span> </span><span class="NLM_article-title">Regulated segregation of kinase Dyrk1A during asymmetric neural stem cell division is critical for EGFR-mediated biased signaling</span> <span class="citation_source-journal">Cell Stem Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">367</span><span class="NLM_x">–</span> <span class="NLM_lpage">379</span><span class="refDoi"> DOI: 10.1016/j.stem.2010.06.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1016%2Fj.stem.2010.06.021" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2010&pages=367-379&author=S.+R.+Ferronauthor=N.+Pozoauthor=A.+Lagunaauthor=S.+Arandaauthor=E.+Porlanauthor=M.+Morenoauthor=C.+Fillatauthor=S.+de+la+Lunaauthor=P.+S%C3%A1nchezauthor=M.+L.+Arbon%C3%A9sauthor=I.+Fari%C3%B1as&title=Regulated+segregation+of+kinase+Dyrk1A+during+asymmetric+neural+stem+cell+division+is+critical+for+EGFR-mediated+biased+signaling&doi=10.1016%2Fj.stem.2010.06.021"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.stem.2010.06.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.stem.2010.06.021%26sid%3Dliteratum%253Aachs%26aulast%3DFerron%26aufirst%3DS.%2BR.%26aulast%3DPozo%26aufirst%3DN.%26aulast%3DLaguna%26aufirst%3DA.%26aulast%3DAranda%26aufirst%3DS.%26aulast%3DPorlan%26aufirst%3DE.%26aulast%3DMoreno%26aufirst%3DM.%26aulast%3DFillat%26aufirst%3DC.%26aulast%3Dde%2Bla%2BLuna%26aufirst%3DS.%26aulast%3DS%25C3%25A1nchez%26aufirst%3DP.%26aulast%3DArbon%25C3%25A9s%26aufirst%3DM.%2BL.%26aulast%3DFari%25C3%25B1as%26aufirst%3DI.%26atitle%3DRegulated%2520segregation%2520of%2520kinase%2520Dyrk1A%2520during%2520asymmetric%2520neural%2520stem%2520cell%2520division%2520is%2520critical%2520for%2520EGFR-mediated%2520biased%2520signaling%26jtitle%3DCell%2520Stem%2520Cell%26date%3D2010%26volume%3D7%26spage%3D367%26epage%3D379%26doi%3D10.1016%2Fj.stem.2010.06.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Takayama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">May, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, R. G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herz, J.</span><span> </span><span class="NLM_article-title">Low density lipoprotein receptor-related Protein 1 (LRP1) controls endocytosis and c-CBL-mediated ubiquitination of the Platelet-Derived Growth Factor Receptor β (PDGFRβ)</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">18504</span><span class="NLM_x">–</span> <span class="NLM_lpage">18510</span><span class="refDoi"> DOI: 10.1074/jbc.M410265200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1074%2Fjbc.M410265200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=15753096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjsl2htbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=18504-18510&author=Y.+Takayamaauthor=P.+Mayauthor=R.+G.+W.+Andersonauthor=J.+Herz&title=Low+density+lipoprotein+receptor-related+Protein+1+%28LRP1%29+controls+endocytosis+and+c-CBL-mediated+ubiquitination+of+the+Platelet-Derived+Growth+Factor+Receptor+%CE%B2+%28PDGFR%CE%B2%29&doi=10.1074%2Fjbc.M410265200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Low density lipoprotein receptor-related protein 1 (LRP1) controls endocytosis and c-CBL-mediated ubiquitination of the platelet-derived growth factor receptor β (PDGFRβ)</span></div><div class="casAuthors">Takayama, Yoshiharu; May, Petra; Anderson, Richard G. W.; Herz, Joachim</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">18504-18510</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The low d. lipoprotein receptor-related protein 1 (LRP1) has been implicated in intracellular signaling functions as well as in lipid metab.  Recent in vivo and in vitro studies suggest that LRP1 is a physiol. modulator of the platelet-derived growth factor (PDGF) signaling pathway.  In mouse fibroblasts LRP1 modulates PDGF-BB signaling by controlling endocytosis and ligand-induced down-regulation of the PDGF receptor β (PDGFRβ).  In LRP1-deficient fibroblasts, basal PDGFRβ tyrosine kinase activity was derepressed, and PDGF-BB-induced endocytosis and degrdn. of PDGFRβ were accelerated as compared with control cells.  This was accompanied by rapid uptake of receptor-bound PDGF-BB into the cells and by attenuated ERK activation in response to PDGF-BB stimulation.  Pulse-chase anal. indicated that the steady-state turnover rate of PDGFRβ was also accelerated in LRP-deficient fibroblasts.  The rapid degrdn. of PDGFRβ in the LRP1-deficient fibroblasts was prevented by MG132 and chloroquine.  Furthermore, the assocn. of PDGFRβ with c-Cbl, a ubiquitin E3-ligase, as well as the ligand-induced ubiquitination of PDGFRβ were increased in LRP1-deficient fibroblasts.  The authors show that LRP1 can directly interact with c-Cbl, suggesting a Sprouty-like role for LRP1 in regulating the access of the PDGFRβ to the ubiquitination machinery.  Thus, LRP1 modulates PDGF signaling by controlling ubiquitination and endocytosis of the PDGFRβ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfC4lhmJd4DbVg90H21EOLACvtfcHk0lion8lcN3XiuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjsl2htbg%253D&md5=74e4d0e145e97e37c746a77a98cb8512</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M410265200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M410265200%26sid%3Dliteratum%253Aachs%26aulast%3DTakayama%26aufirst%3DY.%26aulast%3DMay%26aufirst%3DP.%26aulast%3DAnderson%26aufirst%3DR.%2BG.%2BW.%26aulast%3DHerz%26aufirst%3DJ.%26atitle%3DLow%2520density%2520lipoprotein%2520receptor-related%2520Protein%25201%2520%2528LRP1%2529%2520controls%2520endocytosis%2520and%2520c-CBL-mediated%2520ubiquitination%2520of%2520the%2520Platelet-Derived%2520Growth%2520Factor%2520Receptor%2520%25CE%25B2%2520%2528PDGFR%25CE%25B2%2529%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D18504%26epage%3D18510%26doi%3D10.1074%2Fjbc.M410265200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Holgren, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dougherty, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerasi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fichera, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bissonnette, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khare, S.</span><span> </span><span class="NLM_article-title">Sprouty-2 controls c-Met expression and metastatic potential of colon cancer cells: sprouty/c-Met upregulation in human colonic adenocarcinomas</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">5241</span><span class="NLM_x">–</span> <span class="NLM_lpage">5253</span><span class="refDoi"> DOI: 10.1038/onc.2010.264</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1038%2Fonc.2010.264" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2010&pages=5241-5253&author=C.+Holgrenauthor=U.+Doughertyauthor=F.+Edwinauthor=D.+Cerasiauthor=I.+Taylorauthor=A.+Ficheraauthor=L.+Josephauthor=M.+Bissonnetteauthor=S.+Khare&title=Sprouty-2+controls+c-Met+expression+and+metastatic+potential+of+colon+cancer+cells%3A+sprouty%2Fc-Met+upregulation+in+human+colonic+adenocarcinomas&doi=10.1038%2Fonc.2010.264"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fonc.2010.264&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2010.264%26sid%3Dliteratum%253Aachs%26aulast%3DHolgren%26aufirst%3DC.%26aulast%3DDougherty%26aufirst%3DU.%26aulast%3DEdwin%26aufirst%3DF.%26aulast%3DCerasi%26aufirst%3DD.%26aulast%3DTaylor%26aufirst%3DI.%26aulast%3DFichera%26aufirst%3DA.%26aulast%3DJoseph%26aufirst%3DL.%26aulast%3DBissonnette%26aufirst%3DM.%26aulast%3DKhare%26aufirst%3DS.%26atitle%3DSprouty-2%2520controls%2520c-Met%2520expression%2520and%2520metastatic%2520potential%2520of%2520colon%2520cancer%2520cells%253A%2520sprouty%252Fc-Met%2520upregulation%2520in%2520human%2520colonic%2520adenocarcinomas%26jtitle%3DOncogene%26date%3D2010%26volume%3D29%26spage%3D5241%26epage%3D5253%26doi%3D10.1038%2Fonc.2010.264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Dominguez, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, Y.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weatheritt, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blencowe, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span> </span><span class="NLM_article-title">An extensive program of periodic alternative splicing linked to cell cycle progression</span> <span class="citation_source-journal">eLife</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">e10288</span><span class="refDoi"> DOI: 10.7554/eLife.10288</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.7554%2FeLife.10288" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2016&pages=e10288&author=D.+Dominguezauthor=Y.-H.+Tsaiauthor=R.+Weatherittauthor=Y.+Wangauthor=B.+J.+Blencoweauthor=Z.+Wang&title=An+extensive+program+of+periodic+alternative+splicing+linked+to+cell+cycle+progression&doi=10.7554%2FeLife.10288"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.7554%2FeLife.10288&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7554%252FeLife.10288%26sid%3Dliteratum%253Aachs%26aulast%3DDominguez%26aufirst%3DD.%26aulast%3DTsai%26aufirst%3DY.-H.%26aulast%3DWeatheritt%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DBlencowe%26aufirst%3DB.%2BJ.%26aulast%3DWang%26aufirst%3DZ.%26atitle%3DAn%2520extensive%2520program%2520of%2520periodic%2520alternative%2520splicing%2520linked%2520to%2520cell%2520cycle%2520progression%26jtitle%3DeLife%26date%3D2016%26volume%3D5%26spage%3De10288%26doi%3D10.7554%2FeLife.10288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Salton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misteli, T.</span><span> </span><span class="NLM_article-title">Small molecule modulators of pre-mRNA splicing in cancer therapy</span> <span class="citation_source-journal">Trends Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">28</span><span class="NLM_x">–</span> <span class="NLM_lpage">37</span><span class="refDoi"> DOI: 10.1016/j.molmed.2015.11.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1016%2Fj.molmed.2015.11.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=26700537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFGitr%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2016&pages=28-37&author=M.+Saltonauthor=T.+Misteli&title=Small+molecule+modulators+of+pre-mRNA+splicing+in+cancer+therapy&doi=10.1016%2Fj.molmed.2015.11.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule Modulators of Pre-mRNA Splicing in Cancer Therapy</span></div><div class="casAuthors">Salton, Maayan; Misteli, Tom</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Molecular Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">28-37</span>CODEN:
                <span class="NLM_cas:coden">TMMRCY</span>;
        ISSN:<span class="NLM_cas:issn">1471-4914</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Pre-mRNA splicing is a fundamental process in mammalian gene expression and alternative RNA splicing plays a considerable role in generating protein diversity.  RNA splicing events are also key to the pathol. of numerous diseases, particularly cancers.  Some tumors are molecularly addicted to specific RNA splicing isoforms making interference with pre-mRNA processing a viable therapeutic strategy.  Several RNA splicing modulators have recently been characterized, some showing promise in preclin. studies.  While the targets of most splicing modulators are constitutive RNA processing components, possibly leading to undesirable side effects, selectivity for individual splicing events has been obsd.  Given the high prevalence of splicing defects in cancer, small mol. modulators of RNA processing represent a potentially promising novel therapeutic strategy in cancer treatment.  Here, we review their reported effects, mechanisms, and limitations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeM5XnpAvEVLVg90H21EOLACvtfcHk0lion8lcN3XiuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFGitr%252FK&md5=b1c76eb9e583e3e1da2e2c5918a020d7</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.molmed.2015.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmed.2015.11.005%26sid%3Dliteratum%253Aachs%26aulast%3DSalton%26aufirst%3DM.%26aulast%3DMisteli%26aufirst%3DT.%26atitle%3DSmall%2520molecule%2520modulators%2520of%2520pre-mRNA%2520splicing%2520in%2520cancer%2520therapy%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2016%26volume%3D22%26spage%3D28%26epage%3D37%26doi%3D10.1016%2Fj.molmed.2015.11.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Becker, W.</span><span> </span><span class="NLM_article-title">Emerging role of DYRK family protein kinases as regulators of protein stability in cell cycle control</span> <span class="citation_source-journal">Cell Cycle</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">3389</span><span class="NLM_x">–</span> <span class="NLM_lpage">3394</span><span class="refDoi"> DOI: 10.4161/cc.21404</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.4161%2Fcc.21404" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=22918246" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BC3sXovVCqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=3389-3394&author=W.+Becker&title=Emerging+role+of+DYRK+family+protein+kinases+as+regulators+of+protein+stability+in+cell+cycle+control&doi=10.4161%2Fcc.21404"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging role of DYRK family protein kinases as regulators of protein stability in cell cycle control</span></div><div class="casAuthors">Becker, Walter</div><div class="citationInfo"><span class="NLM_cas:title">Cell Cycle</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">3389-3394</span>CODEN:
                <span class="NLM_cas:coden">CCEYAS</span>;
        ISSN:<span class="NLM_cas:issn">1538-4101</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">A review.  Dual-specificity tyrosine phosphorylation-regulated kinases (DYRKs) constitute an evolutionarily conserved family of protein kinases with key roles in the control of cell proliferation and differentiation.  Members of the DYRK family phosphorylate many substrates, including crit. regulators of the cell cycle.  A recent report revealed that human DYRK2 actas as a neg. regulator of G1/S transition by phosphorylating c-Jun and c-Myc, thereby inducing ubiquitination-mediated degrdn.  Other DYRKs also function as cell cycle regulators by modulating the turnover of their target proteins.  DYRK1B can induce reversible cell arrest in a quiescent G0 state by targeting cyclin D1 for proteasomal degrdn. and stabilizing p27Kip1.  The DYRK2 ortholog of C. elegans, MBK-2, triggers the proteasomal destruction of oocyte proteins after meiosis to allow the mitotic divisions in embryo development.  This review summarizes the accumulating results that provide evidence for a general role of DYRKs in the regulation of protein stability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPnd37_01t3rVg90H21EOLACvtfcHk0lgRtHTKjPoTrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXovVCqug%253D%253D&md5=df11959806a3cd7029023b270f74800f</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.4161%2Fcc.21404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcc.21404%26sid%3Dliteratum%253Aachs%26aulast%3DBecker%26aufirst%3DW.%26atitle%3DEmerging%2520role%2520of%2520DYRK%2520family%2520protein%2520kinases%2520as%2520regulators%2520of%2520protein%2520stability%2520in%2520cell%2520cycle%2520control%26jtitle%3DCell%2520Cycle%26date%3D2012%26volume%3D11%26spage%3D3389%26epage%3D3394%26doi%3D10.4161%2Fcc.21404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Gruber, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutzinger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmer, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parigger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sternberg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cegielkowski, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaja, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leban, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamm, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitt, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aberger, F.</span><span> </span><span class="NLM_article-title">DYRK1B as therapeutic target in Hedgehog/GLI-dependent cancer cells with Smoothened inhibitor resistance</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">7134</span><span class="NLM_x">–</span> <span class="NLM_lpage">7148</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=7134-7148&author=W.+Gruberauthor=M.+Hutzingerauthor=D.+P.+Elmerauthor=T.+Pariggerauthor=C.+Sternbergauthor=L.+Cegielkowskiauthor=M.+Zajaauthor=J.+Lebanauthor=S.+Michelauthor=S.+Hammauthor=D.+Vittauthor=F.+Aberger&title=DYRK1B+as+therapeutic+target+in+Hedgehog%2FGLI-dependent+cancer+cells+with+Smoothened+inhibitor+resistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGruber%26aufirst%3DW.%26aulast%3DHutzinger%26aufirst%3DM.%26aulast%3DElmer%26aufirst%3DD.%2BP.%26aulast%3DParigger%26aufirst%3DT.%26aulast%3DSternberg%26aufirst%3DC.%26aulast%3DCegielkowski%26aufirst%3DL.%26aulast%3DZaja%26aufirst%3DM.%26aulast%3DLeban%26aufirst%3DJ.%26aulast%3DMichel%26aufirst%3DS.%26aulast%3DHamm%26aufirst%3DS.%26aulast%3DVitt%26aufirst%3DD.%26aulast%3DAberger%26aufirst%3DF.%26atitle%3DDYRK1B%2520as%2520therapeutic%2520target%2520in%2520Hedgehog%252FGLI-dependent%2520cancer%2520cells%2520with%2520Smoothened%2520inhibitor%2520resistance%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D7134%26epage%3D7148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Kettle, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballard, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardelle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cockerill, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colclough, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Critchlow, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debreczeni, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairley, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fillery, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodwin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guichard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittaker, D.</span><span> </span><span class="NLM_article-title">Discovery and optimization of a novel series of Dyrk1B kinase inhibitors to explore a MEK resistance hypothesis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">2834</span><span class="NLM_x">–</span> <span class="NLM_lpage">2844</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00098</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00098" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjslemt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2834-2844&author=J.+G.+Kettleauthor=P.+Ballardauthor=C.+Bardelleauthor=M.+Cockerillauthor=N.+Colcloughauthor=S.+E.+Critchlowauthor=J.+Debreczeniauthor=G.+Fairleyauthor=S.+Filleryauthor=M.+A.+Grahamauthor=L.+Goodwinauthor=S.+Guichardauthor=K.+Hudsonauthor=R.+A.+Wardauthor=D.+Whittaker&title=Discovery+and+optimization+of+a+novel+series+of+Dyrk1B+kinase+inhibitors+to+explore+a+MEK+resistance+hypothesis&doi=10.1021%2Facs.jmedchem.5b00098"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and optimization of a novel series of Dyrk1B kinase inhibitors to explore a MEK resistance hypothesis</span></div><div class="casAuthors">Kettle, Jason G.; Ballard, Peter; Bardelle, Catherine; Cockerill, Mark; Colclough, Nicola; Critchlow, Susan E.; Debreczeni, Judit; Fairley, Gary; Fillery, Shaun; Graham, Mark A.; Goodwin, Louise; Guichard, Sylvie; Hudson, Kevin; Ward, Richard A.; Whittaker, David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2834-2844</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Potent and selective inhibitors of Dyrk1B kinase were developed to explore the hypothesis, based on siRNA studies, that Dyrk1B may be a resistance mechanism in cells undergoing a stress response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrl6v6NWFBOvbVg90H21EOLACvtfcHk0lgRtHTKjPoTrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjslemt7c%253D&md5=ab45d835413802a8b75f569eea5b7a2b</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00098%26sid%3Dliteratum%253Aachs%26aulast%3DKettle%26aufirst%3DJ.%2BG.%26aulast%3DBallard%26aufirst%3DP.%26aulast%3DBardelle%26aufirst%3DC.%26aulast%3DCockerill%26aufirst%3DM.%26aulast%3DColclough%26aufirst%3DN.%26aulast%3DCritchlow%26aufirst%3DS.%2BE.%26aulast%3DDebreczeni%26aufirst%3DJ.%26aulast%3DFairley%26aufirst%3DG.%26aulast%3DFillery%26aufirst%3DS.%26aulast%3DGraham%26aufirst%3DM.%2BA.%26aulast%3DGoodwin%26aufirst%3DL.%26aulast%3DGuichard%26aufirst%3DS.%26aulast%3DHudson%26aufirst%3DK.%26aulast%3DWard%26aufirst%3DR.%2BA.%26aulast%3DWhittaker%26aufirst%3DD.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520a%2520novel%2520series%2520of%2520Dyrk1B%2520kinase%2520inhibitors%2520to%2520explore%2520a%2520MEK%2520resistance%2520hypothesis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2834%26epage%3D2844%26doi%3D10.1021%2Facs.jmedchem.5b00098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Ewton, D. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilenchik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luk, K.-c.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polonskaia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zipf, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boylan, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, E. A.</span><span> </span><span class="NLM_article-title">Inactivation of Mirk/Dyrk1b kinase targets quiescent pancreatic cancer cells</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2104</span><span class="NLM_x">–</span> <span class="NLM_lpage">2114</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-11-0498</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1158%2F1535-7163.MCT-11-0498" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=21878655" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVeltLfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=2104-2114&author=D.+Z.+Ewtonauthor=J.+Huauthor=M.+Vilenchikauthor=X.+Dengauthor=K.-c.+Lukauthor=A.+Polonskaiaauthor=A.+F.+Hoffmanauthor=K.+Zipfauthor=J.+F.+Boylanauthor=E.+A.+Friedman&title=Inactivation+of+Mirk%2FDyrk1b+kinase+targets+quiescent+pancreatic+cancer+cells&doi=10.1158%2F1535-7163.MCT-11-0498"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Inactivation of Mirk/Dyrk1b Kinase Targets Quiescent Pancreatic Cancer Cells</span></div><div class="casAuthors">Ewton, Daina Z.; Hu, Jing; Vilenchik, Maria; Deng, Xiaobing; Luk, Kin-chun; Polonskaia, Ann; Hoffman, Ann F.; Zipf, Karen; Boylan, John F.; Friedman, Eileen A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2104-2114</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A major problem in the treatment of cancer arises from quiescent cancer cells that are relatively insensitive to most chemotherapeutic drugs and radiation.  Such residual cancer cells can cause tumor regrowth or recurrence when they reenter the cell cycle.  Earlier studies showed that levels of the serine/theronine kinase Mirk/dyrk1B are elevated up to 10-fold in quiescent G0 tumor cells.  Mirk uses several mechanisms to block cell cycling, and Mirk increases expression of antioxidant genes that decrease reactive oxygen species (ROS) levels and increase quiescent cell viability.  We now show that a novel small mol. Mirk kinase inhibitor blocked tumor cells from undergoing reversible arrest in a quiescent G0 state and enabled some cells to exit quiescence.  The inhibitor increased cycling in Panc1, AsPc1, and SW620 cells that expressed Mirk, but not in HCT116 cells that did not.  Mirk kinase inhibition elevated ROS levels and DNA damage detected by increased phosphorylation of the histone protein H2AX and by S-phase checkpoints.  The Mirk kinase inhibitor increased cleavage of the apoptotic proteins PARP and caspase 3, and increased tumor cell kill several-fold by gemcitabine and cisplatin.  A phenocopy of these effects occurred following Mirk depletion, showing drug specificity.  In previous studies Mirk knockout or depletion had no detectable effect on normal tissue, suggesting that the Mirk kinase inhibitor could have a selective effect on cancer cells expressing elevated levels of Mirk kinase.  Mol Cancer Ther; 10(11); 2104-14.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGricFZy7ipPf7Vg90H21EOLACvtfcHk0lgRtHTKjPoTrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVeltLfO&md5=cac5215a69d1b7f72e4a6e564f8acc35</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-11-0498&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-11-0498%26sid%3Dliteratum%253Aachs%26aulast%3DEwton%26aufirst%3DD.%2BZ.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DVilenchik%26aufirst%3DM.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DLuk%26aufirst%3DK.-c.%26aulast%3DPolonskaia%26aufirst%3DA.%26aulast%3DHoffman%26aufirst%3DA.%2BF.%26aulast%3DZipf%26aufirst%3DK.%26aulast%3DBoylan%26aufirst%3DJ.%2BF.%26aulast%3DFriedman%26aufirst%3DE.%2BA.%26atitle%3DInactivation%2520of%2520Mirk%252FDyrk1b%2520kinase%2520targets%2520quiescent%2520pancreatic%2520cancer%2520cells%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2011%26volume%3D10%26spage%3D2104%26epage%3D2114%26doi%3D10.1158%2F1535-7163.MCT-11-0498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Ori-McKenney, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKenney</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hector, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meltzer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jan, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vale, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiita, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jan, Y. N.</span><span> </span><span class="NLM_article-title">Phosphorylation of β-tubulin by the Down syndrome kinase, Minibrain/DYRK1a, regulates microtubule dynamics and dendrite morphogenesis</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">551</span><span class="NLM_x">–</span> <span class="NLM_lpage">563</span><span class="refDoi"> DOI: 10.1016/j.neuron.2016.03.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1016%2Fj.neuron.2016.03.027" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2016&pages=551-563&author=K.+M.+Ori-McKenneyauthor=+McKenneyauthor=J.+Richardauthor=+Huangauthor=H.+Hectorauthor=T.+Liauthor=S.+Meltzerauthor=L.+Y.+Janauthor=R.+D.+Valeauthor=A.+P.+Wiitaauthor=Y.+N.+Jan&title=Phosphorylation+of+%CE%B2-tubulin+by+the+Down+syndrome+kinase%2C+Minibrain%2FDYRK1a%2C+regulates+microtubule+dynamics+and+dendrite+morphogenesis&doi=10.1016%2Fj.neuron.2016.03.027"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2016.03.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2016.03.027%26sid%3Dliteratum%253Aachs%26aulast%3DOri-McKenney%26aufirst%3DK.%2BM.%26aulast%3DMcKenney%26aulast%3DRichard%26aufirst%3DJ.%26aulast%3DHuang%26aulast%3DHector%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DMeltzer%26aufirst%3DS.%26aulast%3DJan%26aufirst%3DL.%2BY.%26aulast%3DVale%26aufirst%3DR.%2BD.%26aulast%3DWiita%26aufirst%3DA.%2BP.%26aulast%3DJan%26aufirst%3DY.%2BN.%26atitle%3DPhosphorylation%2520of%2520%25CE%25B2-tubulin%2520by%2520the%2520Down%2520syndrome%2520kinase%252C%2520Minibrain%252FDYRK1a%252C%2520regulates%2520microtubule%2520dynamics%2520and%2520dendrite%2520morphogenesis%26jtitle%3DNeuron%26date%3D2016%26volume%3D90%26spage%3D551%26epage%3D563%26doi%3D10.1016%2Fj.neuron.2016.03.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Etienne-Manneville, S.</span><span> </span><span class="NLM_article-title">Actin and microtubules in cell motility: which one is in control?</span> <span class="citation_source-journal">Traffic</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">470</span><span class="NLM_x">–</span> <span class="NLM_lpage">477</span><span class="refDoi"> DOI: 10.1111/j.1600-0854.2004.00196.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1111%2Fj.1600-0854.2004.00196.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=470-477&author=S.+Etienne-Manneville&title=Actin+and+microtubules+in+cell+motility%3A+which+one+is+in+control%3F&doi=10.1111%2Fj.1600-0854.2004.00196.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-0854.2004.00196.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-0854.2004.00196.x%26sid%3Dliteratum%253Aachs%26aulast%3DEtienne-Manneville%26aufirst%3DS.%26atitle%3DActin%2520and%2520microtubules%2520in%2520cell%2520motility%253A%2520which%2520one%2520is%2520in%2520control%253F%26jtitle%3DTraffic%26date%3D2004%26volume%3D5%26spage%3D470%26epage%3D477%26doi%3D10.1111%2Fj.1600-0854.2004.00196.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Schneider, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miguel Bayo-Fina, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar Dhanyamraju, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baier, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fendrich, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramaswamy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumeister, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lauth, M.</span><span> </span><span class="NLM_article-title">Identification of a novel actin-dependent signal transducing module allows for the targeted degradation of GLI1</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">8023</span><span class="refDoi"> DOI: 10.1038/ncomms9023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1038%2Fncomms9023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=26310823" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVKhu77P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=8023&author=P.+Schneiderauthor=J.+Miguel+Bayo-Finaauthor=R.+Singhauthor=P.+Kumar+Dhanyamrajuauthor=P.+Holzauthor=A.+Baierauthor=V.+Fendrichauthor=A.+Ramaswamyauthor=S.+Baumeisterauthor=E.+D.+Martinezauthor=M.+Lauth&title=Identification+of+a+novel+actin-dependent+signal+transducing+module+allows+for+the+targeted+degradation+of+GLI1&doi=10.1038%2Fncomms9023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a novel actin-dependent signal transducing module allows for the targeted degradation of GLI1</span></div><div class="casAuthors">Schneider, Philipp; Miguel Bayo-Fina, Juan; Singh, Rajeev; Kumar Dhanyamraju, Pavan; Holz, Philipp; Baier, Aninja; Fendrich, Volker; Ramaswamy, Annette; Baumeister, Stefan; Martinez, Elisabeth D.; Lauth, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">8023</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The Down syndrome-assocd. DYRK1A kinase has been reported as a stimulator of the developmentally important Hedgehog (Hh) pathway, but cells from Down syndrome patients paradoxically display reduced Hh signalling activity.  Here we find that DYRK1A stimulates GLI transcription factor activity through phosphorylation of general nuclear localization clusters.  In contrast, in vivo and in vitro expts. reveal that DYRK1A kinase can also function as an inhibitor of endogenous Hh signalling by neg. regulating ABLIM proteins, the actin cytoskeleton and the transcriptional co-activator MKL1 (MAL).  As a final effector of the DYRK1A-ABLIM-actin-MKL1 sequence, we identify the MKL1 interactor Jumonji domain demethylase 1A (JMJD1A) as a novel Hh pathway component stabilizing the GLI1 protein in a demethylase-independent manner.  Furthermore, a Jumonji-specific small-mol. antagonist represents a novel and powerful inhibitor of Hh signal transduction by inducing GLI1 protein degrdn. in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0fhhTVI3NPrVg90H21EOLACvtfcHk0li36QU1JzgHZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVKhu77P&md5=2d1cd606db85133bde46a1818098711f</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1038%2Fncomms9023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms9023%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DP.%26aulast%3DMiguel%2BBayo-Fina%26aufirst%3DJ.%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DKumar%2BDhanyamraju%26aufirst%3DP.%26aulast%3DHolz%26aufirst%3DP.%26aulast%3DBaier%26aufirst%3DA.%26aulast%3DFendrich%26aufirst%3DV.%26aulast%3DRamaswamy%26aufirst%3DA.%26aulast%3DBaumeister%26aufirst%3DS.%26aulast%3DMartinez%26aufirst%3DE.%2BD.%26aulast%3DLauth%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520a%2520novel%2520actin-dependent%2520signal%2520transducing%2520module%2520allows%2520for%2520the%2520targeted%2520degradation%2520of%2520GLI1%26jtitle%3DNat.%2520Commun.%26date%3D2015%26volume%3D6%26spage%3D8023%26doi%3D10.1038%2Fncomms9023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Hong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seo, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, S.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, S.</span><span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of 3,5-disubstituted 7-azaindoles as Trk inhibitors with anticancer and antiangiogenic activities</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">5337</span><span class="NLM_x">–</span> <span class="NLM_lpage">5349</span><span class="refDoi"> DOI: 10.1021/jm3002982</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3002982" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5337-5349&author=S.+Hongauthor=J.+Kimauthor=J.+H.+Seoauthor=K.+H.+Jungauthor=S.-S.+Hongauthor=S.+Hong&title=Design%2C+synthesis%2C+and+evaluation+of+3%2C5-disubstituted+7-azaindoles+as+Trk+inhibitors+with+anticancer+and+antiangiogenic+activities&doi=10.1021%2Fjm3002982"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm3002982&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3002982%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DSeo%26aufirst%3DJ.%2BH.%26aulast%3DJung%26aufirst%3DK.%2BH.%26aulast%3DHong%26aufirst%3DS.-S.%26aulast%3DHong%26aufirst%3DS.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%25203%252C5-disubstituted%25207-azaindoles%2520as%2520Trk%2520inhibitors%2520with%2520anticancer%2520and%2520antiangiogenic%2520activities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D5337%26epage%3D5349%26doi%3D10.1021%2Fjm3002982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Goodfellow, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loweth, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravula, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiemann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Todd, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheppard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollack, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polesskaya, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marker, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewhurst, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelbard, H. A.</span><span> </span><span class="NLM_article-title">Discovery, synthesis, and characterization of an orally bioavailable, brain penetrant inhibitor of mixed lineage kinase 3</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">8032</span><span class="NLM_x">–</span> <span class="NLM_lpage">8048</span><span class="refDoi"> DOI: 10.1021/jm401094t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401094t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVGjtrfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=8032-8048&author=V.+S.+Goodfellowauthor=C.+J.+Lowethauthor=S.+B.+Ravulaauthor=T.+Wiemannauthor=T.+Nguyenauthor=Y.+Xuauthor=D.+E.+Toddauthor=D.+Sheppardauthor=S.+Pollackauthor=O.+Polesskayaauthor=D.+F.+Markerauthor=S.+Dewhurstauthor=H.+A.+Gelbard&title=Discovery%2C+synthesis%2C+and+characterization+of+an+orally+bioavailable%2C+brain+penetrant+inhibitor+of+mixed+lineage+kinase+3&doi=10.1021%2Fjm401094t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery, Synthesis, and Characterization of an Orally Bioavailable, Brain Penetrant Inhibitor of Mixed Lineage Kinase 3</span></div><div class="casAuthors">Goodfellow, Val S.; Loweth, Colin J.; Ravula, Satheesh B.; Wiemann, Torsten; Nguyen, Thong; Xu, Yang; Todd, Daniel E.; Sheppard, David; Pollack, Scott; Polesskaya, Oksana; Marker, Daniel F.; Dewhurst, Stephen; Gelbard, Harris A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8032-8048</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibition of mixed lineage kinase 3 (MLK3) is a potential strategy for treatment of Parkinson's disease and HIV-1 assocd. neurocognitive disorders (HAND), requiring an inhibitor that can achieve significant brain concn. levels.  We report here URMC-099 (1) an orally bioavailable (F = 41%), potent (IC50 = 14 nM) MLK3 inhibitor with excellent brain exposure in mouse PK models and minimal interference with key human CYP450 enzymes or hERG channels.  The compd. inhibits LPS-induced TNFα release in microglial cells, HIV-1 Tat-induced release of cytokines in human monocytes and up-regulation of phospho-JNK in Tat-injected brains of mice.  Compd. 1 likely functions in HAND preclin. models by inhibiting multiple kinase pathways, including MLK3 and LRRK2 (IC50 = 11 nM).  We compare the kinase specificity and BBB penetration of 1 with CEP-1347 (2).  Compd. 1 is well tolerated, with excellent in vivo activity in HAND models, and is under investigation for further development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosmrog4axXu7Vg90H21EOLACvtfcHk0lj3y0EhPvAAkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVGjtrfK&md5=53cb667f098b4de13a3a96b92cd546bf</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm401094t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401094t%26sid%3Dliteratum%253Aachs%26aulast%3DGoodfellow%26aufirst%3DV.%2BS.%26aulast%3DLoweth%26aufirst%3DC.%2BJ.%26aulast%3DRavula%26aufirst%3DS.%2BB.%26aulast%3DWiemann%26aufirst%3DT.%26aulast%3DNguyen%26aufirst%3DT.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DTodd%26aufirst%3DD.%2BE.%26aulast%3DSheppard%26aufirst%3DD.%26aulast%3DPollack%26aufirst%3DS.%26aulast%3DPolesskaya%26aufirst%3DO.%26aulast%3DMarker%26aufirst%3DD.%2BF.%26aulast%3DDewhurst%26aufirst%3DS.%26aulast%3DGelbard%26aufirst%3DH.%2BA.%26atitle%3DDiscovery%252C%2520synthesis%252C%2520and%2520characterization%2520of%2520an%2520orally%2520bioavailable%252C%2520brain%2520penetrant%2520inhibitor%2520of%2520mixed%2520lineage%2520kinase%25203%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D8032%26epage%3D8048%26doi%3D10.1021%2Fjm401094t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Himo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovell, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilgraf, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rostovtsev, V. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noodleman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharpless, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fokin, V. V.</span><span> </span><span class="NLM_article-title">Copper(I)-catalyzed synthesis of azoles. DFT study predicts unprecedented reactivity and intermediates</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">210</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span><span class="refDoi"> DOI: 10.1021/ja0471525</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja0471525" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVKrsrfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2005&pages=210-216&author=F.+Himoauthor=T.+Lovellauthor=R.+Hilgrafauthor=V.+V.+Rostovtsevauthor=L.+Noodlemanauthor=K.+B.+Sharplessauthor=V.+V.+Fokin&title=Copper%28I%29-catalyzed+synthesis+of+azoles.+DFT+study+predicts+unprecedented+reactivity+and+intermediates&doi=10.1021%2Fja0471525"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Copper(I)-Catalyzed Synthesis of Azoles. DFT Study Predicts Unprecedented Reactivity and Intermediates</span></div><div class="casAuthors">Himo, Fahmi; Lovell, Timothy; Hilgraf, Robert; Rostovtsev, Vsevolod V.; Noodleman, Louis; Sharpless, K. Barry; Fokin, Valery V.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">210-216</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Huisgen's 1,3-dipolar cycloaddns. become nonconcerted when copper(I) acetylides react with azides and nitrile oxides, providing ready access to 1,4-disubstituted 1,2,3-triazoles and 3,4-disubstituted isoxazoles, resp.  The process is highly reliable and exhibits an unusually wide scope with respect to both components.  Computational studies revealed a stepwise mechanism involving unprecedented metallacycle intermediates, which appear to be common for a variety of dipoles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAVy1fcwAvN7Vg90H21EOLACvtfcHk0lj3y0EhPvAAkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVKrsrfO&md5=74d02d60dd00f8f4221bd47da3d6f514</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fja0471525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0471525%26sid%3Dliteratum%253Aachs%26aulast%3DHimo%26aufirst%3DF.%26aulast%3DLovell%26aufirst%3DT.%26aulast%3DHilgraf%26aufirst%3DR.%26aulast%3DRostovtsev%26aufirst%3DV.%2BV.%26aulast%3DNoodleman%26aufirst%3DL.%26aulast%3DSharpless%26aufirst%3DK.%2BB.%26aulast%3DFokin%26aufirst%3DV.%2BV.%26atitle%3DCopper%2528I%2529-catalyzed%2520synthesis%2520of%2520azoles.%2520DFT%2520study%2520predicts%2520unprecedented%2520reactivity%2520and%2520intermediates%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2005%26volume%3D127%26spage%3D210%26epage%3D216%26doi%3D10.1021%2Fja0471525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Halasz, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biljan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novak, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meštrović, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plavec, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mali, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smrečki, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vančik, H.</span><span> </span><span class="NLM_article-title">Cross-dimerization of nitrosobenzenes in solution and in solid state</span> <span class="citation_source-journal">J. Mol. Struct.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">918</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span><span class="refDoi"> DOI: 10.1016/j.molstruc.2008.07.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1016%2Fj.molstruc.2008.07.035" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=918&publication_year=2009&pages=19-25&author=I.+Halaszauthor=I.+Biljanauthor=P.+Novakauthor=E.+Me%C5%A1trovi%C4%87author=J.+Plavecauthor=G.+Maliauthor=V.+Smre%C4%8Dkiauthor=H.+Van%C4%8Dik&title=Cross-dimerization+of+nitrosobenzenes+in+solution+and+in+solid+state&doi=10.1016%2Fj.molstruc.2008.07.035"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.molstruc.2008.07.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molstruc.2008.07.035%26sid%3Dliteratum%253Aachs%26aulast%3DHalasz%26aufirst%3DI.%26aulast%3DBiljan%26aufirst%3DI.%26aulast%3DNovak%26aufirst%3DP.%26aulast%3DMe%25C5%25A1trovi%25C4%2587%26aufirst%3DE.%26aulast%3DPlavec%26aufirst%3DJ.%26aulast%3DMali%26aufirst%3DG.%26aulast%3DSmre%25C4%258Dki%26aufirst%3DV.%26aulast%3DVan%25C4%258Dik%26aufirst%3DH.%26atitle%3DCross-dimerization%2520of%2520nitrosobenzenes%2520in%2520solution%2520and%2520in%2520solid%2520state%26jtitle%3DJ.%2520Mol.%2520Struct.%26date%3D2009%26volume%3D918%26spage%3D19%26epage%3D25%26doi%3D10.1016%2Fj.molstruc.2008.07.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Kamal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bharathi, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dastagiri, D.</span><span> </span><span class="NLM_article-title">Base-free monosulfonylation of amines using tosyl or mesyl chloride in water</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">348</span><span class="NLM_x">–</span> <span class="NLM_lpage">353</span><span class="refDoi"> DOI: 10.1016/j.tetlet.2007.11.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1016%2Fj.tetlet.2007.11.044" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2008&pages=348-353&author=A.+Kamalauthor=J.+S.+Reddyauthor=E.+V.+Bharathiauthor=D.+Dastagiri&title=Base-free+monosulfonylation+of+amines+using+tosyl+or+mesyl+chloride+in+water&doi=10.1016%2Fj.tetlet.2007.11.044"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2007.11.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2007.11.044%26sid%3Dliteratum%253Aachs%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DReddy%26aufirst%3DJ.%2BS.%26aulast%3DBharathi%26aufirst%3DE.%2BV.%26aulast%3DDastagiri%26aufirst%3DD.%26atitle%3DBase-free%2520monosulfonylation%2520of%2520amines%2520using%2520tosyl%2520or%2520mesyl%2520chloride%2520in%2520water%26jtitle%3DTetrahedron%2520Lett.%26date%3D2008%26volume%3D49%26spage%3D348%26epage%3D353%26doi%3D10.1016%2Fj.tetlet.2007.11.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Mahajan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhardwaj, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, S.</span><span> </span><span class="NLM_article-title">Selective synthesis of mono-substituted ureas in low melting citric acid-urea-mannitol mixture</span> <span class="citation_source-journal">Org. Prep. Proced. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">463</span><span class="NLM_x">–</span> <span class="NLM_lpage">468</span><span class="refDoi"> DOI: 10.1080/00304948.2014.944408</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1080%2F00304948.2014.944408" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFKrtL3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2014&pages=463-468&author=H.+Mahajanauthor=M.+Bhardwajauthor=S.+Paul&title=Selective+synthesis+of+mono-substituted+ureas+in+low+melting+citric+acid-urea-mannitol+mixture&doi=10.1080%2F00304948.2014.944408"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Synthesis of Mono-substituted Ureas in Low Melting Citric Acid-Urea-Mannitol Mixture</span></div><div class="casAuthors">Mahajan, Hitesh; Bhardwaj, Madhvi; Paul, Satya</div><div class="citationInfo"><span class="NLM_cas:title">Organic Preparations and Procedures International</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">463-468</span>CODEN:
                <span class="NLM_cas:coden">OPPIAK</span>;
        ISSN:<span class="NLM_cas:issn">0030-4948</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A simple and mild solvent free methodol. for the selective synthesis of monoarylureas using a low melting mixt. of Citric acid, Urea and Mannitol at 80° is presented.  The present protocol has several addnl. benefits including the use of renewable and biodegradable materials, mild reaction conditions, facile work-up, higher product yields with high selectivity and most importantly avoiding toxic org. solvents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTa4UG-cCdFbVg90H21EOLACvtfcHk0lj7GU3ELjxCmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFKrtL3I&md5=b9870b13643c28492d1f1e1cb9b5c3c2</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1080%2F00304948.2014.944408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00304948.2014.944408%26sid%3Dliteratum%253Aachs%26aulast%3DMahajan%26aufirst%3DH.%26aulast%3DBhardwaj%26aufirst%3DM.%26aulast%3DPaul%26aufirst%3DS.%26atitle%3DSelective%2520synthesis%2520of%2520mono-substituted%2520ureas%2520in%2520low%2520melting%2520citric%2520acid-urea-mannitol%2520mixture%26jtitle%3DOrg.%2520Prep.%2520Proced.%2520Int.%26date%3D2014%26volume%3D46%26spage%3D463%26epage%3D468%26doi%3D10.1080%2F00304948.2014.944408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Gadakh, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chikanna, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rindhe, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karale, B. K.</span><span> </span><span class="NLM_article-title">Heteroaryl hydroxycarbonylation: an efficient, robust, practically scalable approach using formyl acetate as the CO Source</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">658</span><span class="NLM_x">–</span> <span class="NLM_lpage">666</span><span class="refDoi"> DOI: 10.1080/00397911.2010.528851</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1080%2F00397911.2010.528851" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BC38XkslWisro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2012&pages=658-666&author=A.+V.+Gadakhauthor=D.+Chikannaauthor=S.+S.+Rindheauthor=B.+K.+Karale&title=Heteroaryl+hydroxycarbonylation%3A+an+efficient%2C+robust%2C+practically+scalable+approach+using+formyl+acetate+as+the+CO+Source&doi=10.1080%2F00397911.2010.528851"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Heteroaryl Hydroxycarbonylation: An Efficient, Robust, Practically Scalable Approach Using Formyl Acetate as the CO Source</span></div><div class="casAuthors">Gadakh, Amol V.; Chikanna, Dinesh; Rindhe, Sahebrao S.; Karale, Bhausaheb K.</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">658-666</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">A simple, efficient, regioselective, and scalable palladium-catalyzed hydroxycarbonylation of heteroaryl halides to corresponding carboxylic acids using acetic-formic anhydride in presence of Pd(OAc)2, dppf, and diisopropylethyl amine in DMF at 80-90 °C in excellent yields.  E.g., in presence of Pd(OAc)2, dppf, and AcOCHO, hydroxycarbonylation of 5-bromoindazole gave 95% 1H-indazole-5-carboxylic acid.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0cvI5KOiinLVg90H21EOLACvtfcHk0lj7GU3ELjxCmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkslWisro%253D&md5=47182e5a6869277a527e185cce38f523</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1080%2F00397911.2010.528851&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397911.2010.528851%26sid%3Dliteratum%253Aachs%26aulast%3DGadakh%26aufirst%3DA.%2BV.%26aulast%3DChikanna%26aufirst%3DD.%26aulast%3DRindhe%26aufirst%3DS.%2BS.%26aulast%3DKarale%26aufirst%3DB.%2BK.%26atitle%3DHeteroaryl%2520hydroxycarbonylation%253A%2520an%2520efficient%252C%2520robust%252C%2520practically%2520scalable%2520approach%2520using%2520formyl%2520acetate%2520as%2520the%2520CO%2520Source%26jtitle%3DSynth.%2520Commun.%26date%3D2012%26volume%3D42%26spage%3D658%26epage%3D666%26doi%3D10.1080%2F00397911.2010.528851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Zhang, L.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hao, X.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, J.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niu, J.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, M.-P.</span><span> </span><span class="NLM_article-title">Cobalt-catalyzed C(sp2)–H alkoxylation of aromatic and olefinic carboxamides</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">272</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span><span class="refDoi"> DOI: 10.1002/anie.201409751</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1002%2Fanie.201409751" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFShu77P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2015&pages=272-275&author=L.-B.+Zhangauthor=X.-Q.+Haoauthor=S.-K.+Zhangauthor=Z.-J.+Liuauthor=X.-X.+Zhengauthor=J.-F.+Gongauthor=J.-L.+Niuauthor=M.-P.+Song&title=Cobalt-catalyzed+C%28sp2%29%E2%80%93H+alkoxylation+of+aromatic+and+olefinic+carboxamides&doi=10.1002%2Fanie.201409751"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Cobalt-Catalyzed C(sp2)-H Alkoxylation of Aromatic and Olefinic Carboxamides</span></div><div class="casAuthors">Zhang, Lin-Bao; Hao, Xin-Qi; Zhang, Shou-Kun; Liu, Zhan-Jiang; Zheng, Xin-Xiang; Gong, Jun-Fang; Niu, Jun-Long; Song, Mao-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">272-275</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The cobalt-catalyzed alkoxylation of C(sp2)-H bonds in arom. and olefinic carboxamides has been developed.  The reaction proceeded under mild conditions in the presence of Co(OAc)2·4H2O as the catalyst and tolerates a wide range of both alcs. and benzamide substrates, including even olefinic carboxamides.  In addn., this reaction is the first example of the direct alkoxylation of alkenes through C-H bond activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqMTC9T_B3o7Vg90H21EOLACvtfcHk0lgvQJ__kaqvGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFShu77P&md5=f1e32003a6a1373e2a1fea7de689fcf6</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1002%2Fanie.201409751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201409751%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.-B.%26aulast%3DHao%26aufirst%3DX.-Q.%26aulast%3DZhang%26aufirst%3DS.-K.%26aulast%3DLiu%26aufirst%3DZ.-J.%26aulast%3DZheng%26aufirst%3DX.-X.%26aulast%3DGong%26aufirst%3DJ.-F.%26aulast%3DNiu%26aufirst%3DJ.-L.%26aulast%3DSong%26aufirst%3DM.-P.%26atitle%3DCobalt-catalyzed%2520C%2528sp2%2529%25E2%2580%2593H%2520alkoxylation%2520of%2520aromatic%2520and%2520olefinic%2520carboxamides%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2015%26volume%3D54%26spage%3D272%26epage%3D275%26doi%3D10.1002%2Fanie.201409751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Zhi-Yong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan-Guang, W.</span><span> </span><span class="NLM_article-title">A mild, efficient and selective cleavage of aryl tert-butyldimethysilyl ethers using KOH in ethanol</span> <span class="citation_source-journal">Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">568</span><span class="NLM_x">–</span> <span class="NLM_lpage">569</span><span class="refDoi"> DOI: 10.1246/cl.2003.568</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1246%2Fcl.2003.568" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2003&pages=568-569&author=J.+Zhi-Yongauthor=W.+Yan-Guang&title=A+mild%2C+efficient+and+selective+cleavage+of+aryl+tert-butyldimethysilyl+ethers+using+KOH+in+ethanol&doi=10.1246%2Fcl.2003.568"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1246%2Fcl.2003.568&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1246%252Fcl.2003.568%26sid%3Dliteratum%253Aachs%26aulast%3DZhi-Yong%26aufirst%3DJ.%26aulast%3DYan-Guang%26aufirst%3DW.%26atitle%3DA%2520mild%252C%2520efficient%2520and%2520selective%2520cleavage%2520of%2520aryl%2520tert-butyldimethysilyl%2520ethers%2520using%2520KOH%2520in%2520ethanol%26jtitle%3DChem.%2520Lett.%26date%3D2003%26volume%3D32%26spage%3D568%26epage%3D569%26doi%3D10.1246%2Fcl.2003.568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Oakdale, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boger, D. L.</span><span> </span><span class="NLM_article-title">Total synthesis of Lycogarubin C and Lycogalic acid</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1132</span><span class="NLM_x">–</span> <span class="NLM_lpage">1134</span><span class="refDoi"> DOI: 10.1021/ol100146b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol100146b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhvFGqu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=1132-1134&author=J.+S.+Oakdaleauthor=D.+L.+Boger&title=Total+synthesis+of+Lycogarubin+C+and+Lycogalic+acid&doi=10.1021%2Fol100146b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Total Synthesis of Lycogarubin C and Lycogalic Acid</span></div><div class="casAuthors">Oakdale, James S.; Boger, Dale L.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1132-1134</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Two complementary concise total syntheses of lycogarubin C (I) and lycogalic acid (II, aka chromopyrrolic acid) are detailed utilizing a 1,2,4,5-tetrazine → 1,2-diazine → pyrrole Diels-Alder strategy and enlisting acetylenic dienophiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_HS0RerHxzrVg90H21EOLACvtfcHk0lgvQJ__kaqvGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhvFGqu70%253D&md5=f04965ef4eab5fcf9c17432b82aea282</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fol100146b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol100146b%26sid%3Dliteratum%253Aachs%26aulast%3DOakdale%26aufirst%3DJ.%2BS.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26atitle%3DTotal%2520synthesis%2520of%2520Lycogarubin%2520C%2520and%2520Lycogalic%2520acid%26jtitle%3DOrg.%2520Lett.%26date%3D2010%26volume%3D12%26spage%3D1132%26epage%3D1134%26doi%3D10.1021%2Fol100146b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Harrington, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourbeau, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fotsch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frohn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickrell, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichelt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sham, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegmund, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailis, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Escobar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orf, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">San Miguel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zalameda, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, J. G.</span><span> </span><span class="NLM_article-title">The optimization of aminooxadiazoles as orally active inhibitors of Cdc7</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">6396</span><span class="NLM_x">–</span> <span class="NLM_lpage">6400</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.09.055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1016%2Fj.bmcl.2013.09.055" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=6396-6400&author=P.+E.+Harringtonauthor=M.+P.+Bourbeauauthor=C.+Fotschauthor=M.+Frohnauthor=A.+J.+Pickrellauthor=A.+Reicheltauthor=K.+Shamauthor=A.+C.+Siegmundauthor=J.+M.+Bailisauthor=T.+Bushauthor=S.+Escobarauthor=D.+Hickmanauthor=S.+Hellerauthor=F.+Hsiehauthor=J.+N.+Orfauthor=M.+Rongauthor=T.+San+Miguelauthor=H.+Tanauthor=L.+Zalamedaauthor=J.+G.+Allen&title=The+optimization+of+aminooxadiazoles+as+orally+active+inhibitors+of+Cdc7&doi=10.1016%2Fj.bmcl.2013.09.055"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.09.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.09.055%26sid%3Dliteratum%253Aachs%26aulast%3DHarrington%26aufirst%3DP.%2BE.%26aulast%3DBourbeau%26aufirst%3DM.%2BP.%26aulast%3DFotsch%26aufirst%3DC.%26aulast%3DFrohn%26aufirst%3DM.%26aulast%3DPickrell%26aufirst%3DA.%2BJ.%26aulast%3DReichelt%26aufirst%3DA.%26aulast%3DSham%26aufirst%3DK.%26aulast%3DSiegmund%26aufirst%3DA.%2BC.%26aulast%3DBailis%26aufirst%3DJ.%2BM.%26aulast%3DBush%26aufirst%3DT.%26aulast%3DEscobar%26aufirst%3DS.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DHeller%26aufirst%3DS.%26aulast%3DHsieh%26aufirst%3DF.%26aulast%3DOrf%26aufirst%3DJ.%2BN.%26aulast%3DRong%26aufirst%3DM.%26aulast%3DSan%2BMiguel%26aufirst%3DT.%26aulast%3DTan%26aufirst%3DH.%26aulast%3DZalameda%26aufirst%3DL.%26aulast%3DAllen%26aufirst%3DJ.%2BG.%26atitle%3DThe%2520optimization%2520of%2520aminooxadiazoles%2520as%2520orally%2520active%2520inhibitors%2520of%2520Cdc7%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D6396%26epage%3D6400%26doi%3D10.1016%2Fj.bmcl.2013.09.055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Kishore Kumar, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Natarajan, A.</span><span> </span><span class="NLM_article-title">Total synthesis of ovalifoliolatin B, acerogenins A and C</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">2103</span><span class="NLM_x">–</span> <span class="NLM_lpage">2105</span><span class="refDoi"> DOI: 10.1016/j.tetlet.2008.01.135</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1016%2Fj.tetlet.2008.01.135" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2008&pages=2103-2105&author=G.+D.+Kishore+Kumarauthor=A.+Natarajan&title=Total+synthesis+of+ovalifoliolatin+B%2C+acerogenins+A+and+C&doi=10.1016%2Fj.tetlet.2008.01.135"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2008.01.135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2008.01.135%26sid%3Dliteratum%253Aachs%26aulast%3DKishore%2BKumar%26aufirst%3DG.%2BD.%26aulast%3DNatarajan%26aufirst%3DA.%26atitle%3DTotal%2520synthesis%2520of%2520ovalifoliolatin%2520B%252C%2520acerogenins%2520A%2520and%2520C%26jtitle%3DTetrahedron%2520Lett.%26date%3D2008%26volume%3D49%26spage%3D2103%26epage%3D2105%26doi%3D10.1016%2Fj.tetlet.2008.01.135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Brennan, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhaak, R. G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKenna, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campos, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noushmehr, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salama, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakravarty, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanborn, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berman, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beroukhim, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernard, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genovese, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shmulevich, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnholtz-Sloan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vegesna, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shukla, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciriello, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yung, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sougnez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikkelsen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aldape, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigner, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Meir, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prados, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sloan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eschbacher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finocchiaro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guha, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iacocca, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foltz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weisenberger, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penny, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kucherlapati, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perou, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbs, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marra, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lander, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spellman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sander, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstein, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyerson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabriel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laird, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haussler, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Getz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, L.</span><span> </span><span class="NLM_article-title">The somatic genomic landscape of glioblastoma</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">155</span><span class="NLM_x">, </span> <span class="NLM_fpage">462</span><span class="NLM_x">–</span> <span class="NLM_lpage">477</span><span class="refDoi"> DOI: 10.1016/j.cell.2013.09.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1016%2Fj.cell.2013.09.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=24120142" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1Srtb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=2013&pages=462-477&author=C.+W.+Brennanauthor=R.+G.+W.+Verhaakauthor=A.+McKennaauthor=B.+Camposauthor=H.+Noushmehrauthor=S.+R.+Salamaauthor=S.+Zhengauthor=D.+Chakravartyauthor=J.+Z.+Sanbornauthor=S.+H.+Bermanauthor=R.+Beroukhimauthor=B.+Bernardauthor=C.-J.+Wuauthor=G.+Genoveseauthor=I.+Shmulevichauthor=J.+Barnholtz-Sloanauthor=L.+Zouauthor=R.+Vegesnaauthor=S.+A.+Shuklaauthor=G.+Cirielloauthor=W.+K.+Yungauthor=W.+Zhangauthor=C.+Sougnezauthor=T.+Mikkelsenauthor=K.+Aldapeauthor=D.+D.+Bignerauthor=E.+G.+Van+Meirauthor=M.+Pradosauthor=A.+Sloanauthor=K.+L.+Blackauthor=J.+Eschbacherauthor=G.+Finocchiaroauthor=W.+Friedmanauthor=D.+W.+Andrewsauthor=A.+Guhaauthor=M.+Iacoccaauthor=B.+P.+O%E2%80%99Neillauthor=G.+Foltzauthor=J.+Myersauthor=D.+J.+Weisenbergerauthor=R.+Pennyauthor=R.+Kucherlapatiauthor=C.+M.+Perouauthor=D.+N.+Hayesauthor=R.+Gibbsauthor=M.+Marraauthor=G.+B.+Millsauthor=E.+Landerauthor=P.+Spellmanauthor=R.+Wilsonauthor=C.+Sanderauthor=J.+Weinsteinauthor=M.+Meyersonauthor=S.+Gabrielauthor=P.+W.+Lairdauthor=D.+Hausslerauthor=G.+Getzauthor=L.+Chin&title=The+somatic+genomic+landscape+of+glioblastoma&doi=10.1016%2Fj.cell.2013.09.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">The somatic genomic landscape of glioblastoma</span></div><div class="casAuthors">Brennan, Cameron W.; Verhaak, Roel G. W.; McKenna, Aaron; Campos, Benito; Noushmehr, Houtan; Salama, Sofie R.; Zheng, Siyuan; Chakravarty, Debyani; Sanborn, J. Zachary; Berman, Samuel H.; Beroukhim, Rameen; Bernard, Brady; Wu, Chang-Jiun; Genovese, Giannicola; Shmulevich, Ilya; Barnholtz-Sloan, Jill; Zou, Lihua; Vegesna, Rahulsimham; Shukla, Sachet A.; Ciriello, Giovanni; Yung, W. K.; Zhang, Wei; Sougnez, Carrie; Mikkelsen, Tom; Aldape, Kenneth; Bigner, Darell D.; Van Meir, Erwin G.; Prados, Michael; Sloan, Andrew; Black, Keith L.; Eschbacher, Jennifer; Finocchiaro, Gaetano; Friedman, William; Andrews, David W.; Guha, Abhijit; Iacocca, Mary; O'Neill, Brian P.; Foltz, Greg; Myers, Jerome; Weisenberger, Daniel J.; Penny, Robert; Kucherlapati, Raju; Perou, Charles M.; Hayes, D. Neil; Gibbs, Richard; Marra, Marco; Mills, Gordon B.; Lander, Eric; Spellman, Paul; Wilson, Richard; Sander, Chris; Weinstein, John; Meyerson, Matthew; Gabriel, Stacey; Laird, Peter W.; Haussler, David; Getz, Gad; Chin, Lynda</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">155</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">462-477</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">We describe the landscape of somatic genomic alterations based on multidimensional and comprehensive characterization of more than 500 glioblastoma tumors (GBMs).  We identify several novel mutated genes as well as complex rearrangements of signature receptors, including EGFR and PDGFRA.  TERT promoter mutations are shown to correlate with elevated mRNA expression, supporting a role in telomerase reactivation.  Correlative analyses confirm that the survival advantage of the proneural subtype is conferred by the G-CIMP phenotype, and MGMT DNA methylation may be a predictive biomarker for treatment response only in classical subtype GBM.  Integrative anal. of genomic and proteomic profiles challenges the notion of therapeutic inhibition of a pathway as an alternative to inhibition of the target itself.  These data will facilitate the discovery of therapeutic and diagnostic target candidates, the validation of research and clin. observations and the generation of unanticipated hypotheses that can advance our mol. understanding of this lethal cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7Ot1_NzzEC7Vg90H21EOLACvtfcHk0lho2C-hgW-pbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1Srtb7J&md5=2f514c95e40e18c1e11585dafa845fc3</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2013.09.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2013.09.034%26sid%3Dliteratum%253Aachs%26aulast%3DBrennan%26aufirst%3DC.%2BW.%26aulast%3DVerhaak%26aufirst%3DR.%2BG.%2BW.%26aulast%3DMcKenna%26aufirst%3DA.%26aulast%3DCampos%26aufirst%3DB.%26aulast%3DNoushmehr%26aufirst%3DH.%26aulast%3DSalama%26aufirst%3DS.%2BR.%26aulast%3DZheng%26aufirst%3DS.%26aulast%3DChakravarty%26aufirst%3DD.%26aulast%3DSanborn%26aufirst%3DJ.%2BZ.%26aulast%3DBerman%26aufirst%3DS.%2BH.%26aulast%3DBeroukhim%26aufirst%3DR.%26aulast%3DBernard%26aufirst%3DB.%26aulast%3DWu%26aufirst%3DC.-J.%26aulast%3DGenovese%26aufirst%3DG.%26aulast%3DShmulevich%26aufirst%3DI.%26aulast%3DBarnholtz-Sloan%26aufirst%3DJ.%26aulast%3DZou%26aufirst%3DL.%26aulast%3DVegesna%26aufirst%3DR.%26aulast%3DShukla%26aufirst%3DS.%2BA.%26aulast%3DCiriello%26aufirst%3DG.%26aulast%3DYung%26aufirst%3DW.%2BK.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DSougnez%26aufirst%3DC.%26aulast%3DMikkelsen%26aufirst%3DT.%26aulast%3DAldape%26aufirst%3DK.%26aulast%3DBigner%26aufirst%3DD.%2BD.%26aulast%3DVan%2BMeir%26aufirst%3DE.%2BG.%26aulast%3DPrados%26aufirst%3DM.%26aulast%3DSloan%26aufirst%3DA.%26aulast%3DBlack%26aufirst%3DK.%2BL.%26aulast%3DEschbacher%26aufirst%3DJ.%26aulast%3DFinocchiaro%26aufirst%3DG.%26aulast%3DFriedman%26aufirst%3DW.%26aulast%3DAndrews%26aufirst%3DD.%2BW.%26aulast%3DGuha%26aufirst%3DA.%26aulast%3DIacocca%26aufirst%3DM.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%2BP.%26aulast%3DFoltz%26aufirst%3DG.%26aulast%3DMyers%26aufirst%3DJ.%26aulast%3DWeisenberger%26aufirst%3DD.%2BJ.%26aulast%3DPenny%26aufirst%3DR.%26aulast%3DKucherlapati%26aufirst%3DR.%26aulast%3DPerou%26aufirst%3DC.%2BM.%26aulast%3DHayes%26aufirst%3DD.%2BN.%26aulast%3DGibbs%26aufirst%3DR.%26aulast%3DMarra%26aufirst%3DM.%26aulast%3DMills%26aufirst%3DG.%2BB.%26aulast%3DLander%26aufirst%3DE.%26aulast%3DSpellman%26aufirst%3DP.%26aulast%3DWilson%26aufirst%3DR.%26aulast%3DSander%26aufirst%3DC.%26aulast%3DWeinstein%26aufirst%3DJ.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3DGabriel%26aufirst%3DS.%26aulast%3DLaird%26aufirst%3DP.%2BW.%26aulast%3DHaussler%26aufirst%3DD.%26aulast%3DGetz%26aufirst%3DG.%26aulast%3DChin%26aufirst%3DL.%26atitle%3DThe%2520somatic%2520genomic%2520landscape%2520of%2520glioblastoma%26jtitle%3DCell%26date%3D2013%26volume%3D155%26spage%3D462%26epage%3D477%26doi%3D10.1016%2Fj.cell.2013.09.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Pollard, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshikawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, I. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danovi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stricker, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayani, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Head, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernstein, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Squire, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dirks, P.</span><span> </span><span class="NLM_article-title">Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens</span> <span class="citation_source-journal">Cell Stem Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">568</span><span class="NLM_x">–</span> <span class="NLM_lpage">580</span><span class="refDoi"> DOI: 10.1016/j.stem.2009.03.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1016%2Fj.stem.2009.03.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=19497285" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnt1Ggtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=568-580&author=S.+M.+Pollardauthor=K.+Yoshikawaauthor=I.+D.+Clarkeauthor=D.+Danoviauthor=S.+Strickerauthor=R.+Russellauthor=J.+Bayaniauthor=R.+Headauthor=M.+Leeauthor=M.+Bernsteinauthor=J.+A.+Squireauthor=A.+Smithauthor=P.+Dirks&title=Glioma+stem+cell+lines+expanded+in+adherent+culture+have+tumor-specific+phenotypes+and+are+suitable+for+chemical+and+genetic+screens&doi=10.1016%2Fj.stem.2009.03.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens</span></div><div class="casAuthors">Pollard, Steven M.; Yoshikawa, Koichi; Clarke, Ian D.; Danovi, Davide; Stricker, Stefan; Russell, Roslin; Bayani, Jane; Head, Renee; Lee, Marco; Bernstein, Mark; Squire, Jeremy A.; Smith, Austin; Dirks, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Cell Stem Cell</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">568-580</span>CODEN:
                <span class="NLM_cas:coden">CSCEC4</span>;
        ISSN:<span class="NLM_cas:issn">1934-5909</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Human brain tumors appear to have a hierarchical cellular organization suggestive of a stem cell foundation.  In vitro expansion of the putative cancer stem cells as stable cell lines would provide a powerful model system to study their biol.  Here, we demonstrate routine and efficient derivation of adherent cell lines from malignant glioma that display stem cell properties and initiate high-grade gliomas following xenotransplantation.  Significantly, glioma neural stem (GNS) cell lines from different tumors exhibit divergent gene expression signatures and differentiation behavior that correlate with specific neural progenitor subtypes.  The diversity of gliomas may, therefore, reflect distinct cancer stem cell phenotypes.  The purity and stability of adherent GNS cell lines offer significant advantages compared to "sphere" cultures, enabling refined studies of cancer stem cell behavior.  A proof-of-principle live cell imaging-based chem. screen (450 FDA-approved drugs) identifies both differential sensitivities of GNS cells and a common susceptibility to perturbation of serotonin signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGow_cFBCe3CmrVg90H21EOLACvtfcHk0lho2C-hgW-pbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnt1Ggtbg%253D&md5=977d5a7f79ab8b7ee60ea571cf85d543</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.stem.2009.03.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.stem.2009.03.014%26sid%3Dliteratum%253Aachs%26aulast%3DPollard%26aufirst%3DS.%2BM.%26aulast%3DYoshikawa%26aufirst%3DK.%26aulast%3DClarke%26aufirst%3DI.%2BD.%26aulast%3DDanovi%26aufirst%3DD.%26aulast%3DStricker%26aufirst%3DS.%26aulast%3DRussell%26aufirst%3DR.%26aulast%3DBayani%26aufirst%3DJ.%26aulast%3DHead%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DBernstein%26aufirst%3DM.%26aulast%3DSquire%26aufirst%3DJ.%2BA.%26aulast%3DSmith%26aufirst%3DA.%26aulast%3DDirks%26aufirst%3DP.%26atitle%3DGlioma%2520stem%2520cell%2520lines%2520expanded%2520in%2520adherent%2520culture%2520have%2520tumor-specific%2520phenotypes%2520and%2520are%2520suitable%2520for%2520chemical%2520and%2520genetic%2520screens%26jtitle%3DCell%2520Stem%2520Cell%26date%3D2009%26volume%3D4%26spage%3D568%26epage%3D580%26doi%3D10.1016%2Fj.stem.2009.03.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Day, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stringer, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Ejeh, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ting</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michael, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ensbey, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jamieson, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruce, Z. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, Yi C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Offenhäuser, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charmsaz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellacott, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harding, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leveque, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inglis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lackmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osborne, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khanna, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lickliter, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, A. W.</span><span> </span><span class="NLM_article-title">EphA3 maintains tumorigenicity and is a therapeutic target in glioblastoma multiforme</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">238</span><span class="NLM_x">–</span> <span class="NLM_lpage">248</span><span class="refDoi"> DOI: 10.1016/j.ccr.2013.01.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1016%2Fj.ccr.2013.01.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=23410976" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BC3sXisVSnt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=238-248&author=B.+W.+Dayauthor=B.+W.+Stringerauthor=F.+Al-Ejehauthor=+Tingauthor=J.+Michaelauthor=J.+Wilsonauthor=K.+S.+Ensbeyauthor=P.+R.+Jamiesonauthor=Z.+C.+Bruceauthor=Yi+C.+Limauthor=C.+Offenh%C3%A4userauthor=S.+Charmsazauthor=L.+T.+Cooperauthor=J.+K.+Ellacottauthor=A.+Hardingauthor=L.+Levequeauthor=P.+Inglisauthor=S.+Allanauthor=D.+G.+Walkerauthor=M.+Lackmannauthor=G.+Osborneauthor=K.+K.+Khannaauthor=B.+A.+Reynoldsauthor=J.+D.+Lickliterauthor=A.+W.+Boyd&title=EphA3+maintains+tumorigenicity+and+is+a+therapeutic+target+in+glioblastoma+multiforme&doi=10.1016%2Fj.ccr.2013.01.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">EphA3 Maintains Tumorigenicity and Is a Therapeutic Target in Glioblastoma Multiforme</span></div><div class="casAuthors">Day, Bryan W.; Stringer, Brett W.; Al-Ejeh, Fares; Ting, Michael J.; Wilson, John; Ensbey, Kathleen S.; Jamieson, Paul R.; Bruce, Zara C.; Lim, Yi Chieh; Offenhauser, Carolin; Charmsaz, Sara; Cooper, Leanne T.; Ellacott, Jennifer K.; Harding, Angus; Leveque, Lucie; Inglis, Po; Allan, Suzanne; Walker, David G.; Lackmann, Martin; Osborne, Geoffrey; Khanna, Kum Kum; Reynolds, Brent A.; Lickliter, Jason D.; Boyd, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">238-248</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Significant endeavor has been applied to identify functional therapeutic targets in glioblastoma (GBM) to halt the growth of this aggressive cancer.  We show that the receptor tyrosine kinase EphA3 is frequently overexpressed in GBM and, in particular, in the most aggressive mesenchymal subtype.  Importantly, EphA3 is highly expressed on the tumor-initiating cell population in glioma and appears critically involved in maintaining tumor cells in a less differentiated state by modulating mitogen-activated protein kinase signaling.  EphA3 knockdown or depletion of EphA3-pos. tumor cells reduced tumorigenic potential to a degree comparable to treatment with a therapeutic radiolabeled EphA3-specific monoclonal antibody.  These results identify EphA3 as a functional, targetable receptor in GBM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4I9LA-du-dLVg90H21EOLACvtfcHk0ljLbMZXWXzkjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXisVSnt7k%253D&md5=011bdb472829931877f9e952c75d497e</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2013.01.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2013.01.007%26sid%3Dliteratum%253Aachs%26aulast%3DDay%26aufirst%3DB.%2BW.%26aulast%3DStringer%26aufirst%3DB.%2BW.%26aulast%3DAl-Ejeh%26aufirst%3DF.%26aulast%3DTing%26aulast%3DMichael%26aufirst%3DJ.%26aulast%3DWilson%26aufirst%3DJ.%26aulast%3DEnsbey%26aufirst%3DK.%2BS.%26aulast%3DJamieson%26aufirst%3DP.%2BR.%26aulast%3DBruce%26aufirst%3DZ.%2BC.%26aulast%3DLim%26aufirst%3DYi%2BC.%26aulast%3DOffenh%25C3%25A4user%26aufirst%3DC.%26aulast%3DCharmsaz%26aufirst%3DS.%26aulast%3DCooper%26aufirst%3DL.%2BT.%26aulast%3DEllacott%26aufirst%3DJ.%2BK.%26aulast%3DHarding%26aufirst%3DA.%26aulast%3DLeveque%26aufirst%3DL.%26aulast%3DInglis%26aufirst%3DP.%26aulast%3DAllan%26aufirst%3DS.%26aulast%3DWalker%26aufirst%3DD.%2BG.%26aulast%3DLackmann%26aufirst%3DM.%26aulast%3DOsborne%26aufirst%3DG.%26aulast%3DKhanna%26aufirst%3DK.%2BK.%26aulast%3DReynolds%26aufirst%3DB.%2BA.%26aulast%3DLickliter%26aufirst%3DJ.%2BD.%26aulast%3DBoyd%26aufirst%3DA.%2BW.%26atitle%3DEphA3%2520maintains%2520tumorigenicity%2520and%2520is%2520a%2520therapeutic%2520target%2520in%2520glioblastoma%2520multiforme%26jtitle%3DCancer%2520Cell%26date%3D2013%26volume%3D23%26spage%3D238%26epage%3D248%26doi%3D10.1016%2Fj.ccr.2013.01.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Day, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stringer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffree, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jamieson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ensbey, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruce, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inglis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tollesson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Findlay, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadrian, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johns, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartlett, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osborne, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, A.</span><span> </span><span class="NLM_article-title">Glioma surgical aspirate: a viable source of tumor tissue for experimental research</span> <span class="citation_source-journal">Cancers</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">357</span><span class="NLM_x">–</span> <span class="NLM_lpage">371</span><span class="refDoi"> DOI: 10.3390/cancers5020357</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.3390%2Fcancers5020357" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=357-371&author=B.+Dayauthor=B.+Stringerauthor=J.+Wilsonauthor=R.+Jeffreeauthor=P.+Jamiesonauthor=K.+Ensbeyauthor=Z.+Bruceauthor=P.+Inglisauthor=S.+Allanauthor=C.+Winterauthor=G.+Tollessonauthor=S.+Campbellauthor=P.+Lucasauthor=W.+Findlayauthor=D.+Kadrianauthor=D.+Johnsonauthor=T.+Robertsonauthor=T.+Johnsauthor=P.+Bartlettauthor=G.+Osborneauthor=A.+Boyd&title=Glioma+surgical+aspirate%3A+a+viable+source+of+tumor+tissue+for+experimental+research&doi=10.3390%2Fcancers5020357"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.3390%2Fcancers5020357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fcancers5020357%26sid%3Dliteratum%253Aachs%26aulast%3DDay%26aufirst%3DB.%26aulast%3DStringer%26aufirst%3DB.%26aulast%3DWilson%26aufirst%3DJ.%26aulast%3DJeffree%26aufirst%3DR.%26aulast%3DJamieson%26aufirst%3DP.%26aulast%3DEnsbey%26aufirst%3DK.%26aulast%3DBruce%26aufirst%3DZ.%26aulast%3DInglis%26aufirst%3DP.%26aulast%3DAllan%26aufirst%3DS.%26aulast%3DWinter%26aufirst%3DC.%26aulast%3DTollesson%26aufirst%3DG.%26aulast%3DCampbell%26aufirst%3DS.%26aulast%3DLucas%26aufirst%3DP.%26aulast%3DFindlay%26aufirst%3DW.%26aulast%3DKadrian%26aufirst%3DD.%26aulast%3DJohnson%26aufirst%3DD.%26aulast%3DRobertson%26aufirst%3DT.%26aulast%3DJohns%26aufirst%3DT.%26aulast%3DBartlett%26aufirst%3DP.%26aulast%3DOsborne%26aufirst%3DG.%26aulast%3DBoyd%26aufirst%3DA.%26atitle%3DGlioma%2520surgical%2520aspirate%253A%2520a%2520viable%2520source%2520of%2520tumor%2520tissue%2520for%2520experimental%2520research%26jtitle%3DCancers%26date%3D2013%26volume%3D5%26spage%3D357%26epage%3D371%26doi%3D10.3390%2Fcancers5020357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Molina, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jafari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ignatushchenko, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsson, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sreekumar, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nordlund, P.</span><span> </span><span class="NLM_article-title">Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">341</span><span class="NLM_x">, </span> <span class="NLM_fpage">84</span><span class="NLM_x">–</span> <span class="NLM_lpage">87</span><span class="refDoi"> DOI: 10.1126/science.1233606</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1126%2Fscience.1233606" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=23828940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVCgs7rP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=2013&pages=84-87&author=D.+M.+Molinaauthor=R.+Jafariauthor=M.+Ignatushchenkoauthor=T.+Sekiauthor=E.+A.+Larssonauthor=C.+Danauthor=L.+Sreekumarauthor=Y.+Caoauthor=P.+Nordlund&title=Monitoring+drug+target+engagement+in+cells+and+tissues+using+the+cellular+thermal+shift+assay&doi=10.1126%2Fscience.1233606"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay</span></div><div class="casAuthors">Molina, Daniel Martinez; Jafari, Rozbeh; Ignatushchenko, Marina; Seki, Takahiro; Larsson, E. Andreas; Dan, Chen; Sreekumar, Lekshmy; Cao, Yihai; Nordlund, Paer</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">341</span>
        (<span class="NLM_cas:issue">6141</span>),
    <span class="NLM_cas:pages">84-87</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The efficacy of therapeutics is dependent on a drug binding to its cognate target.  Optimization of target engagement by drugs in cells is often challenging, because drug binding cannot be monitored inside cells.  We have developed a method for evaluating drug binding to target proteins in cells and tissue samples.  This cellular thermal shift assay (CETSA) is based on the biophys. principle of ligand-induced thermal stabilization of target proteins.  Using this assay, we validated drug binding for a set of important clin. targets and monitored processes of drug transport and activation, off-target effects and drug resistance in cancer cell lines, as well as drug distribution in tissues.  CETSA is likely to become a valuable tool for the validation and optimization of drug target engagement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaaWSoozY7ObVg90H21EOLACvtfcHk0ljLbMZXWXzkjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVCgs7rP&md5=f8ba686ba38b67dbdf366c49eb7375b4</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1126%2Fscience.1233606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1233606%26sid%3Dliteratum%253Aachs%26aulast%3DMolina%26aufirst%3DD.%2BM.%26aulast%3DJafari%26aufirst%3DR.%26aulast%3DIgnatushchenko%26aufirst%3DM.%26aulast%3DSeki%26aufirst%3DT.%26aulast%3DLarsson%26aufirst%3DE.%2BA.%26aulast%3DDan%26aufirst%3DC.%26aulast%3DSreekumar%26aufirst%3DL.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DNordlund%26aufirst%3DP.%26atitle%3DMonitoring%2520drug%2520target%2520engagement%2520in%2520cells%2520and%2520tissues%2520using%2520the%2520cellular%2520thermal%2520shift%2520assay%26jtitle%3DScience%26date%3D2013%26volume%3D341%26spage%3D84%26epage%3D87%26doi%3D10.1126%2Fscience.1233606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Jafari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almqvist, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Axelsson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ignatushchenko, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundbäck, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nordlund, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molina, D. M.</span><span> </span><span class="NLM_article-title">The cellular thermal shift assay for evaluating drug target interactions in cells</span> <span class="citation_source-journal">Nat. Protoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">2100</span><span class="NLM_x">–</span> <span class="NLM_lpage">2122</span><span class="refDoi"> DOI: 10.1038/nprot.2014.138</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1038%2Fnprot.2014.138" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=25101824" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht12msrfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=2100-2122&author=R.+Jafariauthor=H.+Almqvistauthor=H.+Axelssonauthor=M.+Ignatushchenkoauthor=T.+Lundb%C3%A4ckauthor=P.+Nordlundauthor=D.+M.+Molina&title=The+cellular+thermal+shift+assay+for+evaluating+drug+target+interactions+in+cells&doi=10.1038%2Fnprot.2014.138"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">The cellular thermal shift assay for evaluating drug target interactions in cells</span></div><div class="casAuthors">Jafari, Rozbeh; Almqvist, Helena; Axelsson, Hanna; Ignatushchenko, Marina; Lundbaeck, Thomas; Nordlund, Paer; Molina, Daniel Martinez</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2100-2122</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Thermal shift assays are used to study thermal stabilization of proteins upon ligand binding.  Such assays have been used extensively on purified proteins in the drug discovery industry and in academia to detect interactions.  Recently, we published a proof-of-principle study describing the implementation of thermal shift assays in a cellular format, which we call the cellular thermal shift assay (CETSA).  The method allows studies of target engagement of drug candidates in a cellular context, herein exemplified with exptl. data on the human kinases p38α and ERK1/2.  The assay involves treatment of cells with a compd. of interest, heating to denature and ppt. proteins, cell lysis, and the sepn. of cell debris and aggregates from the sol. protein fraction.  Whereas unbound proteins denature and ppt. at elevated temps., ligand-bound proteins remain in soln.  We describe two procedures for detecting the stabilized protein in the sol. fraction of the samples.  One approach involves sample workup and detection using quant. western blotting, whereas the second is performed directly in soln. and relies on the induced proximity of two target-directed antibodies upon binding to sol. protein.  The latter protocol has been optimized to allow an increased throughput, as potential applications require large nos. of samples.  Both approaches can be completed in a day.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzarqomAK6eLVg90H21EOLACvtfcHk0lhJnRzgXFn1eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht12msrfJ&md5=e7852e1a306bca1698a8e8463ae566b1</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2014.138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2014.138%26sid%3Dliteratum%253Aachs%26aulast%3DJafari%26aufirst%3DR.%26aulast%3DAlmqvist%26aufirst%3DH.%26aulast%3DAxelsson%26aufirst%3DH.%26aulast%3DIgnatushchenko%26aufirst%3DM.%26aulast%3DLundb%25C3%25A4ck%26aufirst%3DT.%26aulast%3DNordlund%26aufirst%3DP.%26aulast%3DMolina%26aufirst%3DD.%2BM.%26atitle%3DThe%2520cellular%2520thermal%2520shift%2520assay%2520for%2520evaluating%2520drug%2520target%2520interactions%2520in%2520cells%26jtitle%3DNat.%2520Protoc.%26date%3D2014%26volume%3D9%26spage%3D2100%26epage%3D2122%26doi%3D10.1038%2Fnprot.2014.138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, B.</span><span> </span><span class="NLM_article-title">Comparison of cancer cell survival triggered by microtubule damage after turning Dyrk1B kinase on and off</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">731</span><span class="NLM_x">–</span> <span class="NLM_lpage">742</span><span class="refDoi"> DOI: 10.1021/cb4005589</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb4005589" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=731-742&author=L.+Liauthor=Y.+Liuauthor=Q.+Zhangauthor=H.+Zhouauthor=Y.+Zhangauthor=B.+Yan&title=Comparison+of+cancer+cell+survival+triggered+by+microtubule+damage+after+turning+Dyrk1B+kinase+on+and+off&doi=10.1021%2Fcb4005589"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fcb4005589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb4005589%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DYan%26aufirst%3DB.%26atitle%3DComparison%2520of%2520cancer%2520cell%2520survival%2520triggered%2520by%2520microtubule%2520damage%2520after%2520turning%2520Dyrk1B%2520kinase%2520on%2520and%2520off%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2014%26volume%3D9%26spage%3D731%26epage%3D742%26doi%3D10.1021%2Fcb4005589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Becker, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wetzel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eirmbter, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tejedor, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joost, H.</span><span> </span><span class="NLM_article-title">Sequence characteristics, subcellular localization, and substrate specificity of DYRK-related kinases, a novel family of dual specificity protein kinases</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">25893</span><span class="NLM_x">–</span> <span class="NLM_lpage">25902</span><span class="refDoi"> DOI: 10.1074/jbc.273.40.25893</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1074%2Fjbc.273.40.25893" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=9748265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADyaK1cXms1egt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1998&pages=25893-25902&author=W.+Beckerauthor=Y.+Weberauthor=K.+Wetzelauthor=K.+Eirmbterauthor=F.+Tejedorauthor=H.+Joost&title=Sequence+characteristics%2C+subcellular+localization%2C+and+substrate+specificity+of+DYRK-related+kinases%2C+a+novel+family+of+dual+specificity+protein+kinases&doi=10.1074%2Fjbc.273.40.25893"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Sequence characteristics, subcellular localization, and substrate specificity of DYRK-related kinases, a novel family of dual specificity protein kinases</span></div><div class="casAuthors">Becker, Walter; Weber, Yvonne; Wetzel, Kristiane; Eirmbter, Klaus; Tejedor, Francisco J.; Joost, Hans-Georg</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">273</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">25893-25902</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">DYRK1 is a dual specificity protein kinase presumably involved in brain development.  The kinase belongs to a new family of protein kinases comprising at least seven mammalian isoforms (DYRK1A, DYRK1B, DYRK1C, DYRK2, DYRK3, DYRK4A, and DYRK4B), the yeast homolog Yak1p, and the Drosophila kinase minibrain (MNB).  In rat tissues, DYRK1A is expressed ubiquitously, whereas transcripts for DYRK1B, DYRK2, DYRK3, and DYRK4 were detected predominantly in testes of adult but not prepuberal rats.  By fluorescence microscopy and subcellular fractionation, a green fluorescent protein (GFP) fusion protein of DYRK1A was found to accumulate in the nucleus of transfected COS-7 and HEK293 cells, whereas GFP-DYRK2 was predominantly detected in the cytoplasm.  DYRK1A exhibited a punctate pattern of GFP fluorescence inside the nucleus and was co-purified with the nuclear matrix.  Anal. of GFP-DYRK1A deletion constructs showed that the nuclear localization of DYRK1A was mediated by its nuclear targeting signal (amino acids 105-139) but that its characteristics subnuclear distribution depended on addnl. N-terminal elements (amino acids 1-104).  When expressed in Escherichia coli, DYRK1A, DYRK2, DYRK3, MNB, and Yak1p catalyzed their autophosphorylation on tyrosine residues.  The kinases differed in their substrate specificity in that DYRK2 and DYRK3, but not DYRK1A and MNB, catalyzed phosphorylation of histone H2B.  The heterogeneity of their subcellular localization and substrate specificity suggests that the kinases are involved in different cellular functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0Q1vPoFEv4LVg90H21EOLACvtfcHk0lhJnRzgXFn1eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXms1egt7g%253D&md5=4b8029c26149c1ecb9d65baf50dd978d</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1074%2Fjbc.273.40.25893&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.273.40.25893%26sid%3Dliteratum%253Aachs%26aulast%3DBecker%26aufirst%3DW.%26aulast%3DWeber%26aufirst%3DY.%26aulast%3DWetzel%26aufirst%3DK.%26aulast%3DEirmbter%26aufirst%3DK.%26aulast%3DTejedor%26aufirst%3DF.%26aulast%3DJoost%26aufirst%3DH.%26atitle%3DSequence%2520characteristics%252C%2520subcellular%2520localization%252C%2520and%2520substrate%2520specificity%2520of%2520DYRK-related%2520kinases%252C%2520a%2520novel%2520family%2520of%2520dual%2520specificity%2520protein%2520kinases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1998%26volume%3D273%26spage%3D25893%26epage%3D25902%26doi%3D10.1074%2Fjbc.273.40.25893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Esvan, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeinyeh, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boibessot, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nauton, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Théry, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaikuad, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loaëc, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anizon, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giraud, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreau, P.</span><span> </span><span class="NLM_article-title">Discovery of pyrido[3,4-g]quinazoline derivatives as CMGC family protein kinase inhibitors: Design, synthesis, inhibitory potency and X-ray co–crystal structure</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">170</span><span class="NLM_x">–</span> <span class="NLM_lpage">177</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2016.04.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1016%2Fj.ejmech.2016.04.004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2016&pages=170-177&author=Y.+J.+Esvanauthor=W.+Zeinyehauthor=T.+Boibessotauthor=L.+Nautonauthor=V.+Th%C3%A9ryauthor=S.+Knappauthor=A.+Chaikuadauthor=N.+Loa%C3%ABcauthor=L.+Meijerauthor=F.+Anizonauthor=F.+Giraudauthor=P.+Moreau&title=Discovery+of+pyrido%5B3%2C4-g%5Dquinazoline+derivatives+as+CMGC+family+protein+kinase+inhibitors%3A+Design%2C+synthesis%2C+inhibitory+potency+and+X-ray+co%E2%80%93crystal+structure&doi=10.1016%2Fj.ejmech.2016.04.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.04.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.04.004%26sid%3Dliteratum%253Aachs%26aulast%3DEsvan%26aufirst%3DY.%2BJ.%26aulast%3DZeinyeh%26aufirst%3DW.%26aulast%3DBoibessot%26aufirst%3DT.%26aulast%3DNauton%26aufirst%3DL.%26aulast%3DTh%25C3%25A9ry%26aufirst%3DV.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DChaikuad%26aufirst%3DA.%26aulast%3DLoa%25C3%25ABc%26aufirst%3DN.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DAnizon%26aufirst%3DF.%26aulast%3DGiraud%26aufirst%3DF.%26aulast%3DMoreau%26aufirst%3DP.%26atitle%3DDiscovery%2520of%2520pyrido%255B3%252C4-g%255Dquinazoline%2520derivatives%2520as%2520CMGC%2520family%2520protein%2520kinase%2520inhibitors%253A%2520Design%252C%2520synthesis%252C%2520inhibitory%2520potency%2520and%2520X-ray%2520co%25E2%2580%2593crystal%2520structure%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D118%26spage%3D170%26epage%3D177%26doi%3D10.1016%2Fj.ejmech.2016.04.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Munoz, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selig, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeung, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peifer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufer, S. A.</span><span> </span><span class="NLM_article-title">Fluorescence polarisation binding assay to develop inhibitors of inactive p38a mitogen-activated protein kinase</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">401</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">133</span><span class="refDoi"> DOI: 10.1016/j.ab.2010.02.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1016%2Fj.ab.2010.02.016" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=401&publication_year=2010&pages=125-133&author=L.+Munozauthor=R.+Seligauthor=Y.+Yeungauthor=C.+Peiferauthor=S.+A.+Laufer&title=Fluorescence+polarisation+binding+assay+to+develop+inhibitors+of+inactive+p38a+mitogen-activated+protein+kinase&doi=10.1016%2Fj.ab.2010.02.016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2010.02.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2010.02.016%26sid%3Dliteratum%253Aachs%26aulast%3DMunoz%26aufirst%3DL.%26aulast%3DSelig%26aufirst%3DR.%26aulast%3DYeung%26aufirst%3DY.%26aulast%3DPeifer%26aufirst%3DC.%26aulast%3DLaufer%26aufirst%3DS.%2BA.%26atitle%3DFluorescence%2520polarisation%2520binding%2520assay%2520to%2520develop%2520inhibitors%2520of%2520inactive%2520p38a%2520mitogen-activated%2520protein%2520kinase%26jtitle%3DAnal.%2520Biochem.%26date%3D2010%26volume%3D401%26spage%3D125%26epage%3D133%26doi%3D10.1016%2Fj.ab.2010.02.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Knight, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">Features of selective kinase inhibitors</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">621</span><span class="NLM_x">–</span> <span class="NLM_lpage">637</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2005.04.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1016%2Fj.chembiol.2005.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=15975507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsFGhtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=621-637&author=Z.+A.+Knightauthor=K.+M.+Shokat&title=Features+of+selective+kinase+inhibitors&doi=10.1016%2Fj.chembiol.2005.04.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Features of Selective Kinase Inhibitors</span></div><div class="casAuthors">Knight, Zachary A.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">621-637</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Summary: Small-mol. inhibitors of protein and lipid kinases have emerged as indispensable tools for studying signal transduction.  Despite the widespread use of these reagents, there is little consensus about the biochem. criteria that define their potency and selectivity in cells.  We discuss some of the features that det. the cellular activity of kinase inhibitors and propose a framework for interpreting inhibitor selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAJWhVxtSrCLVg90H21EOLACvtfcHk0liNRJMEHe__0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsFGhtrc%253D&md5=ce5b3505a0326b04479172ec05573152</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2005.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2005.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DKnight%26aufirst%3DZ.%2BA.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DFeatures%2520of%2520selective%2520kinase%2520inhibitors%26jtitle%3DChem.%2520Biol.%26date%3D2005%26volume%3D12%26spage%3D621%26epage%3D637%26doi%3D10.1016%2Fj.chembiol.2005.04.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Montanari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scalvini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belluti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobbi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ligresti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marzo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rampa, A.</span><span> </span><span class="NLM_article-title">Fatty Acid Amide Hydrolase (FAAH), Acetylcholinesterase (AChE), and Butyrylcholinesterase (BuChE): networked targets for the development of carbamates as potential anti-Alzheimer’s disease agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">6387</span><span class="NLM_x">–</span> <span class="NLM_lpage">6406</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00609</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00609" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BC28XpvFylsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=6387-6406&author=S.+Montanariauthor=L.+Scalviniauthor=M.+Bartoliniauthor=F.+Bellutiauthor=S.+Gobbiauthor=V.+Andrisanoauthor=A.+Ligrestiauthor=V.+Di+Marzoauthor=S.+Rivaraauthor=M.+Morauthor=A.+Bisiauthor=A.+Rampa&title=Fatty+Acid+Amide+Hydrolase+%28FAAH%29%2C+Acetylcholinesterase+%28AChE%29%2C+and+Butyrylcholinesterase+%28BuChE%29%3A+networked+targets+for+the+development+of+carbamates+as+potential+anti-Alzheimer%E2%80%99s+disease+agents&doi=10.1021%2Facs.jmedchem.6b00609"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Fatty Acid Amide Hydrolase (FAAH), Acetylcholinesterase (AChE), and Butyrylcholinesterase (BuChE): Networked Targets for the Development of Carbamates as Potential Anti-Alzheimer's Disease Agents</span></div><div class="casAuthors">Montanari, Serena; Scalvini, Laura; Bartolini, Manuela; Belluti, Federica; Gobbi, Silvia; Andrisano, Vincenza; Ligresti, Alessia; Di Marzo, Vincenzo; Rivara, Silvia; Mor, Marco; Bisi, Alessandra; Rampa, Angela</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">6387-6406</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The modulation of the endocannabinoid system is emerging as a viable avenue for the treatment of neurodegeneration, being involved in neuroprotective and anti-inflammatory processes.  In particular, indirectly enhancing endocannabinoid signaling to therapeutic levels through FAAH inhibition might be beneficial for neurodegenerative disorders such as Alzheimer's disease, effectively preventing or slowing the progression of the disease.  Hence, in the search for a more effective treatment for Alzheimer's disease, in this paper, the multitarget-directed ligand paradigm was applied to the design of carbamates able to simultaneously target the recently proposed endocannabinoid system and the classic cholinesterase system, and achieve effective dual FAAH/cholinesterase inhibitors.  Among the two series of synthesized compds., while some derivs. proved to be extremely potent on a single target, compds. 9 and 19 were identified as effective dual FAAH/ChE inhibitors, with well-balanced nanomolar activities.  Thus, 9 and 19 might be considered as new promising candidates for Alzheimer's disease treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKiL1QuQosRrVg90H21EOLACvtfcHk0liNRJMEHe__0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpvFylsL4%253D&md5=b1dcd2958856cf5bfc9d77c451186b5b</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00609%26sid%3Dliteratum%253Aachs%26aulast%3DMontanari%26aufirst%3DS.%26aulast%3DScalvini%26aufirst%3DL.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DBelluti%26aufirst%3DF.%26aulast%3DGobbi%26aufirst%3DS.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DLigresti%26aufirst%3DA.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DRivara%26aufirst%3DS.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DBisi%26aufirst%3DA.%26aulast%3DRampa%26aufirst%3DA.%26atitle%3DFatty%2520Acid%2520Amide%2520Hydrolase%2520%2528FAAH%2529%252C%2520Acetylcholinesterase%2520%2528AChE%2529%252C%2520and%2520Butyrylcholinesterase%2520%2528BuChE%2529%253A%2520networked%2520targets%2520for%2520the%2520development%2520of%2520carbamates%2520as%2520potential%2520anti-Alzheimer%25E2%2580%2599s%2520disease%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D6387%26epage%3D6406%26doi%3D10.1021%2Facs.jmedchem.6b00609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Tasch, B. O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antovic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merkul, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, T. J. J.</span><span> </span><span class="NLM_article-title">One-pot synthesis of camalexins and 3,3′-biindoles by the Masuda Borylation–Suzuki arylation (MBSA) sequence</span> <span class="citation_source-journal">Eur. J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">2013</span><span class="NLM_x">, </span> <span class="NLM_fpage">4564</span><span class="NLM_x">–</span> <span class="NLM_lpage">4569</span><span class="refDoi"> DOI: 10.1002/ejoc.201300133</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1002%2Fejoc.201300133" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2013&publication_year=2013&pages=4564-4569&author=B.+O.+A.+Taschauthor=D.+Antovicauthor=E.+Merkulauthor=T.+J.+J.+M%C3%BCller&title=One-pot+synthesis+of+camalexins+and+3%2C3%E2%80%B2-biindoles+by+the+Masuda+Borylation%E2%80%93Suzuki+arylation+%28MBSA%29+sequence&doi=10.1002%2Fejoc.201300133"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1002%2Fejoc.201300133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejoc.201300133%26sid%3Dliteratum%253Aachs%26aulast%3DTasch%26aufirst%3DB.%2BO.%2BA.%26aulast%3DAntovic%26aufirst%3DD.%26aulast%3DMerkul%26aufirst%3DE.%26aulast%3DM%25C3%25BCller%26aufirst%3DT.%2BJ.%2BJ.%26atitle%3DOne-pot%2520synthesis%2520of%2520camalexins%2520and%25203%252C3%25E2%2580%25B2-biindoles%2520by%2520the%2520Masuda%2520Borylation%25E2%2580%2593Suzuki%2520arylation%2520%2528MBSA%2529%2520sequence%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2013%26volume%3D2013%26spage%3D4564%26epage%3D4569%26doi%3D10.1002%2Fejoc.201300133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Konishi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manabe, K.</span><span> </span><span class="NLM_article-title">Imidazole derivatives as accelerators for ruthenium-catalyzed hydroesterification and hydrocarbamoylation of alkenes: extensive ligand screening and mechanistic study</span> <span class="citation_source-journal">ChemCatChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">836</span><span class="NLM_x">–</span> <span class="NLM_lpage">845</span><span class="refDoi"> DOI: 10.1002/cctc.201402986</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1002%2Fcctc.201402986" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=836-845&author=H.+Konishiauthor=T.+Mutoauthor=T.+Uedaauthor=Y.+Yamadaauthor=M.+Yamaguchiauthor=K.+Manabe&title=Imidazole+derivatives+as+accelerators+for+ruthenium-catalyzed+hydroesterification+and+hydrocarbamoylation+of+alkenes%3A+extensive+ligand+screening+and+mechanistic+study&doi=10.1002%2Fcctc.201402986"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1002%2Fcctc.201402986&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcctc.201402986%26sid%3Dliteratum%253Aachs%26aulast%3DKonishi%26aufirst%3DH.%26aulast%3DMuto%26aufirst%3DT.%26aulast%3DUeda%26aufirst%3DT.%26aulast%3DYamada%26aufirst%3DY.%26aulast%3DYamaguchi%26aufirst%3DM.%26aulast%3DManabe%26aufirst%3DK.%26atitle%3DImidazole%2520derivatives%2520as%2520accelerators%2520for%2520ruthenium-catalyzed%2520hydroesterification%2520and%2520hydrocarbamoylation%2520of%2520alkenes%253A%2520extensive%2520ligand%2520screening%2520and%2520mechanistic%2520study%26jtitle%3DChemCatChem%26date%3D2015%26volume%3D7%26spage%3D836%26epage%3D845%26doi%3D10.1002%2Fcctc.201402986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Chou, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajagopal, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, H.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, C.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyan, Y.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, P.-C.</span><span> </span><span class="NLM_article-title">Thermally induced denitrogenative annulation for the synthesis of dihydroquinolinimines and chroman-4-imines</span> <span class="citation_source-journal">Chem. - Asian J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">757</span><span class="NLM_x">–</span> <span class="NLM_lpage">765</span><span class="refDoi"> DOI: 10.1002/asia.201501239</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1002%2Fasia.201501239" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=26789740" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVOmtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=757-765&author=C.-H.+Chouauthor=Y.-Y.+Chenauthor=B.+Rajagopalauthor=H.-C.+Tuauthor=K.-L.+Chenauthor=S.-F.+Wangauthor=C.-F.+Liangauthor=Y.-C.+Tyanauthor=P.-C.+Lin&title=Thermally+induced+denitrogenative+annulation+for+the+synthesis+of+dihydroquinolinimines+and+chroman-4-imines&doi=10.1002%2Fasia.201501239"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Thermally Induced Denitrogenative Annulation for the Synthesis of Dihydroquinolinimines and Chroman-4-imines</span></div><div class="casAuthors">Chou, Chih-Hung; Chen, Ying-Yu; Rajagopal, Basker; Tu, Hsiu-Chung; Chen, Kuan-Lin; Wang, Sheng-Fu; Liang, Chien-Fu; Tyan, Yu-Chang; Lin, Po-Chiao</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - An Asian Journal</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">757-765</span>CODEN:
                <span class="NLM_cas:coden">CAAJBI</span>;
        ISSN:<span class="NLM_cas:issn">1861-4728</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A rapid growth in synthetic methods for the prepn. of diverse org. mols. using N-sulfonyl-1,2,3-triazoles is of great interest in org. synthesis.  Transition metals are generally used to activate the α-imino diazo intermediates.  Metal-free methods have not been studied in detail, but can be a good complement to transition metal catalysis in the mild reaction conditions.  The authors herein report a novel method for the prepn. of 2,3-dihydroquinolin-4-imine and chroman-4-imine analogs from their corresponding N-sulfonyl-1,2,3-triazoles in the absence of metal catalysts.  To achieve intramol. annulation, the introduction of an electron-donating group is required (substituent effects) at the meta position of N-sulfonyl-1,2,3-triazole Me anilines.  The inclusion of tailored substituents on the aniline moieties and nitrogen atoms enhances the nucleophilicity of the Ph π-electrons, thus allowing them to undergo a Friedel-Crafts-type reaction with the highly electrophilic ketenimines.  This metal-free method was carefully optimized to generate a variety of dihydroquinolin-4-imines and chroman-4-imines in moderate-to-good yields.  Under optimized conditions the synthesis of the target compds. was achieved using N,N-dimethylformamide (i.e., DMF) as a reagent.  Starting materials included N-methyl-1-[(4-methylphenyl)sulfonyl]-N-phenyl-1H-1,2,3-triazole-4-methanamine derivs.  The title compds. thus formed included N-(quinolinylidene)benzenesulfonamide derivs. (quinoline-imines).  Starting materials also included 4-[(3-methoxyphenoxy)methyl]-1-[(4-methylphenyl)sulfonyl]-1H-1,2,3-triazole derivs.  The products thus formed included N-(benzopyranylidene)benzenesulfonamide derivs. (benzopyran-imines).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGry2PvFvQ3mIbVg90H21EOLACvtfcHk0lifa2MsNuDaJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVOmtrw%253D&md5=4b0ad9e2d6c49226e431ce78f7016abe</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1002%2Fasia.201501239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fasia.201501239%26sid%3Dliteratum%253Aachs%26aulast%3DChou%26aufirst%3DC.-H.%26aulast%3DChen%26aufirst%3DY.-Y.%26aulast%3DRajagopal%26aufirst%3DB.%26aulast%3DTu%26aufirst%3DH.-C.%26aulast%3DChen%26aufirst%3DK.-L.%26aulast%3DWang%26aufirst%3DS.-F.%26aulast%3DLiang%26aufirst%3DC.-F.%26aulast%3DTyan%26aufirst%3DY.-C.%26aulast%3DLin%26aufirst%3DP.-C.%26atitle%3DThermally%2520induced%2520denitrogenative%2520annulation%2520for%2520the%2520synthesis%2520of%2520dihydroquinolinimines%2520and%2520chroman-4-imines%26jtitle%3DChem.%2520-%2520Asian%2520J.%26date%3D2016%26volume%3D11%26spage%3D757%26epage%3D765%26doi%3D10.1002%2Fasia.201501239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Aronov, A.; Lauffer, D. J.; Li, P.; Tomlinson, R. C.</span><span> </span><span class="NLM_article-title">Compositions useful as inhibitors of protein kinases</span>. WO 2003078423A1,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=A.+Aronov&author=D.+J.+Lauffer&author=P.+Li&author=R.+C.+Tomlinson&title=Compositions+useful+as+inhibitors+of+protein+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAronov%26aufirst%3DA.%26atitle%3DCompositions%2520useful%2520as%2520inhibitors%2520of%2520protein%2520kinases%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">McKerlie, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudkin, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wynne, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Procter, D. J.</span><span> </span><span class="NLM_article-title">Evaluation of a new linker system cleaved using samarium(ii) iodide. Application in the solid phase synthesis of carbonyl compounds</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">2805</span><span class="NLM_x">–</span> <span class="NLM_lpage">2816</span><span class="refDoi"> DOI: 10.1039/b506294b</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=10.1039%2Fb506294b" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=16032358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmt1Grtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2005&pages=2805-2816&author=F.+McKerlieauthor=I.+M.+Rudkinauthor=G.+Wynneauthor=D.+J.+Procter&title=Evaluation+of+a+new+linker+system+cleaved+using+samarium%28ii%29+iodide.+Application+in+the+solid+phase+synthesis+of+carbonyl+compounds&doi=10.1039%2Fb506294b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of a new linker system cleaved using samarium(II) iodide. Application in the solid phase synthesis of carbonyl compounds</span></div><div class="casAuthors">McKerlie, Fiona; Rudkin, Iain M.; Wynne, Graham; Procter, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2805-2816</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A new linker design for solid phase synthesis has been developed that is cleaved under mild, neutral conditions using samarium(II) iodide.  The feasibility of the linker approach has been illustrated in the solid phase synthesis of ketones and amides using an oxygen linker.  Insights into the mechanism of the samarium(II) iodide cleavage reaction are described and the potential of a sequential cleavage carbon-carbon bond forming process is assessed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrw_jtnjG5hSLVg90H21EOLACvtfcHk0lifa2MsNuDaJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmt1Grtb4%253D&md5=6c7a311c0bd3611d761604ae8e92aaa1</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1039%2Fb506294b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb506294b%26sid%3Dliteratum%253Aachs%26aulast%3DMcKerlie%26aufirst%3DF.%26aulast%3DRudkin%26aufirst%3DI.%2BM.%26aulast%3DWynne%26aufirst%3DG.%26aulast%3DProcter%26aufirst%3DD.%2BJ.%26atitle%3DEvaluation%2520of%2520a%2520new%2520linker%2520system%2520cleaved%2520using%2520samarium%2528ii%2529%2520iodide.%2520Application%2520in%2520the%2520solid%2520phase%2520synthesis%2520of%2520carbonyl%2520compounds%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2005%26volume%3D3%26spage%3D2805%26epage%3D2816%26doi%3D10.1039%2Fb506294b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i94"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01840">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_17848"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b01840">10.1021/acs.jmedchem.6b01840</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline"><sup>1</sup>H and <sup>13</sup>C NMR spectra and HPLC chromatograms (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01840/suppl_file/jm6b01840_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01840/suppl_file/jm6b01840_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01840/suppl_file/jm6b01840_si_001.pdf">jm6b01840_si_001.pdf (10.1 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01840/suppl_file/jm6b01840_si_002.csv">jm6b01840_si_002.csv (3.43 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-5%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b01840%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b01840" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677a81ad9a5822a8","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
